# ===========================================================================
#
#                            PUBLIC DOMAIN NOTICE
#               National Center for Biotechnology Information
#
#  This software/database is a "United States Government Work" under the
#  terms of the United States Copyright Act.  It was written as part of
#  the author's official duties as a United States Government employee and
#  thus cannot be copyrighted.  This software/database is freely available
#  to the public for use. The National Library of Medicine and the U.S.
#  Government have not placed any restriction on its use or reproduction.
#
#  Although all reasonable efforts have been taken to ensure the accuracy
#  and reliability of the software and data, the NLM and the U.S.
#  Government do not and cannot warrant the performance or results that
#  may be obtained by using this software or data. The NLM and the U.S.
#  Government disclaim all warranties, express or implied, including
#  warranties of performance, merchantability or fitness for any particular
#  purpose.
#
#  For daily update, we screen the search results of this PubMed query:
#  "coronavirus"[All Fields] OR "ncov"[All Fields] OR "cov"[All Fields] OR
#  "2019-nCoV"[All Fields] OR "COVID-19"[All Fields] OR "SARS-CoV-2"[All Fields].
#  Relevant articles are identified and curated with assistance from an automated
#  machine-learning and text-classification algorithm.
#
#  Please cite the authors in any work or product based on this material :
#
#  Chen Q, Allot A, & Lu Z. (2020) Keep up with the latest coronavirus research, Nature 579:193
#
#  Chen Q, Allot A, Lu Z. LitCovid: an open database of COVID-19 literature. Nucleic Acids Research. 2020.
#
# ==========================================================================
pmid	title_e	journal
36254542	Current Knowledge on Psoriasis During the Covid-19 Pandemic.	Acta Dermatovenerol Croat
36253996	Changes of ACE2 in different glucose metabolites and its relationship with COVID-19.	Medicine (Baltimore)
36251675	Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection.	PLoS One
36251583	Testosterone in males with COVID-19: A twelve-month cohort study.	Andrology
36250840	Comparison of Cytokine Hemadsorption as an Immunomodulator Therapy in COVID-19 Patients with and without Bacterial Sepsis.	Clin Lab
36250102	Cytokine levels as predictors of mortality in critically ill patients with severe COVID-19 pneumonia: Case-control study nested within a cohort in Colombia.	Front Med (Lausanne)
36249762	Potential therapeutic strategies for quercetin targeting critical pathological mechanisms associated with colon adenocarcinoma and COVID-19.	Front Pharmacol
36248863	Phosphate and IL-10 concentration as predictors of long-covid in hemodialysis patients: A Brazilian study.	Front Immunol
36248831	Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1beta associate with COVID-19 fatal outcome: A cross-sectional analysis.	Front Immunol
36248791	Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern.	Front Immunol
36248417	Yoga, Meditation, Breathing Exercises, and Inflammatory Biomarkers with Possible Implications in COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.	Evid Based Complement Alternat Med
36248407	Efficacy and Safety of Convalescence Plasma Therapy in COVID-19 Patients: A Systematic Review and Meta-Analysis.	Evid Based Complement Alternat Med
36248353	The relationship between C-reactive protein and levels of various cytokines in patients with COVID-19: A systematic review and correlation analysis.	Health Sci Rep
36248324	Cytokine release syndrome in a patient with non-small cell lung cancer on ipilimumab and nivolumab maintenance therapy after vaccination with the mRNA-1273 vaccine: a case report.	Transl Lung Cancer Res
36242922	Thrombopoietin participates in platelet activation in COVID-19 patients.	EBioMedicine
36238303	Prophylactic treatment of Glycyrrhiza glabra mitigates COVID-19 pathology through inhibition of pro-inflammatory cytokines in the hamster model and NETosis.	Front Immunol
36238287	Time evolution of cytokine profiles associated with mortality in COVID-19 hospitalized patients.	Front Immunol
36238275	OX40 agonist stimulation increases and sustains humoral and cell-mediated responses to SARS-CoV-2 protein and saRNA vaccines.	Front Immunol
36237645	A Plague of Their Own: Injury Incidence Remains Elevated in the 2021 Major League Baseball Season Compared to Pre-COVID-19 Seasons.	Int J Sports Phys Ther
36233840	Age- and Severity-Associated Humoral Immunity Response in COVID-19 Patients: A Cohort Study from Wuhan, China.	J Clin Med
36232891	Evaluation of Free Light Chains (FLCs) Synthesis in Response to Exposure to SARS-CoV-2.	Int J Mol Sci
36230921	Neuroinflammation in Dementia-Therapeutic Directions in a COVID-19 Pandemic Setting.	Cells
36225915	Low baseline IFN-gamma response could predict hospitalization in COVID-19 patients.	Front Immunol
36223617	Survival of critically ill patients with COVID-19 pneumonia-a single-center experience.	J Infect Dev Ctries
36222965	The intercorrelations between blood levels of ferritin, sCD163, and IL-18 in COVID-19 patients and their association to prognosis.	Immunol Res
36222560	The American Society for Clinical Pathology's 2021 Wage Survey of Medical Laboratories in the United States.	Am J Clin Pathol
36221980	Evaluation of simple laboratory parameters in SARS-CoV-2 infection: the role of ratios.	Infect Dis (Lond)
36220879	Galectin-3 binding protein stimulated IL-6 expression is impeded by antibody intervention in SARS-CoV-2 susceptible cell lines.	Sci Rep
36220753	Impact of SARS-CoV-2 infection on the profiles and responses of innate immune cells after recovery.	J Microbiol Immunol Infect
36219652	Circulating tumor necrosis factor receptors are associated with mortality and disease severity in COVID-19 patients.	PLoS One
36219583	alpha2,6-Sialylation Is Upregulated in Severe COVID-19, Implicating the Complement Cascade.	ACS Infect Dis
36215001	SARS-CoV-2 Variants Show a Gradual Declining Pathogenicity and Pro-Inflammatory Cytokine Stimulation, an Increasing Antigenic and Anti-Inflammatory Cytokine Induction, and Rising Structural Protein Instability: A Minimal Number Genome-Based Approach.	Inflammation
36214307	Bioinformatics analysis to identify intersection genes, associated pathways and therapeutic drugs between COVID-19 and Oral candidiasis.	Comb Chem High Throughput Screen
36213654	Case report: Treatment of long COVID with a SARS-CoV-2 antiviral and IL-6 blockade in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence.	Front Med (Lausanne)
36213639	Mesenchymal stem cell therapy on top of triple therapy with remdesivir, dexamethasone, and tocilizumab improves PaO2/FiO2 in severe COVID-19 pneumonia.	Front Med (Lausanne)
36213093	Panax ginseng as a potential therapeutic for neurological disorders associated with COVID-19; Toward targeting inflammasome.	J Ginseng Res
36211634	The potential molecular implications of adiponectin in the evolution of SARS-CoV-2: Inbuilt tendency.	J King Saud Univ Sci
36211483	Effects of physical distancing by COVID-19 pandemic on diet quality, neurological and immunological markers, and fecal microbiota of Brazilian older women.	Front Nutr
36211429	Bioinformatics and systems-biology analysis to determine the effects of Coronavirus disease 2019 on patients with allergic asthma.	Front Immunol
36211417	Immunogenicity and safety of the booster BNT162b2 vaccine in patients with axial spondyloarthritis treated with biological disease-modifying drugs.	Front Immunol
36211365	Kynurenine serves as useful biomarker in acute, Long- and Post-COVID-19 diagnostics.	Front Immunol
36209833	Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2.	Life Sci
36209721	IL-6, IL-10, sFas, granulysin and indicators of intestinal permeability as early biomarkers for a fatal outcome in COVID-19.	Immunobiology
36209522	Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications.	EBioMedicine
36206622	Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2.	EBioMedicine
36206503	Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion.	Blood
36203752	Difference in mortality rates in hospitalized COVID-19 patients identified by cytokine profile clustering using a machine learning approach: An outcome prediction alternative.	Front Med (Lausanne)
36202985	A novel vaccine based on SARS-CoV-2 CD4(+) and CD8(+) T cell conserved epitopes from variants Alpha to Omicron.	Sci Rep
36200898	Superinfection with SARS-CoV-2 Has Deleterious Effects on Mycobacterium bovis BCG Immunity and Promotes Dissemination of Mycobacterium tuberculosis.	Microbiol Spectr
36200522	Pilot Study on the Impact of a Home-Based Exercise Program on Inflammatory Cytokines and Quality of Life in Men with Prostate Cancer Under Active Surveillance.	Cancer Control
36199719	Inflammatory Aseptic Arthropathy in the Setting of COVID-19: A Case Report.	J Orthop Case Rep
36190386	Labor Could Increase Systemic Inflammation and Cause or Deteriorate Cytokine Storm in COVID-19.	Iran J Immunol
36190384	The Chemokine MIG is Associated with an Increased Risk of COVID-19 Mortality in Mexican Patients.	Iran J Immunol
36189576	IL-4 receptor blockade is a global repressor of naive B cell development and responses in a dupilumab-treated patient.	Clin Immunol
36189286	Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.	Front Immunol
36188605	Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments.	Front Pharmacol
36186213	Clinical efficacy analysis of mesenchymal stem cell therapy in patients with COVID-19: A systematic review.	World J Clin Cases
36185969	SARS-CoV-2 vaccine booster in solid organ transplant recipients previously immunised with inactivated versus mRNA vaccines: A prospective cohort study.	Lancet Reg Health Am
36185918	Biochemical Parameters as Prognostic Markers in Severely Ill COVID-19 Patients.	Cureus
36185750	Cytokine nanosponges suppressing overactive macrophages and dampening systematic cytokine storm for the treatment of hemophagocytic lymphohistiocytosis.	Bioact Mater
36184636	Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa.	BMC Med
36181744	Porcine deltacoronavirus E protein induces interleukin-8 production via NF-kappaB and AP-1 activation.	Vet Microbiol
36181009	Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial.	Medicine (Baltimore)
36179036	Can the Prognosis of COVID-19 Disease Be Determined by Fecal Markers and Cytokines?	J Interferon Cytokine Res
36177957	NLRP3-inflammasome activation in male reproductive system diseases.	Minerva Endocrinol (Torino)
36177032	SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-kappaB signaling.	Front Immunol
36176878	Assessment of Awareness and Preparedness About COVID-19 for Oncology Nurses in Saudi Arabia.	Cureus
36176597	Simultaneous detection of sepsis host response biomarkers in whole blood using electrochemical biosensor.	Bioeng Transl Med
36176568	Effects of yoga practice on physiological distress, fatigue and QOL in patients affected by breast cancer undergoing adjuvant radiotherapy.	Tech Innov Patient Support Radiat Oncol
36175845	Effects of growth hormone/estrogen/androgen on COVID-19-type proinflammatory responses in normal human lung epithelial BEAS-2B cells.	BMC Mol Cell Biol
36174875	Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health.	Biochim Biophys Acta Mol Basis Dis
36174772	Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody.	Immunol Lett
36173315	Interaction of HDAC2 with SARS-CoV-2 NSP5 and IRF3 Is Not Required for NSP5-Mediated Inhibition of Type I Interferon Signaling Pathway.	Microbiol Spectr
36171158	Day-to-day impact of COVID-19 and other factors associated with risk of nonfatal overdose among people who use unregulated drugs in five cities in the United States and Canada.	Drug Alcohol Depend
36168944	IL-6 signaling in acute exercise and chronic training: Potential consequences for health and athletic performance.	Scand J Med Sci Sports
36166453	Paradoxical improvement of life quality in the COVID-19 era in psoriasis patients.	PLoS One
36165862	The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial.	Microb Pathog
36165196	Coronavirus Lung Infection Impairs Host Immunity against Secondary Bacterial Infection by Promoting Lysosomal Dysfunction.	J Immunol
36165097	Hybrid and vaccine-induced immunity against SAR-CoV-2 in MS patients on different disease-modifying therapies.	Ann Clin Transl Neurol
36163397	Upregulation of interleukin-19 in saliva of patients with COVID-19.	Sci Rep
36162047	Parental Perceptions of Service Access for Transition-Aged Youth With Autism During COVID-19.	Intellect Dev Disabil
36161599	Evaluation of clinical and laboratory findings in severe group COVID-19 pregnants without comorbidity.	Turk J Med Sci
36161598	Effect of tocilizumab on intensive care patients with Covid-19 pneumonia, a retrospective cohort study.	Turk J Med Sci
36160747	Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression.	World J Gastrointest Oncol
36160152	Randomized double-blind clinical study in patients with COVID-19 to evaluate the safety and efficacy of a phytomedicine (P2Et).	Front Med (Lausanne)
36160151	Behcet uveitis: Current practice and future perspectives.	Front Med (Lausanne)
36159872	PD-1 and ICOS counter-regulate tissue resident regulatory T cell development and IL-10 production during flu.	Front Immunol
36159845	Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity.	Front Immunol
36157452	Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.	Front Endocrinol (Lausanne)
36157132	Interleukin-6 (IL-6) expression of lung tissue in COVID-19 patient severity through core biopsy post mortem.	Ann Med Surg (Lond)
36155902	Beneficial of adding Tocilizumab to standard care in critical forms of Covid-19 pneumonia: Study on paired series.	Tunis Med
36155191	Human gut microbiota and its metabolites impact immune responses in COVID-19 and its complications.	Gastroenterology
36152702	A SARS-CoV-2 vaccine based on conjugation of SARS-CoV-2 RBD with IC28 peptide and mannan.	Int J Biol Macromol
36148243	IL27 gene expression distinguishes multisystem inflammatory syndrome in children from febrile illness in a South African cohort.	Front Immunol
36148234	Longitudinal profiles of plasma gelsolin, cytokines and antibody expression predict COVID-19 severity and hospitalization outcomes.	Front Immunol
36148228	Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy.	Front Immunol
36148163	MIS-C related to SARS-CoV-2 infection: a narrative review of presentation, differential diagnosis, and management.	Infez Med
36147356	Cytokine storm-calming property of the isoquinoline alkaloids in Coptis chinensis Franch.	Front Pharmacol
36146713	Heterogenous CD8+ T Cell Maturation and 'Polarization' in Acute and Convalescent COVID-19 Patients.	Viruses
36146627	Lymphocyte Subpopulations Associated with Neutralizing Antibody Levels of SARS-CoV-2 for COVID-19 Vaccination.	Vaccines (Basel)
36143354	SARS-CoV-2 and HIV: Impact on Pulmonary Epithelial Cells.	Life (Basel)
36142454	The Role of Matrix Metalloproteinase in Inflammation with a Focus on Infectious Diseases.	Int J Mol Sci
36142336	Inflammatory Biomarkers Associated with In-Hospital Mortality in Critical COVID-19 Patients.	Int J Mol Sci
36142258	Hesperetin from Root Extract of Clerodendrum petasites S. Moore Inhibits SARS-CoV-2 Spike Protein S1 Subunit-Induced NLRP3 Inflammasome in A549 Lung Cells via Modulation of the Akt/MAPK/AP-1 Pathway.	Int J Mol Sci
36142255	Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients.	Int J Mol Sci
36140490	Chest CT Severity Score and Systemic Inflammatory Biomarkers as Predictors of the Need for Invasive Mechanical Ventilation and of COVID-19 Patients' Mortality.	Diagnostics (Basel)
36140425	The JAK1/2 Inhibitor Baricitinib Mitigates the Spike-Induced Inflammatory Response of Immune and Endothelial Cells In Vitro.	Biomedicines
36139625	Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination.	Cancers (Basel)
36139488	SARS-CoV-2 Infection of Airway Epithelium Triggers Pulmonary Endothelial Cell Activation and Senescence Associated with Type I IFN Production.	Cells
36139476	Dysregulated Neutrophil Phenotype and Function in Hospitalised Non-ICU COVID-19 Pneumonia.	Cells
36137590	Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms.	Eur Respir J
36136963	Interleukin-17, a salivary biomarker for COVID-19 severity.	PLoS One
36134024	The role of ACE1 I/D and ACE2 polymorphism in the outcome of Iranian COVID-19 patients: A case-control study.	Front Genet
36131937	Autoantibodies elicited with SARS-CoV-2 infection are linked to alterations in double negative B cells.	Front Immunol
36131504	The effects of consuming a Mediterranean style diet on associated COVID-19 severity biomarkers in obese/overweight adults: A systematic review.	Nutr Health
36131342	Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system.	Cardiovasc Diabetol
36130012	IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination.	N Engl J Med
36129990	Electrochemiluminescence in paired signal electrode (ECLipse) enables modular and scalable biosensing.	Sci Adv
36129193	Virus-Like Particles of SARS-CoV-2 as Virus Surrogates: Morphology, Immunogenicity, and Internalization in Neuronal Cells.	ACS Infect Dis
36128334	Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trial.	EClinicalMedicine
36128218	SARS-CoV-2 infection of human pluripotent stem cell-derived liver organoids reveals potential mechanisms of liver pathology.	iScience
36125288	Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses.	Microbiol Spectr
36123778	The impact of maternal SARS-CoV-2 vaccination and first trimester infection on feto-maternal immune responses.	Am J Reprod Immunol
36123740	Immune-inflammatory biomarkers and the risk of cardiac injury in COVID-19 patients with diabetes: a retrospective cohort study.	Cardiovasc Diabetol
36122756	Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function.	Eur J Pharmacol
36121927	The immunological role of B7-H4 in pregnant women with Sars-Cov2 infection.	Am J Reprod Immunol
36121875	Multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS.	PLoS Pathog
36121504	Coagulopathy during COVID-19 infection: a brief review.	Clin Exp Med
36119092	COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19.	Front Immunol
36116582	Deep immunophenotyping reveals biomarkers of MIS-C in a Latin American cohort.	J Allergy Clin Immunol
36116160	Redox imbalance in COVID-19 pathophysiology.	Redox Biol
36112183	Assessment of Association Between the Potential Immunomodulatory Activity and Drinking Olive Leaf Tea in the Coronavirus Disease-2019 Pandemic: An Observational Study.	J Integr Complement Med
36111789	Elevated IL-18 predicts poor prognosis in critically ill COVID-19 patients at a Brazilian hospital in 2020-21.	Future Microbiol
36111104	COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy.	Front Med (Lausanne)
36111072	Incessant pericarditis following the second dose of SARS-CoV-2 mRNA vaccine successfully treated with anakinra: a case report.	Eur Heart J Case Rep
36110852	The multifaceted roles of NLRP3-modulating proteins in virus infection.	Front Immunol
36110850	Immune modulation as a consequence of SARS-CoV-2 infection.	Front Immunol
36109525	SARS-CoV-2 pneumonia and bacterial pneumonia patients differ in a second hit immune response model.	Sci Rep
36107502	Deciphering SARS CoV-2-associated pathways from RNA sequencing data of COVID-19-infected A549 cells and potential therapeutics using in silico methods.	Medicine (Baltimore)
36106521	The Modulatory Action of C-Vx Substance on the Immune System in COVID-19.	Emerg Microbes Infect
36106257	Mortality and Its Predictors in COVID-19 Patients With Pre-existing Interstitial Lung Disease.	Cureus
36105747	Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response.	Oncoimmunology
36104868	Dupilumab use is associated with protection from COVID-19 mortality: A retrospective analysis.	Clin Infect Dis
36104785	The CHARTER-Ireland trial: can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: a study protocol and statistical analysis plan for a randomised control trial.	Trials
36104754	Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with progression to severe disease in hospitalized COVID-19.	Crit Care
36104292	A biomarker assay to risk-stratify patients with symptoms of respiratory tract infection.	Eur Respir J
36104115	Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination.	RMD Open
36102684	Distinct Immune Phenotypes and Cytokine Profiles in Children with Differing Severity of COVID-19.	Pediatr Infect Dis J
36101705	Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients.	Commun Med (Lond)
36101327	Cytokine Profiling among Children with Multisystem Inflammatory Syndrome versus Simple COVID-19 Infection: A Study from Northwest Saudi Arabia.	Biology (Basel)
36100803	Formation and activity of NLRP3 inflammasome and histopathological changes in the lung of corpses with COVID-19.	J Mol Histol
36100326	Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.	J Adv Res
36097511	Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice.	ACS Omega
36097300	Association between chemosensory dysfunctions and inflammatory biomarkers in patients with SARS-CoV-2 infection: a systematic review and meta-analysis.	Inflammopharmacology
36094915	Evaluating immunohaematological profile among COVID-19 active infection and recovered patients in Ghana.	PLoS One
36093318	Continuous renal replacement therapy using a cellulose triacetate hemofilter for severe coronavirus disease.	Ren Replace Ther
36093302	Interleukin-1/6 Blockade for the Treatment of Severe Steroid-Refractory BNT162b2 Vaccine-Induced Adult-Onset Still's Disease.	Eur J Case Rep Intern Med
36091800	Immune-related adverse events of biological immunotherapies used in COVID-19.	Front Pharmacol
36091684	Immunomodulatory effects of new phytotherapy on human macrophages and TLR4- and TLR7/8-mediated viral-like inflammation in mice.	Front Med (Lausanne)
36091037	The effects of nutrition bio-shield superfood powder on immune system function: A clinical trial study among patients with COVID-19.	Front Immunol
36090995	Regulated necrosis in COVID-19: A double-edged sword.	Front Immunol
36090762	Strategies for Cardio-Oncology Care During the COVID-19 Pandemic.	Curr Treat Options Cardiovasc Med
36090585	Down-regulation of RdRp complex and activated immune response due to increased arsenic level leads to decreased corona virus replication.	Curr Res Microb Sci
36090302	Role of Matrix Degradation, Oxidative Stress, Inflammation & Trace Elements in COVID-19 Patients: A Multivariate Study from India.	Indian J Clin Biochem
36089786	Cytokine storm and neuropathological alterations in patients with neurological manifestations of COVID-19.	Curr Alzheimer Res
36088825	Association of TNF-alpha, TGF-beta1, amphiregulin, IL-2, and EGFR WITH pulmonary fibrosis in COVID-19.	J Infect Public Health
36084236	Palmitoylethanolamide Reduces Proinflammatory Markers in Unvaccinated Adults Recently Diagnosed with COVID-19: A Randomized Controlled Trial.	J Nutr
36084120	The complexity of examining laboratory-based biological markers associated with mortality in hospitalized patients during early phase of the COVID-19 pandemic: A systematic review and evidence map.	PLoS One
36081604	Hsa_circ_0000479/Hsa-miR-149-5p/RIG-I, IL-6 Axis: A Potential Novel Pathway to Regulate Immune Response against COVID-19.	Can J Infect Dis Med Microbiol
36078552	The Evolving Scenario of COVID-19 in Hemodialysis Patients.	Int J Environ Res Public Health
36078151	Immune Determinants of Viral Clearance in Hospitalised COVID-19 Patients: Reduced Circulating Naive CD4+ T Cell Counts Correspond with Delayed Viral Clearance.	Cells
36077133	The Severity of COVID-19 Affects the Plasma Soluble Levels of the Immune Checkpoint HLA-G Molecule.	Int J Mol Sci
36076574	Oral IRAK4 inhibitor BAY-1834845 prevents acute respiratory distress syndrome.	Biomed Pharmacother
36076568	Early reduction of estimated Glomerular Filtration Rate (eGFR) predicts poor outcome in acutely ill hospitalized COVID-19 patients firstly admitted to medical regular wards (eGFR-COV19 study).	Biomed Pharmacother
36075894	IFITM3 restricts virus-induced inflammatory cytokine production by limiting Nogo-B mediated TLR responses.	Nat Commun
36075200	Effect of Hemadsorption Therapy in Critically Ill Patients with COVID-19 (CYTOCOV-19): A Prospective Randomized Controlled Pilot Trial.	Blood Purif
36071720	Successful treatment of severe COVID-19 pneumonia, a case series with simultaneous interleukin-1 and interleukin-6 blockade with 1-month follow-up.	Ther Adv Musculoskelet Dis
36070177	Electrolyte imbalances as poor prognostic markers in COVID-19: a systemic review and meta-analysis.	J Endocrinol Invest
36069561	B.1.351 SARS-CoV-2 Variant Exhibits Higher Virulence but Less Viral Shedding than That of the Ancestral Strain in Young Nonhuman Primates.	Microbiol Spectr
36068809	Mucosal Immunity After Novel COVID-19 Infection - Virus-Induced Immunosuppression: Preliminary Study.	Bionanoscience
36068482	The Opioid Epidemic: a Crisis Disproportionately Impacting Black Americans and Urban Communities.	J Racial Ethn Health Disparities
36068454	Variability in Opioid-Related Drug Overdoses, Social Distancing, and Area-Level Deprivation during the COVID-19 Pandemic: a Bayesian Spatiotemporal Analysis.	J Urban Health
36066491	Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting FcepsilonRIgamma expression.	J Exp Med
36066033	Increased Endotoxin Activity in COVID-19 Patients Admitted to the Intensive Care Unit.	J Intensive Care Med
36064560	The impact of the COVID-19 pandemic on stress and other psychological factors in pregnant women giving birth during the first wave of the pandemic.	Reprod Health
36064077	Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis.	Pharmacol Res
36059840	Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection.	Front Med (Lausanne)
36059717	A silver lining for pandemic-weary libraries: How blended and flipped instructional programs have improved upon pre-pandemic norms.	
36058954	Comparison of two porcine acute lung injury models: a post-hoc analysis.	Intensive Care Med Exp
36058151	The landscape of potential health benefits of carotenoids as natural supportive therapeutics in protecting against Coronavirus infection.	Biomed Pharmacother
36057230	IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in Sweden.	Cytokine
36056419	Infliximab in the treatment of patients with severe COVID-19 (INFLIXCOVID): protocol for a randomised, controlled, multicentre, open-label phase II clinical study.	Trials
36052305	Real-World Evidence for COVID-19 Delta Variant's Effects on the Digestive System and Protection of Inactivated Vaccines from a Medical Center in Yangzhou, China: A Retrospective Observational Study.	Int J Clin Pract
36052094	COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic molds.	Front Immunol
36052060	High baseline expression of IL-6 and IL-10 decreased CCR7 B cells in individuals with previous SARS-CoV-2 infection during BNT162b2 vaccination.	Front Immunol
36052011	AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized controlled intervention trial.	Front Public Health
36051596	SARS-CoV-2 consequences for mental health: Neuroinflammatory pathways linking COVID-19 to anxiety and depression.	World J Psychiatry
36050507	Lycopene: a therapeutic strategy against coronavirus disease 19 (COVID- 19).	Inflammopharmacology
36050226	Blood-brain Barrier Damage is Pivotal for SARS-CoV-2 Infection to the Central Nervous System.	Exp Neurobiol
36048462	Clinico-Laboratory Profile, Intensive Care Needs and Short-Term Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience during First and Second Waves from North India.	J Trop Pediatr
36046941	Immunotherapy in atopic dermatitis.	Immunotherapy
36046347	Early Experience With Interleukin-6 Receptor Antagonists in Patients With COVID-19 Admitted to a Community Hospital.	J Pharm Technol
36045873	Lack of Correlation Between Soluble Angiotensin-Converting Enzyme 2 and Inflammatory Markers in Hospitalized COVID-19 Patients with Hypertension.	Infect Drug Resist
36045688	Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study.	Front Immunol
36045686	A novel virotherapy encoding human interleukin-7 improves ex vivo T lymphocyte functions in immunosuppressed patients with septic shock and critically ill COVID-19.	Front Immunol
36045684	Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection.	Front Immunol
36043737	Therapeutic Role of Phytophenol Gallic Acid for the Cure of COVID-19 Pathogenesis.	Endocr Metab Immune Disord Drug Targets
36043698	A New iNKT-Cell Agonist-Adjuvanted SARS-CoV-2 Subunit Vaccine Elicits Robust Neutralizing Antibody Responses.	ACS Infect Dis
36042952	Analysis of cardiovascular disease factors on SARS-CoV-2 infection severity.	Med Clin (Engl Ed)
36042407	The Mann-Kendall-Sneyers test to identify the change points of COVID-19 time series in the United States.	BMC Med Res Methodol
36041645	Diagnostic value of serum KL-6 and IL-6 levels in critically ill patients with COVID-19-associated pneumonia.	J Infect
36041220	Acute vaping of a golden Syrian hamster causes inflammatory response transcriptomic changes.	Am J Physiol Lung Cell Mol Physiol
36040905	Health professional students at the University of Illinois Chicago (HOLISTIC) Cohort Study: A protocol.	PLoS One
36038262	Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis.	Neurol Neuroimmunol Neuroinflamm
36035415	The radiographic assessment of lung edema score of lung edema severity correlates with inflammatory parameters in patients with coronavirus disease 2019-Potential new admission biomarkers to predict coronavirus disease 2019 worsening.	Front Med (Lausanne)
36035409	Impaired tryptophan metabolism in the gastrointestinal tract of patients with critical coronavirus disease 2019.	Front Med (Lausanne)
36034662	Complanatuside alleviates inflammatory cell damage induced by pro-inflammatory cytokines in skin keratinocytes.	Front Chem
36034073	Sweetness and positivity together aren't a happy ending: Case controlled study amongst severe COVID-19 for impact of diabetes mellitus on survival.	Med J Armed Forces India
36033647	Supply Chain Disruptions During COVID-19 Pandemic Uncover Differences in Keratinocyte Culture Media.	JID Innov
36032561	Circulating Cell-Free DNA Level in Prediction of COVID-19 Severity and Mortality: Correlation of with Haematology and Serum Biochemical Parameters.	Indian J Clin Biochem
36032109	Ginsenoside Rg5 allosterically interacts with P2RY12 and ameliorates deep venous thrombosis by counteracting neutrophil NETosis and inflammatory response.	Front Immunol
36030048	Preparation and pre-clinical evaluation of flagellin-adjuvanted NOM vaccine candidate formulated with Spike protein against SARS-CoV-2 in mouse model.	Microb Pathog
36029799	Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.	Lancet Respir Med
36029180	Efficacy of tocilizumab in the treatment of COVID-19: An umbrella review.	Rev Med Virol
36028776	Epicardial adipose tissue volume and CT-attenuation as prognostic factors for pulmonary embolism and mortality in critically ill patients affected by COVID-19.	Eur J Clin Nutr
36028456	Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients.	Vaccine
36028169	Vitamin D modulates systemic inflammation in patients with severe COVID-19.	Life Sci
36018450	Anakinra in pediatric acute fulminant myocarditis.	Ann Intensive Care
36018446	Multisystem inflammatory syndrome in children: clinical presentation, management, and short- and long-term outcomes.	Clin Rheumatol
36016660	Inflammatory-Metal Profile as a Hallmark for COVID-19 Severity During Pregnancy.	Front Cell Dev Biol
36016579	Clinical and epidemiological investigation of a child with asymptomatic COVID-19 infection following reoccurrence.	Health Inf Sci Syst
36016311	Regulatory T Cells Decreased during Recovery from Mild COVID-19.	Viruses
36016235	Cellular and Humoral Immunity against Different SARS-CoV-2 Variants Is Detectable but Reduced in Vaccinated Kidney Transplant Patients.	Vaccines (Basel)
36015163	Efficacy of Kan Jang((R)) in Patients with Mild COVID-19: Interim Analysis of a Randomized, Quadruple-Blind, Placebo-Controlled Trial.	Pharmaceuticals (Basel)
36012968	Application of Machine Learning in Hospitalized Patients with Severe COVID-19 Treated with Tocilizumab.	J Clin Med
36012579	Nebulized Non-Immunogenic Staphylokinase in the Mice Acute Lung Injury Model.	Int J Mol Sci
36012469	Epipharyngeal Abrasive Therapy (EAT) Reduces the mRNA Expression of Major Proinflammatory Cytokine IL-6 in Chronic Epipharyngitis.	Int J Mol Sci
36012323	A Comparative Study of the Plasma Chemokine Profile in COVID-19 Patients Infected with Different SARS-CoV-2 Variants.	Int J Mol Sci
36012146	Cytokine Storm Signature in Patients with Moderate and Severe COVID-19.	Int J Mol Sci
36011997	Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways.	Int J Environ Res Public Health
36006851	Inverse relationship between IL-6 and sodium levels in patients with COVID-19 and other respiratory tract infections: data from the COVIVA study.	Endocr Connect
36005818	Immunological and Pathological Peculiarity of Severe Acute Respiratory Syndrome Coronavirus 2 Beta Variant.	Microbiol Spectr
36004663	COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis.	Brain
36002086	Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-kappaB to alleviate LPS-induced ALI.	J Ethnopharmacol
36001576	Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study.	PLoS One
35998203	Human coronaviruses disassemble processing bodies.	PLoS Pathog
35997599	Expression Pattern of Inflammatory and Anti-Inflammatory Cytokines and Key Differential Transcription Factors in Peripheral Blood Mononuclear Cells of Iranian Coronavirus Disease 2019 Patients with Different Disease Severity.	Viral Immunol
35996823	Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic: A Pilot Randomized Controlled Trial.	Can J Psychiatry
35993660	COVID-19 disease induced alteration of oxidative stress and clinical laboratory parameters in moderate and severe patients.	Eur Rev Med Pharmacol Sci
35993658	Levosimendan for acute right heart failure in COVID-19: another arrow in our quiver?	Eur Rev Med Pharmacol Sci
35992697	Network pharmacology and molecular docking-based investigations of Kochiae Fructus's active phytomolecules, molecular targets, and pathways in treating COVID-19.	Front Microbiol
35992174	NOTCH signaling in COVID-19: a central hub controlling genes, proteins, and cells that mediate SARS-CoV-2 entry, the inflammatory response, and lung regeneration.	Front Cell Infect Microbiol
35991270	Study on the correlations of different clinical types with imaging findings at initial diagnosis and clinical laboratory indexes in COVID-19 patients.	Pak J Med Sci
35990701	Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies.	Front Immunol
35989498	Celastrol: A lead compound that inhibits SARS-CoV-2 replication, the activity of viral and human cysteine proteases, and virus-induced IL-6 secretion.	Drug Dev Res
35989496	Upregulation of hsa_circ_0004812 promotes COVID-19 cytokine storm via hsa-miR-1287-5p/IL6R, RIG-I axis.	J Clin Lab Anal
35986143	SARS CoV-2 detected in neonatal stool remote from maternal COVID-19 during pregnancy.	Pediatr Res
35982898	Interplay of LncRNAs NEAT1 and TUG1 in Incidence of Cytokine Storm in Appraisal of COVID-19 Infection.	Int J Biol Sci
35980979	Excessive neutrophil recruitment promotes typical T-helper 17 responses in Coronavirus disease 2019 patients.	PLoS One
35980161	Systemic redox imbalance in severe COVID-19 patients.	Cell Biochem Funct
35979935	Serum-derived extracellular vesicles: Novel biomarkers reflecting the disease severity of COVID-19 patients.	J Extracell Vesicles
35979361	Robust humoral and cellular immune responses in long-term convalescent COVID-19 individuals following one-dose SARS-CoV-2 inactivated vaccination.	Front Immunol
35975206	Designing multi-epitope based peptide vaccine candidates against SARS-CoV-2 using immunoinformatics approach.	Bioimpacts
35974882	Chest X-ray Findings and Hyponatremia in COVID-19 Pneumonia Patients.	Qatar Med J
35973581	Formation of eicosanoids and other oxylipins in human macrophages.	Biochem Pharmacol
35971974	mRNA-carrying lipid nanoparticles that induce lysosomal rupture activate NLRP3 inflammasome and reduce mRNA transfection efficiency.	Biomater Sci
35971342	Assessment of SARS-CoV-2-Infected Patients and Their Clinical Outcomes During the Third Wave in India: A Single-Center Observational Study.	Cureus
35969896	Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach.	Int Immunopharmacol
35967401	The role of interleukin-22 in lung health and its therapeutic potential for COVID-19.	Front Immunol
35967328	Multiplex protein profiling of bronchial aspirates reveals disease-, mortality- and respiratory sequelae-associated signatures in critically ill patients with ARDS secondary to SARS-CoV-2 infection.	Front Immunol
35967323	Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation.	Front Immunol
35967321	Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave.	Front Immunol
35967091	Elevated Salivary Inflammatory Biomarkers are Associated with SARS-CoV-2 Infection Severity.	Can J Infect Dis Med Microbiol
35966540	Population-wide persistent hemostatic changes after vaccination with ChAdOx1-S.	Front Cardiovasc Med
35965490	Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact.	Immunother Adv
35964413	IL-6 drives T cell death to participate in lymphopenia in COVID-19.	Int Immunopharmacol
35964130	Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases.	Pediatr Rheumatol Online J
35963320	Complete and simultaneous removal of ionic silver and silver nanoparticles by using an ionic liquid supported on a magnetic nanoparticle core.	Environ Res
35962798	Proteomic analysis and identification reveal the anti-inflammatory mechanism of clofazimine on lipopolysaccharide-induced acute lung injury in mice.	Inflamm Res
35962146	Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents.	Commun Biol
35960307	Analysis of Chitinase-3-Like Protein 1, IL-1-Alpha, and IL-6 as Novel Inflammatory Biomarkers for COVID-19.	J Interferon Cytokine Res
35960239	[Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine].	Mikrobiyol Bul
35959207	Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial.	Open Forum Infect Dis
35958623	The effect of reparixin on survival in patients at high risk for in-hospital mortality: a meta-analysis of randomized trials.	Front Immunol
35958594	Inflammatory mediators profile in patients hospitalized with COVID-19: A comparative study.	Front Immunol
35958514	Quantitative chest computed tomography combined with plasma cytokines predict outcomes in COVID-19 patients.	Heliyon
35955801	Angiotensin II Exaggerates SARS-CoV-2 Specific T-Cell Response in Convalescent Individuals following COVID-19.	Int J Mol Sci
35953688	Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection.	Inflammation
35953544	A disturbed balance between blood complement protective factors (FH, ApoE) and common pathway effectors (C5a, TCC) in acute COVID-19 and during convalesce.	Sci Rep
35953263	Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.	Ann Rheum Dis
35953030	An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen.	N Biotechnol
35952950	Imbalance between alpha-1-antitrypsin and interleukin 6 is associated with in-hospital mortality and thrombosis during COVID-19.	Biochimie
35952673	Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization.	Cell Rep
35951629	Tocilizumab treatment in COVID-19: A prognostic study using propensity score matching.	Adv Clin Exp Med
35950953	Detection of the Serum Cytokines Predicts COVID-19 Pathogenesis in Egyptian Patients.	Viral Immunol
35950101	Eosinophil Levels, Neutrophil-Lymphocyte Ratio, and Platelet-Lymphocyte Ratio in the Cytokine Storm Period of Patients with COVID-19.	Int J Clin Pract
35948250	Lidocaine reinforces the anti-inflammatory action of dexamethasone on myeloid and epithelial cells activated by inflammatory cytokines or SARS-CoV-2 infection.	Biomed J
35947634	Assessment of the educational value of endodontic access cavity preparation YouTube video as a learning resource for students.	PLoS One
35947596	Assessing the use of a micro-sampling device for measuring blood protein levels in healthy subjects and COVID-19 patients.	PLoS One
35946342	Advances in delivery methods of Arthrospira platensis (spirulina) for enhanced therapeutic outcomes.	Bioengineered
35946230	Characterizing the third wave of COVID-19: An analysis from the National Clinical Registry of COVID-19.	Indian J Med Res
35944880	Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: an Italian experience.	Clin Immunol
35943976	Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients.	Proc Natl Acad Sci U S A
35943810	NVX-CoV2373 vaccination induces functional SARS-CoV-2-specific CD4+ and CD8+ T cell responses.	J Clin Invest
35942358	Stratification of burnout in health-system pharmacists during the COVID-19 pandemic: A focus on the ambulatory care pharmacist.	J Am Coll Clin Pharm
35937954	Interleukin 6: A biomarker for COVID-19 progression.	Mater Today Proc
35936027	Surgical site infections in patients undergoing breast oncological surgery during the lockdown: An unexpected lesson from the COVID-19 pandemic.	G Chir
35935851	Treatment of COVID-19 Pneumonia and Acute Respiratory Distress With Ramatroban, a Thromboxane A2 and Prostaglandin D2 Receptor Antagonist: A Four-Patient Case Series Report.	Front Pharmacol
35935817	The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19.	Front Pharmacol
35935801	Severity and prognostic factors of SARS-CoV-2-induced pneumonia: The value of clinical and laboratory biomarkers and the A-DROP score.	Front Med (Lausanne)
35935705	Evaluation of perturbed iron-homeostasis in a prospective cohort of patients with COVID-19.	Wellcome Open Res
35933696	Exploring the role of Xingren on COVID-19 based on network pharmacology and molecular docking.	J Food Biochem
35933486	Whole blood DNA methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection.	Nat Commun
35932632	Inflammatory and thrombotic parameters associated with the COVID-19 course in Poland (SARSTer study).	Adv Med Sci
35932220	Enhanced Severe Acute Respiratory Syndrome Coronavirus 2 Antigen-Specific Systemic Immune Responses in Multisystem Inflammatory Syndrome in Children and Reversal After Recovery.	J Infect Dis
35930300	A Nutritional Blend Suppresses the Inflammatory Response from Bronchial Epithelial Cells Induced by SARS-CoV-2.	J Diet Suppl
35930243	The role of kidney injury biomarkers in COVID-19.	Ren Fail
35930194	Jacareubin inhibits TLR4-induced lung inflammatory response caused by the RBD domain of SARS-CoV-2 Spike protein.	Pharmacol Rep
35928823	Editorial: Importance of cytokines and receptor members from the IL-1 family in the context of chronic autoimmune inflammatory diseases.	Front Immunol
35928820	Optimisation of anti-interleukin-6 therapy: Precision medicine through mathematical modelling.	Front Immunol
35928816	The SARS-CoV-2 Nucleoprotein Induces Innate Memory in Human Monocytes.	Front Immunol
35928043	Cytokine Profile in Children with Severe Multisystem Inflammatory Syndrome Related to the Coronavirus Disease 2019.	J Pediatr Intensive Care
35924511	[Retrospective observation and analysis of autoimmune-related indicators in 317 patients with acute Omicron variant infection].	Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
35924510	[Clinical study of awake prone positioning treatment in patients with common coronavirus disease 2019 caused by Omicron variant].	Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
35921571	Pharmacotherapy of Acute COVID-19 Infection and Multisystem Inflammatory Syndrome in Children: Current State of Knowledge.	Pediatr Allergy Immunol Pulmonol
35919675	Severe coronavirus disease 2019 in a patient with TAFRO syndrome: A case report.	Clin Infect Pract
35918160	Prepandemic Alzheimer Disease Biomarkers and Anxious-Depressive Symptoms During the COVID-19 Confinement in Cognitively Unimpaired Adults.	Neurology
35917725	Prognostic significance of serum galectin-3 in hospitalized patients with COVID-19.	Cytokine
35916825	The SARS-CoV-2 rS1-E-PLGA nanovaccine and evaluation of its immune effect in BALB/c mice.	Eur Rev Med Pharmacol Sci
35915975	Association between inflammatory cytokines/chemokines, clinical laboratory parameters, disease severity and in-hospital mortality in critical and mild COVID-19 patients without comorbidities or immune-mediated diseases.	J Immunoassay Immunochem
35915094	mRNA vaccines induce rapid antibody responses in mice.	NPJ Vaccines
35914727	Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients.	Transplant Cell Ther
35911765	A Landscape Study on COVID-19 Immunity at the Single-Cell Level.	Front Immunol
35911743	SARS-CoV2 Infection During Pregnancy Causes Persistent Immune Abnormalities in Women Without Affecting the Newborns.	Front Immunol
35911642	Improvement of the inactivated SARS-CoV-2 vaccine potency through formulation in alum/naloxone adjuvant; Robust T cell and anti-RBD IgG responses.	Iran J Basic Med Sci
35907365	Acute kidney injury associated to COVID-19 leads to a strong unbalance of circulant immune mediators.	Cytokine
35907213	SURGICAL ISCHEMIC ASPECTS OF COVID-19: MANAGEMENT OF PATIENTS WITH COVID TOES AND FINGERS.	Wiad Lek
35905562	Current evidence on the use of anakinra in COVID-19.	Int Immunopharmacol
35901625	Immune system changes in those with hypertension when infected with SARS-CoV-2.	Cell Immunol
35901034	The percentage of CD39+ monocytes is higher in pregnant COVID-19+ patients than in nonpregnant COVID-19+ patients.	PLoS One
35900380	Long-term implications of COVID-19 on bone health: pathophysiology and therapeutics.	Inflamm Res
35899460	Propofol directly binds to and inhibits TLR7.	FASEB J
35898449	Prediabetes Induces More Severe Acute COVID-19 Associated With IL-6 Production Without Worsening Long-Term Symptoms.	Front Endocrinol (Lausanne)
35897800	Prognostic Role of sST2 in Acute Heart Failure and COVID-19 Infection-A Narrative Review on Pathophysiology and Clinical Prospective.	Int J Mol Sci
35896335	Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients.	J Immunol
35893398	Lymphocyte Population Changes at Two Time Points during the Acute Period of COVID-19 Infection.	J Clin Med
35893392	Correlation of Lung Damage on CT Scan with Laboratory Inflammatory Markers in COVID-19 Patients: A Single-Center Study from Romania.	J Clin Med
35891555	SARS-CoV-2 Specific Immune Response and Inflammatory Profile in Advanced HIV-Infected Persons during a COVID-19 Outbreak.	Viruses
35891281	Specific T-Cell Immune Response to SARS-CoV-2 Spike Protein over Time in Naive and SARS-CoV-2 Previously Infected Subjects Vaccinated with BTN162b2.	Vaccines (Basel)
35891209	The Associations between Cytokine Levels, Kidney and Heart Function Biomarkers, and Expression Levels of Angiotensin-Converting Enzyme-2 and Neuropilin-1 in COVID-19 Patients.	Vaccines (Basel)
35891189	Evaluation of Patients with Vaccine Allergies Prior to mRNA-Based COVID-19 Vaccination.	Vaccines (Basel)
35890406	The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b.	Pharmaceutics
35890352	Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and alpha-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 Vaccine.	Pharmaceutics
35890288	Celecoxib Microparticles for Inhalation in COVID-19-Related Acute Respiratory Distress Syndrome.	Pharmaceutics
35890093	The Potential Complementary Role of Using Chinese Herbal Medicine with Western Medicine in Treating COVID-19 Patients: Pharmacology Network Analysis.	Pharmaceuticals (Basel)
35888742	Severe COVID-19 Is Characterised by Perturbations in Plasma Amines Correlated with Immune Response Markers, and Linked to Inflammation and Oxidative Stress.	Metabolites
35887600	Lack of Difference in Tocilizumab Efficacy in the Treatment of Severe COVID-19 Caused by Different SARS-CoV-2 Variants.	J Pers Med
35887555	Gender Differences Associated with the Prognostic Value of BPIFB4 in COVID-19 Patients: A Single-Center Preliminary Study.	J Pers Med
35887351	Patients Recovering from Severe COVID-19 Develop a Polyfunctional Antigen-Specific CD4+ T Cell Response.	Int J Mol Sci
35887283	Comprehensive Cytokine Profiling of Patients with COVID-19 Receiving Tocilizumab Therapy.	Int J Mol Sci
35884833	Cortisol as an Independent Predictor of Unfavorable Outcomes in Hospitalized COVID-19 Patients.	Biomedicines
35883726	Dramatic Decrease of Vitamin K2 Subtype Menaquinone-7 in COVID-19 Patients.	Antioxidants (Basel)
35883618	Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19.	Cells
35883561	Activation and Pharmacological Regulation of Inflammasomes.	Biomolecules
35882784	Current Opinion on the Therapeutic Capacity of Taurine-Containing Halogen Derivatives in Infectious and Inflammatory Diseases.	Adv Exp Med Biol
35882778	Examination of Taurine Chloramine and Taurine on LPS-Induced Acute Pulmonary Inflammatory in Mice.	Adv Exp Med Biol
35874678	Photobiomodulation Improves Serum Cytokine Response in Mild to Moderate COVID-19: The First Randomized, Double-Blind, Placebo Controlled, Pilot Study.	Front Immunol
35873792	An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant replication in rhesus macaques.	PNAS Nexus
35873360	Biomarkers of Inflammation among Patients with COVID-19: A Single-Centre Prospective Study from Prishtina, Kosovo.	Can J Infect Dis Med Microbiol
35872670	Altered serum and cerebrospinal fluid TNF-alpha, caspase 3, and IL 1beta in COVID-19 disease.	Caspian J Intern Med
35870896	COVID-19 related acute necrotizing encephalopathy with extremely high interleukin-6 and RANBP2 mutation in a patient with recently immunized inactivated virus vaccine and no pulmonary involvement.	BMC Infect Dis
35870365	Clinical outcomes and lung ultrasound findings in COVID-19 follow up: Calm comes after the storm?	Respir Med Res
35870095	A synopsis of global frontiers in fertility preservation.	J Assist Reprod Genet
35868344	Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics.	Expert Rev Clin Immunol
35868117	Distinct type I interferon responses between younger women and older men contribute to the variability of COVID-19 outcomes: Hypothesis generating insights from COVID-19 convalescent individuals.	Cytokine
35867189	Mineralocorticoid receptor-antagonism prevents COVID-19-dependent glycocalyx damage.	Pflugers Arch
35867145	Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation.	Histochem Cell Biol
35866847	Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection.	AIDS
35866369	Single-cell immune profiling reveals long-term changes in myeloid cells and identifies a novel subset of CD9(+) monocytes associated with COVID-19 hospitalization.	J Leukoc Biol
35864766	SARS-CoV-2 infection and seizures: the perfect storm.	J Integr Neurosci
35864532	Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19.	Cardiovasc Diabetol
35863846	Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in Adults.	J Am Coll Cardiol
35860660	Percutaneous Auricular Vagus Nerve Stimulation Reduces Inflammation in Critical Covid-19 Patients.	Front Physiol
35860236	In Vitro Exposure of Primary Human T Cells and Monocytes to Polyclonal Stimuli Reveals a Basal Susceptibility to Display an Impaired Cellular Immune Response and Develop Severe COVID-19.	Front Immunol
35859926	Joint Modeling of Repeated Measurements of Different Biomarkers Predicts Mortality in COVID-19 Patients in the Intensive Care Unit.	Biomark Insights
35859470	Role and limitations of high-flow nasal oxygen therapy in COVID-19 patients: An observational study.	Niger J Clin Pract
35859316	Exploration of molecular targets and mechanisms of Chinese medicinal formula Acacia Catechu -Scutellariae Radix in the treatment of COVID-19 by a systems pharmacology strategy.	Phytother Res
35858800	COVID-19 in a Hairy Cell Leukemia Patient: A Rare Case Report.	Tohoku J Exp Med
35858456	Transient and durable T cell reactivity after COVID-19.	Proc Natl Acad Sci U S A
35858016	Highlights of clinical and laboratory parameters among severe COVID-19 patients treated with tocilizumab: a retrospective observational study.	Sao Paulo Med J
35856379	N-acetylcysteine as a therapeutic approach to post-COVID-19 pulmonary fibrosis adjunctive treatment.	Eur Rev Med Pharmacol Sci
35855633	Mesenchymal stem cell treatment for hyperactive immune response in patients with COVID-19.	Immunotherapy
35854977	SARS-CoV-2 Delta spike protein enhances the viral fusogenicity and inflammatory cytokine production.	iScience
35854671	Early increase of serum ferritin among COVID-19 patients is associated with need of invasive mechanical ventilation and with in-hospital death.	Infect Dis (Lond)
35852114	Clinical course of COVID-19 infection in a melanoma patient treated with nivolumab and bempegaldesleukin: a case report.	Immunotherapy
35850675	Children's rates of COVID-19 vaccination as reported by parents, vaccine hesitancy, and determinants of COVID-19 vaccine uptake among children: a multi-country study from the Eastern Mediterranean Region.	BMC Public Health
35849948	Network analysis for elucidating the mechanisms of Shenfu injection in preventing and treating COVID-19 combined with heart failure.	Comput Biol Med
35846757	Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome.	Front Cell Infect Microbiol
35845309	A systems biology analysis of protein-protein interaction of digestive disorders and Covid-19 virus based on comprehensive gene information.	Gastroenterol Hepatol Bed Bench
35844601	Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant.	Front Immunol
35844548	Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1alpha, IFN-alpha and TGF-beta.	Front Immunol
35844497	Exposing and Overcoming Limitations of Clinical Laboratory Tests in COVID-19 by Adding Immunological Parameters; A Retrospective Cohort Analysis and Pilot Study.	Front Immunol
35843095	Immunization with 674-685 fragment of SARS-Cov-2 spike protein induces neuroinflammation and impairs episodic memory of mice.	Biochem Biophys Res Commun
35842705	A comprehensive evaluation of the immune system response and type-I Interferon signaling pathway in hospitalized COVID-19 patients.	Cell Commun Signal
35840680	Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1.	Mucosal Immunol
35838968	Evaluating the Effects of Curcumin on the Cytokine Storm in COVID-19 Using a Chip-Based Multiplex Analysis.	Methods Mol Biol
35838965	Multiplex Immunoassay for Prediction of Disease Severity Associated with the Cytokine Storm in COVID-19 Cases.	Methods Mol Biol
35838212	A review of current evidence from cardiovascular manifestations and outcomes in patients with COVID-19.	Curr Pharm Des
35838211	Prolonged NHE Activation may be both Cause and Outcome of Cytokine Release Syndrome in COVID-19.	Curr Pharm Des
35837606	Cardiorenal Syndrome in COVID-19 Patients: A Systematic Review.	Front Cardiovasc Med
35837388	Mediators of Obesity Do Not Influence SARS-CoV-2 Infection or Activation of Primary Human Lung Microvascular Endothelial Cells In Vitro.	Front Immunol
35835712	Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study.	Lancet Digit Health
35835255	Spontaneous NLRP3 inflammasome-driven IL-1-beta secretion is induced in severe COVID-19 patients and responds to anakinra treatment.	J Allergy Clin Immunol
35834650	The Role of Vitamin D for Modulating the T Helper 1 Immune Response After the Coronavac Vaccination.	J Interferon Cytokine Res
35834501	Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients.	PLoS One
35833395	Retrospective Cohort Observational Study to compare the Effect of Mycobacterium w along with Standard of Care vs Standard of Care alone in critically ill COVID-19 Patients.	J Assoc Physicians India
35833122	Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis.	Front Immunol
35833079	Analysis of Clinical Manifestations and Imaging of COVID-19 Patients in Intensive Care.	Contrast Media Mol Imaging
35831294	Neddylation tunes peripheral blood mononuclear cells immune response in COVID-19 patients.	Cell Death Discov
35822898	PEGylated Polyester Nanoparticles Trigger Adverse Events in a Large Animal Model of Trauma and in Naive Animals: Understanding Cytokine and Cellular Correlations with These Events.	ACS Nano
35822758	Le SARS-CoV-2 leger induit-il des modifications cerebrales et des troubles neuropsychologiques ?	Rev Med Suisse
35822078	Association of interferon gamma inducible protein-10, monocyte chemoattractant protein-1, macrophage inflammatory protein-1 alpha, interleukin-6, and rs12252 single nucleotide polymorphism of interferon-induced transmembrane protein-3 gene with the severity of COVID-19 infection.	Egypt J Intern Med
35820865	Encephalitis with status epilepticus and stroke as complications of non-severe COVID-19 in a young female patient: a case report.	BMC Neurol
35819341	Increased serum citrullinated histone H3 levels in COVID-19 patients with acute ischemic stroke.	Ideggyogy Sz
35817244	N-3 polyunsaturated fatty acids block the trimethylamine-N-oxide- ACE2- TMPRSS2 cascade to inhibit the infection of human endothelial progenitor cells by SARS-CoV-2.	J Nutr Biochem
35816896	Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade.	EBioMedicine
35816430	Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease.	Am J Respir Crit Care Med
35814203	Profiling Differential Effects of 5 Selective Serotonin Reuptake Inhibitors on TLRs-Dependent and -Independent IL-6 Production in Immune Cells Identifies Fluoxetine as Preferred Anti-Inflammatory Drug Candidate.	Front Pharmacol
35813280	Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study.	Lancet Healthy Longev
35812392	Monocytic-Myeloid Derived Suppressor Cells Suppress T-Cell Responses in Recovered SARS CoV2-Infected Individuals.	Front Immunol
35812188	Andrographolide induces anti-SARS-CoV-2 response through host-directed mechanism: an in silico study.	Future Virol
35807916	Cyanidin-3-O-glucoside and Peonidin-3-O-glucoside-Rich Fraction of Black Rice Germ and Bran Suppresses Inflammatory Responses from SARS-CoV-2 Spike Glycoprotein S1-Induction In Vitro in A549 Lung Cells and THP-1 Macrophages via Inhibition of the NLRP3 Inflammasome Pathway.	Nutrients
35806317	Gal-3BP in Viral Infections: An Emerging Role in Severe Acute Respiratory Syndrome Coronavirus 2.	Int J Mol Sci
35803954	Upper airway gene expression shows a more robust adaptive immune response to SARS-CoV-2 in children.	Nat Commun
35803132	Ozone as an adjuvant therapy for COVID-19: A systematic review and meta-analysis.	Int Immunopharmacol
35801597	[Ocena zwiazku stezenia kwasu moczowego z przebiegiem zakazenia SARS-CoV-2].	Pol Merkur Lekarski
35801415	Evaluation of qualitative and quantitative taste alterations in COVID-19.	Bosn J Basic Med Sci
35799708	Integration and Reanalysis of Four RNA-Seq Datasets Including BALF, Nasopharyngeal Swabs, Lung Biopsy, and Mouse Models Reveals Common Immune Features of COVID-19.	Immune Netw
35796445	Therapeutics for the management of cytokine release syndrome in COVID-19.	Curr Top Med Chem
35795713	Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study.	EClinicalMedicine
35795592	Associations of High-Sensitivity C-Reactive Protein and Interleukin-6 with Depression in a Sample of Italian Adolescents During COVID-19 Pandemic.	Neuropsychiatr Dis Treat
35792321	Reactogenic sleepiness after COVID-19 vaccination. A hypothesis involving orexinergic system linked to inflammatory signals.	Sleep Med
35792186	Peritoneal M2 macrophage-derived extracellular vesicles as natural multitarget nanotherapeutics to attenuate cytokine storms after severe infections.	J Control Release
35791866	Current status and prospects of IL-6-targeting therapy.	Expert Rev Clin Pharmacol
35791863	Biologic disease-modifying antirheumatic drugs to treat multisystem inflammatory syndrome in children.	Curr Opin Rheumatol
35791660	Cytokine profiles in intensive care unit delirium.	Acute Crit Care
35790489	Istradefylline, an adenosine A2a receptor antagonist, inhibits the CD4(+) T-cell hypersecretion of IL-17A and IL-8 in humans.	Immunol Med
35789756	Recent advances in antiviral effects of probiotics: potential mechanism study in prevention and treatment of SARS-CoV-2.	Biologia (Bratisl)
35789750	Immunomodulatory LncRNA on antisense strand of ICAM-1 augments SARS-CoV-2 infection-associated airway mucoinflammatory phenotype.	iScience
35787993	JAK inhibition as a new treatment strategy for patients with COVID-19.	Biochem Pharmacol
35786088	Low BALF CD4 T cells count is associated with extubation failure and mortality in critically ill covid-19 pneumonia.	Ann Med
35785915	The effect of statin administration on IL-6 and IL-1b expression in peripheral blood mononuclear cells of a hypertensive patient with SARS-CoV-2 spike protein stimulation.	Med Glas (Zenica)
35785882	VEGF, IL-17 and IgG4 levels of patients with lung sequelae in post-COVID-19 period.	Tuberk Toraks
35785771	Pacritinib Inhibition of IRAK1 Blocks Aberrant TLR8 Signalling by SARS-CoV-2 and HIV-1-Derived RNA.	J Innate Immun
35784975	Acute Respiratory Distress Syndrome Secondary to Enterovirus-Human-Rhinovirus Infection in an Adult.	Cureus
35784888	Pathophysiological Changes in Erythrocytes Contributing to Complications of Inflammation and Coagulation in COVID-19.	Front Physiol
35784698	Qing-Wen-Jie-Re Mixture Ameliorates Poly (I:C)-Induced Viral Pneumonia Through Regulating the Inflammatory Response and Serum Metabolism.	Front Pharmacol
35784687	Withania somnifera (L.) Dunal as Add-On Therapy for COPD Patients: A Randomized, Placebo-Controlled, Double-Blind Study.	Front Pharmacol
35784318	A Vicious Cycle: In Severe and Critically Ill COVID-19 Patients.	Front Immunol
35784283	Resistin Associated With Cytokines and Endothelial Cell Adhesion Molecules Is Related to Worse Outcome in COVID-19.	Front Immunol
35782715	A Molecular Communications System for the Detection of Inflammatory Levels Related to COVID-19 Disease.	IEEE Trans Mol Biol Multiscale Commun
35782480	Vaccination Recommendations for Psoriasis and Atopic Dermatitis Patients on Biologic Therapy: A Practical Guide.	Yale J Biol Med
35782361	Cytokines and microRNAs in SARS-CoV-2: What do we know?	Mol Ther Nucleic Acids
35780641	Roles of Interleukin-6-mediated immunometabolic reprogramming in COVID-19 and other viral infection-associated diseases.	Int Immunopharmacol
35777803	Abstracts of Presentations at the Association of Clinical Scientists 143(rd) Meeting Louisville, KY May 11-14,2022.	Ann Clin Lab Sci
35775687	Does COVID-19 increase the incidence of spontaneous rectus sheath hematoma?	Ulus Travma Acil Cerrahi Derg
35773628	Investigating the burden of disease dimensions (time-dependent, developmental, physical, social and emotional) among family caregivers with COVID-19 patients in Iran.	BMC Prim Care
35772216	Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID.	EBioMedicine
35772080	Interleukin-6 blocking therapy for COVID-19: From immune pathogenesis to clinical outcomes.	Rheumatol Immunol Res
35768148	Acetylcholine, Fatty Acids, and Lipid Mediators Are Linked to COVID-19 Severity.	J Immunol
35767946	Early IFNbeta secretion determines variable downstream IL-12p70 responses upon TLR4 activation.	Cell Rep
35767763	On-admission laboratory predictors for developing critical COVID-19 during hospitalization - a multivariable logistic regression model.	Ann Agric Environ Med
35766852	[Role of inflammasome NLRP3 in the pathophysiology of viral infections: A focus on SARS-CoV-2 infection].	Med Sci (Paris)
35766602	Memory elicitation, T-cell response and antibody production: an independent study of an inactivated entire virus vaccine (Coronavac).	An Acad Bras Cienc
35766069	Accreditation de la mesure de l'expression des molecules HLA-DR a la surface des monocytes (mHLA-DR) par cytometrie en flux.	Ann Biol Clin (Paris)
35765103	Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial.	Stem Cell Res Ther
35764965	Helminth antigens differentially modulate the activation of CD4(+) and CD8(+) T lymphocytes of convalescent COVID-19 patients in vitro.	BMC Med
35764543	[Analysis of liver function injury associated with 2019-nCoV Omicron mutant strains].	Zhonghua Gan Zang Bing Za Zhi
35759224	Immunologic features of asymptomatic postvaccination infections with the Delta variant of SARS-CoV-2 in adults.	Immun Inflamm Dis
35758972	IL-17A )rs2275913; G197A) gene polymorphism as predictor for disease severity and its correlation with IL-17 serum levels in COVID-19 patients.	Egypt J Immunol
35758968	Inetrleukin-6 and C-reactive protein as predictors of mortality among critically ill COVID-19 patients in Assiut university hospitals (ICUs).	Egypt J Immunol
35758225	COVID-19-related headache and innate immune response - a narrative review.	Neurol Neurochir Pol
35757331	Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients.	Front Cardiovasc Med
35756754	Human Placental Mesenchymal Stem Cells for the Treatment of ARDS in Rat.	Stem Cells Int
35756690	Evaluation of C4b as an adjunct marker in symptomatic RT-PCR negative Covid-19 cases.	Indian J Clin Biochem
35754492	Modeling Kaempferol as a Potential Pharmacological Agent for COVID-19/PF Co-Occurrence Based on Bioinformatics and System Pharmacological Tools.	Front Pharmacol
35752943	Induction of a cytokine storm involves suppression of the Osteopontin-dependent TH1 response.	Immunology
35751653	The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19.	Inflamm Res
35751199	Insights into potential mechanisms of asthma patients with COVID-19: A study based on the gene expression profiling of bronchoalveolar lavage fluid.	Comput Biol Med
35750357	Longitudinal T Cell Responses against Ancestral, Delta, and Omicron SARS-CoV-2 Variants Determined by Rapid Cytokine Release Assay in Whole Blood.	Immunohorizons
35747885	Elevated Levels of Pleiotropic Interleukin-6 (IL-6) and Interleukin-10 (IL-10) are Critically Involved With the Severity and Mortality of COVID-19: An Updated Longitudinal Meta-Analysis and Systematic Review on 147 Studies.	Biomark Insights
35746755	Biomarkers Predictive for In-Hospital Mortality in Patients with Diabetes Mellitus and Prediabetes Hospitalized for COVID-19 in Austria: An Analysis of COVID-19 in Diabetes Registry.	Viruses
35746745	Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-beta and IL-6 Secretion.	Viruses
35746736	High and Sustained Ex Vivo Frequency but Altered Phenotype of SARS-CoV-2-Specific CD4(+) T-Cells in an Anti-CD20-Treated Patient with Prolonged COVID-19.	Viruses
35746580	Cellular and Humoral Immunity after the Third Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplant Recipients.	Vaccines (Basel)
35746559	The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19.	Vaccines (Basel)
35746474	What Should We Do after the COVID-19 Vaccination? Vaccine-Associated Diseases and Precautionary Measures against Adverse Reactions.	Vaccines (Basel)
35744958	Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment?	Molecules
35744907	Scutellarein Inhibits LPS-Induced Inflammation through NF-kappaB/MAPKs Signaling Pathway in RAW264.7 Cells.	Molecules
35744777	Chlorpromazine, a Clinically Approved Drug, Inhibits SARS-CoV-2 Nucleocapsid-Mediated Induction of IL-6 in Human Monocytes.	Molecules
35743825	Distinct Cytokine Profiles in Severe COVID-19 and Non-Alcoholic Fatty Liver Disease.	Life (Basel)
35743621	The Assessment of COVID-19 Pneumonia in Neonates: Observed by Lung Ultrasound Technique and Correlated with Biomarkers and Symptoms.	J Clin Med
35742443	Clinical (BMI and MRI) and Biochemical (Adiponectin, Leptin, TNF-alpha, and IL-6) Effects of High-Intensity Aerobic Training with High-Protein Diet in Children with Obesity Following COVID-19 Infection.	Int J Environ Res Public Health
35740960	A Novel Antiviral Protein Derived from Oenanthe javanica: Type I Interferon-Dependent Antiviral Signaling and Its Pharmacological Potential.	Biomolecules
35740951	SCD14-ST and New Generation Inflammatory Biomarkers in the Prediction of COVID-19 Outcome.	Biomolecules
35737819	Codelivery of SARS-CoV-2 Prefusion-Spike Protein with CBLB502 by a Dual-Chambered Ferritin Nanocarrier Potentiates Systemic and Mucosal Immunity.	ACS Appl Bio Mater
35735559	Two Biosensors for the Determination of Interleukin-6 in Blood Plasma by Array SPRi.	Biosensors (Basel)
35733480	Assessment of Six-Minute Walk Test Among Discharge-Ready Severe COVID-19 Patients: A Cross-Sectional Study.	Cureus
35733366	Predictive Role of Blood Cellular Indices and Their Relationship with Endogenous Glycosaminoglycans as Determinants of Inflammatory Biomarkers in Pulmonary Embolism.	Clin Appl Thromb Hemost
35732153	The IL-1beta, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19.	Cell Rep Med
35730384	Long-lasting adaptive immune memory specific to SARS-CoV-2 in convalescent coronavirus disease 2019 stable people with HIV.	AIDS
35729973	Application of Monoclonal Antibody Drugs in Treatment of COVID-19: a Review.	Bionanoscience
35729949	Balanced cytokine upregulation by diluted ethanolic extract of Bryonia alba in Delta SARS-CoV-2 Spike protein RBD-induced pathogenesis in Gallus gallus embryo.	Bull Natl Res Cent
35728583	Does Maternal SARS-CoV-2 Infection or SARS-CoV-2 Vaccination Trigger an Inflammatory Response in the Fetus? A Prospective Cohort Study.	Gynecol Obstet Invest
35726224	The Bioactivities of Phycocyanobilin from Spirulina.	J Immunol Res
35724918	ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate the lung injury microenvironment.	Acta Biomater
35723340	Transcription of the Envelope Protein by 1-L Protein-RNA Recognition Code Leads to Genes/Proteins That Are Relevant to the SARS-CoV-2 Life Cycle and Pathogenesis.	Curr Issues Mol Biol
35721343	Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients.	Int J Inflam
35721065	Case Report: Malignant Melanoma Associated With COVID-19: A Coincidence or a Clue?	Front Med (Lausanne)
35720324	Case Report: New-Onset Rheumatoid Arthritis Following COVID-19 Vaccination.	Front Immunol
35720281	mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273.	Front Immunol
35719441	High-flow Nasal Oxygen Therapy in COVID-19 Critically Ill Patients with Acute Hypoxemic Respiratory Failure: A Prospective Observational Cohort Study.	Indian J Crit Care Med
35714708	Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19.	Chest
35714615	A diminished immune response underlies age-related SARS-CoV-2 pathologies.	Cell Rep
35713893	Lysozyme Protects Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Inflammation in Human Corneal Epithelial Cells.	Invest Ophthalmol Vis Sci
35713624	Baseline plasma SARS-CoV-2 RNA detection predicts an adverse COVID-19 evolution in moderate to severe hospitalized patients.	Panminerva Med
35712732	Corona, Acute Ischemic Stroke, Malignant Cerebral Edema, and Hemo-adsorption: A Case Report.	Indian J Crit Care Med
35712624	Case Report: Ciclosporin A for Refractory Multisystem Inflammatory Syndrome in Children.	Front Pediatr
35712059	Admission Levels of Serum P-Selectin and IL-6 Can Predict Development of Deep Venous Thrombosis in Hospitalized Covid-19 Patients.	Int J Gen Med
35711306	Mechanistic Insights Into Inflammation-Induced Arrhythmias: A Simulation Study.	Front Physiol
35709590	Metformin alleviates prolonged isoflurane inhalation induced cognitive decline via reducing neuroinflammation in adult mice.	Int Immunopharmacol
35709568	Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent.	Cytokine
35709328	Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature.	Cardiovasc Res
35706828	Sex-adjusted approach to baseline variables demonstrated some improved predictive capabilities for disease severity and survival in patients with Coronavirus Disease 19.	Inform Med Unlocked
35704730	Would Tracking Coagulation Together with Inflamation Markers be a Prospect for COVID-19 Disease Prognosis?	Clin Lab
35704508	Circulating IL-6 but not neutrophil extracellular traps levels can predict anakinra effectiveness in patients with severe COVID-19.	J Leukoc Biol
35702842	Effect of Mycobacterium w on IL-6 and Oxygen Requirement in COVID-19.	J Assoc Physicians India
35702393	Different Aspects of Emetine's Capabilities as a Highly Potent SARS-CoV-2 Inhibitor against COVID-19.	ACS Pharmacol Transl Sci
35699447	Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.	J Virol
35698744	COVID-19 Infection in Patients with Comorbidities: Clinical and Immunological Insight.	Clin Appl Thromb Hemost
35698725	Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform.	Lancet Rheumatol
35693828	Post-COVID-19 Fatigue and SARS-CoV-2 Specific Humoral and T-Cell Responses in Male and Female Outpatients.	Front Immunol
35693807	Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies.	Front Immunol
35693606	Comparison of laboratory parameters in mild vs. severe cases and died vs. survived patients with COVID-19: systematic review and meta-analysis.	J Thorac Dis
35693592	Clinical characteristics and determinants of mortality in coronavirus disease 2019 (COVID-19) patients on an intensive care unit-a retrospective explorative 1-year all-comers study.	J Thorac Dis
35692597	SARS-CoV-2 Induces Expression of Cytokine and MUC5AC/5B in Human Nasal Epithelial Cell through ACE 2 Receptor.	Biomed Res Int
35692161	Calprotectin: The Link Between Acute Lung Injury and Gastrointestinal Injury in Covid-19: Ban or Boon.	Curr Protein Pept Sci
35692034	Anti-SARS-CoV2 antibody-mediated cytokine release syndrome in a patient with acute promyelocytic leukemia.	BMC Infect Dis
35691726	Neuropathological findings in fatal COVID-19 and their associated neurological clinical manifestations.	Pathology
35691133	Deciphering the balance of IL-6/IL-10 cytokines in severe to critical COVID-19 patients.	Immunobiology
35690994	Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post-infection and post-vaccination cellular SARS-CoV-2-specific immune response.	Allergy
35690570	T-cell immune response predicts the risk of critical SARS-Cov2 infection in hospitalized COVID-19 patients.	Eur J Intern Med
35689600	Human cardiac organoids to model COVID-19 cytokine storm induced cardiac injuries.	J Tissue Eng Regen Med
35689277	"Even if I'm undetectable, I just feel like I would die": a qualitative study to understand the psychological and socioeconomic impacts of the COVID-19 pandemic on women living with HIV (WLWH) in Chicago, IL.	BMC Womens Health
35687905	Conjugation with 8-arm PEG and CRM197 enhances the immunogenicity of SARS-CoV-2 ORF8 protein.	Int Immunopharmacol
35687631	Up-conversion Luminescence System for Quantitative Detection of IL-6.	IEEE Trans Nanobioscience
35686910	Defining resistance and tolerance traits in Covid-19: towards a stratified medicine approach.	QJM
35686128	Distinct Immunological Profiles Help in the Maintenance of Salivary Secretory IgA Production in Mild Symptoms COVID-19 Patients.	Front Immunol
35685940	Clinical Characteristics of Immune Response in Asymptomatic Carriers and Symptomatic Patients With COVID-19.	Front Microbiol
35685850	A case report of coronavirus disease-2019-induced acute asthma exacerbation in an obese patient.	Respirol Case Rep
35685617	Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors.	RSC Med Chem
35685514	NUTRIC Score Is Not Superior to mNUTRIC Score in Prediction of Mortality of COVID-19 Patients.	Int J Clin Pract
35685049	Is Poliomyelitis Sequelae A Disadvantage for Recovery from Covid-19 ARDS: A Case Report.	Noro Psikiyatr Ars
35684003	Fermented Carica papaya and Morinda citrifolia as Perspective Food Supplements for the Treatment of Post-COVID Symptoms: Randomized Placebo-Controlled Clinical Laboratory Study.	Nutrients
35683340	Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS.	J Clin Med
35682084	The Impact of Hyper-Acute Inflammatory Response on Stress Adaptation and Psychological Symptoms of COVID-19 Patients.	Int J Environ Res Public Health
35681092	Clinical and subclinical acute kidney injury in children with mild-to-moderate COVID-19.	Pediatr Res
35681070	Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients.	Sci Rep
35680931	Elevated plasma level of the glycolysis byproduct methylglyoxal on admission is an independent biomarker of mortality in ICU COVID-19 patients.	Sci Rep
35679246	Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen.	PLoS One
35679009	Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels.	Immunol Res
35678591	Treatment of COVID-19-induced refractory status epilepticus by tocilizumab.	Eur J Neurol
35677450	Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection.	Front Pharmacol
35676607	Saliva as a Potential Specimen to Monitor IL-6, TNF-alpha and IL-10 in COVID-19 Patients.	Inflammation
35676519	The ratio of serum LL-37 levels to blood leucocyte count correlates with COVID-19 severity.	Sci Rep
35675487	Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.	J Dermatol
35672716	Potential role of astrocyte angiotensin converting enzyme 2 in the neural transmission of COVID-19 and a neuroinflammatory state induced by smoking and vaping.	Fluids Barriers CNS
35671982	LNP-CpG ODN-adjuvanted varicella-zoster virus glycoprotein E induced comparable levels of immunity with Shingrix in VZV-primed mice.	Virol Sin
35669496	A Comprehensive Comparison of Clinical Presentation and Outcomes of Kidney Transplant Recipients with COVID-19 during Wave 1 versus Wave 2 at a Tertiary Care Center, India.	Int J Nephrol
35667877	Immunophenotyping of lymphocytes and monocytes and the status of cytokines in the clinical course of Covid-19 patients.	J Med Virol
35665254	Interleukin-6 Elevation Is a Key Pathogenic Factor Underlying COVID-19-Associated Heart Rate-Corrected QT Interval Prolongation.	Front Cardiovasc Med
35665236	Severe acute respiratory syndrome coronavirus 2 infection: Role of interleukin-6 and the inflammatory cascade.	World J Virol
35664035	Review on acute pancreatitis attributed to COVID-19 infection.	World J Gastroenterol
35663992	Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity.	Front Immunol
35663529	Does Interleukin-6 Bridge SARS-CoV-2 With Virus-Associated Cancers?	J Immunother Precis Oncol
35663467	Extracellular ATP and Imbalance of CD4+ T Cell Compartment in Pediatric COVID-19.	Front Cell Infect Microbiol
35661911	The significance of surface neutrophilic MPO expression level in NETosis and NETosis-associated coagulopathies in covid-19 infected patients.	Blood Cells Mol Dis
35660785	The host response in different aetiologies of community-acquired pneumonia.	EBioMedicine
35659223	Association between dexamethasone treatment and the host response in COVID-19 patients admitted to the general ward.	Respir Res
35657993	Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis.	PLoS One
35657200	[Anti-inflammatory drugs : from old classical ones to biotherapies and JAK inhibitors].	Rev Med Liege
35656097	Clinical Features and Outcomes of COVID-19 Patients with Acute Kidney Injury and Acute Kidney Injury on Chronic Kidney Disease.	Aging Dis
35656048	Inflammatory Markers as Early Predictors of Disease Severity in COVID-19 Patients Admitted to Intensive Care Units: A Retrospective Observational Analysis.	Indian J Crit Care Med
35656028	Humoral, Cellular and Cytokine Immune Responses Against SARS-CoV-2 Variants in COVID-19 Convalescent and Confirmed Patients With Different Disease Severities.	Front Cell Infect Microbiol
35654316	N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: A prospective cohort study.	Clin Microbiol Infect
35653885	SOLVx therapeutics vaccine - Activate T-cell immunity using broad surveillance epitope strategy against mutant strains SARS-COV2.	Biomed Pharmacother
35652636	A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021.	Microbiol Spectr
35651623	High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed Lungs.	Front Immunol
35647664	4BNT162b2 mRNA COVID-19 vaccine and semen: What do we know?	Andrology
35646300	Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study.	Ther Adv Hematol
35645319	TNF-alpha/IFN-gamma synergy amplifies senescence-associated inflammation and SARS-CoV-2 receptor expression via hyper-activated JAK/STAT1.	Aging Cell
35645219	Sarilumab Administration in COVID-19 Patients: Literature Review and Considerations.	Infect Dis Rep
35644117	Reviving the mutual impact of SARS-COV-2 and obesity on patients: From morbidity to mortality.	Biomed Pharmacother
35640566	Lianhuaqingwen alleviates p53-mediated apoptosis in alveolar epithelial cells to prevent LPS-induced ALI.	J Pharm Pharmacol
35640535	Th1 Cytokines Signature in 2 Cases of IgA Nephropathy Flare after mRNA-Based SARS-CoV-2 Vaccine: Exploring the Pathophysiology.	Nephron
35639579	Multisystem Inflammatory Syndrome in Children Associated with COVID-19 in a Tertiary Level Hospital in Portugal.	Acta Med Port
35639261	Disengaging the COVID-19 Clutch as a Discerning Eye Over the Inflammatory Circuit During SARS-CoV-2 Infection.	Inflammation
35636166	Glycyrrhetinic acid: A potential drug for the treatment of COVID-19 cytokine storm.	Phytomedicine
35634338	Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2.	Front Immunol
35634332	Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19.	Front Immunol
35634285	SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients - A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease.	Front Immunol
35632725	SARS-CoV-2 Causes Lung Inflammation through Metabolic Reprogramming and RAGE.	Viruses
35632475	BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and Andes orthohantavirus.	Vaccines (Basel)
35631447	Methylene Blue Is a Nonspecific Protein-Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19.	Pharmaceuticals (Basel)
35629072	Comparative Study of Cytokine Storm Treatment in Patients with COVID-19 Pneumonia Using Immunomodulators.	J Clin Med
35627648	Lessons We Have Learned Regarding Seroprevalence in High and Low SARS-CoV-2 Contexts in Greece before the Omicron Pandemic Wave.	Int J Environ Res Public Health
35626318	Rapid Quantum Magnetic IL-6 Point-of-Care Assay in Patients Hospitalized with COVID-19.	Diagnostics (Basel)
35626317	Serum NGF and BDNF in Long-COVID-19 Adolescents: A Pilot Study.	Diagnostics (Basel)
35626194	COVID-19 Disease and Associated Thrombocytopenia: Pathogenesis and a Clue to the Etiology.	Diagnostics (Basel)
35625919	IL-33 Enhances ACE2 Expression on Epidermal Keratinocytes in Atopic Dermatitis: A Plausible Issue for SARS-CoV-2 Transmission in Inflamed Atopic Skin.	Biomedicines
35625896	Altered Ocular Surface Health Status and Tear Film Immune Profile Due to Prolonged Daily Mask Wear in Health Care Workers.	Biomedicines
35625671	The Evolution of Blood Cell Phenotypes, Intracellular and Plasma Cytokines and Morphological Changes in Critically Ill COVID-19 Patients.	Biomedicines
35623041	Signaling via dopamine and adenosine receptors modulate viral peptide-specific and T-cell IL-8 response in COVID-19.	Immunol Med
35622838	Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections-A prospective cohort study.	PLoS One
35622496	Network pharmacology and experimental validation identify the potential mechanism of sophocarpine for COVID-19.	J Med Microbiol
35621229	The role of cytokines and their antagonists in the treatment of COVID-19 patients.	Rev Med Virol
35620768	Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients.	Crit Care Explor
35619189	Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study.	Stem Cell Res Ther
35619180	COVID-19 infection: an overview on cytokine storm and related interventions.	Virol J
35618953	A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia.	Infect Dis Ther
35618731	SARS-CoV-2 accessory proteins reveal distinct serological signatures in children.	Nat Commun
35618154	A Mendelian randomization cytokine screen reveals IL-13 as causal factor in risk of severe COVID-19.	J Infect
35617421	SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2.	PLoS Pathog
35615020	Computational epitope binning reveals functional equivalence of sequence-divergent paratopes.	Comput Struct Biotechnol J
35611100	Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients.	Mediterr J Rheumatol
35610643	Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine.	Immun Ageing
35610196	Red blood cell distribution width as a marker of hyperinflammation and mortality in COVID-19.	Ann Palliat Med
35609792	Dual hit mouse model to examine the long-term effects of maternal immune activation and post-weaning social isolation on schizophrenia endophenotypes.	Behav Brain Res
35609533	New-Onset Primary Adrenal Insufficiency and Autoimmune Hypothyroidism in a Pediatric Patient Presenting with MIS-C.	Horm Res Paediatr
35608267	Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness.	Am J Physiol Lung Cell Mol Physiol
35606235	Phase 1/2 clinical trial of COVID-19 vaccine in Japanese participants: A report of interim findings.	Vaccine
35604688	Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms.	JAMA Netw Open
35603240	COVID-19 pandemic: an assessment of risk perception and the implementation of precautionary measures in a group of primary care workers in Nigeria.	J Prev Med Hyg
35603150	A Case Study to Dissect Immunity to SARS-CoV-2 in a Neonate Nonhuman Primate Model.	Front Immunol
35602886	Organ-specific immune response in lethal SARS-CoV-2 infection by deep spatial phenotyping.	Clin Transl Immunology
35602834	Prevalence of SARS-CoV-2 Infection Among COVID-19 Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Laboratory Workers in Bangladesh.	Cureus
35601726	Virtual Coaching Delivered by Pharmacists to Prevent COVID-19 Transmission.	Hosp Pharm
35601440	Mechanisms of Immune Dysregulation in COVID-19 Are Different From SARS and MERS: A Perspective in Context of Kawasaki Disease and MIS-C.	Front Pediatr
35601022	Gender affects IL-23 serum levels in the hospitalized COVID-19 infected patients.	Am J Clin Exp Immunol
35598232	Immunopathogenesis and Immunogenetic Variants in COVID-19.	Curr Pharm Des
35598128	Circulatory Cytokine Levels as a Predictor of Disease Severity in COVID-19: A Study from Western India.	J Assoc Physicians India
35596055	A comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseases.	Mol Biol Rep
35595949	Acute Pericarditis: Update.	Curr Cardiol Rep
35592324	Intranasal Delivery of Thermostable Subunit Vaccine for Cross-Reactive Mucosal and Systemic Antibody Responses Against SARS-CoV-2.	Front Immunol
35592193	Computed Tomography Severity Scoring on High-Resolution Computed Tomography Thorax and Inflammatory Markers With COVID-19 Related Mortality in a Designated COVID Hospital.	Cureus
35592105	Evaluating the Response and Safety of Inactivated COVID-19 Vaccines in Liver Transplant Recipients.	Infect Drug Resist
35589689	SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity.	Nat Commun
35588734	TNF-alpha(+) CD4(+) T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies.	Cell Rep Med
35588457	Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosis.	Proc Natl Acad Sci U S A
35588018	Inhibition of IRAK4 dysregulates SARS-CoV-2 spike protein-induced macrophage inflammatory and glycolytic reprogramming.	Cell Mol Life Sci
35587188	Circulatory Exosomes from COVID-19 Patients Trigger NLRP3 Inflammasome in Endothelial Cells.	mBio
35587087	Clinical characteristics and treatments of multi-system inflammatory syndrome in children: a systematic review.	Eur Rev Med Pharmacol Sci
35585988	pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury.	Front Immunol
35584141	Inflammation, underweight, malignancy and a marked catabolic state as predictors for worse outcomes in COVID-19 patients with moderate-to-severe disease admitted to Internal Medicine Unit.	PLoS One
35583911	Inflammasome-related Markers upon ICU Admission do not Correlate with Outcome in Critically Ill COVID-19 Patients.	Shock
35582921	Stability of SARS-CoV-2-Encoded Proteins and Their Antibody Levels Correlate with Interleukin 6 in COVID-19 Patients.	mSystems
35580821	Trypsin may induce cytokine storm in M1 macrophages, resulting in critical coronavirus disease.	Respir Physiol Neurobiol
35578681	Application of Extracorporeal Apheresis in Treatment of COVID-19: a Rapid Review.	Bionanoscience
35578169	Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm.	Mol Med
35577892	Anti-nucleocapsid antibodies enhance the production of IL-6 induced by SARS-CoV-2 N protein.	Sci Rep
35574937	A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2.	Gut Microbes
35573725	Comparative Analysis of Long Non-Coding RNA Expression and Immune Response in Mild and Severe COVID-19.	Front Mol Biosci
35573165	Off-target effects of bacillus Calmette-Guerin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19.	Clin Transl Immunology
35572964	T-Cell Subsets and Interleukin-10 Levels Are Predictors of Severity and Mortality in COVID-19: A Systematic Review and Meta-Analysis.	Front Med (Lausanne)
35572945	Case Report: Acute Necrotizing Encephalopathy Following COVID-19 Vaccine.	Front Neurol
35566776	Evaluating Ocular Symptoms and Tear Film Cytokine Profiles in Symptomatic COVID-19 Patients.	J Clin Med
35566412	Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study.	J Clin Med
35566252	Flavonoids as Potential Anti-Inflammatory Molecules: A Review.	Molecules
35566202	Antiinflammation Derived Suzuki-Coupled Fenbufens as COX-2 Inhibitors: Minilibrary Construction and Bioassay.	Molecules
35566097	Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection.	Molecules
35563697	Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro.	Cells
35563282	Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19.	Int J Mol Sci
35563218	Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients.	Int J Mol Sci
35562119	Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved.	J Immunol
35561478	Nitrated fatty acid, 10-nitrooleate protects against hyperoxia-induced acute lung injury in mice.	Int Immunopharmacol
35546159	COVID-19 infections in infants.	Sci Rep
35546150	Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19.	Nat Commun
35545011	IL-1 Mediates Tissue-Specific Inflammation and Severe Respiratory Failure in COVID-19.	J Innate Immun
35540724	Associations between Serum Interleukins (IL-1beta, IL-2, IL-4, IL-6, IL-8, and IL-10) and Disease Severity of COVID-19: A Systematic Review and Meta-Analysis.	Biomed Res Int
35540698	Known data on CoVid-19 infection linked to type-2 diabetes.	Bioinformation
35536644	Favorable vaccine-induced SARS-CoV-2-specific T cell response profile in patients undergoing immune-modifying therapies.	J Clin Invest
35531750	IP-10 and complement activation as friend or foe in COVID-19.	Int J Immunopathol Pharmacol
35530861	Apparent Association of Insulin With Interleukin-6 (IL-6) in Severe COVID-19 Patients Having Chronic Disease Comorbidities.	Cureus
35529881	Memory CD4+ T-Cell Lymphocytic Angiopathy in Fatal Forms of COVID-19 Pulmonary Infection.	Front Immunol
35529862	Identifying Immunological and Clinical Predictors of COVID-19 Severity and Sequelae by Mathematical Modeling.	Front Immunol
35529699	Comparison of the levels of neopterin, CRP, and IL-6 in patients infected with and without SARS-CoV-2.	Heliyon
35529082	Discriminatory Value of Adiponectin to Leptin Ratio for COVID-19 Pneumonia.	Int J Endocrinol
35528283	Th1/Th2/Th17 Cytokine Profile among Different Stages of COVID-19 Infection.	Natl Acad Sci Lett
35526852	High Serum Progranulin Levels in COVID-19 Patients: A Pilot Study.	Biochemistry (Mosc)
35525888	Bioinformatics analysis reveals molecular connections between non-alcoholic fatty liver disease (NAFLD) and COVID-19.	J Cell Commun Signal
35524945	DNA damage in peripheral blood lymphocytes of severely ill COVID-19 patients in relation to inflammatory markers and parameters of hemostasis.	Mutagenesis
35523009	Prognostic serum biomarkers in cancer patients with COVID-19: A systematic review.	Transl Oncol
35514964	Successive Site Translocating Inoculation Improved T Cell Responses Elicited by a DNA Vaccine Encoding SARS-CoV-2 S Protein.	Front Immunol
35512020	Type I interferon regulates proteolysis by macrophages to prevent immunopathology following viral infection.	PLoS Pathog
35510852	SARS-CoV-2 Infection of Microglia Elicits Proinflammatory Activation and Apoptotic Cell Death.	Microbiol Spectr
35510242	A retrospective study of association of CT severity with clinical profile and outcomes of patients with COVID-19 in the second wave.	J Clin Imaging Sci
35509745	Impact of COVID-19 on Basic Life Support Training Among Medical Students: An Experimental Study.	Cureus
35508791	Identification of serum metabolites enhancing inflammatory responses in COVID-19.	Sci China Life Sci
35508669	Increased proinflammatory cytokines in tears correspond with conjunctival SARS-CoV-2 positivity in symptomatic COVID-19 patients.	Sci Rep
35508575	In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection.	Sci Rep
35506060	Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products.	Mol Ther Methods Clin Dev
35505820	The predictive value of epicardial fat volume for clinical severity of COVID-19.	Rev Port Cardiol
35505267	COVID-19 and the role of cytokines in this disease.	Inflammopharmacology
35501841	Single-cell transcriptomics reveal a unique memory-like NK cell subset that accumulates with ageing and correlates with disease severity in COVID-19.	Genome Med
35500008	A cytokine panel and procalcitonin in COVID-19, a comparison between intensive care and non-intensive care patients.	PLoS One
35499468	Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic Islets.	Diabetes
35497096	Cell-Free DNA, Neutrophil extracellular traps (NETs), and Endothelial Injury in Coronavirus Disease 2019- (COVID-19-) Associated Acute Kidney Injury.	Mediators Inflamm
35495619	Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities.	Front Mol Biosci
35494759	A label-free graphene-based impedimetric biosensor for real-time tracing of the cytokine storm in blood serum; suitable for screening COVID-19 patients.	RSC Adv
35493446	Differences in Humoral and Cellular Vaccine Responses to SARS-CoV-2 in Kidney and Liver Transplant Recipients.	Front Immunol
35490738	Outcome predictors in SARS-CoV-2 disease (COVID-19): The prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population.	J Infect
35490452	Cytokine response over the course of COVID-19 infection in pregnant women.	Cytokine
35488021	Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9).	Leukemia
35485813	[The use of a complex of natural antimicrobial peptides and cytokines for treatment of male infertility and chronic prostatitis].	Urologiia
35485381	Blockade of interleukin seventeen (IL-17A) with secukinumab in hospitalized COVID-19 patients - the BISHOP study.	Infect Dis (Lond)
35483404	Inflammasome activation in infected macrophages drives COVID-19 pathology.	Nature
35483276	Cuspareine as alkaloid against COVID-19 designed with ionic liquids: DFT and docking molecular approaches.	J Photochem Photobiol B
35481309	Tocilizumab and Baricitinib for Recovery From Acute Exacerbation of Combined Pulmonary Fibrosis and Emphysema Secondary to COVID-19 Infection: A Case Report.	Cureus
35480999	Identifying Potential Gene Defect Patterns Related to COVID-19 Based on Pharmacological and Bioinformatics Analysis for Lung Adenocarcinoma.	Int J Gen Med
35480398	Serum zinc associated with immunity and inflammatory markers in Covid-19.	Open Med (Wars)
35479098	Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19.	Front Immunol
35479062	CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome.	Front Immunol
35477923	Hypercoagulability, endotheliopathy, and inflammation approximating 1 year after recovery: Assessing the long-term outcomes in COVID-19 patients.	Am J Hematol
35477027	Anti-inflammatory and immune therapy in severe coronavirus disease 2019 (COVID-19) patients: An update.	Clin Immunol
35475648	Status of Humoral and Cellular Immune Responses within 12 Months following CoronaVac Vaccination against COVID-19.	mBio
35473709	Diagnosis and management of covid-19 in pregnancy.	BMJ
35472304	Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.	Lancet Respir Med
35471956	Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases.	JCI Insight
35470980	Characterization of coagulopathy and outcomes in cancer patients with severe COVID -19 illness: Longitudinal changes in hospitalized cancer patients.	Cancer Med
35469826	Safety considerations of chloroquine in the treatment of patients with diabetes and COVID-19.	Chem Biol Interact
35468992	Transcriptional regulation and small compound targeting of ACE2 in lung epithelial cells.	Acta Pharmacol Sin
35468580	Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D.	Biomed Pharmacother
35468147	SARS-CoV2 wild type and mutant specific humoral and T cell immunity is superior after vaccination than after natural infection.	PLoS One
35467316	Stringent public health measures during COVID-19 across ischemic stroke care systems: the potential impact of patient perceptions on health care-seeking behaviors.	Geroscience
35466734	Lipocalin-2, S100A8/A9, and cystatin C: Potential predictive biomarkers of cardiovascular complications in COVID-19.	Exp Biol Med (Maywood)
35464466	Regulation of Proinflammatory Molecules and Tissue Factor by SARS-CoV-2 Spike Protein in Human Placental Cells: Implications for SARS-CoV-2 Pathogenesis in Pregnant Women.	Front Immunol
35464396	Multi-Omics Integration Reveals Only Minor Long-Term Molecular and Functional Sequelae in Immune Cells of Individuals Recovered From COVID-19.	Front Immunol
35464048	Comorbidities and laboratory parameters associated with SARS-CoV-2 infection severity in patients from the southeast of Mexico: a cross-sectional study.	F1000Res
35463996	Triadic Dimensionalities: Knowledge, Movement, and Cultural Discourse-in the Wake of the Covid-19 Pandemic.	Int J Semiot Law
35463461	COVID-19 susceptibility, severity, clinical outcome and Toll-like receptor (7) mRNA expression driven by TLR7 gene polymorphism (rs3853839) in middle-aged individuals without previous comorbidities.	Gene Rep
35462039	Humoral and cellular responses to spike of delta SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases.	Int J Infect Dis
35461335	Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine.	Sci Rep
35461173	Evaluation of the relationship between IL-6 gene single nucleotide polymorphisms and the severity of COVID-19 in an Iranian population.	Cytokine
35460571	SARS-CoV-2 infection of human-induced pluripotent stem cells-derived lung lineage cells evokes inflammatory and chemosensory responses by targeting mitochondrial pathways.	J Cell Physiol
35460059	COVID-19 stressors and symptoms of depression and anxiety among Black cisgender sexual minority men and Black transgender women during the initial peak of the COVID-19 pandemic.	Soc Psychiatry Psychiatr Epidemiol
35459226	Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology.	Microbiome
35458517	Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients.	Viruses
35455334	Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response.	Vaccines (Basel)
35455306	Severe Breakthrough COVID-19 Cases during Six Months of Delta Variant (B.1.617.2) Domination in Poland.	Vaccines (Basel)
35454970	Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm.	Life (Basel)
35454369	New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress.	Medicina (Kaunas)
35454123	Cytokine Profile and Anti-Inflammatory Activity of a Standardized Conditioned Medium Obtained by Coculture of Monocytes and Mesenchymal Stromal Cells (PRS CK STORM).	Biomolecules
35453934	Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2.	Diagnostics (Basel)
35453871	The Utility of Laboratory Parameters for Cardiac Inflammation in Heart Failure Patients Hospitalized with SARS-CoV-2 Infection.	Diagnostics (Basel)
35453074	Vincamine, an active constituent of Vinca rosea ameliorates experimentally induced acute lung injury in Swiss albino mice through modulation of Nrf-2/NF-kappaB signaling cascade.	Int Immunopharmacol
35450509	Evaluation of the toxicological effects of favipiravir (T-705) on liver and kidney in rats: biochemical and histopathological approach.	Drug Chem Toxicol
35449446	Evaluation of maternal-infant dyad inflammatory cytokines in pregnancies affected by maternal SARS-CoV-2 infection in early and late gestation.	J Perinatol
35447311	Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure.	Clin Immunol
35446232	Metronidazole, acyclovir and tetrahydrobiopterin may be promising to treat COVID-19 patients, through interaction with interleukin-12.	J Biomol Struct Dyn
35445260	Identifying factors contributing to increased susceptibility to COVID-19 risk: a systematic review of Mendelian randomization studies.	Int J Epidemiol
35444637	Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients.	Front Immunol
35443481	To Study the Clinical Profile of Thromboembolic Events in Covid 19 Patients.	J Assoc Physicians India
35440370	Beneficial ex vivo immunomodulatory and clinical effects of clarithromycin in COVID-19.	J Infect Chemother
35440319	Prevalence, Presentation and Outcome of Secondary Bloodstream Infections among COVID-19 Patients.	Infect Disord Drug Targets
35439957	The role and diagnostic accuracy of serology for COVID-19.	BMC Infect Dis
35438067	Hospital-Acquired COVID-19 among Patients of Two Acute-Care Hospitals: Implications for Surveillance.	Infect Control Hosp Epidemiol
35437772	Effect of BTN162b2 and CoronaVac boosters on humoral and cellular immunity of individuals previously fully vaccinated with CoronaVac against SARS-CoV-2: A longitudinal study.	Allergy
35436049	Polymorphism in promotor region of IL6 gene as a predictor for severity in COVID -19 patients.	Egypt J Immunol
35434745	A new mouse unilateral model of diffuse alveolar damage of the lung.	Inflamm Res
35432769	Mesenchymal stromal cell delivery as a potential therapeutic strategy against COVID-19: Promising evidence from in vitro results.	World J Biol Chem
35431536	Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?	Bull Natl Res Cent
35428735	Subacute thyroiditis following recovery from COVID-19 infection: novel clinical findings from an Eastern Indian cohort.	Postgrad Med J
35427985	Subtractive proteomics assisted therapeutic targets mining and designing ensemble vaccine against Candida auris for immune response induction.	Comput Biol Med
35426250	Colonization of nasal cavities by Staphylococcus epidermidis mitigates SARS-CoV-2 nucleocapsid phosphoprotein-induced interleukin (IL)-6 in the lung.	Microb Biotechnol
35425776	Hyperinflammatory State and Low T1 Adaptive Immune Response in Severe and Critical Acute COVID-19 Patients.	Front Med (Lausanne)
35423848	Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach.	RSC Adv
35422810	Alterations of Urinary Microbial Metabolites and Immune Indexes Linked With COVID-19 Infection and Prognosis.	Front Immunol
35422799	Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection.	Front Immunol
35422571	Dexamethasone and Nutraceutical Therapy Can Reduce the Myalgia Due to COVID-19 - a Systemic Review of the Active Substances that Can Reduce the Expression of Interlukin-6.	Med Arch
35422374	Interleukin-6 inhibitors reduce mortality in coronavirus disease-2019: An individual patient data meta-analysis from randomized controlled trials.	Eur J Intern Med
35421875	A Houttuynia cordata-based Chinese herbal formula improved symptoms of allergic rhinitis during the COVID-19 pandemic.	J Chin Med Assoc
35421418	Routine laboratory parameters, including complete blood count, predict COVID-19 in-hospital mortality in geriatric patients.	Mech Ageing Dev
35421120	Dysregulation of the leukocyte signaling landscape during acute COVID-19.	PLoS One
35420915	Immune Pathways in Etiology, Acute Phase, and Chronic Sequelae of Ischemic Stroke.	Circ Res
35415890	Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response.	Clin Transl Med
35414513	Technical Note: Negative Interference of Ashwagandha, an Indian Ayurveda Medicine Indicated for Preventing COVID-19, in IL-6 Immunoassay.	Ann Clin Lab Sci
35414120	Endothelial dysfunction and angiogenesis: what is missing from COVID-19 and cannabidiol story?	J Cannabis Res
35413241	Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity.	Cell
35409462	The Impact of the COVID-19 Virus Pandemic on the Incidence of First Psychotic Spectrum Disorders.	Int J Environ Res Public Health
35409421	In Vitro SARS-CoV-2 Infection of Microvascular Endothelial Cells: Effect on Pro-Inflammatory Cytokine and Chemokine Release.	Int J Mol Sci
35408809	Diagnostic and Therapeutic Potential for HNP-1, HBD-1 and HBD-4 in Pregnant Women with COVID-19.	Int J Mol Sci
35406667	Neutrophil Extracellular Traps in Severe SARS-CoV-2 Infection: A Possible Impact of LPS and (1-->3)-beta-D-glucan in Blood from Gut Translocation.	Cells
35403089	Research on the mechanism of berberine in the treatment of COVID-19 pneumonia pulmonary fibrosis using network pharmacology and molecular docking.	Phytomed Plus
35403084	The potential of BEN815 as an anti-inflammatory, antiviral and antioxidant agent for the treatment of COVID-19.	Phytomed Plus
35401811	An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages.	Theranostics
35401543	Cannabidiol and SARS-CoV-2 Infection.	Front Immunol
35401504	Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination.	Front Immunol
35401158	Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro.	Front Pharmacol
35400594	Rapid potency assessment of autologous peripheral blood stem cells by intracellular flow cytometry: the PBSC-IL-3-pSTAT5 assay.	Cytotherapy
35399819	Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic.	Phytomed Plus
35398721	Up-regulated serum levels of interleukin (IL)-17A and IL-22 in Egyptian pediatric patients with COVID-19 and MIS-C: Relation to the disease outcome.	Cytokine
35398099	Structural basis of human IL-18 sequestration by the decoy receptor IL-18 binding protein in inflammation and tumor immunity.	J Biol Chem
35397798	Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis.	Lancet Respir Med
35397768	Hyperinflammation Reduces Midazolam Metabolism in Critically Ill Adults with COVID-19.	Clin Pharmacokinet
35397248	Pro-inflammatory immune profile mediated by TNF and IFN-gamma and regulated by IL-10 is associated to IgG anti-SARS-CoV-2 in asymptomatic blood donors.	Cytokine
35394529	Patients With Inflammatory Bowel Diseases Have Impaired Antibody Production After Anti-SARS-CoV-2 Vaccination: Results From a Panhellenic Registry.	Inflamm Bowel Dis
35394249	COVID-19 Clinical Presentation Among HIV-Infected Persons in China: A Systematic Review.	Curr HIV/AIDS Rep
35390234	A hypothesis that Notopterol may be effective in COVID-19 via JAK/STAT and other signaling pathways.	J Basic Clin Physiol Pharmacol
35390178	Applying Modeling and Simulations for Rational Dose Selection of Novel Toll-Like Receptor 7/8 Inhibitor Enpatoran for Indications of High Medical Need.	Clin Pharmacol Ther
35389124	Potential plants for inflammatory dysfunction in the SARS-CoV-2 infection.	Inflammopharmacology
35388498	Evaluation of interleukin-38 levels in serum of patients with coronavirus disease 2019.	J Med Virol
35387347	Exploration of Q-Marker of Rhubarb Based on Intelligent Data Processing Techniques and the AUC Pooled Method.	Front Pharmacol
35386702	Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival.	Front Immunol
35386227	Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression.	Heliyon
35385549	Structure-based 3D-Pharmacophore modeling to discover novel interleukin 6 inhibitors: An in silico screening, molecular dynamics simulations and binding free energy calculations.	PLoS One
35385545	D-dimer and CoV-2 spike-immune complexes contribute to the production of PGE2 and proinflammatory cytokines in monocytes.	PLoS Pathog
35383273	Relationship of anti-SARS-CoV-2 IgG antibodies with Vitamin D and inflammatory markers in COVID-19 patients.	Sci Rep
35382723	Potential Neuroprotective Effect of Cannabinoids in COVID-19 Patients.	Curr Top Med Chem
35382510	A young child with pediatric multisystem inflammatory syndrome successfully treated with high-dose immunoglobulin therapy.	IDCases
35382199	Relationship of Computed Tomography Severity Score With Patient Characteristics and Survival in Hypoxemic COVID-19 Patients.	Cureus
35381532	Inhalation of nebulized omega-3 fatty acids mitigate LPS-induced acute lung inflammation in rats: Implications for treatment of COPD and COVID-19.	Prostaglandins Leukot Essent Fatty Acids
35381137	MAIT Cells in Respiratory Viral Infections in Mouse and Human.	Crit Rev Immunol
35381016	Detection of SARS-CoV-2 infection by microRNA profiling of the upper respiratory tract.	PLoS One
35380521	Laboratory parameters associated with prolonged hospital length of stay in COVID-19 patients in Johannesburg, South Africa.	S Afr Med J
35379748	Distinct Cellular Immune Responses to SARS-CoV-2 in Pregnant Women.	J Immunol
35379747	Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients.	J Immunol
35379386	Association Between Vitamin D Levels and Inflammatory Markers in COVID-19 Patients: A Meta-Analysis of Observational Studies.	J Pharm Pharm Sci
35379329	Potential effect of amniotic fluid-derived stem cells on hyperoxia-induced pulmonary alveolar injury.	Stem Cell Res Ther
35373052	AKI in COVID-19-Associated Multisystem Inflammatory Syndrome in Children (MIS-C).	Kidney360
35372732	Bihemispheric ischemic strokes in patients with COVID-19.	Brain Circ
35372407	Relationship Between Endothelial and Angiogenesis Biomarkers Envisage Mortality in a Prospective Cohort of COVID-19 Patients Requiring Respiratory Support.	Front Med (Lausanne)
35371880	Post-COVID-19 Pulmonary Fibrosis.	Cureus
35371610	Synergistic Effects of Multiple Factors Involved in COVID-19-dependent Muscle Loss.	Aging Dis
35371043	Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2.	Front Immunol
35370292	[The &quot;redisorganisation&quot; of the Italian Healthcare Service].	Ig Sanita Pubbl
35368387	Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study.	Lancet Rheumatol
35368385	IL-1 receptor antagonist, MIS-C, and the peculiar autoimmunity of SARS-CoV-2.	Lancet Rheumatol
35368020	A genetic variant in IL-6 lowering its expression is protective for critical patients with COVID-19.	Signal Transduct Target Ther
35367669	Novel approach by natural language processing for COVID-19 knowledge discovery.	Biomed J
35366783	The Effect of Aspirin on the Prevention of Pro-thrombotic States in Hospitalized COVID-19 Patients: Systematic Review.	Cardiovasc Hematol Agents Med Chem
35366469	Clinical data mining reveals Gancao-Banxia as a potential herbal pair against moderate COVID-19 by dual binding to IL-6/STAT3.	Comput Biol Med
35366343	Angiotensin-converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end-stage kidney disease.	Eur J Clin Invest
35366176	Diacerein ameliorates acetaminophen hepatotoxicity in rats via inhibiting HMGB1/TLR4/NF-kappaB and upregulating PPAR-gamma signal.	Mol Biol Rep
35365215	Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro.	Chin Med
35363187	The association of clinical features and laboratory findings of COVID-19 infection with computed pneumonia volume.	Medicine (Baltimore)
35363081	The Age-Dependent Role of Th22, Tc22, and Tc17 Cells in the Severity of Pneumonia in COVID-19 Immunopathogenesis.	Viral Immunol
35361913	Serum IL-28A/IFN-lambda2 is linked to disease severity of COVID-19.	Sci Rep
35360982	The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients.	Clin Appl Thromb Hemost
35359931	Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation.	Front Immunol
35358903	Clinical monitored in subjects metabolically healthy and unhealthy before and during a SARS-CoV-2 infection- A cross-sectional study in Mexican population.	Cytokine
35358610	Lung targeted liposomes for treating ARDS.	J Control Release
35357792	The study of serum hsCRP, ferritin, IL-6 and plasma D-dimer in COVID-19: a retrospective study.	Horm Mol Biol Clin Investig
35357063	Antioxidant/anti-inflammatory effect of Mg(2+) in coronavirus disease 2019 (COVID-19).	Rev Med Virol
35356392	Tocilizumab-Associated Small Bowel Perforation in a Young Patient With Rheumatoid Arthritis: A Lesson to Remember During COVID-19 Pandemic.	J Med Cases
35353667	SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13.	Proc Natl Acad Sci U S A
35352005	The difference of the inflammatory milieu in MIS-C and severe COVID-19.	Pediatr Res
35350784	Kinetics of Severity Biomarkers and Immunological Features of Methylprednisolone Therapy for Severe COVID-19 Patients.	Front Immunol
35350780	How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment.	Front Immunol
35350754	Inspiration for COVID-19 Treatment: Network Analysis and Experimental Validation of Baicalin for Cytokine Storm.	Front Pharmacol
35350578	Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis.	Front Med (Lausanne)
35350438	Unvaccinated Children Are an Important Link in the Transmission of SARS-CoV-2 Delta Variant (B1.617.2): Comparative Clinical Evidence From a Recent Community Surge.	Front Cell Infect Microbiol
35349827	T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19.	EBioMedicine
35349756	Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology.	Immun Inflamm Dis
35346253	Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19.	Virol J
35345417	SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.	Lancet Microbe
35344028	Immunothrombosis and the molecular control of tissue factor by pyroptosis: prospects for new anticoagulants.	Biochem J
35343786	Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8.	mBio
35343470	[The OIBOH Registry (Optimal Intensification therapy in a Broad Observed High risk patient population with coronary disease): an Italian observational study of secondary prevention after a coronary event during the pandemic COVID-19 outbreak].	G Ital Cardiol (Rome)
35343397	Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis.	Emerg Microbes Infect
35342986	Computational profiling of natural compounds as promising inhibitors against the spike proteins of SARS-CoV-2 wild-type and the variants of concern, viral cell-entry process, and cytokine storm in COVID-19.	J Cell Biochem
35341398	Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia.	Ann Med
35340920	COVID-19 Mortality in Children: A Referral Center Experience from Iran (Mofid Children's Hospital, Tehran, Iran).	Can J Infect Dis Med Microbiol
35340805	Immunotherapy of COVID-19: Inside and Beyond IL-6 Signalling.	Front Immunol
35340244	Using a System Pharmacology Method to Search for the Potential Targets and Pathways of Yinqiaosan against COVID-19.	J Healthc Eng
35339280	Tranilast as an Adjunctive Therapy in Hospitalized Patients with Severe COVID- 19: A Randomized Controlled Trial.	Arch Med Res
35338116	STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS).	Cell Death Dis
35337143	Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial.	Pharmaceuticals (Basel)
35336973	COVID-19 Vaccination Limits Systemic Danger Signals in SARS-CoV-2 Infected Patients.	Viruses
35336941	Inducible Nitric Oxide Synthase (iNOS): Why a Different Production in COVID-19 Patients of the Two Waves?	Viruses
35336937	Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin.	Viruses
35336861	Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in Healthcare Workers and COVID-19 Patients.	Viruses
35335635	Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence.	Pathogens
35335006	Lack of Induction of RBD-Specific Neutralizing Antibodies despite Repeated Heterologous SARS-CoV-2 Vaccination Leading to Seroconversion and Establishment of T Cell-Specific Memory in a Patient in Remission of Multiple Myeloma.	Vaccines (Basel)
35334359	Predictors of poor outcome in tocilizumab treated patients with Sars-CoV-2 related severe respiratory failure: A multicentre real world study.	Int Immunopharmacol
35332841	Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.	Immunol Invest
35332327	IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines.	Nat Immunol
35331045	Intravenous N-Acetylcysteine in Management of COVID-19: A Case Series.	J Pharm Pract
35330839	17alpha-Hydroxyprogesterone Caproate Inhibits Cytokine Production via Suppression of NF-kappaB Activation.	Front Pharmacol
35330391	Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome.	J Pers Med
35330086	High Dose Intravenous Vitamin C as Adjunctive Therapy for COVID-19 Patients with Cancer: Two Cases.	Life (Basel)
35329121	Effects of Resistance Training on C-Reactive Protein and Inflammatory Cytokines in Elderly Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.	Int J Environ Res Public Health
35328649	SARS-CoV-2 Associated Immune Dysregulation and COVID-Associated Pulmonary Aspergilliosis (CAPA): A Cautionary Tale.	Int J Mol Sci
35327516	Involvement of Il-33 in the Pathogenesis and Prognosis of Major Respiratory Viral Infections: Future Perspectives for Personalized Therapy.	Biomedicines
35327420	Immune-Mediated Inflammatory Responses of Alveolar Epithelial Cells: Implications for COVID-19 Lung Pathology.	Biomedicines
35326695	Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO).	Cancers (Basel)
35325595	Facile discovery of surrogate cytokine agonists.	Cell
35323932	Facilitating Safe Discharge Through Predicting Disease Progression in Moderate Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study to Develop and Validate a Clinical Prediction Model in Resource-Limited Settings.	Clin Infect Dis
35323082	Il-6, Il-1beta and cytokine-targeted therapy for COVID -19 patients: two more reasons to take into account statins?	Expert Rev Cardiovasc Ther
35321737	Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives.	Stem Cell Res Ther
35320939	Aorta in Pathologies May Function as an Immune Organ by Upregulating Secretomes for Immune and Vascular Cell Activation, Differentiation and Trans-Differentiation-Early Secretomes may Serve as Drivers for Trained Immunity.	Front Immunol
35320917	TB and COVID-19: An Exploration of the Characteristics and Resulting Complications of Co-infection.	Front Biosci (Schol Ed)
35320627	Prospective analysis of laboratory blood parameters in patients with cardiovascular diseases who underwent COVID-19-associated pneumonia.	Klin Lab Diagn
35320494	Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR.	Inflammopharmacology
35319722	Human autoantibodies underlying infectious diseases.	J Exp Med
35319335	Low dose radiation therapy attenuates ACE2 depression and inflammatory cytokines induction by COVID-19 viral spike protein in human bronchial epithelial cells.	Int J Radiat Biol
35318338	Angiopathic activity of LRG1 is induced by the IL-6/STAT3 pathway.	Sci Rep
35317812	Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).	J Transl Med
35313959	Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial.	Stem Cell Res Ther
35310397	Neutralizing Antibodies and Cellular Immune Responses Against SARS-CoV-2 Sustained One and a Half Years After Natural Infection.	Front Microbiol
35309297	Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis.	Front Immunol
35308552	Mortality and Pulmonary Embolism in Acute Respiratory Distress Syndrome From COVID-19 vs. Non-COVID-19.	Front Med (Lausanne)
35308307	Tocilizumab, an Exploratory Treatment for Severe COVID-19 Patients.	Can J Infect Dis Med Microbiol
35307003	Increased ACE2, sRAGE, and immune activation, but lowered calcium and magnesium in COVID-19.	Recent Adv Inflamm Allergy Drug Discov
35306774	Vaut-il la peine de vacciner contre SARS-CoV-2 les patients ayant recu des therapies anti-CD20 ? Oui, mais a certaines conditions.	Rev Med Suisse
35304157	Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH).	J Allergy Clin Immunol
35303909	Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab.	J Transl Med
35300337	Reduced T Cell and Antibody Responses to Inactivated Coronavirus Vaccine Among Individuals Above 55 Years Old.	Front Immunol
35299779	Neuro-axonal injury in COVID-19: the role of systemic inflammation and SARS-CoV-2 specific immune response.	Ther Adv Neurol Disord
35299613	MOG Antibody-Associated Disorders Following SARS-CoV-2 Vaccination: A Case Report and Literature Review.	Front Neurol
35298440	RAGE has potential pathogenetic and prognostic value in nonintubated hospitalized patients with COVID-19.	JCI Insight
35297493	Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019.	J Infect Dis
35296346	Autoimmunity is a hallmark of post-COVID syndrome.	J Transl Med
35295802	A Review: The Manifestations, Mechanisms, and Treatments of Musculoskeletal Pain in Patients With COVID-19.	Front Pain Res (Lausanne)
35295608	Vaccination for SARS-CoV-2 in Patients With Psoriatic Arthritis: Can Therapy Affect the Immunological Response?	Front Med (Lausanne)
35293799	Diagnostic Performance of Six Rapid Antigen Tests for SARS-CoV-2.	Microbiol Spectr
35293744	Aspulvins A-H, Aspulvinone Analogues with SARS-CoV-2 M(pro) Inhibitory and Anti-inflammatory Activities from an Endophytic Cladosporium sp.	J Nat Prod
35293289	Selected phytochemicals to combat lungs injury: Natural care.	Comb Chem High Throughput Screen
35291694	A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19.	Med (N Y)
35291542	Multiple Ischemic Strokes Due to Multisystem Inflammatory Syndrome in Adults (MIS-A).	Cureus
35291195	Interleukin-6 is upregulated and may be associated with myocardial injury in some patients who have recovered from COVID-19.	Glob Health Med
35289960	Cellular and Humoral Immunity to SARS-CoV-2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease-Modifying Therapies: A Multi-Ethnic Observational Study.	Ann Neurol
35285608	Corrigendum to Gathmyr D, Maruhum Bonar M, Susilo A, Harimurti K. "The relationship between IL-6, IL-10, TNF-alpha with AKI in moderate and severe COVID-19 patients [abstract POS-014]." Kidney Int Rep. 2022;7(suppl 1):S6.	Kidney Int Rep
35284826	SARS-CoV-2 S Protein Subunit 1 Elicits Ca(2+) Influx - Dependent Ca(2+) Signals in Pancreatic Stellate Cells and Macrophages In Situ.	Function (Oxf)
35284646	Interleukin-29 profiles in COVID-19 patients: Survival is associated with IL-29 levels.	Health Sci Rep
35283947	Predictive hematological and immunological parameters associated with postpartum progressed Covid-19 disease.	Afr Health Sci
35283631	Vascular Dysfunction and Its Cardiovascular Consequences During and After COVID-19 Infection: A Narrative Review.	Vasc Health Risk Manag
35281571	The Potential Predictive Role of Tumour Necrosis Factor-alpha, Interleukin-1beta, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival.	Infect Drug Resist
35281402	Knowledge and performance of the Iranian general population in the use of masks during the 2019 coronavirus.	J Educ Health Promot
35281046	Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine.	Front Immunol
35281029	Simian Immunodeficiency Virus Infection Mediated Changes in Jejunum and Peripheral SARS-CoV-2 Receptor ACE2 and Associated Proteins or Genes in Rhesus Macaques.	Front Immunol
35280992	SARS-CoV-2 Induces Cytokine Responses in Human Basophils.	Front Immunol
35280907	Subcutaneous IL-6 Inhibitor Sarilumab vs. Standard Care in Hospitalized Patients With Moderate-To-Severe COVID-19: An Open Label Randomized Clinical Trial.	Front Med (Lausanne)
35280425	Network pharmacology and molecular docking analysis reveals the mechanism of asiaticoside on COVID-19.	Ann Transl Med
35279628	Home-based aerobic training and vitamin D improve neurotrophins and inflammatory biomarkers in MS patients.	Mult Scler Relat Disord
35277472	New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts.	Cell Death Discov
35274908	Effectiveness of Tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real life study.	Panminerva Med
35273735	Treatment efficacy of Lianhua Qingwen capsules for eraly-stage COVID-19.	Am J Transl Res
35273611	Dominant CD8(+) T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination.	Front Immunol
35272139	Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19.	Biomed Pharmacother
35266905	Advances in the epidemiology, clinical features, diagnosis, clinical management and prevention of coronavirus disease 2019.	Curr Opin Pulm Med
35265086	Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies.	Front Immunol
35264878	Secondary Infections in Patients with COVID-19 Pneumonia Treated with Tocilizumab Compared to Those Not Treated with Tocilizumab: A Retrospective Study at a Tertiary Hospital in Kenya.	Int J Gen Med
35263747	First-Trimester SARS-CoV-2 Infection: Clinical Presentation, Inflammatory Markers, and Obstetric Outcomes.	Fetal Diagn Ther
35262035	Case series of HIV SARS-CoV-2 co-infection in Chinese adults.	J Clin Virol Plus
35261923	AMP5A modulates Toll-like receptors 7 and 8 single-stranded RNA immune responses in PMA-differentiated THP-1 and PBMC.	Transl Med Commun
35261665	Vitamin D and COVID-19 - Let's Explore the Relationship!	Maedica (Bucur)
35261664	Association of Inflammatory Markers with COVID-19 Outcome among Hospitalized Patients: Experience from a Tertiary Healthcare Center in Western India.	Maedica (Bucur)
35260945	An overview of the biological and multifunctional roles of IL-38 in different infectious diseases and COVID-19.	Immunol Res
35259186	Association of renalase with clinical outcomes in hospitalized patients with COVID-19.	PLoS One
35258807	Influence of exercise and vitamin D on the immune system against Covid-19: an integrative review of current literature.	Mol Cell Biochem
35258122	Characterization of memory T cell subsets and common gamma-chain cytokines in convalescent COVID-19 individuals.	J Leukoc Biol
35256513	LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity.	Life Sci Alliance
35254021	Deficiency of Vitamin D, a Major Risk Factor for SARS-CoV-2 Severity.	Clin Lab
35252093	Flavonoids for Treating Viral Acute Respiratory Tract Infections: A Systematic Review and Meta-Analysis of 30 Randomized Controlled Trials.	Front Public Health
35251909	Mechanistic insights from the review and evaluation of ayurvedic herbal medicines for the prevention and management of COVID-19 patients.	J Herb Med
35251905	COVID-19's impact on lung tissue: A case report.	Int J Surg Case Rep
35251595	Case Report: Asymptomatic COVID-19 patient with a subtle hypercoagulable state and fluctuating D-dimer level.	F1000Res
35251049	Increased Interleukin 18-Dependent Immune Responses Are Associated With Myopericarditis After COVID-19 mRNA Vaccination.	Front Immunol
35250984	A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.	Front Immunol
35250975	Increased Expression of Tim-3 Is Associated With Depletion of NKT Cells In SARS-CoV-2 Infection.	Front Immunol
35249135	High levels of extracellular ATP lead to different inflammatory responses in COVID-19 patients according to the severity.	J Mol Med (Berl)
35248063	Association between inflammatory cytokines and anti-SARS-CoV-2 antibodies in hospitalized patients with COVID-19.	Immun Ageing
35246750	IL-6 serum level and olfactory dysfunction severity in COVID-19: correspondence.	Eur Arch Otorhinolaryngol
35246280	Findings From Mayo Clinic's Post-COVID Clinic: PASC Phenotypes Vary by Sex and Degree of IL-6 Elevation.	Mayo Clin Proc
35242747	Interleukin-6 Test Strip Combined With a Spectrum-Based Optical Reader for Early Recognition of COVID-19 Patients With Risk of Respiratory Failure.	Front Bioeng Biotechnol
35240959	HDAC Inhibition as Neuroprotection in COVID-19 Infection.	Curr Top Med Chem
35237703	Serologic and Cytokine Signatures in Children With Multisystem Inflammatory Syndrome and Coronavirus Disease 2019.	Open Forum Infect Dis
35237386	D-dimer, CRP, PCT, and IL-6 Levels at Admission to ICU Can Predict In-Hospital Mortality in Patients with COVID-19 Pneumonia.	Oxid Med Cell Longev
35237279	Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure.	Front Immunol
35237162	Increased Circulating Cytokines Have a Role in COVID-19 Severity and Death With a More Pronounced Effect in Males: A Systematic Review and Meta-Analysis.	Front Pharmacol
35233394	Anxiety, stress and depression levels among nurses of educational hospitals in Iran: Time of performing nursing care for suspected and confirmed COVID-19 patients.	J Educ Health Promot
35233153	Evaluating the structural and immune mechanism of Interleukin-6 for the investigation of goat milk peptides as potential treatments for COVID-19.	J King Saud Univ Sci
35231754	Decidual immune response following COVID-19 during pregnancy varies by timing of maternal SARS-CoV-2 infection.	J Reprod Immunol
35230977	In-depth analysis of SARS-CoV-2-specific T cells reveals diverse differentiation hierarchies in vaccinated individuals.	JCI Insight
35228783	An open labeled, randomized, controlled clinical study to evaluate the efficacy of Torchnil capsules and Febcin tablet as add-on therapy for Covid-19 patients.	J Ayurveda Integr Med
35227178	Therapeutic Mechanism of Xiaoqinglong Decoction against COVID-19 Based on Network Pharmacology and Molecular Docking Technology.	Comb Chem High Throughput Screen
35223745	Targeting TNF-alpha for COVID-19: Recent Advanced and Controversies.	Front Public Health
35222429	Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults.	Front Immunol
35222320	Potential of Bacillus subtilis Against SARS-CoV-2 - A Sustainable Drug Development Perspective.	Front Microbiol
35222040	Exploring the Anti-Pulmonary Fibrosis Mechanism of Jingyin Granule by Network Pharmacology Strategy.	Front Pharmacol
35219277	Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial.	Clin Infect Dis
35218276	Seroconversion after anti-SARS-CoV-2 mRNA vaccinations among moderate-to-severe psoriatic patients receiving systemic biologicals-Prospective observational cohort study.	Dermatol Ther
35217407	Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications.	EBioMedicine
35215969	Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells.	Viruses
35215940	T Cell Response following Anti-COVID-19 BNT162b2 Vaccination Is Maintained against the SARS-CoV-2 Omicron B.1.1.529 Variant of Concern.	Viruses
35215365	Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case-Control Study.	Pharmaceuticals (Basel)
35215266	Exploring Toxins for Hunting SARS-CoV-2 Main Protease Inhibitors: Molecular Docking, Molecular Dynamics, Pharmacokinetic Properties, and Reactome Study.	Pharmaceuticals (Basel)
35215199	SARS-CoV-2 Infects Primary Neurons from Human ACE2 Expressing Mice and Upregulates Genes Involved in the Inflammatory and Necroptotic Pathways.	Pathogens
35215138	The Association between TNF-alpha, IL-6, and Vitamin D Levels and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis.	Pathogens
35214755	Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review.	Vaccines (Basel)
35213582	Novel prognostic determinants of COVID-19-related mortality: A pilot study on severely-ill patients in Russia.	PLoS One
35213547	Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial.	PLoS One
35212647	Synergism of CD28 Immune Molecule in Late Immunosuppressive Phase of COVID-19: Effectiveness in Vaccinated Individuals.	Altern Ther Health Med
35212163	2-Deoxy-d-glucose induces deglycosylation of proinflammatory cytokine receptors and strongly reduces immunological responses in mouse models of inflammation.	Pharmacol Res Perspect
35210610	Interleukin 6 as an energy allocator in muscle tissue.	Nat Metab
35209989	Recent research on the application of biologics in the treatment of multisystem inflammatory syndrome in children after SARS-CoV-2 infection.	Zhongguo Dang Dai Er Ke Za Zhi
35208467	Cytokine Storm in COVID-19: Immunopathogenesis and Therapy.	Medicina (Kaunas)
35205926	Molecular Profiling Reveals Characteristic and Decisive Signatures in Patients after Allogeneic Stem Cell Transplantation Suffering from Invasive Pulmonary Aspergillosis.	J Fungi (Basel)
35204430	Analysis of Early Biomarkers Associated with the Development of Critical Respiratory Failure in Coronavirus Disease 2019 (COVID-19).	Diagnostics (Basel)
35204178	Assessment of Antioxidant, Immunomodulatory Activity of Oxidised Epigallocatechin-3-Gallate (Green Tea Polyphenol) and Its Action on the Main Protease of SARS-CoV-2-An In Vitro and In Silico Approach.	Antioxidants (Basel)
35203844	Treatment Outcomes of Tocilizumab in Critically-Ill COVID-19 Patients, Single-Centre Retrospective Study.	Antibiotics (Basel)
35203646	Molecular Insights of SARS-CoV-2 Antivirals Administration: A Balance between Safety Profiles and Impact on Cardiovascular Phenotypes.	Biomedicines
35203474	Circulating LIGHT (TNFSF14) and Interleukin-18 Levels in Sepsis-Induced Multi-Organ Injuries.	Biomedicines
35203438	Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease.	Biomedicines
35203299	Hypothesis: Emerging Roles for Aryl Hydrocarbon Receptor in Orchestrating CoV-2-Related Inflammation.	Cells
35201518	Inflawell((R)) improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial.	Inflammopharmacology
35200527	Efficacy of Single Tocilizumab Administration in an 88-Year-Old Patient with Severe COVID-19 and a Mini Literature Review.	Geriatrics (Basel)
35199888	Circulating B10 regulatory cells are decreased in severe and critical COVID-19.	J Leukoc Biol
35197719	A Review of Coronaviruses Associated With Kawasaki Disease: Possible Implications for Pathogenesis of the Multisystem Inflammatory Syndrome Associated With COVID-19.	Clin Med Insights Pediatr
35196819	Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays.	Microbiol Spectr
35194462	Positive role of continuous positive airway pressure for intensive care unit patients with severe hypoxaemic respiratory failure due to COVID-19 pneumonia: A single centre experience.	J Intensive Care Soc
35193654	The effects of L-carnitine supplementation on inflammatory factors, oxidative stress, and clinical outcomes in patients with sepsis admitted to the intensive care unit (ICU): study protocol for a double blind, randomized, placebo-controlled clinical trial.	Trials
35192635	COVID-19 IgG/IgM patterns, early IL-6 elevation and long-term radiological sequelae in 75 patients hospitalized due to interstitial pneumonia followed up from 3 to 12 months.	PLoS One
35192617	Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients.	PLoS One
35192547	CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination.	JCI Insight
35189802	Impact of Tocilizumab on Inflammatory Markers and Oxygen Status in Severe COVID-19 Patients: A Single Centre Retrospective Study.	Infect Disord Drug Targets
35187271	Decreased serum levels of angiotensin converting enzyme (ACE)2 and enhanced cytokine levels with severity of COVID-19: normalisation upon disease recovery.	Heliyon
35186275	Effectiveness of low-dose radiation therapy in COVID-19 patients globally: A systematic review.	F1000Res
35185912	Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy.	Front Immunol
35185571	Continuous Renal Replacement Therapy With oXiris Filter May Not be an Effective Resolution to Alleviate Cytokine Release Syndrome in Non-AKI Patients With Severe and Critical COVID-19.	Front Pharmacol
35181630	Technical Note: Bimodal Negative Interference of Biotin in Roche IL-6 Immunoassay.	Ann Clin Lab Sci
35180460	Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients.	Blood Cells Mol Dis
35180397	A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4.	Stem Cell Reports
35179604	Diagnostic and Prognostic Biomarkers of Coronavirus Disease 2019 in Children.	J Trop Pediatr
35179184	Repurposing low-dose naltrexone for the prevention and treatment of immunothrombosis in COVID-19.	Eur Heart J Cardiovasc Pharmacother
35178710	TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection.	EMBO J
35178272	Clinicolaboratory Profile, Treatment, Intensive Care Needs, and Outcome of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2: A Systematic Review and Meta-analysis.	J Pediatr Intensive Care
35177474	Targeting ectromelia virus and TNF/NF-kappaB or STAT3 signaling for effective treatment of viral pneumonia.	Proc Natl Acad Sci U S A
35177337	Mechanism for the attenuation of neutrophil and complement hyperactivity by MSC exosomes.	Cytotherapy
35176735	Fluctuations in Interleukin-6 Levels during Hemodialysis Sessions with Medium Cutoff Membranes: An Analysis on COVID-19 Case Series.	Blood Purif
35172759	Chronic diseases, chest computed tomography, and laboratory tests as predictors of severe respiratory failure and death in elderly Brazilian patients hospitalized with COVID-19: a prospective cohort study.	BMC Geriatr
35171706	Interleukin-1 Receptor-Like 2: One Receptor, Three Agonists, and Many Implications.	J Interferon Cytokine Res
35170078	Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID-19: An open-label pilot study.	J Gastroenterol Hepatol
35165529	Identifying absorbable bioactive constituents of Yupingfeng Powder acting on COVID-19 through integration of UPLC-Q/TOF-MS and network pharmacology analysis.	Chin Herb Med
35164548	Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets.	mBio
35164139	A New Butyrate Releaser Exerts a Protective Action against SARS-CoV-2 Infection in Human Intestine.	Molecules
35163833	AKR1B10, One of the Triggers of Cytokine Storm in SARS-CoV2 Severe Acute Respiratory Syndrome.	Int J Mol Sci
35163636	COVID-19 and Lung Mast Cells: The Kallikrein-Kinin Activation Pathway.	Int J Mol Sci
35160114	Laboratory Profile of COVID-19 Patients with Hepatitis C-Related Liver Cirrhosis.	J Clin Med
35157175	Citrus fruits are rich in flavonoids for immunoregulation and potential targeting ACE2.	Nat Prod Bioprospect
35157090	Cytokine producing ability of peripheral blood cells from COVID-19 patients after unspecific in vitro stimulation.	Inflamm Res
35156638	What are the main factors affecting the outcome of tocilizumab therapy in COVID-19-induced cytokine release syndrome?	Eur J Rheumatol
35156528	COVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study.	Leuk Lymphoma
35154139	Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria.	Front Immunol
35154066	Interleukin-1 Inhibitors and Vaccination Including COVID-19 in Inflammatory Rheumatic Diseases: A Nonsystematic Review.	Front Immunol
35152041	IL13Pred: A method for predicting immunoregulatory cytokine IL-13 inducing peptides.	Comput Biol Med
35150306	In reply to: IL-6 serum level and olfactory dysfunction severity in COVID-19: correspondence.	Eur Arch Otorhinolaryngol
35148782	Clinical outcomes after IL-6 blockade in patients with COVID-19 and HIV: a case series.	AIDS Res Ther
35147323	[Multisystemic inflammatory syndrome in children (MIS-C) associated with Covid].	Rev Prat
35147230	COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals-EAACI recommendations.	Allergy
35146763	The relationship between peripheral immune response and disease severity in SARS-CoV-2-infected subjects: A cross-sectional study.	Immunology
35146357	Infection risk with the use of interleukin inhibitors in hospitalized patients with COVID-19: A narrative review.	Infez Med
35146336	Current status of therapeutic alternatives for COVID-19: A narrative review.	Infez Med
35145559	Exploration of the Mechanism of Lianhua Qingwen in Treating Influenza Virus Pneumonia and New Coronavirus Pneumonia with the Concept of "Different Diseases with the Same Treatment" Based on Network Pharmacology.	Evid Based Complement Alternat Med
35145069	Blocking the human common beta subunit of the GM-CSF, IL-5 and IL-3 receptors markedly reduces hyperinflammation in ARDS models.	Cell Death Dis
35143839	The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin alpha5beta1 and NF-kappaB signaling.	J Biol Chem
35142777	Vasculature-on-a-chip platform with innate immunity enables identification of angiopoietin-1 derived peptide as a therapeutic for SARS-CoV-2 induced inflammation.	Lab Chip
35140709	The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAs.	Front Immunol
35140702	Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19?	Front Immunol
35138033	Scavenging ROS to Alleviate Acute Liver Injury by ZnO-NiO@COOH.	Adv Sci (Weinh)
35137532	A randomized, controlled, feasibility study of RD-X19 in subjects with mild-to-moderate COVID-19 in the outpatient setting.	Clin Transl Sci
35137414	Amyloid processing in COVID-19-associated neurological syndromes.	J Neurochem
35136705	Serum level estimation of some biomarkers in diabetic and non-diabetic COVID-19 infected patients.	Appl Nanosci
35136584	Inflammatory laboratory findings associated with severe illness among hospitalized individuals with COVID-19 in Medan, Indonesia: a cross-sectional study.	F1000Res
35135695	The Female-Predominant Persistent Immune Dysregulation of the Post-COVID Syndrome.	Mayo Clin Proc
35134736	Pathogenetic factors fanning the flames of COVID-19 to cause rhino-orbito-cerebral mucormycosis: An observational study.	J Mycol Med
35132595	Immunological and Hematological Response in COVID-19.	Adv Exp Med Biol
35131031	Investigating phenotypes of pulmonary COVID-19 recovery: A longitudinal observational prospective multicenter trial.	Elife
35128349	The interplay between SARS-CoV-2 infected airway epithelium and immune cells modulates regulatory/inflammatory signals.	iScience
35126884	Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing.	Comput Struct Biotechnol J
35126355	Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities.	Front Immunol
35126138	Specific Interleukin-1 Inhibitors, Specific Interleukin-6 Inhibitors, and GM-CSF Blockades for COVID-19 (at the Edge of Sepsis): A Systematic Review.	Front Pharmacol
35124011	A comprehensive assessment of long-term SARS-CoV-2-specific adaptive immune memory in convalescent COVID-19 Solid Organ Transplant recipients.	Kidney Int
35123303	Hemoperfusion during veno-venous ECMO in severe COVID-19 with IL-6 elevation.	Cytokine
35121489	Diagnostic accuracy of a rapid diagnostic test for the early detection of COVID-19.	J Clin Virol
35120332	Dihydroartemisinin attenuates pulmonary inflammation and fibrosis in rats by suppressing JAK2/STAT3 signaling.	Aging (Albany NY)
35118946	Post-COVID-19 arthritis: is it hyperinflammation or autoimmunity?	Eur Cytokine Netw
35115337	Effect of interleukin-6 receptor antagonists in critically ill adult patients with COVID-19 pneumonia: two randomised controlled trials of the CORIMUNO-19 Collaborative Group.	Eur Respir J
35114443	Systems pharmacology-based drug discovery and active mechanism of natural products for coronavirus pneumonia (COVID-19): An example using flavonoids.	Comput Biol Med
35113729	IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19.	Annu Rev Immunol
35113446	Utility of serum Galactomannan in diagnosing COVID-19 patients with suspected IPA: an observational study in resource limited settings.	Eur Rev Med Pharmacol Sci
35113267	Supporting Retention in HIV Care: Comparing In-Person and Telehealth Visits in a Chicago-Based Infectious Disease Clinic.	AIDS Behav
35113170	Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.	Inflamm Res
35111793	Effects of Vitamin D and K on Interleukin-6 in COVID-19.	Front Nutr
35111777	Inflammation-Induced Coagulopathy Substantially Differs Between COVID-19 and Septic Shock: A Prospective Observational Study.	Front Med (Lausanne)
35111161	Asthma Associated Cytokines Regulate the Expression of SARS-CoV-2 Receptor ACE2 in the Lung Tissue of Asthmatic Patients.	Front Immunol
35110842	Interleukin 6 and Its Correlation with COVID-19 in Terms of Outcomes in an Intensive Care Unit of a Rural Hospital:A Cross-sectional Study.	Indian J Crit Care Med
35109926	Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients.	Infect Dis Poverty
35107821	EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake CounTy, Illinois (CONTACT): Methodology and Baseline Characteristics of a Community-Based Surveillance Study.	Infect Dis Ther
35104727	Clinical and laboratory predictors at ICU admission affecting course of illness and mortality rates in a tertiary COVID-19 center.	Heart Lung
35104583	Psoriatic lesional expression of SARS-CoV-2 receptor ACE2 is reduced by blockade of IL-17 signaling but not by other biologic treatments.	J Am Acad Dermatol
35103207	Four Distinct Cases of Multisystem Inflammatory Syndrome in Adults Associated With SARS-CoV-2 Infection at a Community Hospital in New Jersey.	Cureus
35103112	An analysis of hematological, coagulation and biochemical markers in COVID-19 disease and their association with clinical severity and mortality: an Indian outlook.	Am J Blood Res
35101812	Evaluation of erythrocyte membrane fatty-acid compositions in association with interleukin-6 levels in patients with COVID-19.	Nutrition
35098177	Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.	Lancet Microbe
35097067	Methylprednisolone accelerate chest computed tomography absorption in COVID-19: A three-centered retrospective case control study from China.	World J Clin Cases
35095908	The beta-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19.	Front Immunol
35095880	Persistent Oxidative Stress and Inflammasome Activation in CD14(high)CD16(-) Monocytes From COVID-19 Patients.	Front Immunol
35095877	Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis.	Front Immunol
35095855	Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration.	Front Immunol
35095801	Interleukin-37: A Link Between COVID-19, Diabetes, and the Black Fungus.	Front Microbiol
35095519	The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome.	Front Pharmacol
35095231	Molecular docking analysis of potential compounds from an Indian medicinal soup "kabasura kudineer" extract with IL-6.	Bioinformation
35093528	Treatment with Tocilizumab in Adult Patients with Moderate to Critical COVID-19 Pneumonia: A Single-Center Retrospective Study.	Int J Infect Dis
35092836	The effect of IGF-1 plasma concentration on COVID-19 severity.	Microb Pathog
35092710	Kynurenine pathway in Coronavirus disease (COVID-19): Potential role in prognosis.	J Clin Lab Anal
35091065	Impact of SARS-CoV-2 on saliva: TNF-, IL-6, IL-10, lactoferrin, lysozyme, IgG, IgA, and IgM.	J Oral Biosci
35090528	Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients.	Crit Care
35090394	Comparison of cytokines levels among COVID-19 patients living at sea level and high altitude.	BMC Infect Dis
35090021	Duodenal Mucosal Expression of COVID-19-Related Genes in Health, Diabetic Gastroenteropathy, and Functional Dyspepsia.	J Clin Endocrinol Metab
35089406	Bradykinin-target therapies in SARS-CoV-2 infection: current evidence and perspectives.	Naunyn Schmiedebergs Arch Pharmacol
35089113	Delayed inflammation decrease is associated with mortality in Tocilizumab-treated critically ill SARS-CoV-2 patients: A retrospective matched-cohort analysis.	Innate Immun
35088968	[The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].	Mikrobiyol Bul
35087712	Antiviral and anti-inflammatory drugs to combat COVID-19: Effects on cardiac ion channels and risk of ventricular arrhythmias.	Bioimpacts
35087533	A Differential Signature of Circulating miRNAs and Cytokines Between COVID-19 and Community-Acquired Pneumonia Uncovers Novel Physiopathological Mechanisms of COVID-19.	Front Immunol
35086840	Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis.	Eur Respir J
35085577	The importance of accessory protein variants in the pathogenicity of SARS-CoV-2.	Arch Biochem Biophys
35085479	IL-13 Protects against SARS-CoV-2?	Am J Respir Cell Mol Biol
35085462	Tocilizumab-Induced Unexpected Increase of Several Inflammatory Cytokines in Critically Ill COVID-19 Patients: The Anti-Inflammatory Side of IL-6.	Viral Immunol
35085183	Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients.	Transplantation
35083423	Evaluation of I-TAC as a potential early plasma marker to differentiate between critical and non-critical COVID-19.	Cell Stress
35083241	Cytokine Hemoadsorption as Rescue Therapy for Critically Ill Patients With SARS-CoV-2 Pneumonia With Severe Respiratory Failure and Hypercytokinemia.	Front Med (Lausanne)
35080961	The 1918 Influenza Pandemic and the Rise of Italian Fascism: A Cross-City Quantitative and Historical Text Qualitative Analysis.	Am J Public Health
35080773	Interleukin-1 blocking agents for treating COVID-19.	Cochrane Database Syst Rev
35080097	Association between IL-10 systemic low level and highest pain score in patients during symptomatic SARS-CoV-2 infection.	Pain Pract
35079804	Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome.	J Infect Dis
35079746	Extensive mucosal sloughing of the small intestine and colon in a patient with severe COVID-19.	DEN open
35078662	Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine.	Vaccine
35077879	Patients with COVID-19 pneumonia with 25(OH)D levels lower than 12 ng/ml are at increased risk of death.	Int J Infect Dis
35076845	Blocking TNF signaling may save lives in COVID-19 infection.	Mol Biol Rep
35076790	Increased Gal-3BP plasma levels in hospitalized patients infected with SARS-CoV-2.	Clin Exp Med
35075682	Opposing roles for sMAdCAM and IL-15 in COVID-19 associated cellular immune pathology.	J Leukoc Biol
35075140	Galectin-1 as the new player in staging and prognosis of COVID-19.	Sci Rep
35075100	Virtual Screening and Molecular Docking to Study the Mechanism of Chinese Medicines in the Treatment of Coronavirus Infection.	Med Sci Monit
35074571	An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19).	Int Immunopharmacol
35073387	Langerhans cells and cDC1s play redundant roles in mRNA-LNP induced protective anti-influenza and anti-SARS-CoV-2 immune responses.	PLoS Pathog
35072887	A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab.	Adv Ther
35071823	Serum levels of vitamin D and immune system function in patients with COVID-19 admitted to intensive care unit.	Gene Rep
35071136	Transient Early Fine Motor Abnormalities in Infants Born to COVID-19 Mothers Are Associated With Placental Hypoxia and Ischemia.	Front Pediatr
35071113	A BRIEF SYNOPSIS OF MONOCLONAL ANTIBODY FOR THE TREATMENT OF VARIOUS GROUPS OF DISEASES.	World J Pharm Pharm Sci
35070297	Missed opportunities to identify cryptococcosis in COVID-19 patients: a case report and literature review.	Ther Adv Infect Dis
35069552	Cardiovascular Risk After SARS-CoV-2 Infection Is Mediated by IL18/IL18R1/HIF-1 Signaling Pathway Axis.	Front Immunol
35069542	A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics Analysis.	Front Immunol
35068763	Continuous Hemodiafiltration with the oXiris Filter Ameliorates Cytokine Storm and Induces Rapid Clinical Improvement in COVID-19 - A Case Report.	Indian J Nephrol
35068758	COVID-19 in CKD Patients: Report from India.	Indian J Nephrol
35068221	Hyperinflammation after anti-SARS-CoV-2 mRNA/DNA vaccines successfully treated with anakinra: Case series and literature review.	Exp Biol Med (Maywood)
35066912	Lipopolysaccharide induces acute lung injury and alveolar haemorrhage in association with the cytokine storm, coagulopathy and AT1R/JAK/STAT augmentation in a rat model that mimics moderate and severe Covid-19 pathology.	Clin Exp Pharmacol Physiol
35066302	SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway.	Virology
35066108	Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway.	Pharmacol Res
35065299	Interaction of ACEI antihypertensive agent's administration with the inflammatory status at admission concerning COVID-19 clinical stay outcomes.	Vascul Pharmacol
35064576	Immunological and virological aspects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and hepatitis C virus.	J Med Virol
35063722	Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis.	Cytokine
35062231	SARS-CoV-2 Variants of Concern Infect the Respiratory Tract and Induce Inflammatory Response in Wild-Type Laboratory Mice.	Viruses
35060899	Effects of IFIH1 rs1990760 variants on systemic inflammation and outcome in critically ill COVID-19 patients in an observational translational study.	Elife
35058480	Arrhythmogenic mechanisms of interleukin-6 combination with hydroxychloroquine and azithromycin in inflammatory diseases.	Sci Rep
35057809	Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.	J Neuroinflammation
35057437	Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clinical Trials.	Nutrients
35056592	SARS-CoV-2 Evolution and Spike-Specific CD4+ T-Cell Response in Persistent COVID-19 with Severe HIV Immune Suppression.	Microorganisms
35054524	A Comparative and Comprehensive Review of Antibody Applications in the Treatment of Lung Disease.	Life (Basel)
35054372	Assessing SARS-CoV-2 Neutralizing Antibodies after BNT162b2 Vaccination and Their Correlation with SARS-CoV-2 IgG Anti-S1, Anti-RBD and Anti-S2 Serological Titers.	Diagnostics (Basel)
35054342	Early Routine Biomarkers of SARS-CoV-2 Morbidity and Mortality: Outcomes from an Emergency Section.	Diagnostics (Basel)
35054223	A Multimodal Approach for the Risk Prediction of Intensive Care and Mortality in Patients with COVID-19.	Diagnostics (Basel)
35053224	Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19.	Biomolecules
35051738	COVID-19-induced pulmonary sarcoid: A case report and review of the literature.	Clin Imaging
35050236	Vitamin D Inhibits IL-6 Pro-Atherothrombotic Effects in Human Endothelial Cells: A Potential Mechanism for Protection against COVID-19 Infection?	J Cardiovasc Dev Dis
35048518	Changes in peripheral blood cellular morphology as diagnostic markers for COVID-19 infection.	Int J Lab Hematol
35046622	Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment.	World J Gastroenterol
35044570	The Priming Potential of Interferon Lambda-1 for Antiviral Defense in the Oral Mucosa.	Inflammation
35044234	Scrub typhus in two COVID-19 patients: a diagnostic dilemma.	Future Microbiol
35043641	Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome.	Physiol Res
35043384	Alterations in cortisol and interleukin-6 secretion in patients with COVID-19 suggestive of neuroendocrine-immune adaptations.	Endocrine
35043090	Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients.	Gene Rep
35040238	Usage of IL-6 antagonists in COVID-19: A challenge in children.	Respirology
35040210	Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial.	Phytother Res
35040086	Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis.	Clin Rev Allergy Immunol
35039243	SARS-CoV-2 infection. Descriptive analysis of a selected case series.	Rev Esp Anestesiol Reanim (Engl Ed)
35038377	Evaluation of adult patients with atopic dermatitis treated with dupilumab: A single-center real-life experience.	J Cosmet Dermatol
35037900	Severe versus common COVID-19: an early warning nomogram model.	Aging (Albany NY)
35037831	Inflammatory activation and immune cell infiltration are main biological characteristics of SARS-CoV-2 infected myocardium.	Bioengineered
35036347	Role of herbal medicines in the management of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials.	J Tradit Complement Med
35036190	A Complicated Case of COVID-19-Induced Inferolateral Wall Myocardial Infarction Successfully Treated With Streptokinase.	Cureus
35035955	Whole-blood cytokine secretion assay as a high-throughput alternative for assessing the cell-mediated immunity profile after two doses of an adjuvanted SARS-CoV-2 recombinant protein vaccine candidate.	Clin Transl Immunology
35034207	Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality.	Med Microbiol Immunol
35033647	Xuanfei Baidu Decoction reduces acute lung injury by regulating infiltration of neutrophils and macrophages via PD-1/IL17A pathway.	Pharmacol Res
35033181	Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury.	Stem Cell Res Ther
35032828	Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.	Int Immunopharmacol
35032732	Integrated hepatic single-cell RNA sequencing and untargeted metabolomics reveals the immune and metabolic modulation of Qing-Fei-Pai-Du decoction in mice with coronavirus-induced pneumonia.	Phytomedicine
35027798	Clinical Course and Outcome of Critically Ill Obese Patients with COVID-19 Admitted in Intensive Care Unit of a Single Center: Our Experience and Review.	Indian J Crit Care Med
35027728	Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection.	Nat Immunol
35027578	eNAMPT neutralization reduces preclinical ARDS severity via rectified NFkB and Akt/mTORC2 signaling.	Sci Rep
35027498	Molecular Mechanism of -Acute Sarcopenia in Elderly Patient with COVID - 19.	Acta Med Indones
35027492	Herpes Zoster After Tocilizumab Therapy in COVID-19 Survivor: A Case Report.	Acta Med Indones
35024375	Safety and Efficacy of Tocilizumab 4 or 8 mg/kg in Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial.	Open Forum Infect Dis
35021853	The unfavorable clinical outcome of COVID-19 in smokers is mediated by H3K4me3, H3K9me3 and H3K27me3 histone marks.	Epigenomics
35020840	Patients diagnosed with COVID-19 and treated with anakinra: a real-world study in the USA.	Clin Exp Immunol
35020796	Effect of a single high dose of vitamin D3 on cytokines, chemokines, and growth factor in patients with moderate to severe COVID-19.	Am J Clin Nutr
35016172	Effect of Expanded Hemodialysis with Theranova(R) in Patients with COVID-19.	Blood Purif
35015114	Role of Curcumin in Retinal Diseases-A review.	Graefes Arch Clin Exp Ophthalmol
35015084	Galectin-8, cytokines, and the storm.	Biochem Soc Trans
35015026	CD127 imprints functional heterogeneity to diversify monocyte responses in inflammatory diseases.	J Exp Med
35013199	Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts.	Nat Commun
35013191	Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents.	Nat Commun
35011848	Changes in Inflammatory Markers after Administration of Tocilizumab in COVID-19: A Single-Center Retrospective Study.	J Clin Med
35010667	Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community.	Int J Environ Res Public Health
35008594	COVID-19: Immunohistochemical Analysis of TGF-beta Signaling Pathways in Pulmonary Fibrosis.	Int J Mol Sci
35007527	Pattern of serum protein capillary electrophoretogram in SARS- CoV-2 infection.	Clin Chim Acta
35007290	Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19.	PLoS Pathog
35004038	Tocilizumab and Cytokine Release Syndrome in COVID-19 Pneumonia: Experience From a Single Center in Pakistan.	Cureus
35003754	Hyponatremia in Coronavirus Disease-19 Patients: A Retrospective Analysis.	Can J Kidney Health Dis
35003131	Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.	Front Immunol
35003063	Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment.	Front Immunol
35002723	Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS via Inhibiting TLR4/NF-kB Pathway and NLRP3 Inflammasome Activation.	Front Pharmacol
35002537	Identification of Differentially Expressed Genes in COVID-19 and Integrated Bioinformatics Analysis of Signaling Pathways.	Genet Res (Camb)
34999821	Inflammation and Mortality in COVID-19 Hospitalized Patients With and Without Type 2 Diabetes.	J Clin Endocrinol Metab
34999004	Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects.	Infect Genet Evol
34996987	Interrelationship between 2019-nCov receptor DPP4 and diabetes mellitus targets based on protein interaction network.	Sci Rep
34995986	Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study.	Atherosclerosis
34994081	Decreased memory B cell frequencies in COVID-19 delta variant vaccine breakthrough infection.	EMBO Mol Med
34993157	Clinical, Virological, Immunological, and Genomic Characterization of Asymptomatic and Symptomatic Cases With SARS-CoV-2 Infection in India.	Front Cell Infect Microbiol
34991059	Role of immune mediators in predicting hospitalization of SARS-CoV-2 positive patients.	Cytokine
34990767	Cangma Huadu granules, a new drug with great potential to treat coronavirus and influenza infections, exert its efficacy through anti-inflammatory and immune regulation.	J Ethnopharmacol
34989246	Co-Expression and Localization of Angiotensin-Converting Enzyme-2 (ACE2) and the Transmembrane Serine Protease 2 (TMPRSS2) in Paranasal Ciliated Epithelium of Patients with Chronic Rhinosinusitis.	Am J Rhinol Allergy
34988039	Timely Recognition and Early Multi-Step Antinflammatory Therapy May Prevent ICU Admission of Patients With MIS-C: Proposal for a Severity Score.	Front Pediatr
34987205	Body composition, physical capacity, and immuno-metabolic profile in community-acquired pneumonia caused by COVID-19, influenza, and bacteria: a prospective cohort study.	Int J Obes (Lond)
34985993	Activation of the MKK3-p38-MK2-ZFP36 Axis by Coronavirus Infection Restricts the Upregulation of AU-Rich Element-Containing Transcripts in Proinflammatory Responses.	J Virol
34985303	Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.	Microbiol Spectr
34984290	Modifications of IL-6 by Hypochlorous Acids: Effects on Receptor Binding.	ACS Omega
34983950	Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates.	Cell Mol Immunol
34982656	The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium.	Am J Respir Cell Mol Biol
34973134	The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice.	J Cardiovasc Transl Res
34971849	Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses.	J Clin Virol
34970527	Liver Injury and Elevated Levels of Interleukins, Interleukin-2 Receptor, and Interleukin-6 Predict the Severity in Patients With COVID-19.	Front Public Health
34966605	Hematological Manifestations of COVID-19 and Their Prognostic Significance in an Intensive Care Unit: A Cross-Sectional Study.	Cureus
34966215	Relation of interleukin-6 levels in COVID-19 patients with major adverse cardiac events.	Proc (Bayl Univ Med Cent)
34965375	Dynamic Differences of Immunological Parameters Between Severe and Non-severe COVID-19 Patients.	Discov Med
34965194	Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.	Gut Microbes
34965080	[Anterior eye segment damage in coronavirus infection (COVID-19)].	Vestn Oftalmol
34963729	Early Experience of High-dose Intravenous Mycobacterium w in Critically Ill Patients of COVID-19.	Indian J Crit Care Med
34962970	Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination.	PLoS Pathog
34962614	Discovery of potential anti-SARS-CoV-2 drugs based on large-scale screening in vitro and effect evaluation in vivo.	Sci China Life Sci
34960806	Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity.	Viruses
34960790	sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity.	Viruses
34960782	Inflammasomes and SARS-CoV-2 Infection.	Viruses
34960775	High-Fat High-Sugar Diet-Induced Changes in the Lipid Metabolism Are Associated with Mildly Increased COVID-19 Severity and Delayed Recovery in the Syrian Hamster.	Viruses
34960751	Iron Related Biomarkers Predict Disease Severity in a Cohort of Portuguese Adult Patients during COVID-19 Acute Infection.	Viruses
34960725	Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection.	Viruses
34960708	Protective Immunity against Gamma and Zeta Variants after Inactivated SARS-CoV-2 Virus Immunization.	Viruses
34960687	Single-Cell and Bulk RNASeq Profiling of COVID-19 Patients Reveal Immune and Inflammatory Mechanisms of Infection-Induced Organ Damage.	Viruses
34960684	COVID-19 Modulates Inflammatory and Renal Markers That May Predict Hospital Outcomes among African American Males.	Viruses
34960185	Comparison of the Development of SARS-Coronavirus-2-Specific Cellular Immunity, and Central Memory CD4+ T-Cell Responses Following Infection versus Vaccination.	Vaccines (Basel)
34960054	Dracocephalum moldavica Ethanol Extract Suppresses LPS-Induced Inflammatory Responses through Inhibition of the JNK/ERK/NF-kappaB Signaling Pathway and IL-6 Production in RAW 264.7 Macrophages and in Endotoxic-Treated Mice.	Nutrients
34959713	Promising Antiviral Activity of Agrimonia pilosa Phytochemicals against Severe Acute Respiratory Syndrome Coronavirus 2 Supported with In Vivo Mice Study.	Pharmaceuticals (Basel)
34959657	Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists.	Pharmaceuticals (Basel)
34959594	High CD169 Monocyte/Lymphocyte Ratio Reflects Immunophenotype Disruption and Oxygen Need in COVID-19 Patients.	Pathogens
34958811	Advances in clinical outcomes: What we have learned during the COVID-19 pandemic.	J Allergy Clin Immunol
34958809	Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial).	Radiother Oncol
34957352	Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer.	Sci Afr
34956783	Clinical and Laboratory Factors in Predicting Mortality Among COVID-19 RT-PCR Positive Patients: A Retrospective Observational Study From a Tertiary Care Center.	Cureus
34956420	Plasma S-Adenosylmethionine Is Associated with Lung Injury in COVID-19.	Dis Markers
34955842	Screening of Microbial Natural Products and Biological Evaluation of Trichomicin as Potential Anti-Cytokine Storm Agents.	Front Pharmacol
34953981	Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE).	J Control Release
34953018	Lichen planus and lichen planopilaris flare after COVID-19 vaccination.	Dermatol Ther
34952919	Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein.	Sci Rep
34952899	Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice.	Signal Transduct Target Ther
34952759	Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein.	Vaccine
34952468	The JAK inhibitor ruxolitinib abrogates immune hepatitis instigated by concanavalin A in mice.	Int Immunopharmacol
34952211	Low transferrin levels predict heightened inflammation in patients with COVID-19: New insights.	Int J Infect Dis
34951137	Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated Cohort.	Arthritis Rheumatol
34950134	Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma.	Front Immunol
34947041	COVID-19-Associated Pulmonary Aspergillosis in Russia.	J Fungi (Basel)
34945736	Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19.	J Pers Med
34945060	Anti-Inflammatory Effects of Immunostimulation in Patients with COVID-19 Pneumonia.	J Clin Med
34944747	Post-COVID-19 Patients Who Develop Lung Fibrotic-like Changes Have Lower Circulating Levels of IFN-beta but Higher Levels of IL-1alpha and TGF-beta.	Biomedicines
34944606	Dynamic Changes in Central and Peripheral Neuro-Injury vs. Neuroprotective Serum Markers in COVID-19 Are Modulated by Different Types of Anti-Viral Treatments but Do Not Affect the Incidence of Late and Early Strokes.	Biomedicines
34944517	Essential Fatty Acids and Their Metabolites in the Pathobiology of Inflammation and Its Resolution.	Biomolecules
34943881	Age Related Differences in Monocyte Subsets and Cytokine Pattern during Acute COVID-19-A Prospective Observational Longitudinal Study.	Cells
34943719	A Closer Look at Dexamethasone and the SARS-CoV-2-Induced Cytokine Storm: In Silico Insights of the First Life-Saving COVID-19 Drug.	Antibiotics (Basel)
34943656	Antibacterial, Immunomodulatory, and Lung Protective Effects of Boswelliadalzielii Oleoresin Ethanol Extract in Pulmonary Diseases: In Vitro and In Vivo Studies.	Antibiotics (Basel)
34943063	Increased Kynurenine Indicates a Fatal Course of COVID-19.	Antioxidants (Basel)
34940401	SARS-CoV-2 and the Immune Response in Pregnancy with Delta Variant Considerations.	Infect Dis Rep
34938289	Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.	Front Immunol
34938083	Embelin Alleviates Severe Airway Inflammation in OVA-LPS-Induced Rat Model of Allergic Asthma.	J Asthma Allergy
34935434	A Hybrid Soluble gp130/Spike-Nanobody Fusion Protein Simultaneously Blocks Interleukin-6 trans-Signaling and Cellular Infection with SARS-CoV-2.	J Virol
34934894	ChAdOx1 vaccination, blood coagulation, and inflammation: No effect on coagulation but increased interleukin-6.	Res Pract Thromb Haemost
34934655	Awareness and perception of COVID-19 among final-year dental students, Sudan.	J Family Med Prim Care
34934335	Impact of Anti-Type 2 Inflammation Biologic Therapy on COVID-19 Clinical Course and Outcome.	J Inflamm Res
34933950	Effect of Chloroquine and Hydroxychloroquine on Cytokine Release Syndrome in Patients with COVID-19.	Clin Med Res
34933240	Effect of SARS-CoV-2 seropositivity on antigen - specific cytokine and chemokine responses in latent tuberculosis.	Cytokine
34933172	Specific cytokines of interleukin-6 family interact with S100 proteins.	Cell Calcium
34933051	RBC-hitchhiking chitosan nanoparticles loading methylprednisolone for lung-targeting delivery.	J Control Release
34933044	COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment - Meeting report from an isirv-WHO virtual conference.	Antiviral Res
34931618	More Evidence of the Link of Interleukin-6 and Interleukin-10 with Critical COVID-19: A Report in Mexican Patients.	Iran J Immunol
34930492	Disseminated Kaposi sarcoma following COVID-19 in a 61-year-old Albanian immunocompetent man: a case report and review of the literature.	Eur J Med Res
34930441	Sex differences in the immune response to acute COVID-19 respiratory tract infection.	Biol Sex Differ
34928757	Interleukin (IL)-33 immunobiology in asthma and airway inflammatory diseases.	J Asthma
34928722	Early use of canakinumab to prevent mechanical ventilation in select COVID-19 patients: A retrospective, observational analysis.	Int J Immunopathol Pharmacol
34927104	Association of serum interleukin-6 and C-reactive protein with depressive and adjustment disorders in COVID-19 inpatients.	Brain Behav Immun Health
34925610	COVID-19 Infection - the Possibility to Involve Oxygen as Immunogen in the ARDS Determinism (Acute Respiratory Distress Syndrome).	Maedica (Bucur)
34924584	A causa di covid-19 il consumo di alcolici e aumentato?	Recenti Prog Med
34923232	Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.	Phytomedicine
34922160	Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19.	Thromb Res
34920336	Prognostic role of Interleukin-6/lymphocytes ratio in SARS-CoV2 related pneumonia.	Int Immunopharmacol
34919937	Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types.	Clin Chim Acta
34917633	Short-Course of Methylprednisolone Improves Respiratory Functional Parameters After 120 Days in Hospitalized COVID-19 Patients (Metcovid Trial): A Randomized Clinical Trial.	Front Med (Lausanne)
34917631	IL 33 Correlates With COVID-19 Severity, Radiographic and Clinical Finding.	Front Med (Lausanne)
34916147	Characterizing progressive beta-cell recovery after new-onset DKA in COVID-19 provoked A-beta+ KPD (ketosis-prone diabetes): A prospective study from Eastern India.	J Diabetes Complications
34915155	SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties.	Brain Behav Immun
34914941	Endothelial injury in COVID-19 and septic patients.	Microvasc Res
34913347	Effects of selected inherited factors on susceptibility to SARS-CoV-2 infection and COVID-19 progression.	Physiol Res
34911695	The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline.	Eur Respir Rev
34910336	Comparison of IL-6 measurement methods with a special emphasis on COVID-19 patients according to equipment and sample type.	J Clin Lab Anal
34909094	Outcomes of treatment of severe COVID-19 pneumonia with tocilizumab: a report of two cases from Tunisia.	Pan Afr Med J
34908795	AYUSH-64 as an add-on to standard care in asymptomatic and mild cases of COVID-19: A randomized controlled trial.	Ayu
34908254	The second wave of COVID-19 results in outbreak of mucormycosis: diabetes and immunological perspective.	Horm Mol Biol Clin Investig
34907516	The Probable Protective Effect of Photobiomodulation on the Inflammation of the Airway and Lung in COVID-19 Treatment: A Preclinical and Clinical Meta-Analysis.	Adv Exp Med Biol
34907480	Correction to: Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1beta, IL-6, IL-15 and TNF-alpha.	Forensic Sci Med Pathol
34906598	Targeting the NLRP3 inflammasome in cardiovascular diseases.	Pharmacol Ther
34906553	Understanding immune-modulatory efficacy in vitro.	Chem Biol Interact
34905588	Association of ABO blood group with COVID-19 severity, acute phase reactants and mortality.	PLoS One
34903642	Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom Onset.	J Immunol
34903319	Hyper-inflammatory responses in COVID-19 and anti-inflammatory therapeutic approaches.	BMB Rep
34902346	Assessment of tryptophan and kynurenine as prognostic markers in patients with SARS-CoV-2.	Clin Chim Acta
34902262	Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial.	Antimicrob Agents Chemother
34901384	Ultrasensitive Detection of Dopamine, IL-6 and SARS-CoV-2 Proteins on Crumpled Graphene FET Biosensor.	Adv Mater Technol
34901054	Case Report: Tocilizumab for Acute Kidney Graft Dysfunction in Patient Affected by COVID-19.	Front Med (Lausanne)
34899693	Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases.	Front Immunol
34898490	IL-17A in COVID-19 Cases: a meta-analysis.	J Infect Dev Ctries
34895748	Analysis of cardiovascular disease factors on SARS-CoV-2 infection severity.	Med Clin (Barc)
34895167	Toward finding the difference between untreated celiac disease and COVID-19 infected patients in terms of CD4, CD25 (IL-2 Ralpha), FOXP3 and IL-6 expressions as genes affecting immune homeostasis.	BMC Gastroenterol
34889061	Anakinra reduces lung inflammation in experimental acute lung injury.	Immun Inflamm Dis
34887867	Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis.	Front Immunol
34887501	The potential of COVID-19 patients' sera to cause antibody-dependent enhancement of infection and IL-6 production.	Sci Rep
34886758	Vitamin D and COVID-19: where are we now?	Postgrad Med
34884175	Increase in Ischemia-Modified Albumin and Pregnancy-Associated Plasma Protein-A in COVID-19 Patients.	J Clin Med
34882757	Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens.	PLoS Pathog
34882217	Food Handling Concerns and Practices at Home during the COVID-19 Pandemic by Food Security Status.	J Food Prot
34882013	Interleukin-1 in COVID-19 Infection: Immunopathogenesis and Possible Therapeutic Perspective.	Viral Immunol
34875673	Signature of long-lived memory CD8(+) T cells in acute SARS-CoV-2 infection.	Nature
34875602	[Clinical practice guideline: tocilizumab for patients with severe and critical COVID-19].	Medicina (B Aires)
34874079	Association between serum inflammatory parameters and the disease severity in COVID-19 patients.	J Clin Lab Anal
34873980	A Multistate Comparison Study of COVID-19 Cases Among Accredited and Nonaccredited Nursing Homes.	Policy Polit Nurs Pract
34870329	Metabolic reprograming shapes neutrophil functions in severe COVID-19.	Eur J Immunol
34870152	Can NLRP3 inhibitors improve on dexamethasone for the treatment of COVID-19?	Curr Res Pharmacol Drug Discov
34870129	<em>Staphylococcus aureus costochondritis</em> and chest wall abscess in a COVID-19 patient treated with tocilizumab.	Turk J Phys Med Rehabil
34869156	Blood Purification in Severe and Critical COVID-19 Patients: A Case Series of 5 Patients.	Front Public Health
34869111	Comparison of Interleukin-6 Plasma Concentration in Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Pediatric Sepsis.	Front Pediatr
34868744	Dynamics of Inflammatory Markers in Predicting Mortality in COVID-19.	Cureus
34868558	Presentation of cytokine profile in relation to oxidative stress parameters in patients with severe COVID-19: a case-control pilot study.	F1000Res
34868051	Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People.	Front Immunol
34867390	Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells.	Front Pharmacol
34866927	Toll-Like Receptor 4 Polymorphisms (896A/G and 1196C/T) as an Indicator of COVID-19 Severity in a Convenience Sample of Egyptian Patients.	J Inflamm Res
34866574	SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-kappaB pathway.	Elife
34866562	Neurological Presentations in Patients with COVID-19 in Cytokine Storm.	Can J Neurol Sci
34866537	SARS-CoV-2 induces mitochondrial dysfunction and cell death by oxidative stress/inflammation in leukocytes of COVID-19 patients.	Free Radic Res
34865363	[Development of multiple organ dysfunction syndrome in patients with Coronavirus Disease 2019: clinical characteristics and risk factors].	Zhonghua Jie He He Hu Xi Za Zhi
34865201	Hemophagocytosis, hyper-inflammatory responses, and multiple organ damages in COVID-19-associated hyperferritinemia.	Ann Hematol
34864855	The American Society for Clinical Pathology 2020 Vacancy Survey of Medical Laboratories in the United States.	Am J Clin Pathol
34860474	Modifying effects of TNF-alpha, IL-6 and VDR genes on the development risk and the course of COVID-19. Pilot study.	Drug Metab Pers Ther
34859018	Identification of Endotypes of Hospitalized COVID-19 Patients.	Front Med (Lausanne)
34858428	A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels.	Front Immunol
34858407	SARS-CoV-2 Nsp5 Activates NF-kappaB Pathway by Upregulating SUMOylation of MAVS.	Front Immunol
34858403	Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.	Front Immunol
34857198	Rays of immunity: Role of sunshine vitamin in management of COVID-19 infection and associated comorbidities.	Clin Nutr ESPEN
34855834	Serial measurement of cytokines strongly predict COVID-19 outcome.	PLoS One
34855144	Abnormal Transcript Levels of Cytokines Among Iranian COVID-19 Patients.	J Mol Neurosci
34855084	Secretome of Mesenchymal Bone Marrow Stem Cells: Is It Immunosuppressive or Proinflammatory?	Bull Exp Biol Med
34852756	A Composite Study of Coagulation Milieu in Covid-19: Experience from a Tertiary Care Centre from India.	Cardiovasc Hematol Disord Drug Targets
34852217	Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses.	Immunity
34850411	Combination therapy of tocilizumab and steroid for COVID-19 patients: A meta-analysis.	J Med Virol
34850365	Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease.	J Endocrinol Invest
34847238	Periodontitis as an inflammatory trigger in hypertension: From basic immunology to clinical implications.	Kardiol Pol
34844296	Immune dysfunction in COVID-19 and judicious use of antirheumatic drugs for the treatment of hyperinflammation	Turk J Med Sci
34843666	Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.	Lancet Respir Med
34841370	Proof-of-concept trial of an amniotic fluid-derived extracellular vesicle biologic for treating high risk patients with mild-to-moderate acute COVID-19 infection.	Biomater Biosyst
34841222	Pannexin-1 channel opening is critical for COVID-19 pathogenesis.	iScience
34840499	Plasma Phospholipids: A Promising Simple Biochemical Parameter to Evaluate COVID-19 Infection Severity.	Bioinform Biol Insights
34840031	Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study.	Biomed Pharmacother
34838735	Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage.	Vascul Pharmacol
34838020	Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review.	Respir Res
34837630	Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years.	Rheumatol Ther
34836187	Vitamin D Serum Levels in Subjects Tested for SARS-CoV-2: What Are the Differences among Acute, Healed, and Negative COVID-19 Patients? A Multicenter Real-Practice Study.	Nutrients
34835384	Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1beta, Early Predictors of Severe COVID-19.	Microorganisms
34835296	SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody.	Vaccines (Basel)
34835155	The Involvement of CXC Motif Chemokine Ligand 10 (CXCL10) and Its Related Chemokines in the Pathogenesis of Coronary Artery Disease and in the COVID-19 Vaccination: A Narrative Review.	Vaccines (Basel)
34833991	Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms.	Molecules
34831410	Immunological Characterization of HIV and SARS-CoV-2 Coinfected Young Individuals.	Cells
34831404	NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19.	Cells
34831403	Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2.	Cells
34831104	Instructions for Flow Cytometric Detection of ASC Specks as a Readout of Inflammasome Activation in Human Blood.	Cells
34830872	Blood Cytokine Analysis Suggests That SARS-CoV-2 Infection Results in a Sustained Tumour Promoting Environment in Cancer Patients.	Cancers (Basel)
34830648	Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials.	J Clin Med
34829949	Protective Role of Combined Polyphenols and Micronutrients against Influenza A Virus and SARS-CoV-2 Infection In Vitro.	Biomedicines
34829906	Impact of the Innate Inflammatory Response on ICU Admission and Death in Hospitalized Patients with COVID-19.	Biomedicines
34829418	Diagnostic Approaches for COVID-19 and Its Associated Complications.	Diagnostics (Basel)
34826840	[Clinical benefit of Tocilizumab and other immunomodulating agents for treatment of COVID-19].	Dtsch Med Wochenschr
34824035	Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV.	Int Immunopharmacol
34823899	Design, synthesis and biological evaluation of 1,5-disubstituted alpha-amino tetrazole derivatives as non-covalent inflammasome-caspase-1 complex inhibitors with potential application against immune and inflammatory disorders.	Eur J Med Chem
34823820	Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab.	Reumatol Clin (Engl Ed)
34822072	Both Baicalein and Gallocatechin Gallate Effectively Inhibit SARS-CoV-2 Replication by Targeting M(pro) and Sepsis in Mice.	Inflammation
34820310	Molecular docking of anthocyanins and ternatin in Clitoria ternatea as coronavirus disease oral manifestation therapy.	J Adv Pharm Technol Res
34817840	Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection.	Infect Dis Ther
34817280	Plasma gp96 is a Novel Predictive Biomarker for Severe COVID-19.	Microbiol Spectr
34815772	Lactobacillus plantarum induces innate cytokine responses that potentially provide a protective benefit against COVID-19: A single-arm, double-blind, prospective trial combined with an in vitro cytokine response assay.	Exp Ther Med
34813629	Intestinal Collinsella may mitigate infection and exacerbation of COVID-19 by producing ursodeoxycholate.	PLoS One
34812424	Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial.	Lancet Rheumatol
34807729	Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.	OMICS
34806405	Nimotuzumab for COVID-19: case series.	Immunotherapy
34804033	The Pathogenesis of COVID-19 Myocardial Injury: An Immunohistochemical Study of Postmortem Biopsies.	Front Immunol
34803696	Phillyrin for COVID-19 and Influenza Co-infection: A Potential Therapeutic Strategy Targeting Host Based on Bioinformatics Analysis.	Front Pharmacol
34803441	Pathogenesis and treatment of cytokine storm in COVID-19.	Turk J Biol
34801920	Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?	Thromb Res
34800305	Profiling serum levels of glutathione reductase and interleukin-10 in positive and negative-PCR COVID-19 outpatients: A comparative study from southwestern Iran.	J Med Virol
34797216	Common points of therapeutic intervention in COVID-19 and in allogeneic hematopoietic stem cell transplantation associated severe cytokine release syndrome.	Acta Microbiol Immunol Hung
34794908	Efficacy and safety of convalescent plasma therapy in patients with moderate-to-severe COVID-19: A non-randomized comparative study with historical control in a referral hospital in Indonesia.	J Infect Public Health
34794863	Cancer and Covid-19: Collectively catastrophic.	Cytokine Growth Factor Rev
34793331	Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza.	JCI Insight
34793272	Anaemia and enhancement of coagulation are associated with severe COVID-19 infection.	Scand J Clin Lab Invest
34792882	[NEUROLOGICAL COMPLICATIONS OF COVID-19: REVIEW OF LITERATURE AND OWN EXPERIENCE].	Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med
34792686	Immune-Mediated Glycocalyx Remodeling in Hospitalized COVID-19 Patients.	Cardiovasc Drugs Ther
34791869	[Michelangelo COVID hotel in Milan (Northern Italy): analysis of a hospitality experience in time of Coronavirus].	Epidemiol Prev
34790623	Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients with Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report.	Eur J Case Rep Intern Med
34788827	The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19.	Int Immunol
34788765	Increase in Chondroitin Sulfate and Decline in Arylsulfatase B May Contribute to Pathophysiology of COVID-19 Respiratory Failure.	Pathobiology
34788645	Inhibitory effects and mechanisms of the anti-covid-19 traditional Chinese prescription, Keguan-1, on acute lung injury.	J Ethnopharmacol
34786155	Age and genotype dependent erythropoietin protection in COVID-19.	World J Stem Cells
34785872	Retrospective Analysis of Clinical Laboratory Parameters, Therapeutics and Outcome in Patients Infected with SARS-CoV2.	Indian J Clin Biochem
34785108	Yindan Jiedu granules exhibit anti-inflammatory effect in patients with novel Coronavirus disease (COVID-19) by suppressing the NF-kappaB signaling pathway.	Phytomedicine
34784544	Diagnostic and Therapeutic Costs of Patients With a Diagnosis of or Suspected Coronavirus Disease in Iran.	Value Health Reg Issues
34784300	PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response.	JCI Insight
34783218	Maternal and Neonatal Outcomes of Critically Ill Pregnant and Puerperal Patients Diagnosed with COVID-19 Disease: Retrospective Comparative Study.	J Korean Med Sci
34782790	Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19.	Nat Med
34781692	25-Hydroxycholesterol Inhibits Kaposi's Sarcoma Herpesvirus and Epstein-Barr Virus Infections and Activates Inflammatory Cytokine Responses.	mBio
34781162	Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.	J Autoimmun
34781146	Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications.	Biomed Pharmacother
34778846	Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study.	Lancet Rheumatol
34778302	Astrocytes Downregulate Inflammation in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome: Applicability to COVID-19.	Front Med (Lausanne)
34778296	Prognostic Role and Diagnostic Power of Seven Indicators in COVID-19 Patients.	Front Med (Lausanne)
34777333	The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes.	Front Immunol
34775962	Analysis of transcriptomic data sets supports the role of IL-6 in NETosis and immunothrombosis in severe COVID-19.	BMC Genom Data
34775604	Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid-organ cancers.	Immunology
34775160	SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy.	Semin Arthritis Rheum
34773859	Association and predictive value of biomarkers with severe outcomes in hospitalized patients with SARS-CoV-2 infection.	Cytokine
34773693	Effect of Tocilizumab on intensive care patients with Covid-19 pneumonia, a retrospecitve cohort study.	Turk J Med Sci
34769119	Ezrin Peptide Therapy from HIV to COVID: Inhibition of Inflammation and Amplification of Adaptive Anti-Viral Immunity.	Int J Mol Sci
34768653	Severe Hypoalbuminemia at Admission Is Strongly Associated with Worse Prognosis in Older Adults with SARS-CoV-2 Infection.	J Clin Med
34768496	Micro-Elimination: Updated Pathway to Global Elimination of Hepatitis C in Small Communities and Industrial Settings during the COVID 19 Pandemic.	J Clin Med
34767293	Intralesional delivery of glycoprotein IIb/IIIa inhibitors in acute myocardial infarction: Review and recommendations.	Catheter Cardiovasc Interv
34766862	The Role of Anti-IL-1 Treatment in MIS-C Patients.	Expert Opin Biol Ther
34765997	Low dose of emetine as potential anti-SARS-CoV-2 virus therapy: preclinical in vitro inhibition and in vivo pharmacokinetic evidences.	Mol Biomed
34763156	In-vitro cytokine production and nasopharyngeal microbiota composition in the early stage of COVID-19 infection.	Cytokine
34761943	Role of Ionizable Lipids in SARS-CoV-2 Vaccines As Revealed by Molecular Dynamics Simulations: From Membrane Structure to Interaction with mRNA Fragments.	J Phys Chem Lett
34760673	Thyroid Dysfunction in COVID-19.	Indian J Endocrinol Metab
34759825	Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs(R) 7630 in SARS-CoV-2-Infected Human Lung Cells.	Front Pharmacol
34758029	BCG vaccination induces enhanced frequencies of memory T cells and altered plasma levels of common gammac cytokines in elderly individuals.	PLoS One
34757857	High Induction of IL-6 Secretion From hUCMSCs Optimize the Potential of hUCMSCs and TCZ as Therapy for COVID-19-Related ARDS.	Cell Transplant
34757278	Improvement of clinical outcome, laboratory findings and inflammatory cytokines levels using plasmapheresis therapy in severe COVID-19 cases.	Respir Med
34756178	Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.	Lancet Respir Med
34755902	Perforin, COVID-19 and a possible pathogenic auto-inflammatory feedback loop.	Scand J Immunol
34755269	Colchicine Is Safe Though Ineffective in the Treatment of Severe COVID-19: a Randomized Clinical Trial (COLCHIVID).	J Gen Intern Med
34754211	Literature Overview of the IL-17 Inhibition from Psoriasis to COVID-19.	J Inflamm Res
34753027	Broad antiviral and anti-inflammatory activity of Qingwenjiere mixture against SARS-CoV-2 and other human coronavirus infections.	Phytomedicine
34752741	COVID-19 associated coagulopathy: Mechanisms and host-directed treatment.	Am J Med Sci
34751011	Prevalence of SARS-CoV-2 Antibody in 2,935 Healthcare Workers at 6 Major Hospitals, Daegu, Korea.	J Korean Med Sci
34750969	A comparative study of IL-6, CRP and NT-proBNP levels in post-COVID multisystem inflammatory syndrome in children (MISC) and Kawasaki disease patients.	Int J Rheum Dis
34749700	Estimating the viral loads of SARS-CoV-2 in the oral cavity when complicated with periapical lesions.	BMC Oral Health
34746843	IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19.	Lancet Rheumatol
34745109	Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2.	Front Immunol
34743366	Real-life effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis.	Dermatol Ther
34743034	Lupus anticoagulant is an independent risk factor for non-thrombotic in-hospital mortality in COVID-19 patients.	Thromb Res
34741868	Phenylalanine and COVID-19: Tracking disease severity markers.	Int Immunopharmacol
34737699	Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction.	Front Pharmacol
34737108	COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab.	J Allergy Clin Immunol Pract
34736354	Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models.	Emerg Microbes Infect
34735795	Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine.	Cell
34733864	Study on the Effect and Application Value of Heat-Inactivated Serum on the Detection of Thyroid Function, Tumor Markers, and Cytokines During the SARS-CoV-2 Pandemic.	Front Med (Lausanne)
34732621	[Severe aplastic anemia exhibiting mild COVID-19 despite high serum IL-6 levels].	Rinsho Ketsueki
34730221	Suicide associated with COVID-19 infection: an immunological point of view.	Eur Rev Med Pharmacol Sci
34729360	Interleukin-37 gene polymorphism and susceptibility to coronavirus disease 19 among Iraqi patients.	Meta Gene
34728658	Decreased mortality and increased side effects in COVID-19 patients treated with IL-6 receptor antagonists: systematic review and meta-analysis.	Sci Rep
34727881	Persistent intrathecal interleukin-8 production in a patient with SARS-CoV-2-related encephalopathy presenting aphasia: a case report.	BMC Neurol
34725309	Role of tumor necrosis factor-alpha in the mortality of hospitalized patients with severe and critical COVID-19 pneumonia.	Aging (Albany NY)
34724920	Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study.	BMC Infect Dis
34724398	In patients hospitalized for COVID-19, tocilizumab reduces mortality at 28 d.	Ann Intern Med
34723226	The systemic inflammatory landscape of COVID-19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in utero SARS-CoV-2.	Cell Rep Med
34723157	Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19.	iScience
34721573	Efficacy and Safety of Sarilumab in COVID-19: A Systematic Review.	Interdiscip Perspect Infect Dis
34721425	Prime-Boost Vaccination With Covaxin/BBV152 Induces Heightened Systemic Cytokine and Chemokine Responses.	Front Immunol
34721104	First-Time Psychotic Symptoms in a Patient After COVID-19 Infection-A Case Report.	Front Psychiatry
34719107	Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients.	Liver Int
34718927	Neutrophil Extracellular Trap Formation Potential Correlates with Lung Disease Severity in COVID-19 Patients.	Inflammation
34718260	Immunosenescence, Inflammaging and Resilience: An Evolutionary Perspective of Adaptation in the Light of COVID-19 Pandemic.	Psychiatr Danub
34718118	SARS-CoV-2 infection negatively affects ovarian function in ART patients.	Biochim Biophys Acta Mol Basis Dis
34716901	Dynamics of urinary and respiratory shedding of Severe acute respiratory syndrome virus 2 (SARS-CoV-2) RNA excludes urine as a relevant source of viral transmission.	Infection
34716309	Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients.	Cell Death Dis
34715493	Topoisomerase 2 inhibitor etoposide promotes interleukin-10 production in LPS-induced macrophages via upregulating transcription factor Maf and activating PI3K/Akt pathway.	Int Immunopharmacol
34714574	Low-dose tocilizumab is associated with improved outcome and a low risk of secondary infection in severe COVID-19 pneumonia.	Int J Clin Pract
34712742	Kinetics of Neutralizing Antibody Response Underscores Clinical COVID-19 Progression.	J Immunol Res
34712741	COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes.	J Immunol Res
34711897	Co-infection of SARS-CoV-2 and influenza virus causes more severe and prolonged pneumonia in hamsters.	Sci Rep
34710845	Role of interleukin-6 in antigen-specific mucosal immunoglobulin A induction by cationic liposomes.	Int Immunopharmacol
34710657	Immunopathological events surrounding IL-6 and IFN-alpha: A bridge for anti-lupus erythematosus drugs used to treat COVID-19.	Int Immunopharmacol
34710339	Tissue Proteomic Analysis Identifies Mechanisms and Stages of Immunopathology in Fatal COVID-19.	Am J Respir Cell Mol Biol
34709564	SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia.	Mol Neurobiol
34709533	The role of lipoprotein(a) in coronavirus disease 2019 (COVID-19) with relation to development of severe acute kidney injury.	J Thromb Thrombolysis
34704175	Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis of multicentre, randomized trials.	Ann Intensive Care
34699853	Intersections between pneumonia, lowered oxygen saturation percentage and immune activation mediate depression, anxiety, and chronic fatigue syndrome-like symptoms due to COVID-19: A nomothetic network approach.	J Affect Disord
34697842	Garcinia kola and garcinoic acid suppress SARS-CoV-2 spike glycoprotein S1-induced hyper-inflammation in human PBMCs through inhibition of NF-kappaB activation.	Phytother Res
34696506	Viral Glycoproteins Induce NLRP3 Inflammasome Activation and Pyroptosis in Macrophages.	Viruses
34696367	Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2.	Viruses
34696231	Thymus Gland: A Double Edge Sword for Coronaviruses.	Vaccines (Basel)
34696175	Potential Adjuvant Therapeutic Effect of Lactobacillus plantarum Probio-88 Postbiotics against SARS-COV-2.	Vaccines (Basel)
34694503	Influence of photobiomodulation therapy on the treatment of pulmonary inflammatory conditions and its impact on COVID-19.	Lasers Med Sci
34694226	Effect of SARS-CoV-2 proteins on vascular permeability.	Elife
34688775	Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome.	J Allergy Clin Immunol
34687400	Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy.	J Thromb Thrombolysis
34687279	Rapid Detection and Inhibition of SARS-CoV-2-Spike Mutation-Mediated Microthrombosis.	Adv Sci (Weinh)
34687052	The effect of interleukin-6 level at the time of hospitalisation on erectile functions in hospitalised patients with COVID-19.	Andrologia
34684771	Standardized Extract of Asparagus officinalis Stem Attenuates SARS-CoV-2 Spike Protein-Induced IL-6 and IL-1beta Production by Suppressing p44/42 MAPK and Akt Phosphorylation in Murine Primary Macrophages.	Molecules
34683480	The Combined Use of Cytokine Serum Values with Laboratory Parameters Improves Mortality Prediction of COVID-19 Patients: The Interleukin-15-to-Albumin Ratio.	Microorganisms
34682731	Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence.	Int J Environ Res Public Health
34682421	Long-Term Survival of Older Patients Hospitalized for COVID-19. Do Clinical Characteristics upon Admission Matter?	Int J Environ Res Public Health
34679635	Differences in Dynamics of Lung Computed Tomography Patterns between Survivors and Deceased Adult Patients with COVID-19.	Diagnostics (Basel)
34678659	Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients.	J Neurol Sci
34678613	Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study.	EBioMedicine
34678611	Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation.	EBioMedicine
34677731	Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses.	J Neuroimmune Pharmacol
34677394	Clinical Predictors of Mortality and Critical Illness in Patients with COVID-19 Pneumonia.	Metabolites
34676742	Anti-IL-6 receptor antibodies in SARS-Cov-2 infection: perhaps, but certainly not for all.	Minerva Anestesiol
34676126	Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury.	Natl Sci Rev
34676085	Pathological changes in the lungs and lymphatic organs of 12 COVID-19 autopsy cases.	Natl Sci Rev
34675240	Cytokine signature and COVID-19 prediction models in the two waves of pandemics.	Sci Rep
34673905	In-Depth Investigation of Conjunctival Swabs and Tear Fluid of Symptomatic COVID-19 Patients, an Observational Cohort Study.	Transl Vis Sci Technol
34673795	Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease.	PLoS One
34672376	Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19.	J Med Virol
34672164	SARS-CoV-2, alcohol consumption and liver injury.	Minerva Med
34670213	The Gene Signature of Activated M-CSF-Primed Human Monocyte-Derived Macrophages Is IL-10-Dependent.	J Innate Immun
34669512	Functional Effects of Cardiomyocyte Injury in COVID-19.	J Virol
34669281	Immune characterization of a Colombian family cluster with SARS-CoV-2 infection.	Biomedica
34669001	Would carvacrol be a supporting treatment option effective in minimizing the deleterious effects of COVID-19?	Naunyn Schmiedebergs Arch Pharmacol
34668393	Plasma endostatin correlates with hypoxia and mortality in COVID-19-associated acute respiratory failure.	Biomark Med
34668283	Impact of immunosuppression on the immune response to SARS-CoV-2 infection: A mechanistic study.	Transpl Infect Dis
34667241	Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach.	Sci Rep
34667083	B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients.	J Am Soc Nephrol
34666667	[Two Case of Rhino-Orbito-Cerebral Mucormicosis Developed After COVID-19 Infection].	Mikrobiyol Bul
34666654	[Investigation of the Relationship of Systemic Immune-Inflammation Index, C-Reactive Protein and Interleukin-6 with Viral Dynamics in Patients with COVID-19].	Mikrobiyol Bul
34666302	Pentoxifylline effects on hospitalized patients with COVID19: A randomized, double-blind clinical trial.	Int Immunopharmacol
34662075	Evaluating And Referring Patients For Outpatient Monoclonal Antibody Therapy For Coronavirus (COVID-19) In The Emergency Department	StatPearls
34662052	Providing Access To Monoclonal Antibody Treatment Of Coronavirus (COVID-19) Patients In Rural And Underserved Areas	StatPearls
34660145	Tofacitinib Treatment in Patients With Active COVID-19 Infection.	Cureus
34660032	Use of Tocilizumab May Avoid the Need of Invasive Ventilation.	Cureus
34659656	Virus in the pathogenesis of inflammatory bowel disease: role of Toll-like receptor 7/8/3.	Gastroenterol Hepatol Bed Bench
34659433	Antiviral Effect of Hyunggaeyungyo-Tang on A549 Cells Infected with Human Coronavirus.	Evid Based Complement Alternat Med
34657578	The role of toll-like receptors in peptic ulcer disease.	Immunol Med
34656510	The Incidence of COVID-19 Patients in Oral and Maxillofacial Surgery.	J Oral Maxillofac Surg
34655852	The oral vaccine based on self-replicating RNA lipid nanoparticles can simultaneously neutralize both SARS-CoV-2 variants alpha and delta.	Int Immunopharmacol
34655016	Arglabin could target inflammasome-induced ARDS and cytokine storm associated with COVID-19.	Mol Biol Rep
34653729	In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR.	Int Immunopharmacol
34653521	Anti-inflammatory effect of Kaba Sura Kudineer (AYUSH approved COVID-19 drug)-A Siddha poly-herbal formulation against lipopolysaccharide induced inflammatory response in RAW-264.7 macrophages cells.	J Ethnopharmacol
34652339	Cytokine Drizzle-The Rationale for Abandoning "Cytokine Storm".	Shock
34646783	Exhausting T Cells During HIV Infection May Improve the Prognosis of Patients with COVID-19.	Front Cell Infect Microbiol
34646263	Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS Pathogenesis.	Front Immunol
34645689	Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.	J Immunol
34644019	[COVID-19: Do not put the cart before the horse].	Rev Med Suisse
34643000	Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPARgamma-dependent TLR4/NLRP3/Caspase-1 signaling suppression in Caco-2 cell line.	Phytother Res
34642602	Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: Cases series.	Ann Med Surg (Lond)
34642154	[Faut-il vacciner contre la detection par PCR ou contre la maladie Covid-19 ?]	Virologie (Montrouge)
34641388	Pimenta dioica (L.) Merr. Bioactive Constituents Exert Anti-SARS-CoV-2 and Anti-Inflammatory Activities: Molecular Docking and Dynamics, In Vitro, and In Vivo Studies.	Molecules
34639073	Molecular Mechanism of the Anti-Inflammatory Action of Heparin.	Int J Mol Sci
34638691	The MiR-320 Family Is Strongly Downregulated in Patients with COVID-19 Induced Severe Respiratory Failure.	Int J Mol Sci
34635175	Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity.	Clin Epigenetics
34635073	Intriguing findings of liver fibrosis following COVID-19.	BMC Gastroenterol
34634929	A Low-Producing Haplotype of Interleukin-6 Disrupting CTCF Binding Is Protective against Severe COVID-19.	mBio
34633645	Towards Fixed Dosing of Tocilizumab in ICU-Admitted COVID-19 Patients: Results of an Observational Population Pharmacokinetic and Descriptive Pharmacodynamic Study.	Clin Pharmacokinet
34632708	Conquering the cytokine storm in COVID-19-induced ARDS using placenta-derived decidua stromal cells.	J Cell Mol Med
34632596	Hemoperfusion and blood purification strategies in patients with COVID-19: A systematic review.	Artif Organs
34632327	The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery.	iScience
34631752	Prompt Reduction in CRP, IL-6, IFN-gamma, IP-10, and MCP-1 and a Relatively Low Basal Ratio of Ferritin/CRP Is Possibly Associated With the Efficacy of Tocilizumab Monotherapy in Severely to Critically Ill Patients With COVID-19.	Front Med (Lausanne)
34630633	Protective effects elicited by cow milk fermented with L. Paracasei CBAL74 against SARS-CoV-2 infection in human enterocytes.	J Funct Foods
34630379	Will Auranofin Become a Golden New Treatment Against COVID-19?	Front Immunol
34630356	Peptides Derived From S and N Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Induce T Cell Responses: A Proof of Concept for T Cell Vaccines.	Front Microbiol
34629702	Strengthening the Collection and Use of Disaggregated Data to Understand and Monitor the Risk and Burden of COVID-19 Among Racialized Populations.	Can Stud Popul
34628129	IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?	Cytokine
34628127	Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: A prospective observational study.	Cytokine
34626520	Effect of IL-6, IL-8/CXCL8, IP-10/CXCL 10 levels on the severity in COVID 19 infection.	Int J Clin Pract
34624759	Effects of Bacille Calmette Guerin (BCG) vaccination during COVID-19 infection.	Comput Biol Med
34623327	Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals.	J Clin Invest
34622440	Divergent impacts of tocilizumab and colchicine in COVID-19-associated coagulopathy: the role of alpha-defensins.	Br J Haematol
34620584	2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19.	Ann Rheum Dis
34617604	Modulation of Covid-19 cytokine storm by tocilizumab.	J Med Virol
34616409	LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications.	Front Immunol
34616396	SARS-CoV-2 Coronavirus Spike Protein-Induced Apoptosis, Inflammatory, and Oxidative Stress Responses in THP-1-Like-Macrophages: Potential Role of Angiotensin-Converting Enzyme Inhibitor (Perindopril).	Front Immunol
34611251	Tocilizumab reduces COVID-19 mortality and pathology in a dose and timing-dependent fashion: a multi-centric study.	Sci Rep
34611072	The Importance of the Timing of Tocilizumab Administration in Moderate to Severely Ill COVID-19: Single Centered Experience Case series.	Acta Med Indones
34608458	Unraveling the mechanisms of IVIG immunotherapy in MIS-C.	Cell Rep Med
34608231	Longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure.	Sci Rep
34607539	The Relation of the Viral Structure of SARS-CoV-2, High-Risk Condition, and Plasma Levels of IL-4, IL-10, and IL-15 in COVID-19 Patients Compared to SARS and MERS Infections.	Curr Mol Med
34607230	The role of lovastatin in the attenuation of COVID-19.	Int Immunopharmacol
34606948	Xuanfei Baidu Decoction protects against macrophages induced inflammation and pulmonary fibrosis via inhibiting IL-6/STAT3 signaling pathway.	J Ethnopharmacol
34605386	DHA/EPA supplementation decreases anxiety-like behaviour, but it does not ameliorate metabolic profile in obese male rats.	Br J Nutr
34605344	Study on the mechanism of treating COVID-19 with Shenqi Wan based on network pharmacology.	Drug Dev Ind Pharm
34604979	Higher rates of COVID-19 but less severe infections reported for patients on Dupilumab: a Big Data analysis of the World Health Organization VigiBase.	Eur Rev Med Pharmacol Sci
34603560	Effect of ORF7 of SARS-CoV-2 on the Chemotaxis of Monocytes and Neutrophils In Vitro.	Dis Markers
34603318	IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant.	Front Immunol
34600589	Clinical characteristics and outcomes of critically ill mechanically ventilated COVID-19 patients receiving interleukin-6 receptor antagonists and corticosteroid therapy: a preliminary report from a multinational registry.	Eur J Med Res
34597762	Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection.	Int J Infect Dis
34595489	Comparative analysis of machine learning-based approaches for identifying therapeutic peptides targeting SARS-CoV-2.	Brief Bioinform
34595383	GENERATING RESPONSES IMMUNE IN CELLULAR AND HUMORAL TREATMENT WITH EPITOPE SPIKE, EPITOPE ENVELOPE PROTEIN, AND EPITOPE MEMBRANE PROTEIN SARS-COV-2, HONEY, SAUSSUREA LAPPA, AND NIGELLA SATIVA.	Afr J Infect Dis
34594343	ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients.	Front Immunol
34591701	Skin Failure Among Critically Ill Patients Afflicted with Coronavirus Disease 2019 (COVID-19).	J Intensive Care Med
34590186	miRNA-223 as a regulator of inflammation and NLRP3 inflammasome, the main fragments in the puzzle of immunopathogenesis of different inflammatory diseases and COVID-19.	Naunyn Schmiedebergs Arch Pharmacol
34586459	The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study.	Inflamm Res
34584599	Cardiac manifestations of the coronavirus disease-19: a review of pathogenesis, clinical manifestations, diagnosis, and treatment.	Pan Afr Med J
34581925	Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms.	J Clin Immunol
34581315	Optimized detection of lung IL-6 via enzymatic liquefaction of low respiratory tract samples: application for managing ventilated patients.	Analyst
34580601	Network Pharmacology Reveals That Resveratrol Can Alleviate COVID-19-Related Hyperinflammation.	Dis Markers
34579267	Immunological Analysis of People in Northeast China after SARS-CoV-2 Inactivated Vaccine Injection.	Vaccines (Basel)
34579244	Development of an mRNA-LNP Vaccine against SARS-CoV-2: Evaluation of Immune Response in Mouse and Rhesus Macaque.	Vaccines (Basel)
34579211	Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination.	Vaccines (Basel)
34578450	Cytokine Response to SARS-CoV-2 Infection in Children.	Viruses
34578229	Immunobiotic Lactobacilli Improve Resistance of Respiratory Epithelial Cells to SARS-CoV-2 Infection.	Pathogens
34576853	Liver Involvement in Children with COVID-19 and Multisystem Inflammatory Syndrome: A Single-Center Bulgarian Observational Study.	Microorganisms
34576798	The Vitamin D, IL-6 and the eGFR Markers a Possible Way to Elucidate the Lung-Heart-Kidney Cross-Talk in COVID-19 Disease: A Foregone Conclusion.	Microorganisms
34576716	TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection.	Microorganisms
34576169	Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells.	Int J Mol Sci
34576053	Anti-Inflammatory Effect of Muscle-Derived Interleukin-6 and Its Involvement in Lipid Metabolism.	Int J Mol Sci
34575667	Evaluating the Role of the Interleukin-23/17 Axis in Critically Ill COVID-19 Patients.	J Pers Med
34575637	Ways to Address Perinatal Mast Cell Activation and Focal Brain Inflammation, including Response to SARS-CoV-2, in Autism Spectrum Disorder.	J Pers Med
34575353	Soluble IL-2R Levels Predict in-Hospital Mortality in COVID-19 Patients with Respiratory Failure.	J Clin Med
34575258	Biomarkers of Post-COVID Depression.	J Clin Med
34575221	Respiratory Nasal Mucosa in Chronic Rhinosinusitis with Nasal Polyps versus COVID-19: Histopathology, Electron Microscopy Analysis and Assessing of Tissue Interleukin-33.	J Clin Med
34572439	Alterations in Circulating Monocytes Predict COVID-19 Severity and Include Chromatin Modifications Still Detectable Six Months after Recovery.	Biomedicines
34572407	Endothelial Cell Activation by SARS-CoV-2 Spike S1 Protein: A Crosstalk between Endothelium and Innate Immune Cells.	Biomedicines
34570575	Potential benefits of using hydrogen sulfide, vitamin E and necrostatin-1 to counteract acetaminopheninduced hepatotoxicity in rats.	Bratisl Lek Listy
34570442	Focused evaluation of the roles of macrophages in chimeric antigen receptor (CAR) T cell therapy associated cytokine release syndrome.	Cancer Biol Med
34568129	Dynamic profile and clinical implications of hematological and immunological parameters in COVID-19 patients. A retrospective study.	J Family Med Prim Care
34567235	High-value laboratory testing for hospitalized COVID-19 patients: a review.	Future Virol
34564690	CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma.	Signal Transduct Target Ther
34564408	Ultramicronized Palmitoylethanolamide Inhibits NLRP3 Inflammasome Expression and Pro-Inflammatory Response Activated by SARS-CoV-2 Spike Protein in Cultured Murine Alveolar Macrophages.	Metabolites
34560978	Low molecular weight fucoidan attenuating pulmonary fibrosis by relieving inflammatory reaction and progression of epithelial-mesenchymal transition.	Carbohydr Polym
34560283	A distinct association of inflammatory molecules with outcomes of COVID-19 in younger versus older adults.	Clin Immunol
34559474	Clinical features of Chinese children with COVID-19 and other viral respiratory infections.	Pediatr Pulmonol
34557500	Longitudinal Characterization of Cytokine Overproduction: A Case Report in Critically Ill COVID-19 Patients With Hyperinflammation in Bronchoalveolar Lavage.	Front Med (Lausanne)
34557270	Astaxanthin protective barrier and its ability to improve the health in patients with COVID-19.	Iran J Microbiol
34557174	Synthetic SARS-CoV-2 Spike-Based DNA Vaccine Elicits Robust and Long-Lasting Th1 Humoral and Cellular Immunity in Mice.	Front Microbiol
34556244	The Use of Biologics During the COVID-19 Pandemic.	Dermatol Clin
34556132	Cytometric analysis of patients with COVID-19: what is changed in the second wave?	J Transl Med
34554303	Pro-inflammatory CXCL-10, TNF-alpha, IL-1beta, and IL-6: biomarkers of SARS-CoV-2 infection.	Arch Virol
34552685	Infrared light therapy relieves TLR-4 dependent hyper-inflammation of the type induced by COVID-19.	Commun Integr Biol
34552615	Structural Analysis of SARS-CoV-2 ORF8 Protein: Pathogenic and Therapeutic Implications.	Front Genet
34552347	Distinct Patterns of Blood Cytokines Beyond a Cytokine Storm Predict Mortality in COVID-19.	J Inflamm Res
34551966	TLR-4 Agonist Induces IFN-gamma Production Selectively in Proinflammatory Human M1 Macrophages through the PI3K-mTOR- and JNK-MAPK-Activated p70S6K Pathway.	J Immunol
34551674	Can Anakinra and corticosteroid treatment be an effective option in pregnant women with severe Covid-19?	Women Health
34550494	Alzheimer's disease in elderly COVID-19 patients: potential mechanisms and preventive measures.	Neurol Sci
34546607	Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19.	Rev Med Virol
34546583	Detection of SARS-CoV-2-independent immunoregulatory activity of COVID-19 convalescent plasma.	Transfusion
34545717	[Prospects for using low-dose radiation in the complex therapy for COVID-19].	Vopr Virusol
34543980	Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients.	Int Immunopharmacol
34542974	Inflammatory Markers and Cytokines in Moderate and Critical Cases of COVID-19.	Clin Lab
34541720	A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients.	Phytother Res
34540958	Case series of COVID-19 patients from the Qinghai-Tibetan Plateau Area in China.	World J Clin Cases
34539644	Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study.	Front Immunol
34539631	Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.	Front Immunol
34539185	Colchicine in Recently Hospitalized Patients with COVID-19: A Randomized Controlled Trial (COL-COVID).	Int J Gen Med
34538956	Use of the rheumatic drug tocilizumab for treatment of SARS-CoV-2 patients.	Reumatologia
34537720	LUNG ULTRASOUND DURING COVID-19 PANDEMICS: WHY, HOW AND WHEN?	Wiad Lek
34537594	Influence of IL-6 levels on patient survival in COVID-19.	J Crit Care
34536929	Synthesis and pharmacological evaluation of choroquine derivatives bearing long aminated side chains as antivirus and anti-inflammatory agents.	Bioorg Chem
34536744	A possible pathogenic correlation between neutrophil elastase (NE) enzyme and inflammation in the pathogenesis of coronavirus disease 2019 (COVID-19).	Int Immunopharmacol
34536610	SARS-CoV-2 neutralizing antibodies decline over one year and patients with severe COVID-19 pneumonia display a unique cytokine profile.	Int J Infect Dis
34536070	Cytokine profile in Egyptian children and adolescents with COVID-19 pneumonia: A multicenter study.	Pediatr Pulmonol
34535885	The relationship between mortality and inflammatory markers and the systemic immune inflammatory index in patients in the intensive care unit with a pneumothorax as a complication of COVID-19 disease.	Ir J Med Sci
34534925	Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19).	Cytokine
34533859	Lung Ultrasound in Patients With SARS-COV-2 Pneumonia: Correlations With Chest Computed Tomography, Respiratory Impairment, and Inflammatory Cascade.	J Ultrasound Med
34533476	Sodium alterations impair the prognosis of hospitalized patients with COVID-19 pneumonia.	Endocr Connect
34533131	[Progress in the relationship between NLRP3 inflammasome and lung injury in COVID-19].	Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
34532358	Saving critically ill COVID-19 patients with mechanical circulatory support.	Ann Transl Med
34531865	Host Genetics and Antiviral Immune Responses in Adult Patients With Multisystem Inflammatory Syndrome.	Front Immunol
34529726	Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients.	PLoS Pathog
34528526	Expression of innate immune response genes in upper airway samples of SARS-CoV-2 infected patients: A preliminary study.	Indian J Med Res
34526104	Kabasura Kudineer (KSK), a poly-herbal Siddha medicine, reduced SARS-CoV-2 viral load in asymptomatic COVID-19 individuals as compared to vitamin C and zinc supplementation: findings from a prospective, exploratory, open-labeled, comparative, randomized controlled trial, Tamil Nadu, India.	Trials
34525891	COVID-19 and oral diseases: Assessing manifestations of a new pathogen in oral infections.	Int Rev Immunol
34525011	Desideri e considerazioni di Sanita pubblica.	Ig Sanita Pubbl
34524645	Efficacy of IL-6 antagonists in the treatment of COVID-19 patients: further randomized controlled trials are warranted.	Hum Cell
34523302	Does dehydroepiandrosterone sulfate have a role in COVID-19 prognosis and treatment?	Endocr Regul
34522563	Success Rate of Wire Control-Assisted ERCP Sphincterotomy Versus Non-assisted ERCP Cannulation of Common Bile Duct in a Secondary Care Unit During the First COVID-19 Peak: A Retrospective Observational Study of 281 Patients.	Cureus
34518043	SARS-CoV-2 infection. Descriptive analysis of a selected case series.	Rev Esp Anestesiol Reanim (Engl Ed)
34515914	Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study.	Curr Med Sci
34515808	Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls.	Rheumatol Int
34514710	Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic.	Am J Transplant
34513787	Early Fever Is Associated With Clinical Outcomes in Patients With Coronavirus Disease.	Front Public Health
34511718	Investigate the interaction of testosterone/progesterone with ionic liquids on varying the anion to combat COVID-19: Density functional theory calculations and molecular docking approach.	J Phys Org Chem
34509916	Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells.	Redox Biol
34508765	Immunologic resilience and COVID-19 survival advantage.	J Allergy Clin Immunol
34506488	Widespread closure of HIV prevention and care services places youth at higher risk during the COVID-19 pandemic.	PLoS One
34503922	Neurological manifestations in COVID-19 patients and their application in predicting fatal disease: A retrospective cohort study.	J Microbiol Immunol Infect
34501738	Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic.	Int J Environ Res Public Health
34497218	[Respiratory virus infections after hematopoietic cell transplantation].	Rinsho Ketsueki
34496043	Physiologically Based Pharmacokinetic Modelling to Investigate the Impact of the Cytokine Storm on CYP3A Drug Pharmacokinetics in COVID-19 Patients.	Clin Pharmacol Ther
34495692	A Biosafety Level 2 Mouse Model for Studying Betacoronavirus-Induced Acute Lung Damage and Systemic Manifestations.	J Virol
34494942	The ApoA-I mimetic peptide 4F attenuates in vitro replication of SARS-CoV-2, associated apoptosis, oxidative stress and inflammation in epithelial cells.	Virulence
34493491	Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases.	Ann Rheum Dis
34493195	Computational Analysis Illustrates the Mechanism of Qingfei Paidu Decoction in Blocking the Transition of COVID-19 Patients from Mild to Severe Stage.	Curr Gene Ther
34490373	Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Inflammatory Response and Viral Clearance in COVID-19 Patients.	Front Cardiovasc Med
34490312	Epidemiology and Clinical Management of Rheumatic Autoimmune Diseases in the COVID-19 Pandemic: A Review.	Front Med (Lausanne)
34490299	Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era.	Front Med (Lausanne)
34489974	Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients.	Front Immunol
34489933	Cytokine Signature Associated With Disease Severity in COVID-19.	Front Immunol
34488665	Clinical value of blood markers to assess the severity of coronavirus disease 2019.	BMC Infect Dis
34488453	Immunological Profiling of COVID-19 Patients with Pulmonary Sequelae.	mBio
34487649	Haematological Parameters And Outcome In Hospitalized Patients With Covid-19: A Developing Country Experience.	J Ayub Med Coll Abbottabad
34486793	Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically-ill COVID-19 patients.	Ther Apher Dial
34485700	Therapeutic potential of anticoagulant therapy in association with cytokine storm inhibition in severe cases of COVID-19: A case report.	Open Life Sci
34485493	Immunotherapy of COVID-19 with Bacille Calmette - Guerin: Where is the missing red herring?	S Afr J Infect Dis
34484238	Pathogenic Mechanisms of Vaccine-Induced Immune Thrombotic Thrombocytopenia in People Receiving Anti-COVID-19 Adenoviral-Based Vaccines: A Proposal.	Front Immunol
34484133	SARS-CoV-2 Accessory Protein ORF7b Mediates Tumor Necrosis Factor-alpha-Induced Apoptosis in Cells.	Front Microbiol
34483914	Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2.	Front Pharmacol
34483461	Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets.	Chem Zvesti
34480127	Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.	Nat Med
34478955	Upregulation of FOXP3 is associated with severity of hypoxia and poor outcomes in COVID-19 patients.	Virology
34476621	Progranulin signaling in sepsis, community-acquired bacterial pneumonia and COVID-19: a comparative, observational study.	Intensive Care Med Exp
34475873	Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study.	Front Immunol
34474305	Synthesis of novel calcium channel blockers with ACE2 inhibition and dual antihypertensive/anti-inflammatory effects: A possible therapeutic tool for COVID-19.	Bioorg Chem
34474172	Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis.	Autoimmun Rev
34473836	Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail.	Clin Pharmacol Ther
34473563	The 1918 Influenza Pandemic Versus COVID-19: A Historical Perspective From an Italian Point of View.	Am J Public Health
34472806	Clinical Efficacy and Safety of Remdesivir among Hospitalised Adult Patients with RT PCR Confirmed COVID 19 Requiring ICU Care in Kalyana Karnataka.	J Assoc Physicians India
34472783	Assessing the Impact of Inflammatory Markers and CT Severity Score on Disease Severity of COVID-19 Patients Admitted to ICU at a Tertiary Hospital.	J Assoc Physicians India
34472523	Utility of various inflammatory markers in predicting outcomes of hospitalized patients with COVID-19 pneumonia: A single-center experience.	Lung India
34472328	Separable Microneedle Patch to Protect and Deliver DNA Nanovaccines Against COVID-19.	ACS Nano
34471195	A virus-free cellular model recapitulates several features of severe COVID-19.	Sci Rep
34471088	Pro-inflammatory microenvironment and systemic accumulation of CXCR3+ cell exacerbate lung pathology of old rhesus macaques infected with SARS-CoV-2.	Signal Transduct Target Ther
34468398	Thyroid function in COVID-19 and the association with cytokine levels and mortality.	Endocr Connect
34467562	Scientific premise for the involvement of neutrophil extracellular traps (NETs) in vaccine-induced thrombotic thrombocytopenia (VITT).	J Leukoc Biol
34466775	COVID-19 and autoinflammatory diseases: prevalence and outcomes of infection and early experience of vaccination in patients on biologics.	Rheumatol Adv Pract
34464372	Marked self-limiting sinus bradycardia in COVID-19 patients not requiring therapy in the intensive care unit - case series report.	Pol Merkur Lekarski
34464357	Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C.	J Clin Invest
34463916	Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1beta, IL-6, IL-15 and TNF-alpha.	Forensic Sci Med Pathol
34460840	Immunometabolic signatures predict risk of progression to sepsis in COVID-19.	PLoS One
34460125	Elements of Th1/Th2 response and disease severity in COVID-19 patients: A short report.	J Med Virol
34458281	Gut Microbiota Dysbiosis Is a Crucial Player for the Poor Outcomes for COVID-19 in Elderly, Diabetic and Hypertensive Patients.	Front Med (Lausanne)
34457357	Rapid and sustained decline in CXCL-10 (IP-10) annotates clinical outcomes following TNFalpha-antagonist therapy in hospitalized patients with severe and critical COVID-19 respiratory failure.	J Clin Transl Sci
34456365	A Comparative Assessment of Effects of Major Mediators of Acute Phase Response (IL-1, TNF-alpha, IL-6) on Breathing Pattern and Survival Rate in Rats with Acute Progressive Hypoxia.	J Evol Biochem Physiol
34455731	Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19.	Clin Chem Lab Med
34454610	CIDO ontology updates and secondary analysis of host responses to COVID-19 infection based on ImmPort reports and literature.	J Biomed Semantics
34452933	Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19.	J Immunol
34452519	Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice.	Viruses
34452349	What Is the Role of Therapeutic Plasma Exchange as an Adjunctive Treatment in Severe COVID-19: A Systematic Review.	Viruses
34452063	Risk Factors Associated with the Clinical Outcomes of COVID-19 and Its Variants in the Context of Cytokine Storm and Therapeutics/Vaccine Development Challenges.	Vaccines (Basel)
34450504	Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States.	Semin Arthritis Rheum
34450402	Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019.	Int Immunopharmacol
34445747	Cell-Free Hemoglobin Does Not Attenuate the Effects of SARS-CoV-2 Spike Protein S1 Subunit in Pulmonary Endothelial Cells.	Int J Mol Sci
34441862	Weighted Gene Co-Expression Network Analysis Combined with Machine Learning Validation to Identify Key Modules and Hub Genes Associated with SARS-CoV-2 Infection.	J Clin Med
34441819	Supervised Machine Learning Approach to Identify Early Predictors of Poor Outcome in Patients with COVID-19 Presenting to a Large Quaternary Care Hospital in New York City.	J Clin Med
34441262	The Value of Interleukin-6 among Several Inflammatory Markers as a Predictor of Respiratory Failure in COVID-19 Patients.	Diagnostics (Basel)
34440478	The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections.	Life (Basel)
34440121	Innate and Adaptive Immune Assessment at Admission to Predict Clinical Outcome in COVID-19 Patients.	Biomedicines
34439469	Acute Lung Injury Biomarkers in the Prediction of COVID-19 Severity: Total Thiol, Ferritin and Lactate Dehydrogenase.	Antioxidants (Basel)
34436982	Dietary advanced glycation end-products elicit toxicological effects by disrupting gut microbiome and immune homeostasis.	J Immunotoxicol
34436790	Qing-Fei-Pai-Du decoction and wogonoside exert anti-inflammatory action through down-regulating USP14 to promote the degradation of activating transcription factor 2.	FASEB J
34435137	Inflammatory factors in alveolar lavage fluid from severe COVID-19 pneumonia: PCT and IL-6 in epithelial lining fluid.	Open Med (Wars)
34434945	Role of Th22 Cells in Human Viral Diseases.	Front Med (Lausanne)
34434199	The Immunological Factors Predisposing to Severe Covid-19 Are Already Present in Healthy Elderly and Men.	Front Immunol
34433692	Profound Treg perturbations correlate with COVID-19 severity.	Proc Natl Acad Sci U S A
34431629	Faut-il changer le traitement antidiabetique en periode Covid-19 ?	Rev Med Suisse
34429986	Psychogenic fever due to worry about COVID-19: A case report.	Clin Case Rep
34429051	Systematic Review on Treatment Trials of Tocilizumab: A Repurposing Drug against COVID-19.	Rev Recent Clin Trials
34427934	Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID-19.	J Med Virol
34423606	Captopril alleviates lung inflammation in SARS-CoV-2-infected hypertensive mice.	Zool Res
34422966	Severe COVID-19 has a distinct phenotype from bacterial sepsis: a retrospective cohort study in deceased patients.	Ann Transl Med
34422917	Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19.	Front Cardiovasc Med
34422854	Specific Features of the Coagulopathy Signature in Severe COVID-19 Pneumonia.	Front Med (Lausanne)
34422163	[Relevant immunologic markers in COVID-19].	Pan Afr Med J
34422145	Predictive Immunological, Virological, and Routine Laboratory Markers for Critical COVID-19 on Admission.	Can J Infect Dis Med Microbiol
34420903	An Overview on the Epidemiology and Immunology of COVID-19.	J Infect Public Health
34417262	LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes.	Diabetes
34416331	Assessment of adjuvantation strategy of lipid squalene nanoparticles for enhancing the immunogenicity of a SARS-CoV-2 spike subunit protein against COVID-19.	Int J Pharm
34416267	Hypoxia alters the expression of ACE2 and TMPRSS2 SARS-CoV-2 cell entry mediators in hCMEC/D3 brain endothelial cells.	Microvasc Res
34414423	Sample Processing and Stability for Urine Biomarker Studies.	J Appl Lab Med
34414383	Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens.	Med (N Y)
34414143	X-Linked Lymphoproliferative Disease Mimicking Multisystem Inflammatory Syndrome in Children-A Case Report.	Front Pediatr
34413339	SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs.	Sci Rep
34411149	COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab.	PLoS One
34409772	Testosterone in males with COVID-19: A 7-month cohort study.	Andrology
34408875	Rapid whole-blood assay to detect SARS-CoV-2-specific memory T-cell immunity following a single dose of AstraZeneca ChAdOx1-S COVID-19 vaccine.	Clin Transl Immunology
34408743	Fast and Efficient Genome Editing of Human FOXP3(+) Regulatory T Cells.	Front Immunol
34408462	Characterization of Virus Replication, Pathogenesis, and Cytokine Responses in Syrian Hamsters Inoculated with SARS-CoV-2.	J Inflamm Res
34407530	Hemoperfusion with CytoSorb(R) in Critically Ill COVID-19 Patients.	Blood Purif
34406358	Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model.	Clin Infect Dis
34403366	Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19.	JCI Insight
34401147	Association of serum KL-6 levels on COVID-19 severity: A cross-sectional study design with purposive sampling.	Ann Med Surg (Lond)
34398245	Distinct Cytokine and Chemokine Dysregulation in Hospitalized Children With Acute Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome With Similar Levels of Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 Shedding.	J Infect Dis
34398044	Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome: A single center experience from Pune, Western India.	Medicine (Baltimore)
34398008	Early use of tocilizumab in patients with severe pneumonia secondary to severe acute respiratory syndrome coronavirus 2 infection and poor prognostic criteria: Impact on mortality rate and intensive care unit admission.	Medicine (Baltimore)
34397376	[Obesity, inflammation and COVID-19: preventive interest of ketogenic diet?]	Biol Aujourdhui
34396395	BPIFB4 Circulating Levels and Its Prognostic Relevance in COVID-19.	J Gerontol A Biol Sci Med Sci
34395311	Combination Treatment With Remdesivir and Ivermectin Exerts Highly Synergistic and Potent Antiviral Activity Against Murine Coronavirus Infection.	Front Cell Infect Microbiol
34394876	COVID-19 Recombinant mRNA Vaccines and Serious Ocular Inflammatory Side Effects: Real or Coincidence?	J Ophthalmic Vis Res
34394108	Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses.	Front Immunol
34392148	Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples.	EBioMedicine
34392110	Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression.	Mol Immunol
34390244	Physical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administration.	Am J Health Syst Pharm
34387280	Nucleic acid vaccines and CpG oligodeoxynucleotides for allergen immunotherapy.	Curr Opin Allergy Clin Immunol
34386533	IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA Trial.	Front Cardiovasc Med
34386388	Endocrine Dysfunction among Patients with COVID-19: A Single-center Experience from a Tertiary Hospital in India.	Indian J Endocrinol Metab
34385216	Le syndrome inflammatoire multisystemique post-COVID-19 chez les enfants.	Can Fam Physician
34384426	Cardiac adipose tissue volume and IL-6 level at admission are complementary predictors of severity and short-term mortality in COVID-19 diabetic patients.	Cardiovasc Diabetol
34384355	HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism.	J Headache Pain
34383402	A Multivariate Analysis Model of Changes in Some Laboratory Parameters in Response to COVID-19, Diabetes, Gender, and Age.	Clin Lab
34382820	Humoral and Cell-Mediated Immune Response in Colostrum from Women Diagnosed Positive for SARS-CoV-2.	Breastfeed Med
34381495	Inflammation and kidney involvement in human viral diseases caused by SARS-CoV-2, HIV, HCV and HBV.	J Venom Anim Toxins Incl Trop Dis
34381462	Immediate Pre-Partum SARS-CoV-2 Status and Immune Profiling of Breastmilk: A Case-Control Study.	Front Immunol
34379684	Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19.	PLoS One
34374938	Correlation of olfactory dysfunction with lung involvement and severity of COVID-19.	Ir J Med Sci
34373622	Inflammasome activation at the crux of severe COVID-19.	Nat Rev Immunol
34373382	SARS-CoV-2-related Progressive Brain White Matter Lesion Associated with an Increased Cerebrospinal Fluid Level of IL-6.	Intern Med
34370690	Laboratory parameters predicting mortality of adult in-patients with COVID-19 associated cytokine release syndrome treated with high-dose tocilizumab.	Acta Microbiol Immunol Hung
34370622	Polypharmacology of some medicinal plant metabolites against SARS-CoV-2 and host targets: Molecular dynamics evaluation of NSP9 RNA binding protein.	J Biomol Struct Dyn
34369883	Interleukin-6 level is an independent predictor of right ventricular systolic dysfunction in patients hospitalized with COVID-19.	Anatol J Cardiol
34367726	Predicting the Severity of Disease Progression in COVID-19 at the Individual and Population Level: A Mathematical Model.	Clin Exp Pharmacol
34367188	Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19.	Front Immunol
34367117	Differential Association of Viral Dynamics With Disease Severity Depending on Patients' Age Group in COVID-19.	Front Microbiol
34365714	Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course.	J Cosmet Dermatol
34364043	Interleukin-17A (IL-17A): A silent amplifier of COVID-19.	Biomed Pharmacother
34363351	Sustained expression of inflammatory monocytes and activated T cells in COVID-19 patients and recovered convalescent plasma donors.	Immun Inflamm Dis
34363189	Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial.	Infect Dis Ther
34361736	A Potent Leukocyte Transmigration Blocker: GT-73 Showed a Protective Effect against LPS-Induced ARDS in Mice.	Molecules
34360989	The Effects of Abeta1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2.	Int J Mol Sci
34360706	Boosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by alpha-1 Antitrypsin.	Int J Mol Sci
34360684	Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2.	Int J Mol Sci
34359894	ACE2 Is Expressed in Immune Cells That Infiltrate the Placenta in Infection-Associated Preterm Birth.	Cells
34358031	The Potential Role of an Aberrant Mucosal Immune Response to SARS-CoV-2 in the Pathogenesis of IgA Nephropathy.	Pathogens
34357839	Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agents.	Expert Opin Biol Ther
34356687	Adventitial Microcirculation Is a Major Target of SARS-CoV-2-Mediated Vascular Inflammation.	Biomolecules
34356359	Time Course of Redox Biomarkers in COVID-19 Pneumonia: Relation with Inflammatory, Multiorgan Impairment Biomarkers and CT Findings.	Antioxidants (Basel)
34355546	NLRP3 inflammasome activation and oxidative stress status in the mild and moderate SARS-CoV-2 infected patients: impact of melatonin as a medicinal supplement.	Z Naturforsch C J Biosci
34354045	Low level of plasminogen increases risk for mortality in COVID-19 patients.	Cell Death Dis
34353890	Inhibition of elastase enhances the adjuvanticity of alum and promotes anti-SARS-CoV-2 systemic and mucosal immunity.	Proc Natl Acad Sci U S A
34353696	Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients'.	Cytokine
34353036	Impact of Tai Chi on CRP, TNF-alpha and IL-6 in inflammation: a systematic review and meta-analysis.	Ann Palliat Med
34352260	Interleukin-13: A pivotal target against influenza-induced exacerbation of chronic lung diseases.	Life Sci
34352226	Systemic IL-15, IFN-gamma, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients.	Cell Rep
34350146	Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease.	Front Pediatr
34348975	Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.	J Immunol
34347374	A bond between rheumatic diseases and cancer in the elderly: The interleukin-6 pathway.	Int J Rheum Dis
34346869	Interleukin 17 antagonist netakimab is effective and safe in the new coronavirus infection (COVID-19).	Eur Cytokine Netw
34346720	Elevated Rates of Indeterminate Results on QuantiFERON-TB Gold Plus in COVID-19 Patients.	J Clin Microbiol
34344353	Associations of immunological features with COVID-19 severity: a systematic review and meta-analysis.	BMC Infect Dis
34344306	Serum surfactant protein D in COVID-19 is elevated and correlated with disease severity.	BMC Infect Dis
34342597	[More on the COVID 19 pandemic: Public health Apology].	Ig Sanita Pubbl
34341947	Characteristics of immune and inflammatory responses among different age groups of pediatric patients with COVID-19 in China.	World J Pediatr
34341776	A systematic review on the effects of Echinacea supplementation on cytokine levels: Is there a role in COVID-19?	Metabol Open
34341353	SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation.	Nat Commun
34340124	Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes.	Comput Biol Med
34337913	Compassionate use of anti-IL6 receptor antibodies in critically ill patients with acute respiratory distress syndrome due to SARS-CoV-2.	Minerva Anestesiol
34336904	Elevations in Liver Transaminases in COVID-19: (How) Are They Related?	Front Med (Lausanne)
34335580	Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19.	Front Immunol
34335566	Comprehensive Profiling of Inflammatory Factors Revealed That Growth Differentiation Factor-15 Is an Indicator of Disease Severity in COVID-19 Patients.	Front Immunol
34334897	A single-center experience in use of tocilizumab in COVID-19 pneumonia in India.	Med J Armed Forces India
34334626	Is there a role for immune-enhancing therapies for acutely ill patients with coronavirus disease 2019?	Curr Opin Crit Care
34334100	Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis.	Hematology
34334083	Uncovering antiobesity-related hypertension targets and mechanisms of metformin, an antidiabetic medication.	Bioengineered
34333764	Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing.	Eur J Immunol
34333425	Discovery and evolution of 12N-substituted aloperine derivatives as anti-SARS-CoV-2 agents through targeting late entry stage.	Bioorg Chem
34333358	Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study.	Int Immunopharmacol
34333272	Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19.	Mult Scler Relat Disord
34330511	Comparison between Nutric Score and modified nutric score to assess ICU mortality in critically ill patients with COVID-19.	Clin Nutr ESPEN
34329676	Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection.	J Infect
34326952	Immunometabolic bases of type 2 diabetes in the severity of COVID-19.	World J Diabetes
34326336	Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection.	Nat Commun
34326311	Differential immune responses in pregnant patients recovered from COVID-19.	Signal Transduct Target Ther
34322810	Bioinformatic analyses suggest augmented interleukin-17 signaling as the mechanism of COVID-19-associated herpes zoster.	Environ Sci Pollut Res Int
34322120	Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.	Front Immunol
34321327	High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients.	Life Sci Alliance
34318516	COVID-19 acute respiratory distress syndrome: A simulation study of the effects of combination therapy with tocilizumab and siltuximab.	Br J Clin Pharmacol
34316448	SARS-CoV-2 (COVID-19), viral load and clinical outcomes; lessons learned one year into the pandemic: A systematic review.	World J Crit Care Med
34315957	Lower peripheral blood Toll-like receptor 3 expression is associated with an unfavorable outcome in severe COVID-19 patients.	Sci Rep
34314863	Ultraviolet-A light reduces cellular cytokine release from human endotracheal cells infected with Coronavirus.	Photodiagnosis Photodyn Ther
34314405	[Florence Nightingale and the SARS-CoV-2 coronavirus pandemic].	Ig Sanita Pubbl
34313585	Network pharmacology and molecular docking analysis on mechanisms of Tibetan Hongjingtian (Rhodiola crenulata) in the treatment of COVID-19.	J Med Microbiol
34307417	Case Report: Human Umbilical Cord Mesenchymal Stem Cells as a Therapeutic Intervention for a Critically Ill COVID-19 Patient.	Front Med (Lausanne)
34307393	Elevation of Serum Cytokine Profiles and Liver Metabolomic Normalization in Early Convalescence of COVID-19 Patients.	Front Med (Lausanne)
34306796	The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on "Profibrotic Cytokine" IL-1beta Levels in Severe and Critical COVID-19 Patients: A Preliminary Study.	Scientifica (Cairo)
34305416	Coagulopathy in SARS-CoV-2 Infected Patients: Implication for the Management of COVID-19.	J Blood Med
34305277	Precision medicine: Uses and challenges.	Med J Armed Forces India
34305233	[The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness].	Neurologia (Engl Ed)
34303949	An update on the pathogenic role of IL-6 in rheumatic diseases.	Cytokine
34302964	BCG vaccination induces enhanced frequencies of dendritic cells and altered plasma levels of type I and type III interferons in elderly individuals.	Int J Infect Dis
34299865	Influence of Face Masks on the Use of Contact Lenses.	Int J Environ Res Public Health
34299080	Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19.	Int J Mol Sci
34297627	Pathogenesis of Coronaviruses Through Human Monocytes and Tissue Macrophages.	Viral Immunol
34296442	SARS-CoV-2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage.	EMBO J
34295857	Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic.	Front Pediatr
34290821	Association of anemia and COVID-19 in hospitalized patients.	Future Virol
34289718	Pre-analytical sample handling effects on blood cytokine levels: quality control of a COVID-19 biobank.	Biomark Med
34285712	Possible Benefit of Angiotensin II Receptor Blockers in COVID-19 Patients: A Case Series.	J Renin Angiotensin Aldosterone Syst
34284028	Computational analysis of TMPRSS2 expression in normal and SARS-CoV-2-infected human tissues.	Chem Biol Interact
34282808	Viral stimulation modulates endotype-related ACE2 expression in eosinophilic chronic rhinosinusitis.	Rhinology
34282132	Adversity in early life and pregnancy are immunologically distinct from total life adversity: macrophage-associated phenotypes in women exposed to interpersonal violence.	Transl Psychiatry
34280026	Quantitative Insight into Immunopathology of SARS-CoV-2 Infection.	J Interferon Cytokine Res
34276659	Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.	Front Immunol
34276042	Editorial: Tocilizumab, a Humanized Therapeutic IL-6 Receptor (IL-6R) Monoclonal Antibody, and Future Combination Therapies for Severe COVID-19.	Med Sci Monit
34274468	HA of H1N1 enhanced the expression of ICAM-1 and IL-6 in HUVECs and pathological injury in the lungs in mice.	Gene
34271988	Cell therapy in patients with COVID-19 using Wharton's jelly mesenchymal stem cells: a phase 1 clinical trial.	Stem Cell Res Ther
34271099	Gut probiotic Lactobacillus rhamnosus attenuates PDE4B-mediated interleukin-6 induced by SARS-CoV-2 membrane glycoprotein.	J Nutr Biochem
34270918	Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy.	Cell Rep
34266903	Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children.	Pediatrics
34265624	N-acylethanolamine regulation of TLR3-induced hyperthermia and neuroinflammatory gene expression: A role for PPARalpha.	J Neuroimmunol
34265022	SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney.	PLoS Pathog
34262673	Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity.	J Extracell Vesicles
34262570	Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.	Front Immunol
34262564	Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.	Front Immunol
34262116	Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.	Sci Rep
34260780	A systematic meta-analysis of immune signatures in patients with COVID-19.	Rev Med Virol
34260778	Immunity and inflammatory biomarkers in COVID-19: A systematic review.	Rev Med Virol
34260764	Low serum level of apolipoprotein A1 may predict the severity of COVID-19: A retrospective study.	J Clin Lab Anal
34260666	COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes.	PLoS Pathog
34258904	Cardiac manifestations of COVID-19.	Rev Cardiovasc Med
34258628	The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis.	J Mol Med (Berl)
34258590	The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study.	Lancet Rheumatol
34257816	Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score.	Oxid Med Cell Longev
34257657	Evaluation of the Risk of Clinical Deterioration among Inpatients with COVID-19.	Adv Virol
34256745	Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study.	BMC Med
34256643	Adjuvant hemoadsorption therapy in patients with severe COVID-19 and related organ failure requiring CRRT or ECMO therapy: A case series.	Int J Artif Organs
34254465	SSRIs: Applications in inflammatory lung disease and implications for COVID-19.	Neuropsychopharmacol Rep
34253862	Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms.	Exp Mol Med
34253708	The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction.	Signal Transduct Target Ther
34251348	Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.	Acta Med Indones
34248984	Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.	Front Immunol
34248968	SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.	Front Immunol
34248940	Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism.	Front Immunol
34248910	Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study.	Front Microbiol
34248730	Teacher Online Informal Learning as a Means to Innovative Teaching During Home Quarantine in the COVID-19 Pandemic.	Front Psychol
34245743	IL-33 Depletion in COVID-19 Lungs.	Chest
34245398	COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine.	Clin Exp Nephrol
34242356	Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses.	PLoS One
34238985	In vitro Interleukin-7 treatment partially rescues MAIT cell dysfunction caused by SARS-CoV-2 infection.	Sci Rep
34238962	Significance of peripheral blood indexes in differential diagnoses of SARS-CoV-2 and New Bunia virus.	Sci Rep
34238349	Pre-existing asthma as a comorbidity does not modify cytokine responses and severity of COVID-19.	Allergy Asthma Clin Immunol
34238117	Divergence between serum creatine and cystatin C in estimating glomerular filtration rate of critically ill COVID-19 patients.	Ren Fail
34237804	The role of tocilizumab therapy in critically ill patients with severe acute respiratory syndrome coronavirus 2.	J Osteopath Med
34237666	Multifunctional inhibitors of SARS-CoV-2 by MM/PBSA, essential dynamics, and molecular dynamic investigations.	J Mol Graph Model
34237556	Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: A pilot study.	Cytokine
34236264	Efficacy of tocilizumab in COVID-19: A review of the current evidence.	Sci Prog
34236141	Serum triglyceride levels and related factors as prognostic indicators in COVID-19 patients: A retrospective study.	Immun Inflamm Dis
34234102	SARS-CoV-2-specific immune response in COVID-19 convalescent individuals.	Signal Transduct Target Ther
34233388	Comparison of the Clinical and Laboratory Findings in COVID-19 Positive Pregnants without Comorbidity.	Turk J Med Sci
34232823	The blood-gas barrier in COVID-19: an overview of the effects of SARS-CoV-2 infection on the alveolar epithelial and endothelial cells of the lung.	Tissue Barriers
34232708	Indeterminate QuantiFERON Gold Plus Results Reveal Deficient Interferon Gamma Responses in Severely Ill COVID-19 Patients.	J Clin Microbiol
34232441	Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality.	J Clin Immunol
34230225	High Levels of IL-8 and MCP-1 in Cerebrospinal Fluid of COVID-19 Patients with Cerebrovascular Disease.	Exp Neurobiol
34229173	Re-Du-Ning injection ameliorates LPS-induced lung injury through inhibiting neutrophil extracellular traps formation.	Phytomedicine
34228779	IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19: Who, When, and How?	JAMA
34228774	Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.	JAMA
34228363	Clinical features and outcome of COVID-19 positive children from a tertiary healthcare hospital in Karachi.	J Med Virol
34228347	Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021).	Infection
34226825	Testosterone Deficiency Is a Risk Factor for Severe COVID-19.	Front Endocrinol (Lausanne)
34226597	Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors.	Sci Rep
34224783	Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C).	J Allergy Clin Immunol
34222847	Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial.	EClinicalMedicine
34222271	Abnormal Coagulation Function of Patients With COVID-19 Is Significantly Related to Hypocalcemia and Severe Inflammation.	Front Med (Lausanne)
34222268	Immune Response, Viral Shedding Time, and Clinical Characterization in COVID-19 Patients With Gastrointestinal Symptoms.	Front Med (Lausanne)
34221846	Prediction and identification of T cell epitopes of COVID-19 with balanced cytokine response for the development of peptide based vaccines.	In Silico Pharmacol
34221397	Benefits of Tocilizumab in patients with a severe form of SARS-CoV-2 infection: Experience of the intensive care unit of the Mohammed VI university hospital, Oujda.	Ann Med Surg (Lond)
34220854	Chronic Immune Activation and CD4(+) T Cell Lymphopenia in Healthy African Individuals: Perspectives for SARS-CoV-2 Vaccine Efficacy.	Front Immunol
34220807	COVID-19 Severity in Obesity: Leptin and Inflammatory Cytokine Interplay in the Link Between High Morbidity and Mortality.	Front Immunol
34220524	He-Jie-Shen-Shi Decoction as an Adjuvant Therapy on Severe Coronavirus Disease 2019: A Retrospective Cohort and Potential Mechanistic Study.	Front Pharmacol
34220507	Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting M(pro) and Ameliorates Pulmonary Inflammation.	Front Pharmacol
34220505	Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences.	Front Pharmacol
34220307	Multi-biomarker is an early-stage predictor for progression of Coronavirus disease 2019 (COVID-19) infection.	Int J Med Sci
34219277	Hemoadsorption for management of patients on veno-venous ECMO support for severe COVID-19 acute respiratory distress syndrome.	J Card Surg
34216735	Immunological predictors of disease severity in patients with COVID-19.	Int J Infect Dis
34216119	Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.	Infect Chemother
34214571	Performance of the Roche IL-6 chemiluminescent immunoassay in patients with COVID-like respiratory symptoms.	J Virol Methods
34214142	ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions.	PLoS Pathog
34213786	COVID-19 skin lesions are rarely positive at RT-PCR test: the macrophage activation with vascular impact and SARS-CoV-2-induced cytokine storm.	Int J Dermatol
34212921	Predictors of Clinical Outcomes in Adult COVID-19 Patients Admitted to a Tertiary Care Hospital in India: an analytical cross-sectional study.	Acta Biomed
34211953	Prognostic Role of Neutrophil to Lymphocyte Ratio in COVID-19 Patients: Still Valid in Patients That Had Started Therapy?	Front Public Health
34209818	Toward a Coronavirus Knowledge Graph.	Genes (Basel)
34209705	COVID-19-Associated Cardiovascular Complications.	Diseases
34209213	Emerging Evidence for Pleiotropism of Eosinophils.	Int J Mol Sci
34208751	Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine.	Microorganisms
34207510	Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms.	Int J Mol Sci
34207220	Estrogen Receptor Modulators in Viral Infections Such as SARS-CoV-2: Therapeutic Consequences.	Int J Mol Sci
34206219	Vitamin D Metabolites and Clinical Outcome in Hospitalized COVID-19 Patients.	Nutrients
34205262	The Role of Th17 Response in COVID-19.	Cells
34205098	The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner.	Viruses
34203015	Clinical Significance of Micronutrient Supplementation in Critically Ill COVID-19 Patients with Severe ARDS.	Nutrients
34202578	Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial.	Nutrients
34202029	A Hepatitis B Virus-Derived Peptide Can Inhibit Infection of Human Lung Cells with SARS-CoV-2 in a Type-1 Interferon-Dependent Manner.	Viruses
34201817	Comparative Anti-Inflammatory Effects of Salix Cortex Extracts and Acetylsalicylic Acid in SARS-CoV-2 Peptide and LPS-Activated Human In Vitro Systems.	Int J Mol Sci
34201473	Diabetes Mellitus-A Risk Factor for Unfavourable Outcome in COVID-19 Patients-The Experience of an Infectious Diseases Regional Hospital.	Healthcare (Basel)
34200572	Identification of Lung and Blood Microbiota Implicated in COVID-19 Prognosis.	Cells
34199761	The Many Faces of Innate Immunity in SARS-CoV-2 Infection.	Vaccines (Basel)
34199506	Description and Analysis of Cytokine Storm in Registered COVID-19 Clinical Trials: A Systematic Review.	Pathogens
34199203	Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19.	Microorganisms
34197543	High rate of HSV-1 reactivation in invasively ventilated COVID-19 patients: Immunological findings.	PLoS One
34194420	sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.	Front Immunol
34193239	COVID-19 (SARS-CoV-2) lymphocyte responses are associated with inflammatory biomarkers in total joint replacement surgery candidates pre-operatively.	J Orthop Surg Res
34193201	Patient with H syndrome, cardiogenic shock, multiorgan infiltration, and digital ischemia.	Pediatr Rheumatol Online J
34192413	Lymphocytes screening on admission is essential for predicting in-hospital clinical outcome in COVID-19 patients: A retrospective cohort study.	Int J Lab Hematol
34192268	Innate immunology in COVID-19-a living review. Part II: dysregulated inflammation drives immunopathology.	Oxf Open Immunol
34192266	Adaptive immunity to SARS-CoV-2.	Oxf Open Immunol
34188167	Activation of NF-kappaB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2.	Sci Rep
34187224	Circulating furin, IL-6, and presepsin levels and disease severity in SARS-CoV-2-infected patients.	Sci Prog
34185704	IL-13 is a driver of COVID-19 severity.	JCI Insight
34184268	Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience.	Eur J Clin Invest
34184164	COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.	Angiogenesis
34182775	Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.	mBio
34181987	Multisystem Inflammatory Syndrome of Children: Subphenotypes, Risk Factors, Biomarkers, Cytokine Profiles, and Viral Sequencing.	J Pediatr
34180719	The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial.	Cell Transplant
34178527	Tocilizumab and Thromboembolism in COVID-19: A Retrospective Hospital-Based Cohort Analysis.	Cureus
34177897	Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics.	Front Immunol
34177566	Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2.	Front Pharmacol
34177139	Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm.	Indian J Clin Biochem
34176064	SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist.	J Clin Immunol
34175433	Daytime variation in SARS-CoV-2 infection and cytokine production.	Microb Pathog
34174875	Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.	J Transl Med
34174793	Interleukin-21: a potential biomarker for diagnosis and predicting prognosis in COVID-19 patients	Turk J Med Sci
34174375	Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.	J Ethnopharmacol
34173853	How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1alpha.	Inflamm Res
34173452	Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.	Med Microecol
34172783	Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19.	Sci Rep
34171559	COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario.	Cancer Treat Res Commun
34171421	Management of patients with Intestinal Bowel Disease and COVID-19: A review of current evidence and future perspectives.	Gastroenterol Hepatol
34170074	Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.	EMBO Mol Med
34169908	Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors.	Indian J Pharmacol
34169296	Repurposing Interleukin-6 Inhibitors to Combat COVID-19.	J Immunother Precis Oncol
34168484	Gut Microbiota Dysbiosis Correlates with Abnormal Immune Response in Moderate COVID-19 Patients with Fever.	J Inflamm Res
34167463	Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study.	BMC Infect Dis
34166137	Mental Stress, Anxiety and Depressive Symptoms and Interleuken-6 Level among Healthcare Workers during the COVID-19 Pandemic.	J Prim Care Community Health
34163488	Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.	Front Immunol
34163151	Inhibitory Potential of Phytochemicals on Interleukin-6-Mediated T-Cell Reduction in COVID-19 Patients: A Computational Approach.	Bioinform Biol Insights
34162948	Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients.	Sci Rep
34160631	Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.	Intensive Care Med
34160563	ACE2 Expression Is Upregulated in Inflammatory Corneal Epithelial Cells and Attenuated by Resveratrol.	Invest Ophthalmol Vis Sci
34160250	SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells.	J Virol
34160239	Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models.	mSphere
34157321	Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo.	Antiviral Res
34157151	Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID-19 patients.	Allergy
34156332	A comparison of COVID-19 inpatients by HIV status.	Int J STD AIDS
34153723	Interleukin-6 (IL-6) inhibitors as therapeutic agents for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.	J Infect Public Health
34153179	A novel anti-inflammatory treatment for bradykinin-induced sore throat or pharyngitis.	Immun Inflamm Dis
34152424	Clinical Profile and Risk Factors for Severe Disease in 402 Children Hospitalized with SARS-CoV-2 from India: Collaborative Indian Pediatric COVID Study Group.	J Trop Pediatr
34150792	Pneumatosis Intestinalis in the Setting of COVID-19: A Single Center Case Series From New York.	Front Med (Lausanne)
34150352	Identification of Monocytes Associated with Severe COVID-19 in the PBMCs of Severely Infected patients Through Single-Cell Transcriptome Sequencing.	Engineering (Beijing)
34149244	Effets de la COVID-19 sur la variation du revenu et la securite alimentaire des menages au Togo.	Afr Dev Rev
34146478	Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4(+) T cell help.	Cell Rep
34143818	An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia.	PLoS One
34133077	Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19.	EMBO Mol Med
34131192	Cytokine signatures of end organ injury in COVID-19.	Sci Rep
34131024	SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques.	Sci Immunol
34130442	Do Anxiety and Depression Levels Affect the Inflammation Response in Patients Hospitalized for COVID-19.	Psychiatry Investig
34130119	The immunological response among COVID-19 patients with acute respiratory distress syndrome.	J Infect Public Health
34128416	Continuous hemadsorption with cytokine adsorber for severe COVID-19: A case series of 15 patients.	Int J Artif Organs
34127355	Type 1 inflammatory endotype relates to low compliance, lung fibrosis, and severe complications in COVID-19.	Cytokine
34126960	Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy.	BMC Infect Dis
34126617	Extracorporeal Blood Purification in Moderate and Severe COVID-19 Patients: A Prospective Cohort Study.	Blood Purif
34124694	Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study.	Lancet Rheumatol
34124322	Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies.	Regen Ther
34123873	Association of Clinical and Immunological Characteristics With Disease Severity and Outcomes in 211 Patients With COVID-19 in Wuhan, China.	Front Cell Infect Microbiol
34123401	L-arginine as a potential GLP-1-mediated immunomodulator of Th17-related cytokines in people with obesity and asthma.	Obes Sci Pract
34122618	Clinical Characteristics and Early Interventional Responses in Patients with Severe COVID-19 Pneumonia.	Comput Math Methods Med
34122423	Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.	Front Immunol
34122407	Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection.	Front Immunol
34122129	Persistently Increased Systemic ACE2 Activity Is Associated With an Increased Inflammatory Response in Smokers With COVID-19.	Front Physiol
34122073	The Therapeutic Effect of Traditional Chinese Medicine on Inflammatory Diseases Caused by Virus, Especially on Those Caused by COVID-19.	Front Pharmacol
34121671	Low-dose radiotherapy for COVID 19: A radioimmunological perspective.	J Cancer Res Ther
34120824	Tocilizumab in COVID-19: The Cerrahpasa-PREDICT score.	J Infect Chemother
34119855	Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19.	Psychoneuroendocrinology
34118952	Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.	Virol J
34115964	Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation.	Immunity
34115949	Lack of Effects of the Genetic Polymorphisms of Interleukin-10 in Clinical Outcomes of COVID-19.	Viral Immunol
34115314	Impact of Inflammatory Response Modifiers on the Incidence of Hospital-Acquired Infections in Patients with COVID-19.	Infect Dis Ther
34114204	COVID-19 and immunothrombosis: emerging understanding and clinical management.	Br J Haematol
34113636	Development and Validation of a Predictive Model for Severe COVID-19: A Case-Control Study in China.	Front Med (Lausanne)
34111453	Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.	J Allergy Clin Immunol
34111164	Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging.	PLoS One
34110959	Possible therapeutic effects of Nigella sativa and its thymoquinone on COVID-19.	Pharm Biol
34110682	An Intelligent Graphene-Based Biosensing Device for Cytokine Storm Syndrome Biomarkers Detection in Human Biofluids.	Small
34108465	Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection.	Nat Commun
34108284	Combination of a SARS-CoV-2 IgG Assay and RT-PCR for Improved COVID-19 Diagnosis.	Ann Lab Med
34107645	Profiling Inflammatory Cytokines in a Cohort Study of Egyptian Patients with COVID-19 Infection.	Clin Lab
34107113	Changes of serum IL-10, IL-1beta, IL-6, MCP-1, TNF-alpha, IP-10 and IL-4 in COVID-19 patients.	Int J Clin Pract
34107055	Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein.	Eur J Immunol
34106658	Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2.	Medicine (Baltimore)
34106340	Correction to: Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: infammatory response of SARS-CoV-2 patients.	Ann Intensive Care
34105503	[Bioinformatics Analysis of the Influence of Coronavirus Infection on Hematopoietic System and Potential Intervention Drugs and Their Significance for COVID-19].	Zhongguo Shi Yan Xue Ye Xue Za Zhi
34105049	Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis.	Mol Divers
34103886	IL-6 and Other Biomarkers associated with Poor Prognosis in a Cohort of Hospitalized Patients with COVID-19 in Madrid.	Biomark Insights
34103408	Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro.	Sci Transl Med
34103044	COVID-19 related multisystem inflammatory syndrome in children (MIS-C): a case series from a tertiary care pediatric hospital in Qatar.	BMC Pediatr
34099547	CDCP1 on Dendritic Cells Contributes to the Development of a Model of Kawasaki Disease.	J Immunol
34098108	Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen In vivo.	Microbes Infect
34097709	Signal-regulatory protein alpha is an anti-viral entry factor targeting viruses using endocytic pathways.	PLoS Pathog
34095336	Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients.	Open Forum Infect Dis
34092298	Chemical profiling of Huashi Baidu prescription, an effective anti-COVID-19 TCM formula, by UPLC-Q-TOF/MS.	Chin J Nat Med
34091116	Different T cell related immunological profiles in COVID-19 patients compared to healthy controls.	Int Immunopharmacol
34090021	Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm.	J Neurol Sci
34089457	Atypical Inflammatory Syndrome Triggered by SARS-CoV-2 in Infants with Down Syndrome.	J Clin Immunol
34089082	SNPs at 3'UTR of APOL1 and miR-6741-3p target sites associated with kidney diseases more susceptible to SARS-COV-2 infection: in silco and in vitro studies.	Mamm Genome
34088885	Revealing the therapeutic targets and molecular mechanisms of emodin-treated coronavirus disease 2019 via a systematic study of network pharmacology.	Aging (Albany NY)
34088317	Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.	Virol J
34088273	Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients.	J Headache Pain
34087864	Serum IL-6 and procalcitonin are two promising novel biomarkers for evaluating the severity of COVID-19 patients.	Medicine (Baltimore)
34087242	Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity.	J Allergy Clin Immunol
34086061	The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications.	Inflamm Res
34083362	Association between IL-6 and severe disease and mortality in COVID-19 disease: a systematic review and meta-analysis.	Postgrad Med J
34081846	Is Trikatu an ayurvedic formulation effective for the management of flu-like illness? A narrative review.	J Complement Integr Med
34081354	Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID-2019) in 23 countries.	J Med Virol
34081326	Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cells.	Eur J Immunol
34079789	Investigation of Knowledge, Attitude and Practice of Personal Protection Among Different Types of Workers Returning to Work Under COVID-19 Epidemic.	Front Public Health
34079547	Quantification of Cytokine Storms During Virus Infections.	Front Immunol
34079452	Transcriptional Regulation of Drug Metabolizing CYP Enzymes by Proinflammatory Wnt5A Signaling in Human Coronary Artery Endothelial Cells.	Front Pharmacol
34078423	The impact of National Containment Measures on a Pediatric Italian regional Hub for COVID-19, an observational study.	Ital J Pediatr
34076953	A single-center report of COVID-19 disease course and management in liver transplanted pediatric patients.	Pediatr Transplant
34075419	Concordance between the results of randomized and non-randomized interventional clinical trials assessing the efficacy of drugs for COVID-19: a cross-sectional study.	J Antimicrob Chemother
34074585	The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?	Cytokine
34073559	The Relevance of Monoclonal Antibodies in the Treatment of COVID-19.	Vaccines (Basel)
34073283	Induction of the Proinflammatory Chemokine Interleukin-8 Is Regulated by Integrated Stress Response and AP-1 Family Proteins Activated during Coronavirus Infection.	Int J Mol Sci
34071149	Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study.	Cells
34070102	Assessing Biocompatibility of Face Mask Materials during COVID-19 Pandemic by a Rapid Multi-Assays Strategy.	Int J Environ Res Public Health
34069869	Povidone-Iodine Attenuates Viral Replication in Ocular Cells: Implications for Ocular Transmission of RNA Viruses.	Biomolecules
34069835	Evaluation of SARS-CoV-2 Spike S1 Protein Response on PI3K-Mediated IL-8 Release.	Med Sci (Basel)
34069574	Response of Severe EV71-Infected Patients to Hyperimmune Plasma Treatment: A Pilot Study.	Pathogens
34069549	The Efficacy of Antioxidant Oral Supplements on the Progression of COVID-19 in Non-Critically Ill Patients: A Randomized Controlled Trial.	Antioxidants (Basel)
34068473	Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19.	Vaccines (Basel)
34066892	HGF, IL-1alpha, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients.	J Clin Med
34066534	Vicarious Traumatization Questionnaire: Psychometric Properties Using Rasch Model and Structural Equation Modeling.	Int J Environ Res Public Health
34065210	The Emerging Role of Neutrophils in the Pathogenesis of Thrombosis in COVID-19.	Int J Mol Sci
34065123	Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes.	Antioxidants (Basel)
34065057	The Relationship between Inflammatory Cytokines and Coagulopathy in Patients with COVID-19.	J Clin Med
34064802	Cytokines and Leukocytes Subpopulations Profile in SARS-CoV-2 Patients Depending on the CT Score Severity.	Viruses
34064728	Th17 Cells in Viral Infections-Friend or Foe?	Cells
34064210	Dolosigranulum pigrum Modulates Immunity against SARS-CoV-2 in Respiratory Epithelial Cells.	Pathogens
34063554	The Effects of Insulin-Like Growth Factor I and BTP-2 on Acute Lung Injury.	Int J Mol Sci
34061395	Relative expression of proinflammatory molecules in COVID-19 patients who manifested disease severities.	J Med Virol
34060731	Preventive effects of Pycnogenol(R) on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19).	Minerva Med
34060490	Coronavirus-specific antibody production in middle-aged mice requires phospholipase A2G2D.	J Clin Invest
34059786	Are adipokines the missing link between obesity, immune response, and outcomes in severe COVID-19?	Int J Obes (Lond)
34058750	Quercetin for COVID-19 and DENGUE co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and DENV.	Brief Bioinform
34058746	TLR7 Ligation Inhibits TLR8 Responsiveness in IL-27-Primed Human THP-1 Monocytes and Macrophages.	J Innate Immun
34057983	A review of Covid-19 and acute kidney injury: from pathophysiology to clinical results.	J Bras Nefrol
34057608	Upregulation of INF-gamma, IL-6, and IL-8 expression during replication of turkey coronavirus in nonepithelial cells obtained from Meleagris gallopavo.	Arch Virol
34054828	The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?	Front Immunol
34053480	[Evaluation of clinical value of Xuebijing combined with human immunoglobulin in severe and critically ill patients with coronavirus disease 2019].	Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
34053400	High-throughput immunoassays for SARS-CoV-2 - considerable differences in performance when comparing three methods.	Infect Dis (Lond)
34053084	Alpha-defensins: risk factor for thrombosis in COVID-19 infection.	Br J Haematol
34052418	Pathomechanisms, therapeutic targets and potent inhibitors of some beta-coronaviruses from bench-to-bedside.	Infect Genet Evol
34051148	Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.	Immunity
34049969	Metabolic Defects of Peripheral T Cells in COVID-19 Patients.	J Immunol
34049860	Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry.	Ann Rheum Dis
34048587	Optimal serum ferritin level range: iron status measure and inflammatory biomarker.	Metallomics
34047654	Temporal Kinetics of RNAemia and Associated Systemic Cytokines in Hospitalized COVID-19 Patients.	mSphere
34046038	Case Report: Successful Response to Intravenous Immunoglobulin and Steroid Pulses in a Renal Transplant Recipient With Severe Covid-19 Disease and Associated Acute Allograft Failure.	Front Immunol
34046036	Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis.	Front Immunol
34045884	In vivo and in vitro Evaluation of Cytokine Expression Profiles During Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection.	J Inflamm Res
34044428	BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.	Nature
34041137	Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis.	J Family Med Prim Care
34040262	Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2.	Nat Med
34036149	High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections.	Discoveries (Craiova)
34035116	Polyclonal expansion of TCR Vbeta 21.3(+) CD4(+) and CD8(+) T cells is a hallmark of Multisystem Inflammatory Syndrome in Children.	Sci Immunol
34034598	The rationale for including osteopathic manipulative treatment in the management of infections: a hermeneutic review.	Expert Rev Anti Infect Ther
34033999	Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 Spike protein.	Phytomedicine
34033365	Monoclonal Antibody Therapy For High-Risk Coronavirus (COVID 19) Patients With Mild To Moderate Disease Presentations	StatPearls
34032527	The understanding of the immunopathology in COVID-19 infection.	Scand J Clin Lab Invest
34030547	The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey.	J Dermatolog Treat
34027897	The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2-infected patients by sex and age.	JCI Insight
34027650	Phytotherapy for treatment of cytokine storm in COVID-19.	Front Biosci (Landmark Ed)
34027204	Interleukin-13 as a target to alleviate severe coronavirus disease 2019 and restore lung homeostasis.	J Clin Transl Res
34026778	Vagus Nerve Stimulation: A Potential Adjunct Therapy for COVID-19.	Front Med (Lausanne)
34025650	Anti-TNF-alpha agents Modulate SARS-CoV-2 Receptors and Increase the Risk of Infection Through Notch-1 Signaling.	Front Immunol
34023458	SARS-CoV-2 suppresses mRNA expression of selenoproteins associated with ferroptosis, endoplasmic reticulum stress and DNA synthesis.	Food Chem Toxicol
34023234	Immunological map in COVID-19.	J Microbiol Immunol Infect
34022205	Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).	Microvasc Res
34021148	Peripheral and lung resident memory T cell responses against SARS-CoV-2.	Nat Commun
34021143	Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomes.	Nat Commun
34021028	Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study.	Emerg Med J
34020039	Real-Life Head-to-Head Comparison of Performance of Two High-Throughput Automated Assays for the Detection of SARS-CoV-2 RNA in Nasopharyngeal Swabs: The Alinity m and cobas 6800 SARS-CoV-2 Assays.	J Mol Diagn
34019274	Sex Hormones and Lung Inflammation.	Adv Exp Med Biol
34019253	Early echocardiographic findings in patients hospitalized for COVID-19 pneumonia: a prospective, single center study.	Intern Emerg Med
34019232	Acute-care hospital reencounters in COVID-19 patients.	Geroscience
34019122	Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials.	Intensive Care Med
34017249	The Cholinergic Drug Pyridostigmine Alleviates Inflammation During LPS-Induced Acute Respiratory Distress Syndrome.	Front Pharmacol
34016150	The age again in the eye of the COVID-19 storm: evidence-based decision making.	Immun Ageing
34015982	Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19.	Immunopharmacol Immunotoxicol
34015823	COVID-19 biomarkers and their overlap with comorbidities in a disease biomarker data model.	Brief Bioinform
34015316	Evaluation of Th1 and Th2 mediated cellular and humoral immunity in patients with COVID-19 following the use of melatonin as an adjunctive treatment.	Eur J Pharmacol
34014798	IL-6 Inhibition Reduces Neuronal Injury in a Murine Model of Ventilator-induced Lung Injury.	Am J Respir Cell Mol Biol
34013339	Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology.	Clin Infect Dis
34010360	SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: Implications for spillback to New World rodents.	PLoS Pathog
34007877	Point-of-care ultrasonography in the initial characterization of patients with COVID-19.	Med Clin (Engl Ed)
34007862	Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection.	Mol Ther Methods Clin Dev
34004074	Does tocilizumab have a role in dermatology? A review of clinical applications, its adverse side effects and practical considerations.	Dermatol Ther
34003185	[Drug use during the covid-19 pandemic in Italy.]	Recenti Prog Med
34002634	Impact of presymptomatic COVID-19 on vascular and skeletal muscle function: a case study.	J Appl Physiol (1985)
34002013	Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis.	Commun Biol
34000622	Clinical features and prognostic factors in Covid-19: A prospective cohort study.	EBioMedicine
34000358	Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19.	Int J Cardiol
34000236	Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial.	Lancet Respir Med
33999778	Distinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and convalescent phase of COVID-19.	Platelets
33999135	Anakinra in hospitalized non-intubated patients with coronavirus disease 2019: a Systematic review and meta-analysis.	Rheumatology (Oxford)
33995419	Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation.	Front Immunol
33995382	SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs.	Front Immunol
33995361	Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm.	Front Immunol
33995342	Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1).	Front Immunol
33994592	[SARS-CoV-2 infection. Descriptive analysis of a selected case series].	Rev Esp Anestesiol Reanim
33994470	A case report of super responder of critical COVID-19 pneumonia.	J Med Invest
33993845	Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates.	Emerg Microbes Infect
33992179	Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?	J Clin Neurosci
33992044	Pediatric Inflammatory Multisystem Syndrome (PIMS) - Potential role for cytokines such Is IL-6.	Physiol Res
33991637	Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy.	J Hepatol
33988463	Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.	Biomark Med
33988226	Increased Peripheral Blood Neutrophil Activation Phenotypes and Neutrophil Extracellular Trap Formation in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients: A Case Series and Review of the Literature.	Clin Infect Dis
33988136	Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma.	Acta Biomed
33987399	Early risk factors for extrapulmonary organ injury in adult COVID-19 patients.	Ann Transl Med
33986661	Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated with SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking.	Front Pharmacol
33986193	A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients.	JCI Insight
33984571	A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine.	J Autoimmun
33984520	Plant-derived exosomal microRNAs inhibit lung inflammation induced by exosomes SARS-CoV-2 Nsp12.	Mol Ther
33984091	A Novel Report on the Compassionate Use of Baricitinib in Treating a Pediatric Patient With Severe Symptoms of COVID-19 Infection.	J Med Cases
33983525	Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study.	Eur Arch Otorhinolaryngol
33982984	Experience with the use of siltuximab in patients with SARS-CoV-2 infection.	Rev Esp Quimioter
33981314	Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!	Front Immunol
33981229	Ruxolitinib, a JAK1/2 Inhibitor, Ameliorates Cytokine Storm in Experimental Models of Hyperinflammation Syndrome.	Front Pharmacol
33980688	Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.	Clin Microbiol Rev
33978988	Malnutrition is associated with hyperinflammation and immunosuppression in COVID-19 patients: A prospective observational study.	Nutr Clin Pract
33975613	COVID-19 and periodontitis: reflecting on a possible association.	Head Face Med
33973805	Activation of Interleukin-1beta Release and Pyroptosis by Transmissible Gastroenteritis Virus Is Dependent on the NOD-Like Receptor Protein 3 Inflammasome in Porcine Intestinal Epithelial Cell Line.	Viral Immunol
33973280	COVID-19 in DMARD-treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database.	Fundam Clin Pharmacol
33973197	Dietary Supplements for COVID-19.	Adv Exp Med Biol
33973190	Clinical and Laboratory Predictors of Severity, Criticality, and Mortality in COVID-19: A Multisystem Disease.	Adv Exp Med Biol
33973176	How COVID-19 Has Globalized: Unknown Origin, Rapid Transmission, and the Immune System Nourishment.	Adv Exp Med Biol
33972738	IL-33 in COVID-19: friend or foe?	Cell Mol Immunol
33972413	Reply to Cheng et al.: COVID-19 induces lower extent of cytokines, but damages vascular endothelium by IL-6 signaling.	Proc Natl Acad Sci U S A
33972411	COVID-19 induces lower levels of IL-8, IL-10, and MCP-1 than other acute CRS-inducing diseases.	Proc Natl Acad Sci U S A
33971585	An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.	J Autoimmun
33970450	Rifampicin and Letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico study.	Pharmacol Rep
33968948	The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19.	Front Med (Lausanne)
33968298	Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy.	Oxid Med Cell Longev
33968082	Regulation and Function of ILC3s in Pulmonary Infections.	Front Immunol
33967777	Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives.	Front Pharmacol
33967617	Correlation between ground-glass opacity on pulmonary CT and the levels of inflammatory cytokines in patients with moderate-to-severe COVID-19 pneumonia.	Int J Med Sci
33966520	A novel approach utilizing laser acupuncture teletherapy for management of elderly-onset rheumatoid arthritis: A randomized clinical trial.	J Telemed Telecare
33964240	The blueprint of disaster: COVID-19, the Flint water crisis, and unequal ecological impacts.	Lancet Planet Health
33960271	Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic.	Int Rev Immunol
33956286	Sex-specific impact of severe obesity in the outcomes of hospitalized patients with COVID-19: a large retrospective study from the Bronx, New York.	Eur J Clin Microbiol Infect Dis
33953595	Factors Associated with the Expression of ACE2 in Human Lung Tissue: Pathological Evidence from Patients with Normal FEV1 and FEV1/FVC.	J Inflamm Res
33952771	Frequency of Interleukin-6 rs1800795 (-174G/C) and rs1800797 (-597G/A) Polymorphisms in COVID-19 Patients in Turkey Who Develop Macrophage Activation Syndrome.	Jpn J Infect Dis
33951560	Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients.	Int Immunopharmacol
33951210	Maternal selenium status plays a crucial role on clinical outcomes of pregnant women with COVID-19 infection.	J Med Virol
33951196	Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID-19 neuropathy patients.	J Med Virol
33950993	Off-label tocilizumab and adjuvant iron chelator effectiveness in a group of severe COVID-19 pneumonia patients: A single center experience.	Medicine (Baltimore)
33950864	Serum sodium alterations in SARS CoV-2 (COVID-19) infection: impact on patient outcome.	Eur J Endocrinol
33947753	Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.	mBio
33947420	Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents.	Pediatr Rheumatol Online J
33946736	Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm.	Vaccines (Basel)
33945643	Immunological analysis of the murine anti-CD3-induced cytokine release syndrome model and therapeutic efficacy of anti-cytokine antibodies.	Eur J Immunol
33942518	Predictors of fatal outcomes among hospitalized COVID-19 patients with pre-existing hypertension in China.	Clin Respir J
33941758	COVID-19 Presentation in Patients with Sickle Cell Disease: A Case Series.	Am J Case Rep
33941271	Multi-omics reveals age-related differences in the diaphragm response to mechanical ventilation: a pilot study.	Skelet Muscle
33940004	Implications in the quantification of SARS-CoV2 copies in concurrent nasopharyngeal swabs, whole mouth fluid and respiratory droplets.	Virus Res
33939954	Clinical laboratory evaluation of COVID-19.	Clin Chim Acta
33939645	High Mobility Group Box 1 and Interleukin 6 at Intensive Care Unit Admission as Biomarkers in Critically Ill COVID-19 Patients.	Am J Trop Med Hyg
33937333	Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6.	Front Mol Biosci
33937310	Increased Oxidative Stress in the Prefrontal Cortex as a Shared Feature of Depressive- and PTSD-Like Syndromes: Effects of a Standardized Herbal Antioxidant.	Front Nutr
33937285	Management of SARS-CoV-2 Infection: Key Focus in Macrolides Efficacy for COVID-19.	Front Med (Lausanne)
33936053	Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19.	Front Immunol
33935396	Acute Kidney Injury in COVID-19: a Brief Review.	Indian J Surg
33933851	The role of IL-6/lymphocyte ratio in the peripheral blood of severe patients with COVID-19.	Int Immunopharmacol
33933847	Hematological characteristics of patients with novel coronavirus pneumonia in intensive care unit.	Int Immunopharmacol
33933633	Genetic polymorphisms as multi-biomarkers in severe acute respiratory syndrome (SARS) by coronavirus infection: A systematic review of candidate gene association studies.	Infect Genet Evol
33932696	A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19).	Int Immunopharmacol
33930764	Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune simulation.	Comput Biol Med
33930704	Evaluation of hepatic enzymes activities in COVID-19 patients.	Int Immunopharmacol
33930329	Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context.	Lancet Respir Med
33927728	Interplay of Opposing Effects of the WNT/beta-Catenin Pathway and PPARgamma and Implications for SARS-CoV2 Treatment.	Front Immunol
33926774	Perspectives on anti-IL-1 inhibitors as potential therapeutic interventions for severe COVID-19.	Cytokine
33925779	PIMS-TS, the New Paediatric Systemic Inflammatory Disease Related to Previous Exposure to SARS-CoV-2 Infection-"Rheumatic Fever" of the 21st Century?	Int J Mol Sci
33921604	Absence of "Cytokine Storm" in Hospitalized COVID-19 Patients: A Retrospective Cohort Study.	Infect Dis Rep
33920709	COVID-19: Direct and Indirect Mechanisms of Statins.	Int J Mol Sci
33919308	The Effect of Proinflammatory Cytokines on the Proliferation, Migration and Secretory Activity of Mesenchymal Stem/Stromal Cells (WJ-MSCs) under 5% O2 and 21% O2 Culture Conditions.	J Clin Med
33918835	Evaluating the Practice of Preventive Behaviors and the Fear of COVID-19 among Dentists in Oradea Metropolitan Area after the First Wave of Pandemic; a Cross-Sectional Study.	Healthcare (Basel)
33918563	Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6.	J Clin Med
33916122	Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting.	Healthcare (Basel)
33915284	Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update.	Clin Microbiol Infect
33914789	Analysis of cytokines in SARS-CoV-2 or COVID-19 patients in Erbil city, Kurdistan Region of Iraq.	PLoS One
33912084	Under-Reporting of COVID-19 Cases Among Indigenous Peoples in Brazil: A New Expression of Old Inequalities.	Front Psychiatry
33909684	Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: Insights from the MGH COVID-19 patient registry.	PLoS One
33908897	Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques.	JCI Insight
33908688	Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-on-chip model.	EMBO Rep
33907720	Gene expression analysis of MCF7 cell lines of breast cancer treated with herbal extract of Cissampelos pareira revealed association with viral diseases.	Gene Rep
33907612	Comparisons of the immunological landscape between COVID-19, influenza, and respiratory syncytial virus patients by clustering analysis.	Comput Struct Biotechnol J
33907514	The role of CD4(+)FoxP3(+) regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment.	Int J Biol Sci
33907513	Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury.	Int J Biol Sci
33907373	Identification of selected genes associated with the SARS-CoV-2: a therapeutic approach and disease severity.	Bull Natl Res Cent
33905951	Functional responsiveness of memory T cells from COVID-19 patients.	Cell Immunol
33904419	Anti-interleukin-6 therapies for Covid-19: A systematic review, critical appraisal and meta-analysis.	Natl Med J India
33904269	Monoclonal antibody therapy in COVID-19.	J Biol Regul Homeost Agents
33903806	Periodontal health related-inflammatory and metabolic profiles of patients with end-stage renal disease: potential strategy for predictive, preventive, and personalized medicine.	EPMA J
33903660	Analysis of IgM, IgA, and IgG isotype antibodies Directed against SARS-CoV-2 spike glycoprotein and ORF8 in the course of COVID-19.	Sci Rep
33900694	Immunological Biomarkers of COVID-19.	Crit Rev Immunol
33900691	Viral Proteins under 70 Kilodaltons in Size Prevent the Development of Long-Lasting B-Cell Immune Memory and IgG2a Prevention in COVID-19 Vaccines.	Crit Rev Immunol
33900328	N-Glycosylated Ganoderma lucidum immunomodulatory protein improved anti-inflammatory activity via inhibition of the p38 MAPK pathway.	Food Funct
33899032	Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome.	Cell Rep Med
33896708	Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico.	Cytokine
33896114	Laboratory predictors of severe Coronavirus Disease 2019 and lung function in followed-up.	Clin Respir J
33894209	Distinct cytokine profiles associated with COVID-19 severity and mortality.	J Allergy Clin Immunol
33892139	Double stranded RNA drives anti-viral innate immune responses, sickness behavior and cognitive dysfunction dependent on dsRNA length, IFNAR1 expression and age.	Brain Behav Immun
33889239	The risk perception of COVID-19 and practice of precautionary measures amongst healthcare workers in the National Health Insurance Scheme Clinic of a tertiary hospital in Nigeria.	Pan Afr Med J
33889008	Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications.	J Inflamm Res
33887367	Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic data.	Gene
33882609	[Treatment of a Patient with a Pronounced Cytokine Storm in Severe COVID-19 Pneumonia using a Hemoadsorption in Combination with the Administration of tocilizumab].	Pneumologie
33880885	Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers.	Arthritis Rheumatol
33880437	Reduced inflammatory responses to SARS-CoV-2 infection in children presenting to hospital with COVID-19 in China.	EClinicalMedicine
33880051	The Pulsatile Modification Improves Hemodynamics and Attenuates Inflammatory Responses in Extracorporeal Membrane Oxygenation.	J Inflamm Res
33878674	Alterations in the lipid profile associate with a dysregulated inflammatory, prothrombotic, anti-fibrinolytic state and development of severe acute kidney injury in coronavirus disease 2019 (COVID-19): A study from Cincinnati, USA.	Diabetes Metab Syndr
33877681	Prediction of potential therapeutic drugs against SARS-CoV-2 by using Connectivity Map based on transcriptome data.	Eur Rev Med Pharmacol Sci
33877096	Il vaccino per covid-19 e piu efficace se mi faccio un selfie?	Recenti Prog Med
33875810	Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey).	Bone Marrow Transplant
33874981	A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.	Trials
33874829	The role of IL-6 and IL-6 blockade in COVID-19.	Expert Rev Clin Immunol
33872709	Qigong exercise enhances cognitive functions in the elderly via an interleukin-6-hippocampus pathway: A randomized active-controlled trial.	Brain Behav Immun
33872590	Interleukin-6: obstacles to targeting a complex cytokine in critical illness.	Lancet Respir Med
33869774	Clinical features of hypertensive patients with COVID-19 compared with a normotensive group: Single-center experience in China.	Open Med (Wars)
33868301	Lung Neutrophilic Recruitment and IL-8/IL-17A Tissue Expression in COVID-19.	Front Immunol
33868293	MicroLet-7b Regulates Neutrophil Function and Dampens Neutrophilic Inflammation by Suppressing the Canonical TLR4/NF-kappaB Pathway.	Front Immunol
33868080	A Motivational Mechanism Framework for Teachers' Online Informal Learning and Innovation During the COVID-19 Pandemic.	Front Psychol
33866132	Babaodan controls excessive immune responses and may represent a cytokine-targeted agent suitable for COVID-19 treatment.	Biomed Pharmacother
33865340	Early immune responses and prognostic factors in children with COVID-19: a single-center retrospective analysis.	BMC Pediatr
33863660	Effects of Simulated COVID-19 Cytokine Storm on Stent Thrombogenicity.	Cardiovasc Revasc Med
33861409	Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review.	Am J Clin Dermatol
33860869	Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.	Inflammation
33860776	Impact of level of vitamin D in the body on the severity of COVID-19 - review of the literature.	Przegl Epidemiol
33860730	From nicotine to the cholinergic anti-inflammatory reflex - Can nicotine alleviate the dysregulated inflammation in COVID-19?	J Immunotoxicol
33854510	Commensal Microbiome Expands Tgammadelta17 Cells in the Lung and Promotes Particulate Matter-Induced Acute Neutrophilia.	Front Immunol
33853308	The effect of tocilizumab on severe COVID-19 infection: Review of current evidence.	Tuberk Toraks
33852936	C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2-infected primary human airway epithelia.	J Allergy Clin Immunol
33850422	Calming the inflammatory storm in severe COVID-19 infections: Role of biologics- A narrative review.	Saudi Pharm J
33850327	Is IL-6 a key cytokine target for therapy in COVID-19?	Nat Rev Immunol
33850192	A comprehensive evaluation of early potential risk factors for disease aggravation in patients with COVID-19.	Sci Rep
33848432	IL-6 Induction and Signaling: Horizons of COVID-19-Related Pathogenesis.	DNA Cell Biol
33847226	SARSCoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice.	Hum Vaccin Immunother
33841438	Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-gamma Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome.	Front Immunol
33840589	Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity.	Cytokine
33839760	Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19.	Brief Bioinform
33839639	Predictors of new-onset diabetic ketoacidosis in patients with moderate to severe COVID-19 receiving parenteral glucocorticoids: A prospective single-centre study among Indian type 2 diabetes patients.	Diabetes Metab Syndr
33839002	IL-6 and IL-10 are associated with disease severity and higher comorbidity in adults with COVID-19.	Cytokine
33837906	A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm.	Intern Emerg Med
33837377	Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.	Nat Med
33837219	IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals.	Nat Commun
33837054	IL-6 modulation for COVID-19: the right patients at the right time?	J Immunother Cancer
33836287	Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system.	J Vasc Surg Venous Lymphat Disord
33836039	COVID-19 and chronic kidney disease: a comprehensive review.	J Bras Nefrol
33835886	A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19.	Expert Opin Biol Ther
33834387	MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity.	Immunol Res
33833547	Interferon-lambda3 Exacerbates the Inflammatory Response to Microbial Ligands: Implications for SARS-CoV-2 Pathogenesis.	J Inflamm Res
33833543	Association of Early Inflammation with Age and Asymptomatic Disease in COVID-19.	J Inflamm Res
33833542	Anti-Inflammatory and Antiviral Osmotic Polymeric Film to Treat Covid-19 Early-Stage Infection.	J Inflamm Res
33833254	Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients.	Sci Rep
33832495	Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients.	Respir Res
33832291	Investigation into molecular mechanisms and high-frequency core TCM for pulmonary fibrosis secondary to COVID-19 based on network pharmacology and data mining.	Ann Palliat Med
33829055	Analysis of pathological changes in the epithelium in COVID-19 patient airways.	ERJ Open Res
33827651	Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment.	Crit Care
33827266	A composite risk model predicts disease progression in early stages of COVID-19: A propensity score-matched cohort study.	Ann Clin Biochem
33824908	Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19.	Med Clin (Engl Ed)
33824762	The Effect of Chronic and Inhospital Exposure to Renin-Angiotensin System Inhibitors on the Outcome and Inflammatory State of Coronavirus Disease 2019 Adult Inpatients.	Int J Hypertens
33823870	Adhatoda Vasica attenuates inflammatory and hypoxic responses in preclinical mouse models: potential for repurposing in COVID-19-like conditions.	Respir Res
33823303	A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.	Mol Ther
33823154	A novel anti-human IL-1R7 antibody reduces IL-18-mediated inflammatory signaling.	J Biol Chem
33822777	Natural mucosal barriers and COVID-19 in children.	JCI Insight
33822421	Silibinin as potential tool against SARS-Cov-2: In silico spike receptor-binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects.	Phytother Res
33821250	Alterations in T and B cell function persist in convalescent COVID-19 patients.	Med (N Y)
33820446	Immunotherapy in psoriasis.	Immunotherapy
33819261	COVID-IRS: A novel predictive score for risk of invasive mechanical ventilation in patients with COVID-19.	PLoS One
33819170	Enhanced IL-6 and IL-12B Gene Expression After SARS-CoV-2 Infection in Leprosy Patients May Increase the Risk of Neural Damage.	Am J Trop Med Hyg
33815838	Cardiac Injury Biomarkers and the Risk of Death in Patients with COVID-19: A Systematic Review and Meta-Analysis.	Cardiol Res Pract
33815405	The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.	Front Immunol
33815295	The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review.	Front Endocrinol (Lausanne)
33815095	A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review.	Front Pharmacol
33813138	Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children - a cross-sectional observational study from southern India.	EBioMedicine
33813042	Outbreak of COVID-19 and interventions in a large jail - Cook County, IL, United States, 2020.	Am J Infect Control
33813013	Antiviral effect of fufang yinhua jiedu (FFYH) granules against influenza A virus through regulating the inflammatory responses by TLR7/MyD88 signaling pathway.	J Ethnopharmacol
33811957	Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms.	Pharmacol Ther
33811829	Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries.	Lancet Respir Med
33811756	Beneficial effect of Arbidol in the management of COVID-19 infection.	Aging (Albany NY)
33811680	Downregulation of type III interferons in patients with severe COVID-19.	J Med Virol
33810947	Serum IP-10 and IL-7 levels are associated with disease severity of coronavirus disease 2019.	Cytokine
33810808	Effects of pomegranate juice (Punica Granatum) on inflammatory biomarkers and complete blood count in patients with COVID-19: a structured summary of a study protocol for a randomized clinical trial.	Trials
33809913	Predictive Biomarkers of COVID-19 Severity in SARS-CoV-2 Infected Patients with Obesity and Metabolic Syndrome.	J Pers Med
33808205	Effects of Different Dialysis Strategies on Inflammatory Cytokine Profile in Maintenance Hemodialysis Patients with COVID-19: A Randomized Trial.	J Clin Med
33806254	Ribosome-Profiling Reveals Restricted Post Transcriptional Expression of Antiviral Cytokines and Transcription Factors during SARS-CoV-2 Infection.	Int J Mol Sci
33804828	Telecommuting, Off-Time Work, and Intrusive Leadership in Workers' Well-Being.	Int J Environ Res Public Health
33804769	Exosomes from COVID-19 Patients Carry Tenascin-C and Fibrinogen-beta in Triggering Inflammatory Signals in Cells of Distant Organ.	Int J Mol Sci
33802761	Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence.	Int J Mol Sci
33802696	SARS-CoV-2 Infection and Inflammatory Response in a Twin Pregnancy.	Int J Environ Res Public Health
33801959	Emergency Lung Transplantation after COVID-19: Immunopathological Insights on Two Affected Patients.	Cells
33795830	Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience.	Mod Pathol
33795768	PaO2/FiO2 and IL-6 are risk factors of mortality for intensive care COVID-19 patients.	Sci Rep
33794925	Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies.	J Transl Med
33790504	Tocilizumab: An Effective Therapy for Severely and Critically Ill COVID-19 Patients.	Indian J Crit Care Med
33789145	Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2.	Life Sci
33787515	The relationship between serum levels of interleukin-2 and IL-8 with circulating microRNA-10b in patients with COVID-19.	Iran J Immunol
33787514	Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.	Iran J Immunol
33785765	SARS-CoV-2 in severe COVID-19 induces a TGF-beta-dominated chronic immune response that does not target itself.	Nat Commun
33784355	Thyroid function analysis in COVID-19: A retrospective study from a single center.	PLoS One
33783431	[Public Health commitment to the protection of health at the time of the pandemic].	Ig Sanita Pubbl
33781926	Association of hyperglycaemia with hospital mortality in nondiabetic COVID-19 patients: A cohort study.	Diabetes Metab
33781906	Circulating activated neutrophils in COVID-19: An independent predictor for mechanical ventilation and death.	Int J Infect Dis
33781871	Antiviral activity of portulaca oleracea L. extracts against porcine epidemic diarrhea virus by partial suppression on myd88/NF-kappab activation in vitro.	Microb Pathog
33781826	Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients.	Life Sci
33781216	Role of interleukin 6 as a predictive factor for a severe course of Covid-19: retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak.	BMC Infect Dis
33780519	Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19.	PLoS Pathog
33778374	Compassionate Use of Rectal Ozone (O3) in Severe COVID-19 Pneumonia: a Case-Control Study.	SN Compr Clin Med
33778183	The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: A systematic review and meta-analysis.	Clin Epidemiol Glob Health
33777967	Optimizing Management to Reduce the Mortality of COVID-19: Experience From a Designated Hospital for Severely and Critically Ill Patients in China.	Front Med (Lausanne)
33777563	Posterior Reversible Encephalopathy Syndrome in a Patient With SARS-CoV-2 Infection Treated With Tocilizumab.	Cureus
33777012	Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.	Front Immunol
33776910	Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.	Front Endocrinol (Lausanne)
33773618	Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study.	Lancet Infect Dis
33773396	Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication.	Cytokine
33771671	Clinical characteristics and outcomes of hospitalized COVID-19 patients in a MERS-CoV referral hospital during the peak of the pandemic.	Int J Infect Dis
33767713	Blood Interferon-alpha Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients.	Front Immunol
33767626	Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology.	Front Pharmacol
33766078	Association of the host genetic factors, hypercholesterolemia and diabetes with mild influenza in an Iranian population.	Virol J
33763078	The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients.	Front Immunol
33763027	Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019.	Front Endocrinol (Lausanne)
33761696	Role of tocilizumab for concomitant systemic fungal infection in severe COVID-19 patient: Case report.	Medicine (Baltimore)
33760875	Is the heart rate variability monitoring using the analgesia nociception index a predictor of illness severity and mortality in critically ill patients with COVID-19? A pilot study.	PLoS One
33760664	Determinants of Increased Fibrinogen in COVID-19 Patients With and Without Diabetes and Impaired Fasting Glucose.	Clin Appl Thromb Hemost
33759683	Risk of COVID-19 infection, hospitalization, and mortality in patients with psoriasis treated by interleukin-17 inhibitors.	J Dermatolog Treat
33759631	Interleukin-6 Antagonists: Lessons From Cytokine Release Syndrome to the Therapeutic Application in Severe COVID-19 Infection.	J Pharm Pract
33759572	Implications of preexisting asthma on COVID-19 pathogenesis.	Am J Physiol Lung Cell Mol Physiol
33758527	Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction.	J Inflamm Res
33758164	The lncRNA Snhg1-Vps13D vesicle trafficking system promotes memory CD8 T cell establishment via regulating the dual effects of IL-7 signaling.	Signal Transduct Target Ther
33756051	SARS-CoV-2-specific serological and functional T cell immune responses during acute and early COVID-19 convalescence in solid organ transplant patients.	Am J Transplant
33755815	Clinical and neurophysiological characterization of muscular weakness in severe COVID-19.	Neurol Sci
33755708	The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT.	PLoS One
33753947	[COVID-19 in children: SARS-CoV-2-related inflammatory multisystem syndrome mimicking Kawasaki disease].	Bull Acad Natl Med
33753206	Transient plasma cell dyscrasia in COVID-19 patients linked to IL-6 triggering.	Microbes Infect
33751111	Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19.	J Mol Cell Biol
33749932	A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: A computational and mechanistic study.	FASEB J
33749902	Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages.	FASEB J
33748539	Night shift schedule alters endogenous regulation of circulating cytokines.	Neurobiol Sleep Circadian Rhythms
33747583	Targeting Cytokine Storm in COVID-19: A Role of Online Hemodiafiltration with Asymmetric Cellulose Triacetate in Maintenance Hemodialysis Patients-A Report of 10 Cases.	Case Rep Nephrol
33746948	Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19.	Front Immunol
33746945	Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment.	Front Immunol
33746604	A network pharmacology based approach for predicting active ingredients and potential mechanism of Lianhuaqingwen capsule in treating COVID-19.	Int J Med Sci
33745918	IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regression.	J Infect
33743061	Host-dependent molecular factors mediating SARS-CoV-2 infection to gain clinical insights for developing effective targeted therapy.	Mol Genet Genomics
33742367	The most important biomarker associated with coagulation and inflammation among COVID-19 patients.	Mol Cell Biochem
33742107	Clinical characteristics and related risk factors of disease severity in 101 COVID-19 patients hospitalized in Wuhan, China.	Acta Pharmacol Sin
33742062	Identification of macrophage activation-related biomarkers in obese type 2 diabetes that may be indicative of enhanced respiratory risk in COVID-19.	Sci Rep
33739444	Management and outcomes of a COVID-19 outbreak in a nursing home with predominantly Black residents.	J Am Geriatr Soc
33738615	Effects of laser acupuncture tele-therapy for rheumatoid arthritis elderly patients.	Lasers Med Sci
33737877	Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile.	Front Pharmacol
33737851	Smoking Enigma in Coronavirus Disease 2019: A Tug of War between Predisposition and Possible Way Out.	Tob Use Insights
33737684	Proteomic blood profiling in mild, severe and critical COVID-19 patients.	Sci Rep
33736526	Tocilizumab for the Critically Ill With Severe COVID-19: A Community Hospital Case Series.	J Pharm Pract
33735714	Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis.	Int Immunopharmacol
33735325	The effect of age on the clinical and immune characteristics of critically ill patients with COVID-19: A preliminary report.	PLoS One
33735106	Lymphocyte may be a reference index of the outcome of cancer patients with COVID-19.	Aging (Albany NY)
33734435	Interleukin-6 blocking agents for treating COVID-19: a living systematic review.	Cochrane Database Syst Rev
33732720	Interleukin-18 in Inflammatory Kidney Disease.	Front Med (Lausanne)
33732571	Delayed hemodialysis in COVID-19: Case series with literature review.	Clin Nephrol Case Stud
33732466	Multimodality treatment in immunocompromised patients with severe COVID-19: the role of IL-6 inhibitor, intravenous immunoglobulin, and haemoperfusion.	Respirol Case Rep
33732258	A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation.	Front Immunol
33732254	Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.	Front Immunol
33732251	SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.	Front Immunol
33731184	Nomogram for prediction of fatal outcome in patients with severe COVID-19: a multicenter study.	Mil Med Res
33730761	Understanding the role of therapeutic plasma exchange in COVID-19: preliminary guidance and practices.	Vox Sang
33730024	Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.	PLoS Biol
33728295	Regulation of the expression of proinflammatory cytokines induced by SARS-CoV-2.	World J Clin Cases
33727768	Ayurveda co-interventions have supported complete recovery in severe COVID-19 infection with a chest severity score 18/25: A case report.	J Ayurveda Integr Med
33727695	Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19.	Mod Pathol
33725924	The prognostic value of IL-8 for the death of severe or critical patients with COVID-19.	Medicine (Baltimore)
33724123	Does hydroxychloroquine still have any role in the COVID-19 pandemic?	Expert Opin Pharmacother
33723527	ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway.	iScience
33723251	Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients.	Cell Death Discov
33722770	Low Doses of Radiation Increase the Immunosuppressive Profile of Lung Macrophages During Viral Infection and Pneumonia.	Int J Radiat Oncol Biol Phys
33722710	Resveratrol-mediated attenuation of superantigen-driven acute respiratory distress syndrome is mediated by microbiota in the lungs and gut.	Pharmacol Res
33722593	COVID-19 and IL-6: Why vitamin D (probably) helps but tocilizumab might not.	Eur J Pharmacol
33720587	[Experience of olokizumab use in COVID-19 patients].	Ter Arkh
33719967	Tocilizumab: From Rheumatic Diseases to COVID-19.	Curr Pharm Des
33718825	SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway.	iScience
33718270	T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression.	Front Cell Infect Microbiol
33717195	COVID-19 Impairs Immune Response to Candida albicans.	Front Immunol
33717074	In Nasal Mucosal Secretions, Distinct IFN and IgA Responses Are Found in Severe and Mild SARS-CoV-2 Infection.	Front Immunol
33716989	Vitamin D Association With Macrophage-Derived Cytokines in Polycystic Ovary Syndrome: An Enhanced Risk of COVID-19 Infection?	Front Endocrinol (Lausanne)
33715009	IL-6: from arthritis to CAR-T-cell therapy and COVID-19.	Int Immunol
33714884	The role of probiotics in coronavirus disease-19 infection in Wuhan: A retrospective study of 311 severe patients.	Int Immunopharmacol
33713619	Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.	Cell
33712622	Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications.	Nat Commun
33711083	A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study.	JMIRx Med
33710424	Neurological and psychiatric presentations associated with COVID-19.	Eur Arch Psychiatry Clin Neurosci
33708903	Risk factors for mortality due to COVID-19 in intensive care units: a single-center study.	Ann Transl Med
33708828	A novel artificial intelligence-assisted triage tool to aid in the diagnosis of suspected COVID-19 pneumonia cases in fever clinics.	Ann Transl Med
33708752	Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic.	Front Pediatr
33708109	Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19.	Front Pharmacol
33706759	Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19.	Part Fibre Toxicol
33706649	The effect of real-time polymerase chain reaction cycle threshold values on perinatal outcomes of pregnant women with COVID-19.	J Matern Fetal Neonatal Med
33693017	Implications of Laboratory Tests in Disease Grading and Death Risk Stratification of COVID-19: A Retrospective Study in Wuhan, China.	Front Med (Lausanne)
33692788	Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients.	Front Immunol
33692120	Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline.	Eur Respir J
33692097	Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.	Sci Immunol
33691144	Single-cell RNA sequencing reveals the sustained immune cell dysfunction in the pathogenesis of sepsis secondary to bacterial pneumonia.	Genomics
33688583	Interleukin 6 and depression in patients affected by Covid-19.	Med Clin (Engl Ed)
33688459	Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients.	Curr Transplant Rep
33688079	Identification of human immune cell subtypes most responsive to IL-1beta-induced inflammatory signaling using mass cytometry.	Sci Signal
33687643	Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial.	Front Med
33687365	Il vaccino puo causare l'infezione da covid-19?	Recenti Prog Med
33687362	Recensione<br>Il senso dell'insieme Dalla storia dei coniugi cinesi al vaccino per la covid-19.	Recenti Prog Med
33687087	Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio-renal damage in COVID-19 infection.	Drug Dev Res
33686379	The Impact of COVID-19 on Volume of Inpatient Hospitalization Through General Medicine and Medicine Subspecialty Services at US Medical Centers.	Mayo Clin Proc Innov Qual Outcomes
33683968	In quest of a new therapeutic approach in COVID-19: the endocannabinoid system.	Drug Metab Rev
33683214	The spectrum of thyroid function tests during hospitalization for SARS COV-2 infection.	Eur J Endocrinol
33682678	An open label trial of anakinra to prevent respiratory failure in COVID-19.	Elife
33681238	Prevalence and Characteristics of Hypoxic Hepatitis in COVID-19 Patients in the Intensive Care Unit: A First Retrospective Study.	Front Med (Lausanne)
33680800	Cytokine profiles in severe SARS-CoV-2 infection requiring extracorporeal membrane oxygenation support.	Respir Med Case Rep
33680348	Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19.	Comput Struct Biotechnol J
33679771	High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China.	Front Immunol
33679760	Cyclic-di-GMP Induces STING-Dependent ILC2 to ILC1 Shift During Innate Type 2 Lung Inflammation.	Front Immunol
33679753	Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia.	Front Immunol
33679237	Laboratory Predictors of COVID-19 Mortality: A Retrospective Analysis from Tongji Hospital in Wuhan.	Mediators Inflamm
33676592	IL-6 blockade for COVID-19: a global scientific call to arms.	Lancet Respir Med
33676589	Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial.	Lancet Respir Med
33675065	Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection.	Eur J Immunol
33674950	Characteristics of COVID-19 patients with preexisting CKD history.	Int Urol Nephrol
33674800	Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.	Nat Immunol
33673818	Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India.	BMC Infect Dis
33673529	Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-kappaB: A Systematic Review.	Viruses
33672761	Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia.	Int J Environ Res Public Health
33671159	Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.	J Clin Med
33670304	Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.	Int J Mol Sci
33669218	The Rheumatology Drugs for COVID-19 Management: Which and When?	J Clin Med
33668514	Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations.	Cells
33667962	Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: A review.	Cytokine
33666855	Biomarkers of Cardiac Stress and Cytokine Release Syndrome in COVID-19: A Review.	Curr Heart Fail Rep
33664308	MR-proADM as prognostic factor of outcome in COVID-19 patients.	Sci Rep
33662681	Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction.	Comput Biol Med
33662370	IL-6-based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts.	J Allergy Clin Immunol
33661221	Successful Treatment of Life-Threatening COVID-19 Infection in a Face Transplant Recipient.	Ann Plast Surg
33658751	SARS-CoV-2 and the Eye: A Relationship for a Possible Prognostic Tool in COVID-19 Patients.	Clin Ophthalmol
33658066	The important herbal pair for the treatment of COVID-19 and its possible mechanisms.	Chin Med
33655803	Host Modulation and Treatment of Periodontal Disease.	J Dent Res
33655218	Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study.	Lancet Rheumatol
33655086	Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19.	Heliyon
33653795	Letter to the Editor: Morphoproteomics Points to the IL-6 Cytokine Storm as One Factor and a Therapeutic Target in the Pathogenesis of Thrombosis in COVID-19 Patients.	Ann Clin Lab Sci
33652815	SARS-CoV-2 Nonstructural Proteins 1 and 13 Suppress Caspase-1 and the NLRP3 Inflammasome Activation.	Microorganisms
33651636	Deregulated miRNA expression is associated with endothelial dysfunction in post-mortem lung biopsies of COVID-19 patients.	Am J Physiol Lung Cell Mol Physiol
33649297	SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes.	Cell Death Discov
33648924	Extensive longitudinal immune profiling reveals sustained innate immune activation in COVID-19 patients with unfavorable outcome	Eur Cytokine Netw
33646265	Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.	J Exp Med
33644490	A review of the characteristics and outcomes of 900 COVID-19 patients hospitalized at a Tertiary Care Medical Center in New Jersey, USA.	Arch Med Sci Atheroscler Dis
33643083	Impact of SARS-CoV-2 Infection on Cognitive Function: A Systematic Review.	Front Psychiatry
33642749	Chlorhexidine: An effective anticovid mouth rinse.	J Indian Soc Periodontol
33641565	Exposure of human intestinal epithelial cells and primary human hepatocytes to trypsin-like serine protease inhibitors with potential antiviral effect.	J Enzyme Inhib Med Chem
33639176	In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy.	J Infect
33638257	Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study.	J Clin Pharm Ther
33637960	Downregulated miR-451a as a feature of the plasma cfRNA landscape reveals regulatory networks of IL-6/IL-6R-associated cytokine storms in COVID-19 patients.	Cell Mol Immunol
33635589	Severely low testosterone in males with COVID-19: A case-control study.	Andrology
33634100	Human Dental Pulp Stem Cells Modulate Cytokine Production in vitro by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients.	Front Cell Dev Biol
33633944	Multisystem inflammatory syndrome in children during the coronavirus disease 2019 (COVID-19) pandemic: a systematic review of published case studies.	Transl Pediatr
33632295	Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection.	J Ovarian Res
33631907	[Disseminated infection caused by the bacillus Calmette-Guerin vaccine and SARS-CoV-2 coinfection in a patient with IL-12 receptor beta1 subunit deficiency].	Rev Alerg Mex
33631512	Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra.	Int Immunopharmacol
33630767	Efficacy of Serum Angiotensin II Levels in Prognosis of Patients With Coronavirus Disease 2019.	Crit Care Med
33629254	CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients.	Cell Stress Chaperones
33628506	A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections.	Biochem Res Int
33628256	Profiling Laboratory Biomarkers Associated with COVID-19 Disease Progression: A Single-Center Experience.	Int J Microbiol
33628107	Epidemiological, Clinical, Radiological Characteristics and Outcomes of Medical Staff with COVID-19 in Wuhan, China: Analysis of 101 Cases.	Int J Med Sci
33628091	Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome.	Int J Med Sci
33626247	Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative review.	Dent Med Probl
33625297	T Helper 17 Response to Severe Acute Respiratory Syndrome Coronavirus 2: A Type of Immune Response with Possible Therapeutic Implications.	Viral Immunol
33623622	Un cas de COVID-19 complique d embolie avec deux tests PCR initialement negatifs malgre des signes scanographiques.	Pan Afr Med J
33622974	Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients.	Sci Immunol
33622933	Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19.	In Vivo
33622611	Cheap and simple, could it get even cooler? Mild hypothermia and COVID-19.	J Crit Care
33621620	Stroke increases the expression of ACE2, the SARS-CoV-2 binding receptor, in murine lungs.	Brain Behav Immun
33621130	Perspectives on Targeting IL-6 as a Potential Therapeutic Strategy for COVID-19.	J Interferon Cytokine Res
33619281	Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients.	Nat Commun
33618635	Mesenchymal Stem Cell Derived-Exosomes as Effective Factors in Reducing Cytokine Storm Symptoms of COVID-19.	Protein Pept Lett
33617048	B cell analysis in SARS-CoV-2 versus malaria: Increased frequencies of plasmablasts and atypical memory B cells in COVID-19.	J Leukoc Biol
33616462	Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality.	Int Rev Immunol
33615814	Dynamic changes in serum IL-6, IL-8, and IL-10 predict the outcome of ICU patients with severe COVID-19.	Ann Palliat Med
33615209	Benefits of early aggressive immunomodulatory therapy (tocilizumab and methylprednisolone) in COVID-19: Single center cohort study of 685 patients.	J Transl Autoimmun
33615195	Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14(+) monocytes.	iScience
33614627	Targeting Lipid Rafts as a Strategy Against Coronavirus.	Front Cell Dev Biol
33614032	High levels of soluble CD25 in COVID-19 severity suggest a divergence between anti-viral and pro-inflammatory T-cell responses.	Clin Transl Immunology
33613576	An Immunological Perspective: What Happened to Pregnant Women After Recovering From COVID-19?	Front Immunol
33611656	COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study.	Rheumatol Int
33609650	The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?	Microb Pathog
33609349	Complete Blood-count-based Inflammatory Score (CBCS) of COVID-19 Patients at Tertiary Care Center.	Altern Ther Health Med
33608746	Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection.	Inflamm Res
33607804	Very fast-progressive pulmonary opacities and high inflammatory factors levels are associated with decease of young Coronavirus Disease 2019 patients.	Medicine (Baltimore)
33607766	Novel signaling pathways regulate SARS-CoV and SARS-CoV-2 infectious disease.	Medicine (Baltimore)
33603870	Multifactorial expression of IL-6 with update on COVID-19 and the therapeutic strategies of its blockade (Review).	Exp Ther Med
33603836	Recombinant interleukin-2 stimulates lymphocyte recovery in patients with severe COVID-19.	Exp Ther Med
33602937	Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections.	Nat Commun
33600292	Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study.	J Am Nutr Assoc
33596494	Randomized placebo-controlled pilot clinical trial on the efficacy of ayurvedic treatment regime on COVID-19 positive patients.	Phytomedicine
33596158	l-Cysteine Stimulates the Effect of Vitamin D on Inhibition of Oxidative Stress, IL-8, and MCP-1 Secretion in High Glucose Treated Monocytes.	J Am Coll Nutr
33593636	[Point-of-care ultrasonography in the initial characterization of patients with COVID-19].	Med Clin (Barc)
33590853	In vitro selection of an RNA aptamer yields an interleukin-6/interleukin-6 receptor interaction inhibitor.	Biosci Biotechnol Biochem
33588259	Arrhythmias in patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: Incidences and implications.	J Electrocardiol
33588050	A useful and sensitive marker in the prediction of COVID-19 and disease severity: Thiol.	Free Radic Biol Med
33587724	Increased Intracranial Hemorrhage Amid Elevated Inflammatory Markers in Those With COVID-19 Supported With Extracorporeal Membrane Oxygenation.	Shock
33585804	Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy.	iScience
33585554	SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways.	Front Mol Biosci
33585201	Case Report: B Lymphocyte Disorders Under COVID-19 Inflammatory Pressure.	Front Oncol
33584733	High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19.	Front Immunol
33584719	Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.	Front Immunol
33584697	Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective.	Front Immunol
33584679	COVID-19: Imbalanced Immune Responses and Potential Immunotherapies.	Front Immunol
33584285	Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice.	Front Pharmacol
33583045	Network Meta-Analysis on the Mechanisms Underlying Alcohol Augmentation of COVID-19 Pathologies.	Alcohol Clin Exp Res
33582908	Early Warning Factors of Death in COVID-19 Patients.	Curr Med Sci
33582906	Differences in Immune Responses between Children and Adults with COVID-19.	Curr Med Sci
33582900	Self-reported Taste and Smell Disorders in Patients with COVID-19: Distinct Features in China.	Curr Med Sci
33582156	Hyper-Inflammatory Response Involves in Cardiac Injury Among Patients With Coronavirus Disease 2019.	Am J Med Sci
33581979	Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies.	Eur J Intern Med
33581501	Advances in immunotherapy for COVID-19: A comprehensive review.	Int Immunopharmacol
33580566	Background to new treatments for COVID-19, including its chronicity, through altering elements of the cytokine storm.	Rev Med Virol
33579725	The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression.	J Immunol
33578295	Age-dependent effects of the recombinant spike protein/SARS-CoV-2 on the M-CSF- and IL-34-differentiated macrophages in vitro.	Biochem Biophys Res Commun
33578018	The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients.	Int J Infect Dis
33577066	The value of PCT, IL-6, and CRP in the early diagnosis and evaluation of COVID-19.	Eur Rev Med Pharmacol Sci
33575961	Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19.	Stem Cell Rev Rep
33574116	Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider.	RMD Open
33573696	A double blinded placebo controlled comparative clinical trial to evaluate the effectiveness of Siddha medicines, Kaba Sura Kudineer (KSK) & Nilavembu Kudineer (NVK) along with standard Allopathy treatment in the management of symptomatic COVID 19 patients - a structured summary of a study protocol for a randomized controlled trial.	Trials
33573681	Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial.	Trials
33573449	Effects of tocilizumab versus hemoadsorption combined with tocilizumab in patients with SARS-CoV-2 pneumonia: Preliminary results.	Int J Artif Organs
33572938	Expression of the SARS-CoV-2 Receptor ACE2 and Proinflammatory Cytokines Induced by the Periodontopathic Bacterium Fusobacterium nucleatum in Human Respiratory Epithelial Cells.	Int J Mol Sci
33569904	Amino acid sensing pathway: A major check point in the pathogenesis of obesity and COVID-19.	Obes Rev
33569392	Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins-An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic.	Front Mol Biosci
33568715	Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature.	Sci Rep
33565034	Baseline characteristics and changes of biomarkers in disease course predict prognosis of patients with COVID-19.	Intern Emerg Med
33564749	Integrated immune dynamics define correlates of COVID-19 severity and antibody responses.	Cell Rep Med
33564286	Coagulopathy is associated with multiple organ damage and prognosis of COVID-19.	EXCLI J
33562758	COVID-19 in Autoinflammatory Diseases with Immunosuppressive Treatment.	J Clin Med
33562472	Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology.	Int J Mol Sci
33562141	Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization.	Vaccines (Basel)
33561690	The prognostic role of IL-10 in non-severe COVID-19 with chemosensory dysfunction.	Cytokine
33561624	The potential use of lactate blockers for the prevention of COVID-19 worst outcome, insights from exercise immunology.	Med Hypotheses
33560482	Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study.	Virol Sin
33559789	Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6.	Neurol Sci
33558819	Acute transverse myelitis of childhood due to novel coronavirus disease 2019: The first pediatric case report and review of literature.	Iran J Child Neurol
33558375	T Cell Phenotyping in Individuals Hospitalized with COVID-19.	J Immunol
33557779	Differences of blood cells, lymphocyte subsets and cytokines in COVID-19 patients with different clinical stages: a network meta-analysis.	BMC Infect Dis
33557301	Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment.	Cells
33556464	Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia.	J Allergy Clin Immunol
33555895	Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.	J Proteome Res
33554561	The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus disease 2019 (COVID-19).	Clin Chem Lab Med
33553782	IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression.	Heliyon
33553708	Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19.	Heliyon
33553467	Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma.	Open Forum Infect Dis
33552508	Pattern of circulating SARS-CoV-2-specific antibody-secreting and memory B-cell generation in patients with acute COVID-19.	Clin Transl Immunology
33552315	The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial.	Eur J Integr Med
33552062	Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.	Front Immunol
33550688	Therapeutic efficacy, mechanical ventilation, length of hospital stay, and mortality rate in severe COVID-19 patients treated with tocilizumab.	Int J Clin Pract
33550351	[Hypoxia and inflammation are risk factors for acute myocardial injury in patients with coronavirus disease 2019].	Beijing Da Xue Xue Bao Yi Xue Ban
33550165	Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.	Cytokine
33550117	A novel ratio of CD8(+):B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcome.	Virology
33549331	[Interleukin 6 and depression in patients affected by Covid-19].	Med Clin (Barc)
33548798	Prognostic bioindicators in severe COVID-19 patients.	Cytokine
33547819	Inflammatory Cytokine Patterns Associated with Neurological Diseases in Coronavirus Disease 2019.	Ann Neurol
33547169	IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study.	J Immunol
33546489	Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients.	Viruses
33544045	COVID-19 versus Non-COVID-19 Acute Respiratory Distress Syndrome: Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers, and Clinical Outcomes.	Ann Am Thorac Soc
33542929	Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID-19 Patients.	Biomed Res Int
33542445	Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs.	Pharmacogenomics J
33542028	Potent and Selective Knockdown of Tyrosine Kinase 2 by Antisense Oligonucleotides.	Immunohorizons
33540733	Multistate Modeling of COVID-19 Patients Using a Large Multicentric Prospective Cohort of Critically Ill Patients.	J Clin Med
33538817	Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in Japan.	Int Immunol
33537326	Prognostic Value of a Clinical Biochemistry-Based Nomogram for Coronavirus Disease 2019.	Front Med (Lausanne)
33536486	Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19.	Sci Rep
33534923	Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses.	Clin Exp Immunol
33533916	SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4.	J Exp Med
33531826	Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality.	J Inflamm Res
33531712	Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity.	Nat Immunol
33531264	Dynamic changes in monocytes subsets in COVID-19 patients.	Hum Immunol
33530554	Mediterranean Diet for the Prevention of Gestational Diabetes in the Covid-19 Era: Implications of Il-6 In Diabesity.	Int J Mol Sci
33530084	Genetic Variation, Diet, Inflammation, and the Risk for COVID-19.	Lifestyle Genom
33529167	The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity.	J Clin Invest
33528832	Clinical features of neurological patients with coronavirus 2019: an observational study of one centre.	Neurol Neurochir Pol
33527804	Itolizumab Treatment for Cytokine Release Syndrome in Moderate to Severe Acute Respiratory Distress Syndrome Due to COVID-19: Clinical Outcomes, A Retrospective Study.	J Assoc Physicians India
33527487	T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death.	J Leukoc Biol
33526326	The protective effect of rheumatic disease agents in COVID-19.	Best Pract Res Clin Rheumatol
33526003	Flavonol morin targets host ACE2, IMP-alpha, PARP-1 and viral proteins of SARS-CoV-2, SARS-CoV and MERS-CoV critical for infection and survival: a computational analysis.	J Biomol Struct Dyn
33524886	Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome?	Cytokine
33524876	COVID-19 convalescent plasma composition and immunological effects in severe patients.	J Autoimmun
33522983	COVID-19 and male reproductive function: a prospective, longitudinal cohort study.	Reproduction
33522572	Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19.	Hum Reprod
33521676	Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 - Authors' reply.	Lancet Rheumatol
33521675	Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19.	Lancet Rheumatol
33521616	Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.	J Transl Autoimmun
33521303	Clinical characteristics of confirmed and clinically diagnosed patients with 2019 novel coronavirus pneumonia: a single-center, retrospective, case-control study.	Med Clin (Engl Ed)
33521302	Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia.	Med Clin (Engl Ed)
33520118	Meta-analysis of transcriptome datasets: An alternative method to study IL-6 regulation in coronavirus disease 2019.	Comput Struct Biotechnol J
33520015	Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools.	Eur J Integr Med
33519902	Detecting the Multiomics Signatures of Factor-Specific Inflammatory Effects on Airway Smooth Muscles.	Front Genet
33519271	Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19.	Saudi Pharm J
33519090	Paper biosensors for detecting elevated IL-6 levels in blood and respiratory samples from COVID-19 patients.	Sens Actuators B Chem
33518836	Helmet mask and tocilizumab for a patient with hemophagocytic lymphohistiocytosis syndrome and COVID-19: a case report.	Braz J Anesthesiol
33517358	Repurposing approved drugs for cancer therapy.	Br Med Bull
33515095	Integration of heparin-binding protein and interleukin-6 in the early prediction of respiratory failure and mortality in pneumonia by SARS-CoV-2 (COVID-19).	Eur J Clin Microbiol Infect Dis
33514427	Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.	Stem Cell Res Ther
33513419	Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.	J Ethnopharmacol
33512975	Electrocardiographic modifications and cardiac involvement in COVID-19 patients: results from an Italian cohort.	J Cardiovasc Med (Hagerstown)
33511686	Tocilizumab in COVID-19 interstitial pneumonia.	J Intern Med
33511147	Down-Regulation of Colonic ACE2 Expression in Patients With Inflammatory Bowel Disease Responding to Anti-TNF Therapy: Implications for COVID-19.	Front Med (Lausanne)
33510989	Tocilizumab for COVID-19 Acute Respiratory Distress Syndrome: Outcomes Assessment Using the WHO Ordinal Scale.	Cureus
33510459	Widespread myocardial dysfunction in COVID-19 patients detected by myocardial strain imaging using 2-D speckle-tracking echocardiography.	Acta Pharmacol Sin
33510359	Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors.	Sci Rep
33509217	Anti-inflammatory potential of Quercetin in COVID-19 treatment.	J Inflamm (Lond)
33507958	High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response.	PLoS One
33507952	Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium.	PLoS Pathog
33507664	[Rheumatology update 2020: the focus was on Covid-19].	Rev Med Suisse
33506952	Role of Toll-like receptors in the pathogenesis of COVID-19.	J Med Virol
33506950	Clinical significance of cellular immunity function and inflammatory factors assays in alveolar lavage fluid for severe COVID-19 pneumonia.	J Med Virol
33505949	Clinical Characteristics and Diagnostic Challenges of COVID-19: An Update From the Global Perspective.	Front Public Health
33505216	Exploring the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Glycyrrhizic and Glycyrrhetinic Acids.	Mediators Inflamm
33504359	Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients.	Exp Hematol Oncol
33504318	An Alternative "Trojan Horse" Hypothesis for COVID-19: Immune Deficiency of IL-10 and SARS-CoV-2 Biology.	Endocr Metab Immune Disord Drug Targets
33503821	Epigenetic Evolution of ACE2 and IL-6 Genes: Non-Canonical Interferon-Stimulated Genes Correlate to COVID-19 Susceptibility in Vertebrates.	Genes (Basel)
33503581	The impact of COVID-19 infection on the cytokine profile of pregnant women: A prospective case-control study.	Cytokine
33499580	A systematic review of clinical and laboratory parameters of 3,000 COVID-19 cases.	Obstet Gynecol Sci
33497356	Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease.	J Clin Invest
33495967	COVID-19: Before the Fall, An Evidence-Based Narrative Review of Treatment Options.	Infect Dis Ther
33495522	A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients.	Int J Obes (Lond)
33493983	Mechanisms of thrombosis and cardiovascular complications in COVID-19.	Thromb Res
33493945	Inositol and vitamin D may naturally protect human reproduction and women undergoing assisted reproduction from Covid-19 risk.	J Reprod Immunol
33493866	Ergosterol peroxide exhibits antiviral and immunomodulatory abilities against porcine deltacoronavirus (PDCoV) via suppression of NF-kappaB and p38/MAPK signaling pathways in vitro.	Int Immunopharmacol
33493861	Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia.	Cytokine
33493450	Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial.	Lancet Respir Med
33493449	The right place for IL-1 inhibition in COVID-19.	Lancet Respir Med
33492309	Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity.	J Clin Invest
33491580	Immunomodulatory and anti-cytokine therapeutic potential of curcumin and its derivatives for treating COVID-19 - a computational modeling.	J Biomol Struct Dyn
33490288	The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus.	J Diabetes Res
33489899	COVID-19: High-JAKing of the Inflammatory "Flight" by Ruxolitinib to Avoid the Cytokine Storm.	Front Oncol
33489621	Is There any Additional Benefit of Multiple Doses of Tocilizumab in COVID-19 Patients?	Cureus
33489469	Immunological alternation in COVID-19 patients with cancer and its implications on mortality.	Oncoimmunology
33488599	Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients.	Front Immunol
33486829	Association between circulating furin levels, obesity and pro-inflammatory markers in children.	Acta Paediatr
33485957	Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies.	J Allergy Clin Immunol
33484868	Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19.	Semin Cancer Biol
33484168	Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19.	Allergy
33482620	Fecal microbiota transplantation for COVID-19; a potential emerging treatment strategy.	Med Hypotheses
33482337	Interleukin 1alpha: a comprehensive review on the role of IL-1alpha in the pathogenesis and treatment of autoimmune and inflammatory diseases.	Autoimmun Rev
33481950	Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice.	PLoS One
33478794	Immunoinformatics prediction of overlapping CD8(+) T-cell, IFN-gamma and IL-4 inducer CD4(+) T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2).	Vaccine
33475159	Co-infection of influenza A virus and SARS-CoV-2: A retrospective cohort study.	J Med Virol
33472985	Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.	mSphere
33469522	Case Report: Case Series of Children With Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Switzerland.	Front Pediatr
33469465	Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation.	Front Genet
33468250	MSC-NTF (NurOwn(R)) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model.	Stem Cell Res Ther
33467724	Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages-Potential Implications for Cytokine Storm Syndrome.	Vaccines (Basel)
33467441	May Ibrutinib Have Activity in Respiratory Complications by SARS-CoV-2? Clinical Experience in a Patient with Chronic Lymphocytic Leukemia.	Healthcare (Basel)
33465050	Fighting the storm: could novel anti-TNFalpha and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?	Aging (Albany NY)
33464224	Management of patients with severe acute respiratory failure due to SARS-CoV-2 pneumonia with noninvasive ventilatory support outside Intensive Care Unit.	Minerva Med
33462706	Age-associated difference in circulating ACE2, the gateway for SARS-COV-2, in humans: results from the InCHIANTI study.	Geroscience
33461503	Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.	BMC Infect Dis
33459964	Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.	J Clin Immunol
33457304	Epidemiological and clinical characteristics analysis of 11 children with 2019 novel coronavirus infection in Chongqing: a single-center retrospective study.	Transl Pediatr
33455938	Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation: protocol for a randomised, controlled, open-label intervention, multicentre trial.	BMJ Open
33455920	Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?	RMD Open
33452858	Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity.	Immun Inflamm Dis
33452734	Exploring the treatment of COVID-19 with Yinqiao powder based on network pharmacology.	Phytother Res
33446817	Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages.	Sci Rep
33442386	Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic.	Front Pharmacol
33441142	On the role of bacterial metalloproteases in COVID-19 associated cytokine storm.	Cell Commun Signal
33439360	Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory response of SARS-CoV-2 patients.	Ann Intensive Care
33439304	G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?	Ann Hematol
33438250	A comprehensive review of COVID-19 in India: A frequent catch of the information.	Biotechnol Appl Biochem
33433966	Clinical Outcomes and Inflammatory Markers by HIV Serostatus and Viral Suppression in a Large Cohort of Patients Hospitalized With COVID-19.	J Acquir Immune Defic Syndr
33432248	The implementation and effectiveness of intergenerational learning during the COVID-19 pandemic: Evidence from China.	Int Rev Educ
33430891	Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.	Trials
33428154	Screening druggable targets and predicting therapeutic drugs for COVID-19 via integrated bioinformatics analysis.	Genes Genomics
33426894	NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV-2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines.	J Proteome Res
33426604	ACE-2-interacting Domain of SARS-CoV-2 (AIDS) Peptide Suppresses Inflammation to Reduce Fever and Protect Lungs and Heart in Mice: Implications for COVID-19 Therapy.	J Neuroimmune Pharmacol
33425951	A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure.	Front Med (Lausanne)
33425823	Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis-A Critical Review of Its Pathogenesis and Treatment.	Front Pediatr
33424856	HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients.	Front Immunol
33424804	Imaging Mass Cytometric Analysis of Postmortem Tissues Reveals Dysregulated Immune Cell and Cytokine Responses in Multiple Organs of COVID-19 Patients.	Front Microbiol
33424586	Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection.	Front Pharmacol
33422991	Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice.	EBioMedicine
33422990	SARS-CoV-2 leads to a small vessel endotheliitis in the heart.	EBioMedicine
33422363	Tackling the COVID-19 "cytokine storm" with microRNA mimics directly targeting the 3'UTR of pro-inflammatory mRNAs.	Med Hypotheses
33422296	[Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19].	Med Clin (Barc)
33421743	Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs.	Virology
33421440	Immune reactivity during COVID-19: Implications for treatment.	Immunol Lett
33420963	Pilot trial of high-dose vitamin C in critically ill COVID-19 patients.	Ann Intensive Care
33419825	Lymphocytes, Interleukin 6 and D-dimer Cannot Predict Clinical Outcome in Coronavirus Cancer Patients: LyNC1.20 Study.	Anticancer Res
33419750	Successful treatment of severe COVID-19 pneumonia and hyperinflammatory syndrome with tocilizumab.	BMJ Case Rep
33417230	Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study.	Infect Dis Ther
33416946	Are all cytokine storms the same?	Cancer Immunol Immunother
33415866	[Effect of moxibustion on clinical symptoms, peripheral inflammatory indexes and T lymphocyte subsets in COVID-19 patients].	Zhongguo Zhen Jiu
33414643	Calcio-Herbal Medicine Divya-Swasari-Vati Ameliorates SARS-CoV-2 Spike Protein-Induced Pathological Features and Inflammation in Humanized Zebrafish Model by Moderating IL-6 and TNF-alpha Cytokines.	J Inflamm Res
33414457	Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections.	Cell Death Dis
33413026	Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity.	Ann Am Thorac Soc
33412294	SARS-CoV-2 infection associated with hepatitis in an infant with X-linked severe combined immunodeficiency.	Clin Immunol
33411411	Hypoalbuminemia in COVID-19: assessing the hypothesis for underlying pulmonary capillary leakage.	J Intern Med
33410720	Clinical and inflammatory features based machine learning model for fatal risk prediction of hospitalized COVID-19 patients: results from a retrospective cohort study.	Ann Med
33404078	Leptin correlates with monocytes activation and severe condition in COVID-19 patients.	J Leukoc Biol
33397460	Protective reactive thymus hyperplasia in COVID-19 acute respiratory distress syndrome.	Crit Care
33397449	Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).	Trials
33397150	An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases.	Immunotherapy
33396578	Interferon-alpha2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities.	Viruses
33395783	Elevated interleukin levels are associated with higher severity and mortality in COVID 19 - A systematic review, meta-analysis, and meta-regression.	Diabetes Metab Syndr
33395641	DEMOGRAPHIC AND CLINICAL FACTORS ASSOCIATED WITH INCREASED IL-6 LEVELS IN AMBULATORY PATIENTS WITH CHRONIC HEART FAILURE.	Georgian Med News
33395482	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses.	Clin Infect Dis
33394360	The Association of Low Molecular Weight Heparin Use and In-hospital Mortality Among Patients Hospitalized with COVID-19.	Cardiovasc Drugs Ther
33393678	Inflammation-associated factors for predicting in-hospital mortality in patients with COVID-19.	J Med Virol
33392485	Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial.	EClinicalMedicine
33391477	Immunopathogenesis and treatment of cytokine storm in COVID-19.	Theranostics
33391014	COVID-19-Associated Hyper-Fibrinolysis: Mechanism and Implementations.	Front Physiol
33390771	Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19.	Int J Med Sci
33390322	The role of obesity in inflammatory markers in COVID-19 patients.	Obes Res Clin Pract
33387537	Urinary trace elements in association with disease severity and outcome in patients with COVID-19.	Environ Res
33387453	COVID-19-positive cancer patients undergoing active anticancer treatment: An analysis of clinical features and outcomes.	Hematol Oncol Stem Cell Ther
33385878	The plausible mechanisms of tramadol for treatment of COVID-19.	Med Hypotheses
33385581	Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study.	Int J Infect Dis
33385239	Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge.	Inflamm Res
33384605	Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis.	Front Pharmacol
33382773	Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis.	PLoS One
33382747	The risk factors for mortality of diabetic patients with severe COVID-19: A retrospective study of 167 severe COVID-19 cases in Wuhan.	PLoS One
33382215	Risk factors and outcomes for acute respiratory failure in coronavirus disease 2019: An observational cohort study.	Adv Clin Exp Med
33380357	Association between iron status and the risk of adverse outcomes in COVID-19.	Clin Nutr
33378989	Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size.	Biomed Pharmacother
33378571	A retrospective matched cohort single-center study evaluating outcomes of COVID-19 and the impact of immunomodulation on COVID-19-related cytokine release syndrome in solid organ transplant recipients.	Transpl Infect Dis
33378277	Long-term application of hydroxychloroquine could not prevent the infection of COVID-19.	J Infect Dev Ctries
33378057	Aerobic exercises recommendations and specifications for patients with COVID-19: a systematic review.	Eur Rev Med Pharmacol Sci
33377359	The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.	J Biol Regul Homeost Agents
33372280	Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients.	J Cell Physiol
33371832	The Potential Mechanism of N-acetylcysteine in Treating COVID-19.	Curr Pharm Biotechnol
33370397	Simple predictive models identify patients with COVID-19 pneumonia and poor prognosis.	PLoS One
33365277	Clinical Characteristics and Immune Responses of 137 Deceased Patients With COVID-19: A Retrospective Study.	Front Cell Infect Microbiol
33363865	Treatment of cytokine storm syndrome with IL-1 receptor antagonist anakinra in a patient with ARDS caused by COVID-19 infection: A case report.	Clin Case Rep
33363221	The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System.	Front Cardiovasc Med
33363088	Bee Venom-A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections.	Front Public Health
33362916	Clinical features and radiological manifestations of COVID-19 disease.	World J Radiol
33361013	Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality.	Eur Cytokine Netw
33358260	Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS).	Pulmonology
33357409	The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells.	Immunity
33357215	Phosphatidylserine inside out: a possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19.	Cell Commun Signal
33356606	Association of ACEI/ARB, inflammatory cytokines, and antiviral drugs with liver dysfunction in patients with hypertension and COVID-19.	Clin Exp Hypertens
33353546	Effects of Tocilizumab in COVID-19 patients: a cohort study.	BMC Infect Dis
33351831	Manufacturing of convalescent plasma of COVID-19 patients: Aspects of quality.	PLoS One
33351817	Obesity and smoking as risk factors for invasive mechanical ventilation in COVID-19: A retrospective, observational cohort study.	PLoS One
33351265	Clinical characteristics of COVID-19 patients with hepatitis B virus infection - a retrospective study.	Liver Int
33350580	Biochemical study on the protective effect of curcumin on acetaminophen and gamma-irradiation induced hepatic toxicity in rats.	Environ Toxicol
33349715	Everything is going to be all right. Psychopathology in the time of an epidemic in Italy.	Riv Psichiatr
33349263	Beneficial effect of Indigo Naturalis on acute lung injury induced by influenza A virus.	Chin Med
33349241	Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study.	BMC Infect Dis
33348065	Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.	Cytokine
33344529	Possible Prophylactic Approach for SARS-CoV-2 Infection by Combination of Melatonin, Vitamin C and Zinc in Animals.	Front Vet Sci
33341023	Transcranial Doppler Ultrasound Evidence of Active Cerebral Embolization in COVID-19.	J Stroke Cerebrovasc Dis
33340765	In vitro display evolution of IL-6R-binding unnatural peptides ribosomally initiated and cyclized with m-(chloromethyl)benzoic acid.	Biochem Biophys Res Commun
33339534	Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report.	J Med Case Rep
33338559	Early clinical outcomes with tocilizumab for severe COVID-19: a two-centre retrospective study.	Int J Antimicrob Agents
33337480	IL-6 in inflammation, autoimmunity and cancer.	Int Immunol
33336774	Dynamics of cytokines and lymphocyte subsets associated with the poor prognosis of severe COVID-19.	Eur Rev Med Pharmacol Sci
33336771	Duodenal perforation in a SARS-CoV-2-positive patient with negative PCR results for SARS-CoV-2 in the peritoneal fluid.	Eur Rev Med Pharmacol Sci
33336592	Serum-soluble ST2 as a novel biomarker reflecting inflammatory status and illness severity in patients with COVID-19.	Biomark Med
33335906	Case Report: A Patient With COVID-19 Who Benefited From Hemoadsorption.	Front Med (Lausanne)
33335532	Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?	Front Immunol
33333696	[Association of D-dimer, inflammatory markers, cytokines abnormality, and disease severity in COVID-19 severe/critical patients in Wuhan].	Zhonghua Xue Ye Xue Za Zhi
33333641	[A comparison of clinical characteristics between patients with and without"recurrence"RNA positive with COVID-19].	Zhonghua Jie He He Hu Xi Za Zhi
33333393	Experience of using tocilizumab for treatment in Indonesian patients with severe COVID-19.	Cytokine
33329518	Analysis of Peripheral Blood IL-6 and Leukocyte Characteristics in 364 COVID-19 Patients of Wuhan.	Front Immunol
33326621	Effect of artificial liver blood purification treatment on the survival of critical ill COVID-19 patients.	Artif Organs
33323111	Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor.	Thromb J
33320755	Low-dose radiotherapy (LD-RT) for COVID-19-induced pneumopathy: a worth considering approach.	Int J Radiat Biol
33319166	Transcriptional response modules characterize IL-1beta and IL-6 activity in COVID-19.	iScience
33318472	Scoring cytokine storm by the levels of MCP-3 and IL-8 accurately distinguished COVID-19 patients with high mortality.	Signal Transduct Target Ther
33317616	Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19.	Crit Care
33316234	Identification of Distinct Immunophenotypes in Critically Ill Coronavirus Disease 2019 Patients.	Chest
33315291	Does inflammation link stress to poor COVID-19 outcome?	Stress Health
33313194	Chest CT imaging features and severity scores as biomarkers for prognostic prediction in patients with COVID-19.	Ann Transl Med
33312795	Relationships between Demographic, Geographic, and Environmental Statistics and the Spread of Novel Coronavirus Disease (COVID-19) in Italy.	Cureus
33312565	Rapid detection of SARS-CoV-2-specific memory T-cell immunity in recovered COVID-19 cases.	Clin Transl Immunology
33307107	Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients.	Mech Ageing Dev
33305624	IL-6 and other biomarkers as predictors of severity in COVID-19.	Ann Med
33304877	A Non-severe Coronavirus Disease 2019 Patient With Persistently High Interleukin-6 Level.	Front Public Health
33303843	Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19.	Sci Rep
33303577	Management of immune checkpoint therapy for patients with cancer in the face of COVID-19.	J Immunother Cancer
33303188	Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature.	Biochem Biophys Res Commun
33302889	Risk factors and clinical features of deterioration in COVID-19 patients in Zhejiang, China: a single-centre, retrospective study.	BMC Infect Dis
33302033	The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease.	Int Immunopharmacol
33301988	Covid-19 pathogenesis in prostatic cancer and TMPRSS2-ERG regulatory genetic pathway.	Infect Genet Evol
33301474	The transcriptomic profiling of SARS-CoV-2 compared to SARS, MERS, EBOV, and H1N1.	PLoS One
33301216	New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection.	Dermatol Ther
33298875	Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility.	Cell Discov
33298617	Repurposed Tocilizumab in Patients with Severe COVID-19.	J Immunol
33298615	A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4(+) and CD8(+) T Cells in COVID-19 Patients.	J Immunol
33297909	The Role of Interleukin-6 in the Pathogenesis, Prognosis and Treatment of Severe COVID-19.	Curr Med Chem
33296336	Atypical course of COVID-19 in patient with Bruton agammaglobulinemia.	J Infect Dev Ctries
33296106	COVID-19, microthromboses, inflammation, and platelet activating factor.	Biofactors
33292846	Autonomic balance determines the severity of COVID-19 courses.	Bioelectron Med
33292350	An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients.	Immun Ageing
33289233	Alimentary system is directly attacked by SARS-COV-2 and further prevents immune dysregulation caused by COVID-19.	Int J Clin Pract
33289169	Neutrophils mediate Th17 promotion in COVID-19 patients.	J Leukoc Biol
33289142	Development and validation of a nomogram using on admission routine laboratory parameters to predict in-hospital survival of patients with COVID-19.	J Med Virol
33288475	Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19.	J Cyst Fibros
33288414	Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus.	J Diabetes Complications
33285628	Interstitial lung opacities in patients with severe COVID-19 pneumonia by bedside high-resolution ultrasound in association to CO2 retention.	Clin Hemorheol Microcirc
33284859	SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells.	PLoS Pathog
33283602	Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads.	J Renin Angiotensin Aldosterone Syst
33283178	The "sex gap" in COVID-19 trials: a scoping review.	EClinicalMedicine
33281252	Modeling and simulations of CoViD-19 molecular mechanism induced by cytokines storm during SARS-CoV2 infection.	J Mol Liq
33277638	Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.	Nat Immunol
33277106	Can chloroquine/hydroxychloroquine prove efficient in cancer cachexia? A hypothesis in the era of COVID-19.	Med Hypotheses
33276811	Safety and Efficacy of Ixekizumab and Antiviral Treatment for Patients with COVID-19: A structured summary of a study protocol for a Pilot Randomized Controlled Trial.	Trials
33275095	Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia.	Clin Exp Rheumatol
33274223	Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID-19.	Biomed Res Int
33274180	An Experimental Model for Peri-conceptual COVID-19 Pregnancy Loss and Proposed Interventions to Optimize Outcomes.	Int J Mol Cell Med
33273888	Inflammatory-Related Clinical and Metabolic Outcomes in COVID-19 Patients.	Mediators Inflamm
33272291	The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome.	J Transl Med
33271549	Association between Prolonged Intermittent Renal Replacement Therapy and All-Cause Mortality in COVID-19 Patients Undergoing Invasive Mechanical Ventilation: A Retrospective Cohort Study.	Blood Purif
33270024	Therapeutic targeting of interleukin-6 for the treatment of COVID-19.	Eur Cytokine Netw
33262810	Interleukin-6 signaling blockade treatment for cytokine release syndrome in COVID-19 (Review).	Exp Ther Med
33257703	Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility.	Sci Rep
33257492	Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study.	BMJ Open
33257107	Biomolecular endotype factors involved in COVID-19 airway infectivity: A systematic review.	Auris Nasus Larynx
33256816	Letter to the Editor in response to Chen et al. 2020.	Respir Res
33256749	LMWF5A suppresses cytokine release by modulating select inflammatory transcription factor activity in stimulated PBMC.	J Transl Med
33254564	Role of inositol to improve surfactant functions and reduce IL-6 levels: A potential adjuvant strategy for SARS-CoV-2 pneumonia?	Med Hypotheses
33253854	Peripheral immunological features of COVID-19 patients in Taizhou, China: A retrospective study.	Clin Immunol
33252122	Low serum calcium: a new, important indicator of COVID-19 patients from mild/moderate to severe/critical.	Biosci Rep
33252101	Multisystem inflammatory syndrome in children and SARS-CoV-2: A scoping review.	J Pediatr Rehabil Med
33252008	Design of a multi-epitope-based vaccine targeting M-protein of SARS-CoV2: an immunoinformatics approach.	J Biomol Struct Dyn
33251234	Absolute Eosinophil Count Predicts Intensive Care Unit Transfer Among Elderly COVID-19 Patients From General Isolation Wards.	Front Med (Lausanne)
33251228	Epidemiological Characteristics and Clinical Features of Patients Infected With the COVID-19 Virus in Nanchang, Jiangxi, China.	Front Med (Lausanne)
33250935	Relationship between children physical activity, inflammatory mediators and lymphocyte activation: possible impact of social isolation (COVID-19).	Sport Sci Health
33250601	Network pharmacology of AYUSH recommended immune-boosting medicinal plants against COVID-19.	J Ayurveda Integr Med
33250487	Association of Interleukin-6 Levels with Morbidity and Mortality in Patients with Coronavirus Disease 2019 (COVID-19).	Jpn J Infect Dis
33249766	First expert elicitation of knowledge on drivers of emergence of influenza D in Europe.	Transbound Emerg Dis
33249471	Serum Protein Profiling Reveals a Specific Upregulation of the Immunomodulatory Protein Progranulin in Coronavirus Disease 2019.	J Infect Dis
33249290	A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient.	Int J Infect Dis
33249281	A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study.	Biomed Pharmacother
33249060	The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines.	Virus Res
33247138	Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates.	Nat Commun
33246770	An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis.	Cytokine
33245731	MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection.	Oncotarget
33245278	The paradoxical effect of IL-6 and implications for the use of Tocilizumab in Covid-19 patients.	Med Hypotheses
33244382	Significant changes of CD4, FOXP3, CD25, and IL6 expression level in Iranian COVID-19 patients.	Gastroenterol Hepatol Bed Bench
33244370	Increased inflammatory markers correlate with liver damage and predict severe COVID-19: a systematic review and meta-analysis.	Gastroenterol Hepatol Bed Bench
33242672	Cytokine storm of a different flavour: The different cytokine signature of SARS-CoV-2, the cause of COVID-19, from the original SARS outbreak.	J Glob Antimicrob Resist
33241658	Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin.	J Cell Mol Med
33239683	Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19.	Sci Rep
33238863	Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.	Curr Pharm Des
33236373	Role of extracorporeal membrane oxygenation in critically Ill COVID-19 patients and predictors of mortality.	Artif Organs
33236293	The Relation Between Trace Element Status (Zinc, Copper, Magnesium) and Clinical Outcomes in COVID-19 Infection During Pregnancy.	Biol Trace Elem Res
33236284	Inflammasomes and Childhood Autoimmune Diseases: A Review of Current Knowledge.	Clin Rev Allergy Immunol
33235833	Colchicine in Dermatology: Rediscovering an Old Drug with Novel Uses.	Indian Dermatol Online J
33235616	Clinical characteristics of 78 cases of patients infected with coronavirus disease 2019 in Wuhan, China.	Exp Ther Med
33235220	Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19.	Sci Rep
33234322	Experimental study of Forsythoside A on prevention and treatment of avian infectious bronchitis.	Res Vet Sci
33232865	SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.	Immunobiology
33232303	An immune-based biomarker signature is associated with mortality in COVID-19 patients.	JCI Insight
33232277	Estimating the release of inflammatory factors and use of glucocorticoid therapy for COVID-19 patients with comorbidities.	Aging (Albany NY)
33231770	Down's syndrome and COVID-19: risk or protection factor against infection? A molecular and genetic approach.	Neurol Sci
33231615	Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.	J Exp Med
33230491	Liver Injury in Patients Hospitalized with Coronavirus Disease 2019 Correlates with Hyperinflammatory Response and Elevated Interleukin-6.	Hepatol Commun
33225517	Peripheral blood inflammatory markers in predicting prognosis in patients with COVID-19. Some differences with influenza A.	J Clin Lab Anal
33224575	Cardiovascular risk in COVID-19 infection.	Am J Cardiovasc Dis
33223833	D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.	Vasc Health Risk Manag
33221483	The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury.	Transl Res
33220354	Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study.	J Allergy Clin Immunol
33216906	The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter Study.	J Infect Dis
33216184	Risk for COVID-19 infection in patients with tobacco smoke-associated cancers of the upper and lower airway.	Eur Arch Otorhinolaryngol
33214648	Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers.	Sci Rep
33214057	A Potential Role of Interleukin 10 in COVID-19 Pathogenesis.	Trends Immunol
33211319	Routine laboratory testing to determine if a patient has COVID-19.	Cochrane Database Syst Rev
33211155	Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry.	Clin Res Cardiol
33211045	A digital protein microarray for COVID-19 cytokine storm monitoring.	Lab Chip
33210302	COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia.	Clin Pharmacol Ther
33209547	Pneumatosis Intestinalis in COVID-19: Case Series.	Cureus
33209300	Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19.	Clin Transl Immunology
33206688	EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2.	PLoS One
33205775	Sulle raccomandazioni di etica clinica della SIAARTI per il trattamento dei pazienti CoViD-19.	Recenti Prog Med
33205000	Hypoferremia is Associated With Increased Hospitalization and Oxygen Demand in COVID-19 Patients.	Hemasphere
33204749	Occult Colonic Perforation in a Patient With Coronavirus Disease 2019 After Interleukin-6 Receptor Antagonist Therapy.	Open Forum Infect Dis
33203890	Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses.	Nat Commun
33202670	Vitamin D3 as Potential Treatment Adjuncts for COVID-19.	Nutrients
33202218	Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19: a meta-analysis and insights into pathogenesis.	Int J Infect Dis
33202195	Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19.	Viral Immunol
33201896	Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review.	PLoS One
33200105	COVID-19: psychological effects on a COVID-19 quarantined population in Bangladesh.	Heliyon
33200067	Covid-19 cytokine storm in pulmonary tissue: Anatomopathological and immunohistochemical findings.	Respir Med Case Rep
33199926	[Proinflammatory cytokines and cardio-vascular risk: From myocardial infarction tocytokine storm of COVID-19].	Bull Acad Natl Med
33199778	Similarities and differences between the 'cytokine storms' in acute dengue and COVID-19.	Sci Rep
33199178	A clinical trial of IL-15 and IL-21 combination therapy for COVID-19 is warranted.	Cytokine Growth Factor Rev
33198856	[Value of interleukin-6 and CD4(+) T-lymphocytopenia in assessing the severity and prognosis of coronavirus disease 2019].	Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
33198751	Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome.	BMC Pulm Med
33197260	Correlation Between Early Plasma Interleukin 37 Responses With Low Inflammatory Cytokine Levels and Benign Clinical Outcomes in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.	J Infect Dis
33197212	The treatment of SARS-CoV2 with antivirals and mitigation of the cytokine storm syndrome: the role of gene expression.	Genome
33196005	COVID-19: An Archetype Innate Immunity Reaction and Modes of Treatment.	Mediterr J Rheumatol
33196004	Kawasaki Disease and COVID-19.	Mediterr J Rheumatol
33196003	Anti-Rheumatic Drugs for the Fight Against the Novel Coronavirus Infection (SARSCoV-2): What is the Evidence?	Mediterr J Rheumatol
33195334	IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary Infections.	Front Med (Lausanne)
33195321	Coagulopathy as a Prodrome of Cytokine Storm in COVID-19-Infected Patients.	Front Med (Lausanne)
33195318	Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)?	Front Med (Lausanne)
33194450	The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review.	PeerJ
33194329	Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach.	PeerJ
33194116	Clinical characteristics and outcomes of critically ill patients with COVID-19 in a tertiary community hospital in upstate New York.	J Community Hosp Intern Med Perspect
33194050	Gender, age and comorbidities as the main prognostic factors in patients with COVID-19 pneumonia.	Am J Transl Res
33193384	Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness.	Front Immunol
33191263	Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial.	BMJ Open
33191068	Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia.	Phytomedicine
33190086	Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19.	Respir Med
33189888	Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort.	Clin Immunol
33188624	Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis.	J Clin Immunol
33187979	Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm.	Sci Adv
33186795	Kefir: A protective dietary supplementation against viral infection.	Biomed Pharmacother
33186704	CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14.	Int J Infect Dis
33186186	Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.	Curr Opin Allergy Clin Immunol
33185926	SARS-CoV-2-mediated immune system activation and potential application in immunotherapy.	Med Res Rev
33185910	Risk factors for severe and critically ill COVID-19 patients: A review.	Allergy
33185828	Potential approaches to combat COVID-19: a mini-review.	Mol Biol Rep
33182059	Correlation between premorbid IL-6 levels and COVID-19 mortality: Potential role for Vitamin D.	Int Immunopharmacol
33181508	Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia.	Blood Purif
33180935	Immunological Assessment of Pediatric Multisystem Inflammatory Syndrome Related to Coronavirus Disease 2019.	J Pediatric Infect Dis Soc
33180882	Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression.	PLoS Pathog
33178522	Use of Tocilizumab in COVID-19: A Systematic Review and Meta-Analysis of Current Evidence.	Cureus
33175722	Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020.	Med Sci Monit
33173434	Herbal plants coordinate COVID-19 in multiple dimensions - An insight analysis for clinically applied remedies.	Int J Med Sci
33171111	Acute Respiratory Distress in Aged, SARS-CoV-2-Infected African Green Monkeys but Not Rhesus Macaques.	Am J Pathol
33166287	Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection.	PLoS One
33166093	Can immunological manipulation defeat SARS-CoV-2? Why G-CSF induced neutrophil expansion is worth a clinical trial: G-CSF treatment against COVID-19.	Bioessays
33165762	The effect of tocilizumab on cytokine release syndrome in COVID-19 patients.	Pharmacol Rep
33165417	Network pharmacology-based study of the molecular mechanisms of Qixuekang in treating COVID-19 during the recovery period.	Int J Clin Exp Pathol
33163981	Inflammatory Biomarker Trends Predict Respiratory Decline in COVID-19 Patients.	Cell Rep Med
33163956	COVID-19-associated encephalitis successfully treated with combination therapy.	Clin Infect Pract
33163955	Hereditary haemochromatosis, haemophagocytic lymphohistiocytosis and COVID-19.	Clin Infect Pract
33162345	Application value of artificial liver support system in the treatment of cytokine storm in patients with COVID-19.	Int Immunopharmacol
33161757	A comprehensive review on sarilumab in COVID-19.	Expert Opin Biol Ther
33161478	Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy.	Intern Emerg Med
33161150	Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis.	Clin Microbiol Infect
33161002	Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab.	Immunol Lett
33160854	Gender-associated difference following COVID-19 virus infection: Implications for thymosin alpha-1 therapy.	Int Immunopharmacol
33160363	COVID-19: Is there a role for immunonutrition in obese patient?	J Transl Med
33159988	If skin is a potential host of SARS-CoV-2, IL-17 antibody could reduce the risk of COVID-19.	J Am Acad Dermatol
33159954	Biclonal gammopathay in a case of severe COVID-19.	Clin Chim Acta
33159646	The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.	Inflammopharmacology
33159040	Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients.	Cell Death Dis
33158717	Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study.	Phytomedicine
33155686	Defining IL-6 levels in healthy individuals: A meta-analysis.	J Med Virol
33154753	Elevated Exhaustion Levels of NK and CD8(+) T Cells as Indicators for Progression and Prognosis of COVID-19 Disease.	Front Immunol
33153974	Laboratory biomarkers associated with COVID-19 severity and management.	Clin Immunol
33153922	Repurposing Antimalarials to Tackle the COVID-19 Pandemic.	Trends Parasitol
33153403	Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection?	Autophagy
33152573	Relationship between disease severity and serum IL-6 levels in COVID-19 anosmia.	Am J Otolaryngol
33152343	Detection of Viral Infections by Innate Immunity.	Biochem Pharmacol
33149733	The Inflammasome in Times of COVID-19.	Front Immunol
33149652	Selection of an Optimal Combination Panel to Better Triage COVID-19 Hospitalized Patients.	J Inflamm Res
33148390	[Progress on role of cytokine storm in exacerbation of coronavirus disease 2019 (COVID-19): Review].	Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
33147871	New Insights in Laboratory Testing for COVID-19 Patients: Looking for the Role and Predictive Value of Human epididymis secretory protein 4 (HE4) and the Innate Immunity of the Oral Cavity and Respiratory Tract.	Microorganisms
33147850	Application of Humanized Zebrafish Model in the Suppression of SARS-CoV-2 Spike Protein Induced Pathology by Tri-Herbal Medicine Coronil via Cytokine Modulation.	Molecules
33147503	Host sphingolipids: Perspective immune adjuvant for controlling SARS-CoV-2 infection for managing COVID-19 disease.	Prostaglandins Other Lipid Mediat
33146673	Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6.	Biosci Rep
33146561	Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation.	Expert Rev Clin Immunol
33146036	Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution.	Cephalalgia
33144402	Rationale for the use of sphingosine analogues in COVID-19 patients.	Clin Med (Lond)
33141519	Immunosuppressive drugs for patients with psoriasis during the COVID-19 pandemic era. A review.	Dermatol Ther
33141018	COVID-19: Cytokine storm modulation/blockade with oral polyvalent immunoglobulins (PVIG, KMP01D): A potential and safe therapeutic agent (Primum nil nocere).	Int J Clin Pharmacol Ther
33138839	CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS.	Crit Care
33137863	[Potential therapeutic drugs for novel coronavirus pneumonia].	Zhonghua Jie He He Hu Xi Za Zhi
33136592	Treatment of Cytokine Storm in COVID-19 Patients With Immunomodulatory Therapy.	ASAIO J
33134901	Impaired spermatogenesis in COVID-19 patients.	EClinicalMedicine
33134238	Health Disparities in COVID-19: Addressing the Role of Social Determinants of Health in Immune System Dysfunction to Turn the Tide.	Front Public Health
33134148	Clinical Management of Il-6 Driven Cytokine Storm Related to COVID-19 in a Patient with Recent Spinal Cord Stimulator Implants: A Case Report.	Anesth Pain Med
33133104	Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients.	Front Immunol
33132558	Tocilizumab Use in COVID-19 Cytokine-release Syndrome: Retrospective Study of Two Centers.	Indian J Crit Care Med
33132549	Tocilizumab and COVID-19.	Indian J Crit Care Med
33132153	The effect of environmental pollution on immune evasion checkpoints of SARS-CoV-2.	Environ Toxicol Pharmacol
33131070	Novel insight from the first lung transplant of a COVID-19 patient.	Eur J Clin Invest
33129099	Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients.	Int Immunopharmacol
33129009	Ac2-26 mimetic peptide of annexin A1 to treat severe COVID-19: A hypothesis.	Med Hypotheses
33128927	Probable positive effects of the photobiomodulation as an adjunctive treatment in COVID-19: A systematic review.	Cytokine
33128665	Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.	J Clin Immunol
33127906	SARS-CoV-2 viral load is associated with increased disease severity and mortality.	Nat Commun
33123167	Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.	Front Immunol
33122784	IL-4/IL-13 remodeling pathway of COVID-19 lung injury.	Sci Rep
33121927	The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro.	Biochem Pharmacol
33121497	Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study.	J Transl Med
33117402	Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.	Front Immunol
33117379	ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19.	Front Immunol
33116977	Coagulopathy of Patients with COVID-19 is Associated with Infectious and Inflammatory Markers.	Risk Manag Healthc Policy
33116747	Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.	J Inflamm Res
33115682	Compassionate use of tocilizumab in severe SARS-CoV2 pneumonia.	Int J Infect Dis
33115677	HIV/SARS-CoV-2 co-infection: T cell profile, cytokine dynamics and role of exhausted lymphocytes.	Int J Infect Dis
33115543	Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.	Trials
33114676	Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19.	Int J Mol Sci
33113418	Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19.	Biomed Pharmacother
33113325	Early Initiation of Extracorporeal Blood Purification Using the AN69ST (oXiris((R))) Hemofilter as a Treatment Modality for COVID-19 Patients: a Single-Centre Case Series.	Braz J Cardiovasc Surg
33113222	T cell immunobiology and cytokine storm of COVID-19.	Scand J Immunol
33112637	Mechanisms and potential therapeutic targets of hyperinflammatory responses in SARS-CoV-2.	Acta Virol
33111624	Deciphering underlying mechanism of Sars-CoV-2 infection in humans and revealing the therapeutic potential of bioactive constituents from Nigella sativa to combat COVID19: in-silico study.	J Biomol Struct Dyn
33110739	Immunomodulatory Therapies for COVID-19 in Solid Organ Transplant Recipients.	Curr Transplant Rep
33110074	Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome.	Cell Death Dis
33109252	The efficacy of Siddha Medicine, Kabasura Kudineer (KSK) compared to Vitamin C & Zinc (CZ) supplementation in the management of asymptomatic COVID-19 cases: A structured summary of a study protocol for a randomised controlled trial.	Trials
33108622	Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19.	Adv Ther
33107641	Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19.	J Med Virol
33106171	Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.	Trials
33105142	Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19.	Gerontology
33101458	Tocilizumab and liver injury in patients with COVID-19.	Therap Adv Gastroenterol
33099890	COVID-19: A Case for Inhibiting NLRP3 Inflammasome, Suppression of Inflammation with Curcumin?	Basic Clin Pharmacol Toxicol
33098952	Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19).	Int J Cardiol
33098139	Tocilizumab use in patients with moderate to severe COVID-19: A retrospective cohort study.	J Clin Pharm Ther
33094669	Overview on the use of IL-6 agents in the treatment of patients with cytokine release syndrome (CRS) and pneumonitis related to COVID-19 disease.	Expert Opin Investig Drugs
33092653	The clinical effect of Nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance changes following treatment: A structured summary of a study protocol for a randomised controlled trial.	Trials
33089052	Successful treatment of acute heart failure in COVID-19-induced cytokine storm with tocilizumab: a case report.	Eur Heart J Case Rep
33089038	Temporal Clinical and Laboratory Response to Interleukin-6 Receptor Blockade With Tocilizumab in 89 Hospitalized Patients With COVID-19 Pneumonia.	Pathog Immun
33087150	Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.	J Transl Med
33086028	Assessing the Elevation of Cardiac Biomarkers and the Severity of COVID-19 Infection: A Meta-analysis.	J Pharm Pharm Sci
33084021	Hemoadsorption cartridge and coronavirus disease 2019 infections: A case report and brief literature review.	Artif Organs
33082935	Immunopathology of galectin-3: an increasingly promising target in COVID-19.	F1000Res
33082858	Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology.	BioData Min
33082451	Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses.	Sci Rep
33082053	Portable Pocket-Sized Ultrasound Scanner for the Evaluation of Lung Involvement in Coronavirus Disease 2019 Patients.	Ultrasound Med Biol
33081905	[Metformin: one of the possible options to reduce the mortality of severe coronavirus disease 2019?]	Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
33081889	[Analysis of the changes of inflammatory cytokine levels in patients with critical coronavirus disease 2019 undergoing invasive mechanical ventilation].	Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
33080435	The role of Interleukin-4 in COVID-19 associated male infertility - A hypothesis.	J Reprod Immunol
33078567	Antibody Micropatterned Lubricant-Infused Biosensors Enable Sub-Picogram Immunofluorescence Detection of Interleukin 6 in Human Whole Plasma.	Small
33078545	Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia.	EMBO Mol Med
33078369	Neurobiochemical Cross-talk Between COVID-19 and Alzheimer's Disease.	Mol Neurobiol
33076830	New HIV diagnoses in patients with COVID-19: two case reports and a brief literature review.	BMC Infect Dis
33076729	Immune system changes during COVID-19 recovery play key role in determining disease severity.	Int J Immunopathol Pharmacol
33075636	High serum IL-6 values increase the risk of mortality and the severity of pneumonia in patients diagnosed with COVID-19.	Mol Immunol
33075608	The clinical spectrum of pulmonary thromboembolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: A European case series.	J Crit Care
33075378	Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm.	Chest
33073969	An Overview on the Common Laboratory Parameter Alterations and their Related Molecular Pathways in Screening for COVID-19 Patients.	Clin Lab
33073612	Infusion of HLA-matched and static magnetic field-exposed allogenic lymphocytes treating lymphocytopenia and cytokine storm syndrome: A treatment proposal for COVID-19 patients.	Electromagn Biol Med
33073244	Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?	Lancet Rheumatol
33072191	MiR-146a rs2910164 G > C polymorphism modulates Notch-1/IL-6 signaling during infection: a possible risk factor for Crohn's disease.	Gut Pathog
33072117	Familial Mediterranean Fever and COVID-19: Friends or Foes?	Front Immunol
33071786	Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome.	Front Pharmacol
33070537	Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy.	Rev Cardiovasc Med
33068863	Nucleic acid and antibody assay results in Chinese patients with coronavirus disease 2019 (COVID-19).	Int Immunopharmacol
33068796	Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients.	Clin Immunol
33067719	Effect of Ergothioneine on 7-Ketocholesterol-Induced Endothelial Injury.	Neuromolecular Med
33067641	Elevated interleukin-6 and adverse outcomes in COVID-19 patients: a meta-analysis based on adjusted effect estimates.	Immunogenetics
33067568	Clinical characteristics and survival analysis in critical and non-critical patients with COVID-19 in Wuhan, China: a single-center retrospective case control study.	Sci Rep
33067472	Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19.	Nat Commun
33066459	Presentation, Treatment Response and Short-Term Outcomes in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS).	J Clin Med
33066442	The Inhibition of NLRP3 Inflammasome and IL-6 Production by Hibiscus noldeae Baker f. Derived Constituents Provides a Link to Its Anti-Inflammatory Therapeutic Potentials.	Molecules
33065551	CD45: a critical regulator in immune cells to predict severe and non-severe COVID-19 patients.	Aging (Albany NY)
33065030	Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques.	Cell
33064176	[Fatal course of COVID-19 despite IL-6 receptor blockade in cytokine storm : Perimyocarditis and coagulopathy after administration of tocilizumab].	Anaesthesist
33062720	Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine.	J Immunol Res
33062712	Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia.	J Diabetes Res
33062077	Immunopathogenesis of SARS-CoV-2-induced pneumonia: lessons from influenza virus infection.	Inflamm Regen
33061829	Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals.	Mediators Inflamm
33060840	Unique immunological profile in patients with COVID-19.	Cell Mol Immunol
33059878	La pandemie de COVID-19 ne sera pas la derniere (ni la pire) : Il est temps d'integrer la resilience a nos objectifs d'elimination du cancer du col de l'uterus.	J Obstet Gynaecol Can
33059711	Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.	Virol J
33058143	Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis.	Eur J Clin Invest
33053788	Effect of Income Level and Perception of Susceptibility and Severity of COVID-19 on Stay-at-Home Preventive Behavior in a Group of Older Adults in Mexico City.	Int J Environ Res Public Health
33052896	Clinical Characteristics of 3 Patients Infected with COVID-19: Age, Interleukin 6 (IL-6), Lymphopenia, and Variations in Chest Computed Tomography (CT).	Am J Case Rep
33052619	The clinical characteristics and prognosis of COVID-19 patients with cerebral stroke: A retrospective study of 113 cases from one single-centre.	Eur J Neurosci
33052054	Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia.	Arterioscler Thromb Vasc Biol
33051610	IL-18-dependent MAIT cell activation in COVID-19.	Nat Rev Immunol
33051534	Lack of tocilizumab effect on mortality in COVID19 patients.	Sci Rep
33050972	Predictive indicators of severe COVID-19 independent of comorbidities and advanced age: a nested case-control study.	Epidemiol Infect
33048116	Longitudinal Profile of Laboratory Parameters and Their Application in the Prediction for Fatal Outcome Among Patients Infected With SARS-CoV-2: A Retrospective Cohort Study.	Clin Infect Dis
33046696	Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium.	Nat Commun
33046113	Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID-19: a pilot study.	Crit Care
33045526	Cytokine profile and disease severity in patients with COVID-19.	Cytokine
33045370	A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.	Clin Microbiol Infect
33045281	COVID-19 risk stratification algorithms based on sTREM-1 and IL-6 in emergency department.	J Allergy Clin Immunol
33043284	Sarilumab use in severe SARS-CoV-2 pneumonia.	EClinicalMedicine
33043232	Thromboinflammation response to tocilizumab in COVID-19.	Res Pract Thromb Haemost
33043164	A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis plan.	Contemp Clin Trials Commun
33042873	Analysis of Risk Factors for 24 Patients With COVID-19 Developing From Moderate to Severe Condition.	Front Cell Infect Microbiol
33042157	Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis.	Front Immunol
33041191	Fungal co-infection in COVID-19 patients: Should we be concerned?	Rev Iberoam Micol
33040779	Interleukin-6 role in the severity of COVID-19 and intensive care unit stay length.	Cell Mol Biol (Noisy-le-grand)
33040384	Frontline Science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes.	J Leukoc Biol
33039966	Continuous tracking of COVID-19 patients' immune status.	Int Immunopharmacol
33039964	Risk factors for prolonged viral clearance in adult patients with COVID-19 in Beijing, China: A prospective observational study.	Int Immunopharmacol
33039714	A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19.	EBioMedicine
33039609	A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer.	Int J Infect Dis
33038939	Cytokine Storms in Cancer and COVID-19.	Cancer Cell
33038012	Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.	J Med Virol
33034338	Computer-aided prediction and design of IL-6 inducing peptides: IL-6 plays a crucial role in COVID-19.	Brief Bioinform
33031955	TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol.	Contemp Clin Trials
33031791	Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19.	Chem Biol Interact
33031060	Efficacy and safety of tocilizumab in COVID-19 patients.	Aging (Albany NY)
33028689	Descriptive, Retrospective Study of the Clinical Characteristics of Asymptomatic COVID-19 Patients.	mSphere
33026573	Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China.	Hepatol Int
33024459	Outlook of IL-6 signaling blockade for COVID-19 pneumonia.	Inflamm Regen
33024017	Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines.	Proc Natl Acad Sci U S A
33023989	Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy.	Diabetes Care
33023827	Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis.	Dig Liver Dis
33022800	IL-10 served as an indicator in severe COVID-19 patients.	J Med Virol
33021572	Microcirculatory, Endothelial, and Inflammatory Responses in Critically Ill Patients With COVID-19 Are Distinct From Those Seen in Septic Shock: A Case Control Study.	Shock
33016027	Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.	J Biol Regul Homeost Agents
33015641	Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19.	Lancet Rheumatol
33015550	SARS-CoV-2, an Underestimated Pathogen of the Nervous System.	SN Compr Clin Med
33015428	Biosurfactants and anti-inflammatory activity: A potential new approach towards COVID-19.	Curr Opin Environ Sci Health
33014208	How COVID-19 induces cytokine storm with high mortality.	Inflamm Regen
33014130	Possible mechanisms of action of clarithromycin and its clinical application as a repurposing drug for treating multiple myeloma.	Ecancermedicalscience
33013759	Is There a Link Between the Pathogenic Human Coronavirus Envelope Protein and Immunopathology? A Review of the Literature.	Front Microbiol
33013413	A Review of the Pharmacological Properties of Psoralen.	Front Pharmacol
33011959	Continuous extracorporeal treatments in a dialysis patient with COVID-19.	CEN Case Rep
33010257	IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study.	J Allergy Clin Immunol
33008960	Review on therapeutic targets for COVID-19: insights from cytokine storm.	Postgrad Med J
33007455	COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies.	Int J Infect Dis
33007369	"Cytokine storm", not only in COVID-19 patients. Mini-review.	Immunol Lett
33006723	HLA and immunological features of SARS-CoV-2-induced Guillain-Barre syndrome.	Neurol Sci
33002827	Rhamnocitrin extracted from Nervilia fordii inhibited vascular endothelial activation via miR-185/STIM-1/SOCE/NFATc3.	Phytomedicine
33002740	Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19.	Cytokine
33002623	Patients with Covid-19 exhibit different immunological profiles according to their clinical presentation.	Int J Infect Dis
33002613	Tocilizumab therapy for COVID-19: A comparison of subcutaneous and intravenous therapies.	Int J Infect Dis
32999229	Tocilizumab-induced Leukoencephalopathy with a Reversible Clinical Course.	Intern Med
32997660	IL6-mediated HCoV-host interactome regulatory network and GO/Pathway enrichment analysis.	PLoS Comput Biol
32995708	Lung Ultrasound and Respiratory Pathophysiology in Mechanically Ventilated COVID-19 Patients-an Observational Trial.	SN Compr Clin Med
32993821	Clinical characteristics of imported and second-generation coronavirus disease 2019 (COVID-19) cases in Shaanxi outside Wuhan, China: a multicentre retrospective study.	Epidemiol Infect
32993751	Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation.	Crit Care
32992775	Glutathione Supplementation as an Adjunctive Therapy in COVID-19.	Antioxidants (Basel)
32992282	Selenium and selenoproteins in viral infection with potential relevance to COVID-19.	Redox Biol
32991843	Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C).	Cell
32991819	Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection.	Am J Respir Cell Mol Biol
32990479	Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.	Expert Rev Mol Diagn
32989838	Prediction of adverse clinical outcomes in patients with coronavirus disease 2019.	J Clin Lab Anal
32989677	Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2.	Immunol Res
32989174	MAIT cell activation and dynamics associated with COVID-19 disease severity.	Sci Immunol
32988728	Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?	Cytokine Growth Factor Rev
32986663	Clinical and demographic characteristics of patients with COVID-19 infection: Statistics from a single hospital in Iran.	Hum Antibodies
32986248	Risk factors for mortality among patients with SARS-CoV-2 infection: A longitudinal observational study.	J Med Virol
32983180	Neutrophil-to-Lymphocyte Ratios Are Closely Associated With the Severity and Course of Non-mild COVID-19.	Front Immunol
32983123	Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome.	Front Immunol
32982743	Immunosuppressive Drugs and COVID-19: A Review.	Front Pharmacol
32981925	Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Platform to Study SARS-CoV-2 Related Myocardial Injury.	Circ J
32981754	Bioactive Lipids in COVID-19-Further Evidence.	Arch Med Res
32980515	Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor.	Bioorg Med Chem Lett
32979474	IFN-gamma is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection.	Virus Res
32979342	Compartmental immunophenotyping in COVID-19 ARDS: A case series.	J Allergy Clin Immunol
32979318	Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.	Lancet Infect Dis
32978651	Why COVID-19 is less frequent and severe in children: a narrative review.	World J Pediatr
32976665	Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement.	J Intern Med
32976531	The changes of the peripheral CD4+ lymphocytes and inflammatory cytokines in Patients with COVID-19.	PLoS One
32973818	PI3Kdelta Inhibition as a Potential Therapeutic Target in COVID-19.	Front Immunol
32973666	Acute Ischemic Stroke and COVID-19: Experience From a Comprehensive Stroke Center in Midwest US.	Front Neurol
32969629	Endocrinological disorders and inflammatory skin diseases during COVID-19 outbreak: a review of the literature.	Minerva Endocrinol
32969557	Low risk of hepatitis B reactivation in patients with severe COVID-19 who receive immunosuppressive therapy.	J Viral Hepat
32969125	Azithromycin in viral infections.	Rev Med Virol
32968624	Analysis of influencing factors related to elevated serum troponin I level for COVID-19 patients in Yichang, China.	Cardiovasc Diagn Ther
32966765	The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.	Cell
32964913	Decreased Mortality in Coronavirus Disease 2019 Patients Treated With Tocilizumab: A Rapid Systematic Review and Meta-analysis of Observational Studies.	Clin Infect Dis
32964337	CT imaging of pulmonary embolism in patients with COVID-19 pneumonia: a retrospective analysis.	Eur Radiol
32964179	Safety of intravenous anakinra in COVID-19 with evidence of hyperinflammation, a case series.	Rheumatol Adv Pract
32963155	Acute Hypertriglyceridaemia Caused by Tocilizumab in a Patient with Severe COVID-19.	Intern Med
32962703	Inflammatory phenotyping predicts clinical outcome in COVID-19.	Respir Res
32962623	The Role of Tocilizumab in Cytokine Storm and Improving Outcomes in COVID-19.	Recent Pat Antiinfect Drug Discov
32961333	Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy.	Clin Immunol
32958614	Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients.	Sci Transl Med
32957548	Complex Immunometabolic Profiling Reveals the Activation of Cellular Immunity and Biliary Lesions in Patients with Severe COVID-19.	J Clin Med
32956615	A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process.	Lancet Child Adolesc Health
32955926	Role of IL-6 in Severe Inflammation.	Am J Respir Crit Care Med
32955921	Is IL-6 the Right Target in COVID-19 Severe Pneumonia?	Am J Respir Crit Care Med
32954754	Xuebijing injection in the treatment of COVID-19: a retrospective case-control study.	Ann Palliat Med
32954492	The role of methylprednisolone on preventing disease progression for hospitalized patients with severe COVID-19.	Eur J Clin Invest
32953852	Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients.	World J Clin Cases
32952855	Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection.	World J Stem Cells
32950268	Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China.	Hum Immunol
32950258	[Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia].	Med Clin (Barc)
32950003	Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study.	EBioMedicine
32949577	Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients.	Exp Eye Res
32949308	Clinical characteristics of moderate and severe cases with COVID-19 in Wuhan, China: a retrospective study.	Clin Exp Med
32946851	The associations between fasting plasma glucose levels and mortality of COVID-19 in patients without diabetes.	Diabetes Res Clin Pract
32945158	Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.	J Biol Regul Homeost Agents
32943758	Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy.	Bone Marrow Transplant
32943497	Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19.	Sci Immunol
32943233	Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab.	Immunobiology
32941953	Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19.	Gene
32941741	Clinical evaluation of Shufeng Jiedu Capsules combined with umifenovir (Arbidol) in the treatment of common-type COVID-19: a retrospective study.	Expert Rev Respir Med
32940187	Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.	Rev Recent Clin Trials
32938545	AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm.	Cytokine Growth Factor Rev
32938496	Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.	Trials
32938231	Patients With Lung Cancer Have High Susceptibility of COVID-19: A Retrospective Study in Wuhan, China.	Cancer Control
32937615	High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.	JCI Insight
32935813	Laboratory findings in SARS-CoV-2 infections: State of the art.	Rev Assoc Med Bras (1992)
32934862	Cerium nitrate enhances anti-bacterial effects and imparts anti-inflammatory properties to silver dressings in a rat scald burn model.	Int J Burns Trauma
32933891	Interleukin-6 and severe COVID-19: a systematic review and meta-analysis.	Eur Cytokine Netw
32933031	Neutrophil Extracellular Traps and By-Products Play a Key Role in COVID-19: Pathogenesis, Risk Factors, and Therapy.	J Clin Med
32931985	Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review.	Semin Arthritis Rheum
32931637	Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany.	Cancer Med
32930458	Regulatory CD4(+) and CD8(+) T cells are negatively correlated with CD4(+) /CD8(+) T cell ratios in patients acutely infected with SARS-CoV-2.	J Leukoc Biol
32930456	Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex.	J Leukoc Biol
32928313	A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.	Trials
32926425	Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls.	J Cell Physiol
32924825	Computational insight of dexamethasone against potential targets of SARS-CoV-2.	J Biomol Struct Dyn
32922210	Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost?	Clin Mol Allergy
32921830	Rheumatological aspects of pathogenesis and treatment of COVID-19 infection.	Reumatologia
32921796	Obesity is a potential risk factor contributing to clinical manifestations of COVID-19.	Int J Obes (Lond)
32921216	COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.	Expert Rev Anti Infect Ther
32920514	The role of Interleukin 6 inhibitors in therapy of severe COVID-19.	Biomed Pharmacother
32920092	Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19.	J Allergy Clin Immunol
32919938	Macrophage responses associated with COVID-19: A pharmacological perspective.	Eur J Pharmacol
32918792	Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2.	Clin Transl Sci
32918755	Efficacy of tocilizumab in COVID-19: A systematic review and meta-analysis.	J Med Virol
32918573	Are Serum Interleukin 6 and Surfactant Protein D Levels Associated with the Clinical Course of COVID-19?	Lung
32916949	Can Nuclear Imaging of Activated Macrophages with Folic Acid-Based Radiotracers Serve as a Prognostic Means to Identify COVID-19 Patients at Risk?	Pharmaceuticals (Basel)
32915649	Potential mechanism underlying the effect of matrine on COVID-19 patients revealed through network pharmacological approaches and molecular docking analysis.	Arch Physiol Biochem
32914787	Il condizionatore va sanificato per non rischiare CoViD-19?	Recenti Prog Med
32912961	Observational study on off-label use of tocilizumab in patients with severe COVID-19.	Eur J Hosp Pharm
32912598	The landscape of cognitive function in recovered COVID-19 patients.	J Psychiatr Res
32912236	Duplex Shiny app quantification of the sepsis biomarkers C-reactive protein and interleukin-6 in a fast quantum dot labeled lateral flow assay.	J Nanobiotechnology
32909961	Clinical course and risk factors for recurrence of positive SARS-CoV-2 RNA: a retrospective cohort study from Wuhan, China.	Aging (Albany NY)
32908494	Immuno-Inflammatory Characteristics in Low Severity COVID-19 Patients with Digestive Symptoms.	Gastroenterol Res Pract
32907638	Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.	Trials
32905072	Impact of glycemic control in diabetes mellitus on management of COVID-19 infection.	Int J Diabetes Dev Ctries
32904892	Bone Metabolism in SARS-CoV-2 Disease: Possible Osteoimmunology and Gender Implications.	Clin Rev Bone Miner Metab
32903864	Preliminary Exploration of the Cause of Liver Disorders During Early Stages in COVID-19 Patients.	Front Med (Lausanne)
32903644	Clinical Characteristics and Risk Factors for Disease Severity and Death in Patients With Coronavirus Disease 2019 in Wuhan, China.	Front Med (Lausanne)
32903555	Immunomodulatory Drugs in the Management of SARS-CoV-2.	Front Immunol
32902413	Caring for patients in a new pandemic: the necessity and challenges of observational research.	J Clin Invest
32900588	Anti-inflammatory properties of antidiabetic drugs: A "promised land" in the COVID-19 era?	J Diabetes Complications
32896310	The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection.	J Allergy Clin Immunol
32895645	Tocilizumab for severe COVID-19 related illness - A community academic medical center experience.	Cytokine X
32895295	Correction: Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy.	J Immunother Cancer
32891904	Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients.	Thromb Res
32890967	Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19.	Biomed Pharmacother
32890937	Unexpected diagnosis of COVID-19-associated disorders by SARS-CoV-2-specific serology.	J Clin Virol
32890913	Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-kappaB) signaling pathway.	Phytomedicine
32889241	Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial.	Int Immunopharmacol
32888840	Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics.	J Formos Med Assoc
32887691	A living WHO guideline on drugs for covid-19	BMJ
32883943	Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD).	Med Sci Monit
32883328	The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial.	Trials
32883116	Future perspective: biologic agents in patients with severe COVID-19.	Immunopharmacol Immunotoxicol
32882666	SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients.	J Clin Virol
32882061	Hyperferritinemia in patients with COVID-19: An opportunity for iron chelation?	Artif Organs
32881340	The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID-19 Patients: A Retrospective Cohort Study.	Clin Transl Sci
32880774	Acute kidney injury in patients with SARS-CoV-2 infection.	Ann Intensive Care
32879102	Relation between blood glucose and the prognosis of severe coronavirus disease 2019.	Zhong Nan Da Xue Xue Bao Yi Xue Ban
32878912	Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.	J Immunol
32875578	Continuous EEG findings in patients with COVID-19 infection admitted to a New York academic hospital system.	Epilepsia
32873520	Systemic inflammation as fuel for acute liver injury in COVID-19.	Dig Liver Dis
32872439	What Protective Health Measures Are Americans Taking in Response to COVID-19? Results from the COVID Impact Survey.	Int J Environ Res Public Health
32871847	Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality.	In Vivo
32871183	Immunocytometric analysis of COVID patients: A contribution to personalized therapy?	Life Sci
32870351	Future perspective: high-throughput construction of new ultrasensitive cytokine and virion liquid chips for high-throughput screening (HTS) of anti-inflammatory drugs or clinical diagnosis and treatment of inflammatory diseases.	Anal Bioanal Chem
32868435	Correction for Cauchois et al., Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19.	Proc Natl Acad Sci U S A
32867310	The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury.	Int J Mol Sci
32866053	The effect of drugs used in rheumatology for treating SARS-CoV2 infection.	Expert Opin Biol Ther
32866033	Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome.	Am J Respir Crit Care Med
32864576	Posterior Reversible Encephalopathy Syndrome in COVID-19 Disease: a Case-Report.	SN Compr Clin Med
32864338	Coronavirus disease-2019 (COVID-19) infection in a 3-month-old infant: Clinical features, treatment and probable route of transmission.	IDCases
32863636	Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations.	Indian J Crit Care Med
32861275	Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study.	Lancet Respir Med
32860454	Clinical features and potential risk factors for discerning the critical cases and predicting the outcome of patients with COVID-19.	J Clin Lab Anal
32860431	Evaluation of 17 patients with COVID-19 pneumonia treated with anakinra according to HScore, SOFA, MuLBSTA, and Brescia-COVID respiratory severity scale (BCRSS) scoring systems.	J Med Virol
32860278	Associations between serum amyloid A, interleukin-6, and COVID-19: A cross-sectional study.	J Clin Lab Anal
32858231	Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.	Infect Genet Evol
32857671	Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine.	OMICS
32857620	Azithromycin Downregulates Gene Expression of IL-1beta and Pathways Involving TMPRSS2 and TMPRSS11D Required by SARS-CoV-2.	Am J Respir Cell Mol Biol
32856707	Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity.	Clin Infect Dis
32856282	Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6.	Clin Pharmacokinet
32854774	How to follow-up a patient who received tocilizumab in severe COVID-19: a case report.	Eur J Med Res
32854750	Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.	Crit Care
32850977	Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19.	Front Mol Biosci
32850926	Clinical Characteristics and Short-Term Outcomes of Severe Patients With COVID-19 in Wuhan, China.	Front Med (Lausanne)
32850082	COVID-19 infection and its deadly cytokine storm in a young obese adult.	J Community Hosp Intern Med Perspect
32849654	Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.	Front Immunol
32849309	Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity.	Front Endocrinol (Lausanne)
32848776	Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention.	Front Pharmacol
32847728	Systematic Review of COVID-19 Related Myocarditis: Insights on Management and Outcome.	Cardiovasc Revasc Med
32847594	The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.	J Transl Med
32847008	Biosensing Cytokine IL-6: A Comparative Analysis of Natural and Synthetic Receptors.	Biosensors (Basel)
32846644	Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19.	Environ Res
32846427	Sex differences in immune responses that underlie COVID-19 disease outcomes.	Nature
32846329	Drug repurposing of anti-infective clinical drugs: Discovery of two potential anti-cytokine storm agents.	Biomed Pharmacother
32845568	Interleukin-6 in Covid-19: A systematic review and meta-analysis.	Rev Med Virol
32844538	Alpha-1-antitrypsin: A possible host protective factor against Covid-19.	Rev Med Virol
32844290	Be aware of acute kidney injury in critically ill children with COVID-19.	Pediatr Nephrol
32843335	Amendment to 'Correction: Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19'.	J Immunother Cancer
32843231	High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients.	J Autoimmun
32841294	Chest CT findings related to mortality of patients with COVID-19: A retrospective case-series study.	PLoS One
32840387	Synthesis of N,N'-bis(1,5-dimethyl-2-phenyl-1,2-dihydro-3-oxopyrazol-4-yl) sebacamide that ameliorate osteoarthritis symptoms and improve bone marrow matrix structure and cartilage alterations induced by monoiodoacetate in the rat model: "Suggested potent anti-inflammatory agent against COVID-19".	Hum Exp Toxicol
32839624	An inflammatory cytokine signature predicts COVID-19 severity and survival.	Nat Med
32838367	COVID-19: A review of therapeutics under investigation.	J Am Coll Emerg Physicians Open
32838362	Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.	Med (N Y)
32838352	Validation of Predictors of Disease Severity and Outcomes in COVID-19 Patients: A Descriptive and Retrospective Study.	Med (N Y)
32838293	Hyperinflammation with COVID-19: The key to patient deterioration?	Clin Infect Pract
32838290	Dialysis, COVID-19, Poverty, and Race in Greater Chicago: An Ecological Analysis.	Kidney Med
32838235	Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up.	EClinicalMedicine
32838232	Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study.	EClinicalMedicine
32838231	Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort.	EClinicalMedicine
32838181	Effect of Rectal Ozone (O3) in Severe COVID-19 Pneumonia: Preliminary Results.	SN Compr Clin Med
32838168	The Central Role of Clinical Nutrition in COVID-19 Patients During and After Hospitalization in Intensive Care Unit.	SN Compr Clin Med
32838148	The Association of Cardiovascular Diseases and Diabetes Mellitus with COVID-19 (SARS-CoV-2) and Their Possible Mechanisms.	SN Compr Clin Med
32837741	Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes.	J Pharm Anal
32835245	Anakinra for severe forms of COVID-19: a cohort study.	Lancet Rheumatol
32834982	Awareness of COVID 19 pandemic among dental practioners of Telangana state, India: A cross sectional survey.	J Oral Biol Craniofac Res
32833687	SARS-CoV-2-specific T cell responses and correlations with COVID-19 patient predisposition.	J Clin Invest
32830894	Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study).	Clin Cardiol
32829962	The looming storm: Blood and cytokines in COVID-19.	Blood Rev
32828694	SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation.	Transfus Apher Sci
32827510	Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.	J Mol Cell Cardiol
32826331	IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.	Proc Natl Acad Sci U S A
32826326	Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort.	J Am Soc Nephrol
32824985	4,4'-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor.	Int J Mol Sci
32822911	A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases.	Cytokine
32822430	Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.	PLoS One
32819415	Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19.	Crit Care
32819292	Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19).	BMC Nephrol
32817460	Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS.	mSphere
32812012	Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection.	Nat Med
32811531	Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells.	Stem Cell Res Ther
32809969	Baricitinib restrains the immune dysregulation in patients with severe COVID-19.	J Clin Invest
32809918	Oxytocin's anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approach.	Physiol Genomics
32809207	Early detection of deep vein thrombosis in patients with coronavirus disease 2019: who to screen and who not to with Doppler ultrasound?	J Ultrasound
32808940	The therapeutic potential of colchicine in the complications of COVID19. Could the immunometabolic properties of an old and cheap drug help?	Metabol Open
32806657	COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions.	Microorganisms
32805781	Critical Illness Due to Covid-19: A Description of the Surge in a Single Center in Sioux Falls.	S D Med
32803479	COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties.	Inflammopharmacology
32803145	Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ involvement and affected subgroups in COVID-19.	Cardiovasc Endocrinol Metab
32801727	Spotlight on Tocilizumab in the Treatment of CAR-T-Cell-Induced Cytokine Release Syndrome: Clinical Evidence to Date.	Ther Clin Risk Manag
32799566	Emerging therapeutics for the management of COVID 19.	Expert Opin Emerg Drugs
32798339	Appraisal of Critically Ill COVID-19 Patients at a Dedicated COVID Hospital.	J Assoc Physicians India
32797724	The potential involvement of P2X7 receptor in COVID-19 pathogenesis: A new therapeutic target?	Scand J Immunol
32796043	COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience' by Khan et al, 'Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M et al' by Andreica et al and 'COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs' by Ansarin et al.	Ann Rheum Dis
32795898	Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported.	Int Immunopharmacol
32795834	IL-17A and TNF-alpha as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19.	Med Hypotheses
32794348	Mismatch between circulating cytokines and spontaneous cytokine production by leukocytes in hyperinflammatory COVID-19.	J Leukoc Biol
32794180	IL-18 and infections: Is there a role for targeted therapies?	J Cell Physiol
32792492	Clinical characteristics and corticosteroids application of different clinical types in patients with corona virus disease 2019.	Sci Rep
32790733	Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study.	PLoS One
32788884	Analysis of inflammatory parameters and disease severity for 88 hospitalized COVID-19 patients in Wuhan, China.	Int J Med Sci
32787748	Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the "Cytokine Release (Storm) Syndrome" Caused by SARS-CoV-2?	Curr Pharm Des
32786691	Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level.	J Proteome Res
32786309	Taste and Smell Disorders in COVID-19 Patients: Role of Interleukin-6.	ACS Chem Neurosci
32784217	Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy.	J Immunother Cancer
32783921	Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients.	Immunity
32782109	Clinical characteristics of confirmed and clinically diagnosed patients with 2019 novel coronavirus pneumonia: a single-center, retrospective, case-control study.	Med Clin (Barc)
32782031	La necessite des approches interdisciplinaires et collaboratives pour evaluer l'impact de la COVID-19 sur les personnes agees et le vieillissement: declaration conjointe de l'ACG / CAG et de la RCV / CJA.	Can J Aging
32780165	Increased mortality in patients with severe SARS-CoV-2 infection admitted within seven days of disease onset.	Intensive Care Med
32779813	Rugosic acid A, derived from Rosa rugosa Thunb., is novel inhibitory agent for NF-kappaB and IL-6/STAT3 axis in acute lung injury model.	Phytother Res
32779790	Obesity as a contributor to immunopathology in pregnant and non-pregnant adults with COVID-19.	Am J Reprod Immunol
32779755	Hydroxychloroquine treatment in COVID-19: A descriptive observational analysis of 30 cases from a single center in Wuhan, China.	J Med Virol
32779737	The absorbing filter Oxiris in severe coronavirus disease 2019 patients: A case series.	Artif Organs
32779280	Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study.	Dermatol Ther
32778962	Repurposing of Kinase Inhibitors for Treatment of COVID-19.	Pharm Res
32776551	Association between markers of immune response at hospital admission and COVID-19 disease severity and mortality: A meta-analysis and meta-regression.	J Med Virol
32774170	A gendered magnifying glass on COVID-19.	Clin Mol Allergy
32771053	Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients.	Crit Care
32769398	Shedding Light on COVID-19: ADAM17 the Missing Link?	Am J Ther
32768938	Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a.	Biomed Pharmacother
32767929	Theoretical Study of the Molecular Mechanism of Maxingyigan Decoction Against COVID-19: Network Pharmacology-based Strategy.	Comb Chem High Throughput Screen
32767348	Inhibitory effects of Vitamin D on inflammation and IL-6 release. A further support for COVID-19 management?	Eur Rev Med Pharmacol Sci
32766256	Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?	Front Cell Dev Biol
32766161	Prominent Hypercoagulability Associated With Inflammatory State Among Cancer Patients With SARS-CoV-2 Infection.	Front Oncol
32765942	Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in Elderly Patients.	Aging Dis
32765941	Bioactive Lipids as Mediators of the Beneficial Action(s) of Mesenchymal Stem Cells in COVID-19.	Aging Dis
32765283	Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19.	Front Pharmacol
32764665	Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm.	Nat Commun
32763356	Formation of lamellar body-like structure may be an initiator of didecyldimethylammonium chloride-induced toxic response.	Toxicol Appl Pharmacol
32762443	Endothelial Dysfunction and Thrombosis in Patients With COVID-19-Brief Report.	Arterioscler Thromb Vasc Biol
32761894	COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.	J Dtsch Dermatol Ges
32760206	Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels.	Int J Biol Sci
32760013	Anti-IL-6Rs falter in COVID-19.	Nat Rev Drug Discov
32759267	Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production.	Antimicrob Agents Chemother
32759007	Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease.	Med Hypotheses
32758889	Rethinking interleukin-6 blockade for treatment of COVID-19.	Med Hypotheses
32758871	COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease.	Med Hypotheses
32755466	Human Cardiac Mesenchymal Stem Cells Remodel in Disease and Can Regulate Arrhythmia Substrates.	Circ Arrhythm Electrophysiol
32754163	Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies.	Front Immunol
32754041	Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy.	Front Pharmacol
32754036	BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine?	Front Pharmacol
32752936	Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19.	J Biomol Struct Dyn
32752138	Tobacco, but Not Nicotine and Flavor-Less Electronic Cigarettes, Induces ACE2 and Immune Dysregulation.	Int J Mol Sci
32750259	COVID-19: Clean up on IL-6.	Am J Respir Cell Mol Biol
32746929	Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.	Eur J Med Res
32745348	Use of the IL-6R antagonist tocilizumab in hospitalized COVID-19 patients.	J Intern Med
32744241	SARS-CoV-2 infection in a psoriatic arthritis patient treated with IL-17 inhibitor.	Med Hypotheses
32744052	IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).	J Biol Regul Homeost Agents
32743793	COVID-19 and diabetes mellitus: how one pandemic worsens the other.	Rev Endocr Metab Disord
32743022	Targeting the cholinergic anti-inflammatory pathway with vagus nerve stimulation in patients with Covid-19?	Bioelectron Med
32742654	Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection.	Clin Transl Immunology
32737112	Targeting IL-6 in COVID-19. Response to: 'Rational use of tocilizumab in COVID-19' by Jain and Sharma.	Ann Rheum Dis
32737105	Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli.	Ann Rheum Dis
32736596	ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial.	Trials
32735885	The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.	Life Sci
32735768	Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2.	J Pharm Pharm Sci
32733921	High Inflammatory Burden: A Potential Cause of Myocardial Injury in Critically Ill Patients With COVID-19.	Front Cardiovasc Med
32733487	Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements.	Front Immunol
32731283	[COVID-19 in GP Practice and Emergency Rooms].	Dtsch Med Wochenschr
32731277	[COVID-19 from the Perspective of Haematology and Haemostaseology].	Dtsch Med Wochenschr
32730233	Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2.	J Clin Invest
32728733	No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic.	Rheumatology (Oxford)
32728438	Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019.	Clin Transl Immunology
32727811	SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.	J Immunother Cancer
32727465	Association between cytokine profiles and lung injury in COVID-19 pneumonia.	Respir Res
32727176	[Analysis of clinical characteristics of 49 cases of COVID-19].	Zhonghua Jie He He Hu Xi Za Zhi
32727107	Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab and NIV in a Patient with COVID-19 Pneumonia/ARDS.	Medicina (Kaunas)
32726724	Appropriate use of tocilizumab in COVID-19 infection.	Int J Infect Dis
32726007	[Study on therapeutic effect of Chaiyin Particles on combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome based on regulation of immune function].	Zhongguo Zhong Yao Za Zhi
32725927	The ACE2-deficient mouse: A model for a cytokine storm-driven inflammation.	FASEB J
32725596	Absent immune response to SARS-CoV-2 in a 3-month recurrence of coronavirus disease 2019 (COVID-19) case.	Infection
32723797	Comparative Genomic Analysis of Rapidly Evolving SARS-CoV-2 Reveals Mosaic Pattern of Phylogeographical Distribution.	mSystems
32723362	Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review.	Crit Care
32720702	The association of interleukin-6 value, interleukin inhibitors, and outcomes of patients with COVID-19 in New York City.	J Med Virol
32719810	Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19.	Front Mol Biosci
32719447	Covid-19 and the cardiovascular system: a comprehensive review.	J Hum Hypertens
32718670	Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infection.	Clin Investig Arterioscler
32718345	Inhibiting IL-6 in COVID-19: we are not sure.	Crit Care
32718086	Interleukin-6 in Rheumatoid Arthritis.	Int J Mol Sci
32717743	Longitudinal analyses reveal immunological misfiring in severe COVID-19.	Nature
32716553	Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19.	Allergy
32714336	Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19.	Front Immunol
32713784	Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review.	Pulmonology
32712122	Hyperglycemia is a strong predictor of poor prognosis in COVID-19.	Diabetes Res Clin Pract
32710975	IL-6-based mortality risk model for hospitalized patients with COVID-19.	J Allergy Clin Immunol
32710733	Impact of COVID-19 on Nephrology Patients: A Mechanistic Outlook for Pathogenesis of Acute Kidney Injury.	Altern Ther Health Med
32710255	Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis.	Curr Atheroscler Rep
32708750	The Spectrum of Clinical and Serological Features of COVID-19 in Urban Hemodialysis Patients.	J Clin Med
32706339	Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.	JCI Insight
32706089	Potential usefulness of pentoxifylline, a non-specific phosphodiesterase inhibitor with anti-inflammatory, anti-thrombotic, antioxidant, and anti-fibrogenic properties, in the treatment of SARS-CoV-2.	Eur Rev Med Pharmacol Sci
32706087	A systematic review on the efficacy and safety of IL-6 modulatory drugs in the treatment of COVID-19 patients.	Eur Rev Med Pharmacol Sci
32704455	Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide.	PeerJ
32702997	IL-6 (Interleukin 6) Blockade and Heart Rate Corrected QT Interval Prolongation in COVID-19.	Circ Arrhythm Electrophysiol
32702150	Kidney transplant recipients infected by COVID-19: Review of the initial published experience.	Transpl Infect Dis
32701511	Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.	J Clin Invest
32699972	Mild Cytokine Elevation, Moderate CD4(+) T Cell Response and Abundant Antibody Production in Children with COVID-19.	Virol Sin
32699149	Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19.	Proc Natl Acad Sci U S A
32699094	Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.	J Virol
32698147	Thyrotoxicosis in patients with COVID-19: the THYRCOV study.	Eur J Endocrinol
32697835	Potential Influence of Menstrual Status and Sex Hormones on Female Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Cross-sectional Multicenter Study in Wuhan, China.	Clin Infect Dis
32696108	Pharmaco-Immunomodulatory Therapy in COVID-19.	Drugs
32694244	The Combined Use of Tocilizumab and Hemoadsorption in a Patient with SARS-COV-2-19-Associated Pneumonia: A Case Report.	Nephron
32693241	Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.	Life Sci
32687484	Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.	JCI Insight
32685628	Haematological and immunological data of Chinese children infected with coronavirus disease 2019.	Data Brief
32685369	Early use of tocilizumab in respiratory failure associated with acute COVID -19 pneumonia in recipients with solid organ transplantation.	IDCases
32684080	COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.	Neuroscientist
32682575	Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.	Arch Med Res
32682440	Blocking IL-1 to prevent respiratory failure in COVID-19.	Crit Care
32682358	COVID-19 experience of the major pandemic response center in the capital: results of the pandemic's first month in Turkey	Turk J Med Sci
32681866	Factors related to mental health of inpatients with COVID-19 in Wuhan, China.	Brain Behav Immun
32681716	Why does COVID-19 kill more elderly men than women? Is there a role for testosterone?	Andrology
32681497	COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.	Immunol Res
32680957	SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production.	J Immunol
32679620	Biotin Functionalized Self-Assembled Peptide Nanofiber as an Adjuvant for Immunomodulatory Response.	Biotechnol J
32679148	The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics.	Life Sci
32677844	The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort.	Biomark Med
32676080	"Small" Intestinal Immunopathology Plays a "Big" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-gamma, IL-17A, and a Janus Kinase Inhibitor.	Front Immunol
32673773	The importance of IL-6 blockade beyond the COVID-19 pandemic: Consideration for cancer care.	Radiother Oncol
32672430	Predictors of Intensive Care Unit admission in patients with coronavirus disease 2019 (COVID-19).	Monaldi Arch Chest Dis
32671966	Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.	Rev Med Virol
32669467	Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.	mSphere
32668803	COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.	Int J Mol Sci
32663575	Tackling the cytokine storm in COVID-19, challenges and hopes.	Life Sci
32659373	Long-term infection of SARS-CoV-2 changed the body's immune status.	Clin Immunol
32659126	Pharmacotherapeutic considerations in solid organ transplant patients with COVID-19.	Expert Opin Pharmacother
32655741	First Reported Use of Highly Adsorptive Hemofilter in Critically Ill COVID-19 Patients in the USA.	J Clin Med Res
32655582	Targeting the NLRP3 Inflammasome in Severe COVID-19.	Front Immunol
32654514	Cardiac Arrest Risk During Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-Mediated Effects on Potassium Channel Expression.	Circ Arrhythm Electrophysiol
32654422	Use of tocilizumab in kidney transplant recipients with COVID-19.	Am J Transplant
32651997	Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19.	Clin Infect Dis
32651736	Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis.	Eur J Clin Microbiol Infect Dis
32651218	A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections.	J Immunol
32651212	Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.	Sci Immunol
32649367	Potential Immunotherapeutic Targets for Hypoxia Due to COVI-Flu.	Shock
32648313	Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection.	Rev Med Virol
32646930	Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1.	Cleve Clin J Med
32645391	Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU.	Clin Chim Acta
32645044	Clinical characteristics of 82 cases of death from COVID-19.	PLoS One
32644254	Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management.	J Med Virol
32642806	Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab.	Infection
32640747	Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications.	Int J Mol Sci
32640487	BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy.	J Leukoc Biol
32638109	Mild COVID-19 infection in an NMO patient treated with tocilizumab: a confirmation of anti-IL-6 protective role?	J Neurol
32637365	Participation of the IL-10RB Related Cytokines, IL-22 and IFN-lambda in Defense of the Airway Mucosal Barrier.	Front Cell Infect Microbiol
32636755	Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19.	Front Pharmacol
32636114	Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption.	Transfus Apher Sci
32635752	Role of inflammatory markers in corona virus disease (COVID-19) patients: A review.	Exp Biol Med (Maywood)
32635353	Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.	Trop Med Infect Dis
32635302	Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm.	J Clin Med
32633162	Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature.	Immunol Invest
32632359	Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention.	Toxicol Rep
32632085	Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.	Nat Commun
32628591	Elucidating the Pivotal Role of Immune Players in the Management of COVID-19: Focus on Mesenchymal Stem Cells and Inflammation.	Curr Stem Cell Res Ther
32628040	Comparison of Venous Thromboembolism Risks Between COVID-19 Pneumonia and Community-Acquired Pneumonia Patients.	Arterioscler Thromb Vasc Biol
32627226	Potential role of IL-17 blocking agents in the treatment of severe COVID-19?	Br J Clin Pharmacol
32626733	Effect of Thymoquinone on Acute Kidney Injury Induced by Sepsis in BALB/c Mice.	Biomed Res Int
32622796	Prevalence and predictive value of hypocalcemia in severe COVID-19 patients.	J Infect Public Health
32622469	Is Inhaled Furosemide a Potential Therapeutic for COVID-19?	Am J Med Sci
32622146	Reply to: "Do IL-17 inhibitors increase risk of respiratory tract infections?"	J Am Acad Dermatol
32621284	Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibration.	Int J Dermatol
32620597	Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study.	Ann Rheum Dis
32620513	Is pregnancy a risk factor of COVID-19?	Eur J Obstet Gynecol Reprod Biol
32620125	The timeline and risk factors of clinical progression of COVID-19 in Shenzhen, China.	J Transl Med
32617527	Whole Genome Analysis and Targeted Drug Discovery Using Computational Methods and High Throughput Screening Tools for Emerged Novel Coronavirus (2019-nCoV).	J Pharm Drug Res
32611761	Increased CSF levels of IL-1beta, IL-6, and ACE in SARS-CoV-2-associated encephalitis.	Neurol Neuroimmunol Neuroinflamm
32607928	Risk Factors for Mortality in Patients with COVID-19 in New York City.	J Gen Intern Med
32607684	The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation.	Virchows Arch
32605182	Pulmonary Toxicity and Inflammatory Response of E-Cigarette Vape Cartridges Containing Medium-Chain Triglycerides Oil and Vitamin E Acetate: Implications in the Pathogenesis of EVALI.	Toxics
32604223	Therapeutic Potential of B-1a Cells in COVID-19.	Shock
32603484	Matrix metalloproteinase 3 as a valuable marker for patients with COVID-19.	J Med Virol
32602128	Diarrhea and altered inflammatory cytokine pattern in severe coronavirus disease 2019: Impact on disease course and in-hospital mortality.	J Gastroenterol Hepatol
32596244	The Inhibitory Effect of Curcumin on Virus-Induced Cytokine Storm and Its Potential Use in the Associated Severe Pneumonia.	Front Cell Dev Biol
32594778	The cytokine storm of COVID-19: a spotlight on prevention and protection.	Expert Opin Ther Targets
32594204	The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 : Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?	Eur J Clin Pharmacol
32592406	Immune response in children with COVID-19 is characterized by lower levels of T-cell activation than infected adults.	Eur J Immunol
32591970	Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.	Rheumatol Int
32591408	Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.	Sci Immunol
32589760	Attenuated early inflammatory response in solid organ recipients with COVID-19.	Clin Transplant
32589755	Detection and analysis of clinical features of patients with different types of coronavirus disease 2019.	J Med Virol
32588367	A prospective clinical study of detailed neurological manifestations in patients with COVID-19.	Neurol Sci
32587806	A potential role for Galectin-3 inhibitors in the treatment of COVID-19.	PeerJ
32587367	Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients.	Cell Mol Immunol
32586396	CytoResc - "CytoSorb" Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trial.	Trials
32586394	Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.	Trials
32585765	A case of successful treatment of severe COVID-19 pneumonia with favipiravir and tocilizumab in post-kidney transplant recipient.	Transpl Infect Dis
32584597	Characterization of the Inflammatory Response to Severe COVID-19 Illness.	Am J Respir Crit Care Med
32584487	Multisystem inflammatory syndrome in children related to COVID-19: A New York City experience.	J Med Virol
32584451	COVID-19 infection on IL-23 inhibition.	Dermatol Ther
32584421	Combined IL-6 and JAK/STAT inhibition therapy in COVID-19-related sHLH, potential game changer.	Br J Haematol
32584199	Human and novel coronavirus infections in children: a review.	Paediatr Int Child Health
32583087	IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection.	Ann Hematol
32582743	Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis.	Front Med (Lausanne)
32581077	COVID-19 Hyperinflammation: What about Neutrophils?	mSphere
32581017	Morphoproteomics and Etiopathogenic Features of Pulmonary COVID-19 with Therapeutic Implications: A Case Study.	Ann Clin Lab Sci
32580895	Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19.	Trends Pharmacol Sci
32576347	[Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].	Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
32576346	[Value of neutrophil-to-lymphocyte ratio in the classification diagnosis of coronavirus disease 2019].	Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
32575124	Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia.	Clin Infect Dis
32574840	Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19.	J Allergy Clin Immunol Pract
32574694	Relationship between chest CT manifestations and immune response in COVID-19 patients.	Int J Infect Dis
32574285	Is SARS-CoV-2 Vertically Transmitted?	Front Pediatr
32574284	Clinical Characteristics of 5 COVID-19 Cases With Non-respiratory Symptoms as the First Manifestation in Children.	Front Pediatr
32574272	Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?	Front Immunol
32574268	Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs.	Front Immunol
32574262	Interferon-alpha2b Treatment for COVID-19.	Front Immunol
32574107	Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?	Emerg Microbes Infect
32573419	Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaboration.	Clin Exp Rheumatol
32571730	Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab.	Reumatol Clin (Engl Ed)
32570043	Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care.	J Clin Virol
32568969	Pharmacological development of the potential adjuvant therapeutic agents against coronavirus disease 2019.	J Chin Med Assoc
32568282	Emerging pharmacotherapy for COVID-19.	J R Coll Physicians Edinb
32565364	All Hands on Deck: A synchronized whole-of-world approach for COVID-19 mitigation.	Int J Infect Dis
32565226	Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study.	J Allergy Clin Immunol Pract
32563584	Successful Treatment of Severe COVID-19 Pneumonia With Clazakizumab in a Heart Transplant Recipient: A Case Report.	Transplant Proc
32563194	Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.	J Infect Dis
32562915	A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application.	Med Hypotheses
32562070	A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab.	Clin Rheumatol
32561873	COVID-19 revisiting inflammatory pathways of arthritis.	Nat Rev Rheumatol
32559180	COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status.	JCI Insight
32558946	Distinct infection process of SARS-CoV-2 in human bronchial epithelial cell lines.	J Med Virol
32558516	[Coronavirus disease (COVID-19) and sirtuins].	Rev Fac Cien Med Univ Nac Cordoba
32557541	A Comprehensive Review of Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome.	J Clin Pharmacol
32557214	Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks.	BioDrugs
32556649	Clinical course of a critically ill patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).	J Artif Organs
32554953	Can mesenchymal stem cell therapy be the interim management of COVID-19?	Drug Discov Ther
32553536	Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical Outcomes.	Chest
32550702	Early experience with COVID-19 in kidney transplantation recipients: update and review.	Int Braz J Urol
32547323	Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.	Int J Med Sci
32546188	The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection.	Crit Care
32546029	Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019.	Immunotherapy
32545518	Nrf2 Activator PB125((R)) as a Potential Therapeutic Agent against COVID-19.	Antioxidants (Basel)
32545412	COVID-19 Infection Diagnosis: Potential Impact of Isothermal Amplification Technology to Reduce Community Transmission of SARS-CoV-2.	Diagnostics (Basel)
32545268	Potential of Flavonoid-Inspired Phytomedicines against COVID-19.	Molecules
32544099	IL-6 and CD8+ T cell counts combined are an early predictor of in-hospital mortality of patients with COVID-19.	JCI Insight
32543756	Immune-related factors associated with pneumonia in 127 children with coronavirus disease 2019 in Wuhan.	Pediatr Pulmonol
32541972	[Risks factors for death among COVID-19 patients combined with hypertension, coronary heart disease or diabetes].	Beijing Da Xue Xue Bao Yi Xue Ban
32541245	Immune monitoring of a child with autoimmune hepatitis and type 1 diabetes during COVID-19 infection.	Eur J Gastroenterol Hepatol
32539627	Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications.	Ther Adv Respir Dis
32536965	Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking.	Chin Med
32536564	IL-15 immunotherapy is a viable strategy for COVID-19.	Cytokine Growth Factor Rev
32535732	IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?	Pharmaceut Med
32534467	Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.	J Leukoc Biol
32534337	Diacerein: A potential multi-target therapeutic drug for COVID-19.	Med Hypotheses
32534189	Macrolides and viral infections: focus on azithromycin in COVID-19 pathology.	Int J Antimicrob Agents
32533777	Clinical characteristics of COVID-19 in patients with preexisting ILD: A retrospective study in a single center in Wuhan, China.	J Med Virol
32532356	Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).	Trials
32528233	SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping.	J Inflamm (Lond)
32527341	[Analysis of the clinical characteristics and early warning model construction of severe/critical coronavirus disease 2019 patients].	Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
32527304	Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients.	Crit Care
32527257	Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19.	Cardiovasc Diabetol
32526511	A potential role for cyclophosphamide in the mitigation of acute respiratory distress syndrome among patients with SARS-CoV-2.	Med Hypotheses
32526372	Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests.	Travel Med Infect Dis
32525657	Proinflammatory Cytokines in the Olfactory Mucosa Result in COVID-19 Induced Anosmia.	ACS Chem Neurosci
32524611	Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.	Allergy
32523930	Effectiveness of Tocilizumab in a COVID-19 Patient with Cytokine Release Syndrome.	Eur J Case Rep Intern Med
32522278	Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis.	J Hematol Oncol
32522223	A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave?	J Exp Clin Cancer Res
32519921	COVID-19 in a severe eosinophilic asthmatic receiving benralizumab - a case study.	J Asthma
32519779	Circulating levels of IL-2, IL-4, TNF-alpha, IFN-gamma, and C-reactive protein are not associated with severity of COVID-19 symptoms.	J Med Virol
32519406	Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation.	Am J Transplant
32519164	Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19.	J Thromb Thrombolysis
32517353	Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients.	J Clin Med
32516772	SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features?	Urol Int
32515499	Higher levels of IL-6 early after tocilizumab distinguish survivors from nonsurvivors in COVID-19 pneumonia: A possible indication for deeper targeting of IL-6.	J Med Virol
32514047	Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).	Cell Death Differ
32513989	The inhibition of IL-2/IL-2R gives rise to CD8(+) T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia.	Cell Death Dis
32513859	Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2.	J Clin Microbiol
32513566	SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.	Cytokine Growth Factor Rev
32512263	COVID-19 in rheumatic disease patients on immunosuppressive agents.	Semin Arthritis Rheum
32511971	Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19.	Clin Chim Acta
32505910	Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1beta/neutrophil extracellular traps feedback loop.	Med Hypotheses
32505821	Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools.	Biomed Pharmacother
32504751	A novel role of nifuroxazide in attenuation of sepsis-associated acute lung and myocardial injuries; role of TLR4/NLPR3/IL-1beta signaling interruption.	Life Sci
32504360	SARS-CoV-2 infection in infants under 1 year of age in Wuhan City, China.	World J Pediatr
32503877	Inhibition of Bruton tyrosine kinase in patients with severe COVID-19.	Sci Immunol
32503382	Biomarkers associated with COVID-19 disease progression.	Crit Rev Clin Lab Sci
32501293	Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease.	JCI Insight
32500858	Serum Concentrations of Interleukin 6 in the General Adult Population: Possible Implications for Anti-IL-6 Therapy in SARS-Cov-2 Infection and IL-6-Related Diseases.	J Investig Allergol Clin Immunol
32497535	Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19.	Metabolism
32496710	Transmission secondaire de SARS-CoV-2 : pendant combien de temps un cas symptomatique peut-il transmettre le virus ?	Rev Med Suisse
32493441	Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.	Trials
32492562	The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.	Med Hypotheses
32489696	Whole-lung Low Dose Irradiation for SARS-Cov2 Induced Pneumonia in the Geriatric Population: An Old Effective Treatment for a New Disease? Recommendation of the International Geriatric Radiotherapy Group.	Aging Dis
32489023	[Therapeutic effect of Compound Qinlan Oral Liquid on treating combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome].	Zhongguo Zhong Yao Za Zhi
32489022	[Application of Reyanning Mixture in evaluating combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome].	Zhongguo Zhong Yao Za Zhi
32488505	Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children.	Ann Intensive Care
32487282	Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020.	Emerg Infect Dis
32485858	Javamide-II Inhibits IL-6 without Significant Impact on TNF-alpha and IL-1beta in Macrophage-Like Cells.	Biomedicines
32484930	Tocilizumab challenge: A series of cytokine storm therapy experiences in hospitalized COVID-19 pneumonia patients.	J Med Virol
32484453	Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients.	Aging (Albany NY)
32482597	Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study.	Eur J Intern Med
32482538	[Proposal for the use of anakinra in acute respiratory distress secondary to COVID-19].	Reumatol Clin (Engl Ed)
32482373	Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19.	Arch Med Res
32476380	SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines.	J Biol Regul Homeost Agents
32476261	Tocilizumab therapy in 5 solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2.	Am J Transplant
32475880	Prediction of the Severity of the Coronavirus Disease and Its Adverse Clinical Outcomes.	Jpn J Infect Dis
32475759	IL-6: Relevance for immunopathology of SARS-CoV-2.	Cytokine Growth Factor Rev
32475230	Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.	Emerg Microbes Infect
32474885	Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.	Clin Rheumatol
32473600	Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.	EMBO Mol Med
32472655	Cytokine storm in COVID-19 and parthenolide: Preclinical evidence.	Phytother Res
32471782	Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department.	Am J Emerg Med
32471001	COVID-19 in elderly kidney transplant recipients.	Am J Transplant
32470153	Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.	J Med Virol
32469225	COVID-19 and the immune system.	Physiol Res
32469137	A novel simple scoring model for predicting severity of patients with SARS-CoV-2 infection.	Transbound Emerg Dis
32468411	COVID-19 and Asthma: Reflection During the Pandemic.	Clin Rev Allergy Immunol
32463803	Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.	J Clin Invest
32463794	Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19.	Aging (Albany NY)
32462717	COVID-19: Consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients.	J Med Virol
32461554	Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial.	Int J Obes (Lond)
32460839	Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia.	Stem Cell Res Ther
32460357	Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China.	Immunology
32459524	Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes.	Am J Physiol Endocrinol Metab
32458536	Considerations for safety in the use of systemic medications for psoriasis and atopic dermatitis during the COVID-19 pandemic.	Dermatol Ther
32456948	Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19.	Nutr Metab Cardiovasc Dis
32452979	Pediatric Crohn Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated With Infliximab.	J Pediatr Gastroenterol Nutr
32452345	The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart.	Clin Exp Rheumatol
32451971	Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together?	J Endocrinol Invest
32450346	Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications.	Pharmacol Res
32448770	Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy.	Eur J Intern Med
32447665	Mit IL-6-Inhibitor gegen COVID-19 : Corona-Pandemie.	MMW Fortschr Med
32447102	Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients.	Diabetes Metab
32445956	Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19).	Pharmacol Res
32445955	Letter to the Editor in response to the article "Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?"	Pharmacol Res
32443442	Intensive Care Risk Estimation in COVID-19 Pneumonia Based on Clinical and Imaging Parameters: Experiences from the Munich Cohort.	J Clin Med
32441764	Repositioning PARP inhibitors for SARS-CoV-2 infection(COVID-19); a new multi-pronged therapy for acute respiratory distress syndrome?	Br J Pharmacol
32439209	Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience.	J Autoimmun
32437934	Use of anakinra in severe COVID-19: A case report.	Int J Infect Dis
32437740	The immunologic status of newborns born to SARS-CoV-2-infected mothers in Wuhan, China.	J Allergy Clin Immunol
32436994	Clinical outcomes in COVID-19 patients treated with tocilizumab: An individual patient data systematic review.	J Med Virol
32436460	TNFalpha inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis.	Ther Adv Respir Dis
32436355	Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients.	Andrology
32434788	COVID-19 and lung cancer: risks, mechanisms and treatment interactions.	J Immunother Cancer
32434211	Viral and host factors related to the clinical outcome of COVID-19.	Nature
32433216	Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus.	Shock
32432519	Does the compromised sleep and circadian disruption of night and shiftworkers make them highly vulnerable to 2019 coronavirus disease (COVID-19)?	Chronobiol Int
32430456	Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?	Diabetes Care
32428990	The role of interleukin-6 in monitoring severe case of coronavirus disease 2019.	EMBO Mol Med
32427582	Clinical and pathological investigation of patients with severe COVID-19.	JCI Insight
32426374	Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy.	Front Cardiovasc Med
32425950	Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).	Front Immunol
32425643	Association of inflammatory markers with the severity of COVID-19: A meta-analysis.	Int J Infect Dis
32425269	Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19.	J Allergy Clin Immunol
32425003	Clinical characteristics of 34 COVID-19 patients admitted to intensive care unit in Hangzhou, China.	J Zhejiang Univ Sci B
32422376	Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report.	Int J Infect Dis
32422320	p38 MAPK inhibition: A promising therapeutic approach for COVID-19.	J Mol Cell Cardiol
32422146	Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells.	J Allergy Clin Immunol
32421092	SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the 'culprit lesion' of ARDS onset? What is there besides Tocilizumab? SGP130Fc.	Cytokine X
32418885	Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens?	Metabolism
32418114	Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19.	Sci China Life Sci
32416070	Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.	Cell
32413619	beta-Glucan extracts from the same edible shiitake mushroom Lentinus edodes produce differential in-vitro immunomodulatory and pulmonary cytoprotective effects - Implications for coronavirus disease (COVID-19) immunotherapies.	Sci Total Environ
32412891	Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series.	J Wound Care
32411313	Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis.	Cell Host Microbe
32410772	Emerging pharmacotherapies for COVID-19.	Biomed Pharmacother
32409439	Practical aspects of targeting IL-6 in COVID-19 disease.	Cleve Clin J Med
32407836	Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China.	J Allergy Clin Immunol
32406606	Positive detection of SARS-CoV-2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a non-conjunctivitis COVID-19 patient with obstruction of common lacrimal duct.	Acta Ophthalmol
32406594	The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single-centre, retrospective, observational study in Wuhan.	Diabetes Obes Metab
32406037	COVID-19: is fibrosis the killer?	J Cell Commun Signal
32405877	A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?	Pulm Ther
32405160	Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia.	Eur J Intern Med
32404512	Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?	mSphere
32399455	Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome.	Eur J Case Rep Intern Med
32399213	Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence.	Clin Transl Immunology
32395418	An Update on Current Therapeutic Drugs Treating COVID-19.	Curr Pharmacol Rep
32391671	[Pregnant women complicated with COVID-19: a clinical analysis of 3 cases].	Zhejiang Da Xue Xue Bao Yi Xue Ban
32391669	[Clinical observation of 6 severe COVID-19 patients treated with plasma exchange or tocilizumab].	Zhejiang Da Xue Xue Bao Yi Xue Ban
32391668	[Dynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroids].	Zhejiang Da Xue Xue Bao Yi Xue Ban
32391242	A Precision Medicine Approach to SARS-CoV-2 Pandemic Management.	Curr Treat Options Allergy
32385523	IL-6 may be a good biomarker for earlier detection of COVID-19 progression.	Intensive Care Med
32385146	The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response.	J Immunother Cancer
32384798	Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19.	Antioxidants (Basel)
32384397	Children Hospitalized With Severe COVID-19 in Wuhan.	Pediatr Infect Dis J
32382823	HIV Care Continuum and COVID-19 Outcomes Among People Living with HIV During the COVID-19 Pandemic, Chicago, IL.	AIDS Behav
32380318	Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection.	Autoimmun Rev
32378647	Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?	Drug Discov Ther
32377375	Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.	Cell Discov
32376398	Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy.	Autoimmun Rev
32376394	Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review.	Autoimmun Rev
32376393	Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms.	Autoimmun Rev
32376392	Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions.	Autoimmun Rev
32374474	Natural antiviral compound silvestrol modulates human monocyte-derived macrophages and dendritic cells.	J Cell Mol Med
32373721	Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment.	Clin Transl Radiat Oncol
32367812	[First case of COVID-19 treated with tocilizumab in Iceland].	Laeknabladid
32365944	SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation.	Int J Mol Sci
32365221	Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.	Clin Exp Immunol
32364527	Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.	Aging (Albany NY)
32362061	Dupilumab and COVID-19: What should we expect?	Dermatol Ther
32361327	Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China.	J Clin Virol
32361250	Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.	EBioMedicine
32361193	Re: Patiently waiting for the results of anti-IL 6 therapy in severe COVID-19 infection.	Autoimmun Rev
32360580	Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-kappaB signaling pathway.	Pharmacol Res
32360516	The first case of COVID-19 treated with the complement C3 inhibitor AMY-101.	Clin Immunol
32360484	Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study.	Pharmacol Res
32360479	2019 Novel coronavirus disease (COVID-19) in hemodialysis patients: A report of two cases.	Clin Biochem
32359943	A cluster of health care workers with COVID-19 pneumonia caused by SARS-CoV-2.	J Microbiol Immunol Infect
32359035	Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19.	Clin Exp Rheumatol
32358791	SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor.	J Eur Acad Dermatol Venereol
32358580	COVID-19: a case for inhibiting IL-17?	Nat Rev Immunol
32357072	CLINICAL CHARACTERISTICS OF 28 PATIENTS WITH DIABETES AND COVID-19 IN WUHAN, CHINA.	Endocr Pract
32354634	A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia.	Kidney Int
32354030	Functional Role of Dietary Intervention to Improve the Outcome of COVID-19: A Hypothesis of Work.	Int J Mol Sci
32353742	Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19?	Med Hypotheses
32352535	COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.	Cardiovasc Res
32352361	Facing the SARS-CoV-2 (COVID-19) outbreak with IL-6R antagonists.	Eur J Rheumatol
32350134	Effective treatment of severe COVID-19 patients with tocilizumab.	Proc Natl Acad Sci U S A
32345630	Correction: Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.	J Immunother Cancer
32345579	Clinical characteristics and outcomes of patients with severe covid-19 with diabetes.	BMJ Open Diabetes Res Care
32344321	Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.	J Clin Virol
32344313	Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19?	Med Hypotheses
32344011	Mild versus severe COVID-19: Laboratory markers.	Int J Infect Dis
32343968	Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report.	Chest
32341519	Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia.	Lab Invest
32340978	The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta et al and 'Antirheumatic agents in covid-19: is IL-6 the right target?' by Capeechi et al.	Ann Rheum Dis
32340759	Possible Cause of Inflammatory Storm and Septic Shock in Patients Diagnosed with (COVID-19).	Arch Med Res
32339777	May IL-17 have a role in COVID-19 infection?	Med Hypotheses
32337664	Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia.	Clin Drug Investig
32337591	Early Risk Factors for the Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Positivity in Patients With Coronavirus Disease 2019.	Clin Infect Dis
32336586	Pharmacotherapy in COVID-19; A narrative review for emergency providers.	Am J Emerg Med
32334118	Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019.	Int J Infect Dis
32333818	COVID-19: lambda interferon against viral load and hyperinflammation.	EMBO Mol Med
32327746	Translating IL-6 biology into effective treatments.	Nat Rev Rheumatol
32325129	The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia.	J Infect
32325025	COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome.	Immunity
32324595	The laboratory tests and host immunity of COVID-19 patients with different severity of illness.	JCI Insight
32320677	Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.	Cell Host Microbe
32320156	<<Il faut sortir de la crise intelligemment et rapidement >>.	Rev Med Suisse
32317220	The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.	J Autoimmun
32315725	Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.	J Infect
32314492	Doxycycline, a widely used antibiotic in dermatology with a possible anti-inflammatory action against IL-6 in COVID-19 outbreak.	Dermatol Ther
32313848	Precision Medicine in COVID-19: IL-1beta a Potential Target.	JACC Basic Transl Sci
32308263	CoViD-19 Immunopathology and Immunotherapy.	Bioinformation
32307550	Downregulated Gene Expression Spectrum and Immune Responses Changed During the Disease Progression in Patients With COVID-19.	Clin Infect Dis
32305588	Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies.	Int J Antimicrob Agents
32302707	Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?	Pharmacol Res
32301997	Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.	Clin Infect Dis
32301311	Il est urgent d'aider les cabinets medicaux.	Rev Med Suisse
32300051	Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.	J Immunother Cancer
32299796	Antirheumatic agents in covid-19: is IL-6 the right target?	Ann Rheum Dis
32299202	COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs	Turk J Med Sci
32297995	High IL-6/IFN-gamma ratio could be associated with severe disease in COVID-19 patients.	J Med Virol
32297828	Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19.	Viral Immunol
32297671	Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients.	Br J Haematol
32294485	Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.	J Allergy Clin Immunol
32294258	SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor.	J Eur Acad Dermatol Venereol
32291137	Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?	J Autoimmun
32290839	Why tocilizumab could be an effective treatment for severe COVID-19?	J Transl Med
32286245	Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.	Clin Chem Lab Med
32282949	Hematological findings and complications of COVID-19.	Am J Hematol
32282502	Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19).	J Cardiovasc Pharmacol
32281329	[Study on treatment of "cytokine storm" by anti-2019-nCoV prescriptions based on arachidonic acid metabolic pathway].	Zhongguo Zhong Yao Za Zhi
32276453	Exploring the Relevance of Senotherapeutics for the Current SARS-CoV-2 Emergency and Similar Future Global Health Threats.	Cells
32271462	Inositol and pulmonary function. Could myo-inositol treatment downregulate inflammation and cytokine release syndrome in SARS-CoV-2?	Eur Rev Med Pharmacol Sci
32267072	Intravenous Anakinra for Macrophage Activation Syndrome May Hold Lessons for Treatment of Cytokine Storm in the Setting of Coronavirus Disease 2019.	ACR Open Rheumatol
32259129	Metronidazole; a Potential Novel Addition to the COVID-19 Treatment Regimen.	Arch Acad Emerg Med
32257537	Transplantation of ACE2(-) Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia.	Aging Dis
32256705	Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence.	Ecancermedicalscience
32253888	Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.	J Biol Regul Homeost Agents
32253759	Tocilizumab treatment in COVID-19: A single center experience.	J Med Virol
32253400	Flavonoids isolated from loquat (Eriobotrya japonica) leaves inhibit oxidative stress and inflammation induced by cigarette smoke in COPD mice: the role of TRPV1 signaling pathways.	Food Funct
32253068	Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy.	J Autoimmun
32251717	The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.	Autoimmun Rev
32247642	Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report.	Ann Oncol
32234467	Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.	Int J Antimicrob Agents
32233018	Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics.	Diabetes Metab Res Rev
32233013	Diabetes is a risk factor for the progression and prognosis of COVID-19.	Diabetes Metab Res Rev
32229706	COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?	Aging (Albany NY)
32228827	[Exploration of omics mechanism and drug prediction of coronavirus-induced heart failure based on clinical bioinformatics].	Zhonghua Xin Xue Guan Bing Za Zhi
32228825	How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.	J Biol Regul Homeost Agents
32228222	Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension.	Emerg Microbes Infect
32227274	The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients.	Inflamm Res
32222466	The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.	Clin Immunol
32217835	Clinical and immunological features of severe and moderate coronavirus disease 2019.	J Clin Invest
32217834	SARS-CoV-2: a storm is raging.	J Clin Invest
32205232	Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).	Pharmacol Res
32193831	Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study.	World J Pediatr
32181911	Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.	J Med Virol
32176772	Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China.	Clin Infect Dis
32171193	Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies.	J Biol Regul Homeost Agents
32164089	[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].	Zhonghua Jie He He Hu Xi Za Zhi
32026671	[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].	Zhonghua Jie He He Hu Xi Za Zhi
32013309	Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy.	J Biol Regul Homeost Agents
